Entry,Reviewed,Entry Name,Protein names,Gene Names,Organism,Length,Gene Ontology (biological process),Gene Ontology (cellular component),Gene Ontology (GO),Gene Ontology (molecular function),Gene Ontology IDs,Lipidation
A2A259,reviewed,PK2L1_MOUSE,Polycystin-2-like protein 1 (Polycystin-2L1) (Polycystic kidney disease 2-like 1 protein) (Polycystin-2 homolog),Pkd2l1 Trpp3,Mus musculus (Mouse),760,cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transport [GO:0006812]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725],actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]; cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transport [GO:0006812]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725],alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272],GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0008092; GO:0009415; GO:0015269; GO:0015629; GO:0016020; GO:0031410; GO:0034703; GO:0034704; GO:0035725; GO:0042802; GO:0043231; GO:0043235; GO:0050912; GO:0050915; GO:0050982; GO:0051262; GO:0051289; GO:0051371; GO:0051393; GO:0060170; GO:0071467; GO:0071468; GO:0071805; GO:0097730; GO:0098662,"LIPID 38; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9P0L9"""
B2RSH2,reviewed,GNAI1_MOUSE,Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein),Gnai1 Gnai-1,Mus musculus (Mouse),354,adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236],cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236],G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287],GO:0000287; GO:0001664; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005834; GO:0005886; GO:0005938; GO:0007049; GO:0007186; GO:0007188; GO:0016020; GO:0019003; GO:0030496; GO:0031683; GO:0031821; GO:0032794; GO:0032991; GO:0043949; GO:0045121; GO:0050805; GO:0051301; GO:0060236; GO:0099738; GO:1904322; GO:1904778,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:P63096""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P10824"""
B9EHT4,reviewed,CLIP3_MOUSE,CAP-Gly domain-containing linker protein 3 (Cytoplasmic linker protein 170-related 59 kDa protein) (CLIP-170-related 59 kDa protein) (CLIPR-59),Clip3 Clipr59,Mus musculus (Mouse),547,cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein transport along microtubule [GO:0098840],cell cortex [GO:0005938]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],cell cortex [GO:0005938]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein transport along microtubule [GO:0098840],ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010],GO:0001934; GO:0005634; GO:0005795; GO:0005802; GO:0005886; GO:0005938; GO:0008017; GO:0010828; GO:0018230; GO:0031115; GO:0031122; GO:0031901; GO:0032588; GO:0035371; GO:0035594; GO:0043065; GO:0044091; GO:0045121; GO:0045444; GO:0045807; GO:0051010; GO:0055038; GO:0098840; GO:1903078,"LIPID 534; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 535; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
D3YVF0,reviewed,AKAP5_MOUSE,A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein),Akap5 Akap150,Mus musculus (Mouse),745,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; clustering of voltage-gated calcium channels [GO:0070073]; clustering of voltage-gated potassium channels [GO:0045163]; establishment of localization in cell [GO:0051649]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of monoatomic ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; postsynaptic neurotransmitter receptor cycle [GO:0099630]; protein-containing complex disassembly [GO:0032984]; receptor clustering [GO:0043113]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; synapse assembly [GO:0007416],"asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic recycling endosome [GO:0098837]; protein serine/threonine phosphatase complex [GO:0008287]","asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic recycling endosome [GO:0098837]; protein serine/threonine phosphatase complex [GO:0008287]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; clustering of voltage-gated calcium channels [GO:0070073]; clustering of voltage-gated potassium channels [GO:0045163]; establishment of localization in cell [GO:0051649]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of monoatomic ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; postsynaptic neurotransmitter receptor cycle [GO:0099630]; protein-containing complex disassembly [GO:0032984]; receptor clustering [GO:0043113]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; synapse assembly [GO:0007416]",actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124],GO:0001664; GO:0001934; GO:0003779; GO:0005516; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007193; GO:0007194; GO:0007416; GO:0008179; GO:0008287; GO:0009898; GO:0010524; GO:0010738; GO:0014069; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032984; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043113; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0044877; GO:0045121; GO:0045163; GO:0045296; GO:0045762; GO:0048471; GO:0050775; GO:0050811; GO:0051649; GO:0060076; GO:0060090; GO:0070073; GO:0070886; GO:0097110; GO:0098837; GO:0098978; GO:0099092; GO:0099149; GO:0099630; GO:1900273; GO:1901387; GO:1903078; GO:1905665; GO:1905751,"LIPID 36; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 123; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O08530,reviewed,S1PR1_MOUSE,Sphingosine 1-phosphate receptor 1 (S1P receptor 1) (S1P1) (Endothelial differentiation G-protein coupled receptor 1) (Lysophospholipid receptor B1) (Sphingosine 1-phosphate receptor Edg-1) (S1P receptor Edg-1) (CD antigen CD363),S1pr1 Edg1 Lpb1,Mus musculus (Mouse),382,actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; chemotaxis [GO:0006935]; endothelial cell differentiation [GO:0045446]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; negative regulation of stress fiber assembly [GO:0051497]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678]; transmission of nerve impulse [GO:0019226],caveola [GO:0005901]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],caveola [GO:0005901]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; sphingolipid binding [GO:0046625]; sphingosine-1-phosphate receptor activity [GO:0038036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; chemotaxis [GO:0006935]; endothelial cell differentiation [GO:0045446]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; negative regulation of stress fiber assembly [GO:0051497]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678]; transmission of nerve impulse [GO:0019226],G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; sphingolipid binding [GO:0046625]; sphingosine-1-phosphate receptor activity [GO:0038036],GO:0001525; GO:0001664; GO:0001955; GO:0003245; GO:0003376; GO:0004930; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0006935; GO:0007186; GO:0007193; GO:0007420; GO:0008283; GO:0008284; GO:0009897; GO:0016477; GO:0019226; GO:0030032; GO:0030155; GO:0030182; GO:0030335; GO:0030500; GO:0030595; GO:0031532; GO:0038036; GO:0043231; GO:0043547; GO:0045124; GO:0045446; GO:0045944; GO:0046625; GO:0048661; GO:0050927; GO:0051482; GO:0051497; GO:0061384; GO:0072678,"LIPID 328; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O08738,reviewed,CASP6_MOUSE,Caspase-6 (CASP-6) (EC 3.4.22.59) (Apoptotic protease Mch-2) [Cleaved into: Caspase-6 subunit p18; Caspase-6 subunit p11],Casp6 Mch2,Mus musculus (Mouse),276,activation of cysteine-type endopeptidase activity [GO:0097202]; activation of innate immune response [GO:0002218]; acute inflammatory response to non-antigenic stimulus [GO:0002525]; axonal fasciculation [GO:0007413]; cellular response to staurosporine [GO:0072734]; epithelial cell differentiation [GO:0030855]; hepatocyte apoptotic process [GO:0097284]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of retinal cell programmed cell death [GO:0046670]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; pyroptosis [GO:0070269]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of programmed cell death [GO:0043067]; response to cytokine [GO:0034097]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039],axon [GO:0030424]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],axon [GO:0030424]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of innate immune response [GO:0002218]; acute inflammatory response to non-antigenic stimulus [GO:0002525]; axonal fasciculation [GO:0007413]; cellular response to staurosporine [GO:0072734]; epithelial cell differentiation [GO:0030855]; hepatocyte apoptotic process [GO:0097284]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of retinal cell programmed cell death [GO:0046670]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; pyroptosis [GO:0070269]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of programmed cell death [GO:0043067]; response to cytokine [GO:0034097]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039],cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677],GO:0002218; GO:0002525; GO:0004175; GO:0004197; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0007413; GO:0008303; GO:0009749; GO:0010039; GO:0016540; GO:0030424; GO:0030855; GO:0034097; GO:0042542; GO:0042802; GO:0043025; GO:0043065; GO:0043067; GO:0043525; GO:0046670; GO:0060545; GO:0070269; GO:0072332; GO:0072734; GO:0097153; GO:0097200; GO:0097202; GO:0097284; GO:0140677; GO:1901028,"LIPID 246; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P55212""; LIPID 259; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P55212"""
O08786,reviewed,CCKAR_MOUSE,Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R),Cckar,Mus musculus (Mouse),436,actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cellular response to hormone stimulus [GO:0032870]; cholecystokinin signaling pathway [GO:0038188]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric acid secretion [GO:0001696]; insulin secretion [GO:0030073]; neuron migration [GO:0001764]; pancreatic juice secretion [GO:0030157]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of somatostatin secretion [GO:0090274]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of calcium ion transport [GO:0051924]; regulation of hormone secretion [GO:0046883]; regulation of potassium ion transport [GO:0043266]; response to heat [GO:0009408]; response to starvation [GO:0042594]; temperature homeostasis [GO:0001659],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; cholecystokinin receptor activity [GO:0004951]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cellular response to hormone stimulus [GO:0032870]; cholecystokinin signaling pathway [GO:0038188]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric acid secretion [GO:0001696]; insulin secretion [GO:0030073]; neuron migration [GO:0001764]; pancreatic juice secretion [GO:0030157]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of somatostatin secretion [GO:0090274]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of calcium ion transport [GO:0051924]; regulation of hormone secretion [GO:0046883]; regulation of potassium ion transport [GO:0043266]; response to heat [GO:0009408]; response to starvation [GO:0042594]; temperature homeostasis [GO:0001659],cholecystokinin receptor activity [GO:0004951]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046],GO:0001659; GO:0001696; GO:0001764; GO:0002023; GO:0004951; GO:0005654; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005829; GO:0005886; GO:0007186; GO:0007204; GO:0007409; GO:0007631; GO:0009408; GO:0016020; GO:0017046; GO:0030073; GO:0030157; GO:0030900; GO:0031532; GO:0032870; GO:0038188; GO:0042277; GO:0042594; GO:0042755; GO:0043195; GO:0043266; GO:0046883; GO:0051924; GO:0090274,"LIPID 395; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O08858,reviewed,SSR5_MOUSE,Somatostatin receptor type 5 (SS-5-R) (SS5-R) (SS5R),Sstr5 Smstr5,Mus musculus (Mouse),362,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to glucocorticoid stimulus [GO:0071385]; glucose homeostasis [GO:0042593]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]; regulation of insulin secretion [GO:0050796],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; somatostatin receptor activity [GO:0004994]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to glucocorticoid stimulus [GO:0071385]; glucose homeostasis [GO:0042593]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]; regulation of insulin secretion [GO:0050796],somatostatin receptor activity [GO:0004994],GO:0004994; GO:0005737; GO:0005886; GO:0007193; GO:0007218; GO:0032467; GO:0042593; GO:0043005; GO:0050796; GO:0071385,"LIPID 319; /note=""S-palmitoyl cysteine; by ZDHHC5""; /evidence=""ECO:0000269|PubMed:21820437"""
O09044,reviewed,SNP23_MOUSE,Synaptosomal-associated protein 23 (SNAP-23) (Syndet) (Vesicle-membrane fusion protein SNAP-23),Snap23 Sndt,Mus musculus (Mouse),210,exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; exocytosis [GO:0006887]; histamine secretion by mast cell [GO:0002553]; membrane fusion [GO:0061025]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exocytosis [GO:0017157]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003],adherens junction [GO:0005912]; azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032],adherens junction [GO:0005912]; azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; exocytosis [GO:0006887]; histamine secretion by mast cell [GO:0002553]; membrane fusion [GO:0061025]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exocytosis [GO:0017157]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003],SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075],GO:0002553; GO:0005484; GO:0005654; GO:0005737; GO:0005739; GO:0005886; GO:0005912; GO:0006887; GO:0015031; GO:0016082; GO:0016192; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0031410; GO:0031629; GO:0042581; GO:0042582; GO:0043005; GO:0061025; GO:0065003; GO:0070032; GO:0098793; GO:0098794; GO:0098967; GO:0098978; GO:0098982; GO:0099003,"LIPID 79; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 80; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 83; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 85; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 87; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O54799,reviewed,NMBR_MOUSE,Neuromedin-B receptor (NMB-R) (Neuromedin-B-preferring bombesin receptor),Nmbr,Mus musculus (Mouse),390,antiviral innate immune response [GO:0140374]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of interleukin-6 production [GO:0032715]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of respiratory gaseous exchange [GO:1903942]; sneeze reflex [GO:0160023],cytosol [GO:0005829]; plasma membrane [GO:0005886],cytosol [GO:0005829]; plasma membrane [GO:0005886]; bombesin receptor activity [GO:0004946]; neuropeptide receptor activity [GO:0008188]; antiviral innate immune response [GO:0140374]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of interleukin-6 production [GO:0032715]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of respiratory gaseous exchange [GO:1903942]; sneeze reflex [GO:0160023],bombesin receptor activity [GO:0004946]; neuropeptide receptor activity [GO:0008188],GO:0004946; GO:0005829; GO:0005886; GO:0007186; GO:0008188; GO:0032715; GO:0032727; GO:0090290; GO:0140374; GO:0160023; GO:1903942,"LIPID 341; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21917"""
O54957,reviewed,LAT_MOUSE,Linker for activation of T-cells family member 1 (36 kDa phospho-tyrosine adapter protein) (pp36) (p36-38),Lat,Mus musculus (Mouse),242,adaptive immune response [GO:0002250]; calcium-mediated signaling [GO:0019722]; cellular defense response [GO:0006968]; gene expression [GO:0010467]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lymphocyte homeostasis [GO:0002260]; mast cell degranulation [GO:0043303]; positive regulation of protein kinase activity [GO:0045860]; Ras protein signal transduction [GO:0007265]; regulation of T cell activation [GO:0050863]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; membrane [GO:0016020]; plasma membrane [GO:0005886],cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159]; adaptive immune response [GO:0002250]; calcium-mediated signaling [GO:0019722]; cellular defense response [GO:0006968]; gene expression [GO:0010467]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lymphocyte homeostasis [GO:0002260]; mast cell degranulation [GO:0043303]; positive regulation of protein kinase activity [GO:0045860]; Ras protein signal transduction [GO:0007265]; regulation of T cell activation [GO:0050863]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159],GO:0001772; GO:0002250; GO:0002260; GO:0005794; GO:0005886; GO:0005911; GO:0006954; GO:0006955; GO:0006968; GO:0007169; GO:0007229; GO:0007265; GO:0008180; GO:0010467; GO:0016020; GO:0019722; GO:0019901; GO:0030159; GO:0035556; GO:0043303; GO:0045860; GO:0048872; GO:0050852; GO:0050863,"LIPID 27; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19592663""; LIPID 30; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19592663"""
O55013,reviewed,TPPC3_MOUSE,Trafficking protein particle complex subunit 3 (BET3 homolog),Trappc3 Bet3,Mus musculus (Mouse),180,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022],cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072],cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022],,GO:0000139; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0033106; GO:0048208; GO:0099022; GO:1990071; GO:1990072,"LIPID 68; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:15608655"""
O55074,reviewed,AKA7A_MOUSE,A-kinase anchor protein 7 isoform alpha (AKAP-7 isoform alpha) (A-kinase anchor protein 18) (AKAP-18) (A-kinase anchor protein 9 kDa) (AKAP 9) (Protein kinase A-anchoring protein 7 isoform alpha) (PRKA7 isoform alpha),Akap7 Akap18,Mus musculus (Mouse),81,cellular response to cAMP [GO:0071320]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of potassium ion transmembrane transport [GO:1901381]; protein localization [GO:0008104]; regulation of membrane repolarization [GO:0060306]; regulation of protein kinase A signaling [GO:0010738]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178],apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315],apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]; AMP binding [GO:0016208]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; cellular response to cAMP [GO:0071320]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of potassium ion transmembrane transport [GO:1901381]; protein localization [GO:0008104]; regulation of membrane repolarization [GO:0060306]; regulation of protein kinase A signaling [GO:0010738]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178],AMP binding [GO:0016208]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901],GO:0005634; GO:0005829; GO:0007178; GO:0008104; GO:0010738; GO:0016020; GO:0016208; GO:0016324; GO:0016328; GO:0016529; GO:0019901; GO:0019904; GO:0030315; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0060306; GO:0070382; GO:0071320; GO:0098686; GO:1901381; GO:1902261,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000269|PubMed:9545239""; LIPID 5; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:9545239""; LIPID 6; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:9545239"""
O70166,reviewed,STMN3_MOUSE,Stathmin-3 (Hippocampus abundant transcript 3) (SCG10-like protein) (SCG10-related protein HiAT3),Stmn3 Sclip,Mus musculus (Mouse),180,blastocyst hatching [GO:0001835]; cytoplasmic microtubule organization [GO:0031122]; microtubule depolymerization [GO:0007019]; negative regulation of Rac protein signal transduction [GO:0035021]; neuron projection development [GO:0031175]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of microtubule polymerization or depolymerization [GO:0031110],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; protein domain specific binding [GO:0019904]; protein-folding chaperone binding [GO:0051087]; tubulin binding [GO:0015631]; blastocyst hatching [GO:0001835]; cytoplasmic microtubule organization [GO:0031122]; microtubule depolymerization [GO:0007019]; negative regulation of Rac protein signal transduction [GO:0035021]; neuron projection development [GO:0031175]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of microtubule polymerization or depolymerization [GO:0031110],protein domain specific binding [GO:0019904]; protein-folding chaperone binding [GO:0051087]; tubulin binding [GO:0015631],GO:0001835; GO:0005737; GO:0005794; GO:0005829; GO:0007019; GO:0015631; GO:0019904; GO:0030426; GO:0031110; GO:0031122; GO:0031175; GO:0035021; GO:0043005; GO:0043087; GO:0048471; GO:0051087; GO:0051493,"LIPID 22; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 24; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O70174,reviewed,ACHA4_MOUSE,Neuronal acetylcholine receptor subunit alpha-4,Chrna4 Acra4,Mus musculus (Mouse),629,"acetylcholine receptor signaling pathway [GO:0095500]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; exploration behavior [GO:0035640]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine-gated cation channel activity [GO:1903048]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202],"acetylcholine-gated channel complex [GO:0005892]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; monoatomic ion channel activity [GO:0005216]; protein-containing complex binding [GO:0044877]; quaternary ammonium group binding [GO:0050997]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; exploration behavior [GO:0035640]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine-gated cation channel activity [GO:1903048]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; monoatomic ion channel activity [GO:0005216]; protein-containing complex binding [GO:0044877]; quaternary ammonium group binding [GO:0050997]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0001666; GO:0005216; GO:0005886; GO:0005892; GO:0006281; GO:0006816; GO:0006979; GO:0007165; GO:0007268; GO:0007271; GO:0007585; GO:0007626; GO:0009897; GO:0014059; GO:0015464; GO:0016020; GO:0019228; GO:0019233; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0035094; GO:0035095; GO:0035640; GO:0042113; GO:0042166; GO:0042391; GO:0042734; GO:0043025; GO:0044877; GO:0045202; GO:0050877; GO:0050890; GO:0050997; GO:0051899; GO:0060080; GO:0095500; GO:0098691; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1903048; GO:1904315; GO:1905144,"LIPID 273; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O70293,reviewed,GRK6_MOUSE,G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6),Grk6 Gprk6,Mus musculus (Mouse),576,desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; negative regulation of anion channel activity [GO:0010360]; protein phosphorylation [GO:0006468]; regulation of signal transduction [GO:0009966]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; negative regulation of anion channel activity [GO:0010360]; protein phosphorylation [GO:0006468]; regulation of signal transduction [GO:0009966]; Wnt signaling pathway [GO:0016055],ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703],GO:0002029; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0009966; GO:0010360; GO:0016055; GO:0047696,"LIPID 561; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 562; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 565; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O70342,reviewed,NPY5R_MOUSE,Neuropeptide Y receptor type 5 (NPY5-R) (NPY-Y5 receptor) (NPYY5-R) (Y5 receptor),Npy5r Npy5,Mus musculus (Mouse),466,"aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of ovulation cycle rhythm [GO:0060112]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; outflow tract morphogenesis [GO:0003151]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of smooth muscle cell proliferation [GO:0048661]; synaptic signaling via neuropeptide [GO:0099538]",cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793],"cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; neuropeptide binding [GO:0042923]; neuropeptide Y receptor activity [GO:0004983]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601]; aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of ovulation cycle rhythm [GO:0060112]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; outflow tract morphogenesis [GO:0003151]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of smooth muscle cell proliferation [GO:0048661]; synaptic signaling via neuropeptide [GO:0099538]",neuropeptide binding [GO:0042923]; neuropeptide Y receptor activity [GO:0004983]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601],GO:0001601; GO:0001602; GO:0002675; GO:0002865; GO:0003151; GO:0003214; GO:0004983; GO:0005737; GO:0005886; GO:0007186; GO:0007268; GO:0007568; GO:0008284; GO:0014050; GO:0016020; GO:0032229; GO:0042755; GO:0042923; GO:0043005; GO:0043066; GO:0048661; GO:0060112; GO:0070374; GO:0098793; GO:0098982; GO:0099538,"LIPID 462; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
O70443,reviewed,GNAZ_MOUSE,Guanine nucleotide-binding protein G(z) subunit alpha (G(x) alpha chain) (Gz-alpha),Gnaz,Mus musculus (Mouse),355,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled serotonin receptor signaling pathway [GO:0098664]; negative regulation of insulin secretion [GO:0046676],cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; plasma membrane [GO:0005886],cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled serotonin receptor signaling pathway [GO:0098664]; negative regulation of insulin secretion [GO:0046676],adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0001664; GO:0003924; GO:0005525; GO:0005829; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007193; GO:0010855; GO:0016020; GO:0030425; GO:0031683; GO:0031821; GO:0044297; GO:0046676; GO:0046872; GO:0098664,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O88319,reviewed,NTR1_MOUSE,Neurotensin receptor type 1 (NT-R-1) (NTR1),Ntsr1 Ntsr,Mus musculus (Mouse),424,adult locomotory behavior [GO:0008344]; D-aspartate import across plasma membrane [GO:0070779]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inositol phosphate catabolic process [GO:0071545]; L-glutamate import across plasma membrane [GO:0098712]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of apoptotic process [GO:0043065]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of action potential [GO:0098900]; regulation of membrane depolarization [GO:0003254]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of sensory perception of pain [GO:0051930]; response to lipid [GO:0033993]; temperature homeostasis [GO:0001659],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; synapse [GO:0045202]; terminal bouton [GO:0043195],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; synapse [GO:0045202]; terminal bouton [GO:0043195]; G protein-coupled neurotensin receptor activity [GO:0016492]; identical protein binding [GO:0042802]; neuropeptide receptor activity [GO:0008188]; protein-containing complex binding [GO:0044877]; adult locomotory behavior [GO:0008344]; D-aspartate import across plasma membrane [GO:0070779]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inositol phosphate catabolic process [GO:0071545]; L-glutamate import across plasma membrane [GO:0098712]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of apoptotic process [GO:0043065]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of action potential [GO:0098900]; regulation of membrane depolarization [GO:0003254]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of sensory perception of pain [GO:0051930]; response to lipid [GO:0033993]; temperature homeostasis [GO:0001659],G protein-coupled neurotensin receptor activity [GO:0016492]; identical protein binding [GO:0042802]; neuropeptide receptor activity [GO:0008188]; protein-containing complex binding [GO:0044877],GO:0001659; GO:0003085; GO:0003254; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005886; GO:0007218; GO:0007612; GO:0008188; GO:0008344; GO:0009898; GO:0009986; GO:0010628; GO:0014049; GO:0014054; GO:0016492; GO:0030424; GO:0030425; GO:0032280; GO:0033993; GO:0042802; GO:0043025; GO:0043065; GO:0043066; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0043576; GO:0043679; GO:0044309; GO:0044877; GO:0045121; GO:0045202; GO:0050965; GO:0051092; GO:0051280; GO:0051281; GO:0051930; GO:0060732; GO:0070779; GO:0071545; GO:0090238; GO:0097151; GO:0098712; GO:0098900; GO:2001259,"LIPID 386; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P30989""; LIPID 388; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P30989"""
O88572,reviewed,LRP6_MOUSE,Low-density lipoprotein receptor-related protein 6 (LRP-6),Lrp6,Mus musculus (Mouse),1613,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851],caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0001702; GO:0001756; GO:0001843; GO:0001933; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005901; GO:0006355; GO:0006469; GO:0007204; GO:0007268; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010463; GO:0010976; GO:0014029; GO:0014033; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045202; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051091; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0061310; GO:0061324; GO:0061347; GO:0061348; GO:0061349; GO:0061350; GO:0061354; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072089; GO:0072659; GO:0090009; GO:0090118; GO:0090179; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051; GO:2000149; GO:2000151; GO:2000162; GO:2000164; GO:2000166; GO:2000168; GO:2000648,"LIPID 1394; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 1399; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O88697,reviewed,STK16_MOUSE,Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Embryo-derived protein kinase) (Edpk) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase Krct) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2),Stk16 Edpk Krct Mpsk1 Pkl12 Tsf1,Mus musculus (Mouse),305,cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0000978; GO:0004672; GO:0004674; GO:0004715; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0006468; GO:0045944; GO:0046777; GO:0048471; GO:0071560; GO:0106310,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250""; LIPID 6; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 8; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O88721,reviewed,V2R_MOUSE,Vasopressin V2 receptor (V2R) (AVPR V2) (Antidiuretic hormone receptor) (Renal-type arginine vasopressin receptor),Avpr2 V2r,Mus musculus (Mouse),371,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of renal sodium excretion [GO:0035814]; negative regulation of urine volume [GO:0035811]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to cytokine [GO:0034097]; telencephalon development [GO:0021537],endocytic vesicle [GO:0030139]; endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],endocytic vesicle [GO:0030139]; endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; peptide binding [GO:0042277]; vasopressin receptor activity [GO:0005000]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of renal sodium excretion [GO:0035814]; negative regulation of urine volume [GO:0035811]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to cytokine [GO:0034097]; telencephalon development [GO:0021537],peptide binding [GO:0042277]; vasopressin receptor activity [GO:0005000],GO:0001992; GO:0003084; GO:0005000; GO:0005768; GO:0005886; GO:0007186; GO:0007249; GO:0008284; GO:0008285; GO:0010628; GO:0021537; GO:0030139; GO:0032870; GO:0034097; GO:0035811; GO:0035814; GO:0042277; GO:0045777; GO:0045907; GO:0048471,"LIPID 341; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 342; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O88728,reviewed,IFM5_MOUSE,Interferon-induced transmembrane protein 5 (Bone-restricted interferon-induced transmembrane protein-like protein) (Bril) (Dispanin subfamily A member 1) (DSPA1) (Fragilis family member 4),Ifitm5 Bril Fragilis4,Mus musculus (Mouse),134,bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; in utero embryonic development [GO:0001701]; regulation of bone mineralization [GO:0030500],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; in utero embryonic development [GO:0001701]; regulation of bone mineralization [GO:0030500],,GO:0001701; GO:0005829; GO:0005886; GO:0016020; GO:0030282; GO:0030500; GO:0043231; GO:0060349,"LIPID 52; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:24058703, ECO:0000305|PubMed:24715519""; LIPID 53; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:24058703, ECO:0000305|PubMed:24715519""; LIPID 86; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:24058703, ECO:0000305|PubMed:24715519"""
O89001,reviewed,CBPD_MOUSE,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180),Cpd,Mus musculus (Mouse),1377,peptide metabolic process [GO:0006518]; protein processing [GO:0016485],extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; metallocarboxypeptidase activity [GO:0004181]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485],metallocarboxypeptidase activity [GO:0004181]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270],GO:0004181; GO:0005615; GO:0005634; GO:0005802; GO:0005886; GO:0006518; GO:0008270; GO:0016485; GO:0043231; GO:0044877; GO:0048471; GO:0051721,"LIPID 1314; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 1318; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 1320; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P04919,reviewed,B3AT_MOUSE,Band 3 anion transport protein (Anion exchange protein 1) (AE 1) (Anion exchanger 1) (MEB3) (Solute carrier family 4 member 1) (CD antigen CD233),Slc4a1 Ae1,Mus musculus (Mouse),929,bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of T cell proliferation [GO:0042102]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to carbon dioxide [GO:0010037]; response to hydrogen peroxide [GO:0042542]; transmembrane transport [GO:0055085],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; intercalated disc [GO:0014704]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Z disc [GO:0030018],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; intercalated disc [GO:0014704]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; enzyme binding [GO:0019899]; hemoglobin binding [GO:0030492]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; solute:inorganic anion antiporter activity [GO:0005452]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of T cell proliferation [GO:0042102]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to carbon dioxide [GO:0010037]; response to hydrogen peroxide [GO:0042542]; transmembrane transport [GO:0055085],actin binding [GO:0003779]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; enzyme binding [GO:0019899]; hemoglobin binding [GO:0030492]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; solute:inorganic anion antiporter activity [GO:0005452],GO:0003779; GO:0005452; GO:0005886; GO:0006821; GO:0007596; GO:0009898; GO:0009986; GO:0010037; GO:0014704; GO:0014823; GO:0015106; GO:0015108; GO:0015701; GO:0016020; GO:0016323; GO:0017121; GO:0019899; GO:0030018; GO:0030492; GO:0030506; GO:0030863; GO:0035811; GO:0042102; GO:0042542; GO:0042803; GO:0044877; GO:0045852; GO:0046685; GO:0048821; GO:0051354; GO:0051453; GO:0055085; GO:0072659; GO:0140900; GO:1902476; GO:1904539,"LIPID 861; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P06240,reviewed,LCK_MOUSE,Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK),Lck Lsk-t,Mus musculus (Mouse),509,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell surface receptor signaling pathway [GO:0007166]; Fc-gamma receptor signaling pathway [GO:0038094]; gamma-delta T cell differentiation [GO:0042492]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular zinc ion homeostasis [GO:0006882]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of T cell activation [GO:0050870]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of uterine smooth muscle contraction [GO:0070474]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of T cell receptor signaling pathway [GO:0050856]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; response to metal ion [GO:0010038]; response to xenobiotic stimulus [GO:0009410]; T cell differentiation [GO:0030217]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]","cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]; antigen binding [GO:0003823]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein antigen binding [GO:1990405]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell surface receptor signaling pathway [GO:0007166]; Fc-gamma receptor signaling pathway [GO:0038094]; gamma-delta T cell differentiation [GO:0042492]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular zinc ion homeostasis [GO:0006882]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of T cell activation [GO:0050870]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of uterine smooth muscle contraction [GO:0070474]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of T cell receptor signaling pathway [GO:0050856]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; response to metal ion [GO:0010038]; response to xenobiotic stimulus [GO:0009410]; T cell differentiation [GO:0030217]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]",antigen binding [GO:0003823]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein antigen binding [GO:1990405]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608],GO:0000242; GO:0001772; GO:0001784; GO:0003823; GO:0004713; GO:0004715; GO:0004722; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006882; GO:0006919; GO:0007166; GO:0007169; GO:0009410; GO:0009612; GO:0010038; GO:0010628; GO:0016004; GO:0018108; GO:0019901; GO:0019903; GO:0030139; GO:0030217; GO:0031234; GO:0034116; GO:0035556; GO:0038083; GO:0038094; GO:0042169; GO:0042492; GO:0042531; GO:0042542; GO:0042608; GO:0042609; GO:0042610; GO:0042802; GO:0043274; GO:0043548; GO:0044877; GO:0045087; GO:0045121; GO:0045588; GO:0045589; GO:0046777; GO:0050853; GO:0050856; GO:0050870; GO:0051117; GO:0051209; GO:0070474; GO:0098978; GO:0099091; GO:1903039; GO:1990405; GO:2001244,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000305|PubMed:7980442""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:7980442, ECO:0000269|PubMed:8413237""; LIPID 5; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:7980442, ECO:0000269|PubMed:8413237"""
P06332,reviewed,CD4_MOUSE,T-cell surface glycoprotein CD4 (T-cell differentiation antigen L3T4) (T-cell surface antigen T4/Leu-3) (CD antigen CD4),Cd4,Mus musculus (Mouse),457,adaptive immune response [GO:0002250]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; defense response to Gram-negative bacterium [GO:0050829]; helper T cell enhancement of adaptive immune response [GO:0035397]; interleukin-15-mediated signaling pathway [GO:0035723]; macrophage differentiation [GO:0030225]; maintenance of protein location in cell [GO:0032507]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of viral entry into host cell [GO:0046598]; regulation of calcium ion transport [GO:0051924]; regulation of T cell activation [GO:0050863]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell selection [GO:0045058],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; interleukin-16 binding [GO:0042011]; interleukin-16 receptor activity [GO:0042012]; lipid binding [GO:0008289]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; defense response to Gram-negative bacterium [GO:0050829]; helper T cell enhancement of adaptive immune response [GO:0035397]; interleukin-15-mediated signaling pathway [GO:0035723]; macrophage differentiation [GO:0030225]; maintenance of protein location in cell [GO:0032507]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of viral entry into host cell [GO:0046598]; regulation of calcium ion transport [GO:0051924]; regulation of T cell activation [GO:0050863]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell selection [GO:0045058],coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; interleukin-16 binding [GO:0042011]; interleukin-16 receptor activity [GO:0042012]; lipid binding [GO:0008289]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270],GO:0001934; GO:0002250; GO:0005102; GO:0005788; GO:0005789; GO:0005886; GO:0007155; GO:0007166; GO:0008270; GO:0008289; GO:0009897; GO:0009986; GO:0010524; GO:0015026; GO:0018108; GO:0019722; GO:0019865; GO:0019899; GO:0019901; GO:0023026; GO:0030217; GO:0030225; GO:0032507; GO:0033674; GO:0035397; GO:0035723; GO:0042011; GO:0042012; GO:0042102; GO:0042110; GO:0042289; GO:0042802; GO:0042803; GO:0043123; GO:0043410; GO:0045058; GO:0045121; GO:0045657; GO:0045860; GO:0045893; GO:0046598; GO:0050731; GO:0050829; GO:0050850; GO:0050863; GO:0050870; GO:0051924; GO:0070374; GO:0097011; GO:1990782,"LIPID 418; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 421; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P06837,reviewed,NEUM_MOUSE,Neuromodulin (Axonal membrane protein GAP-43) (Calmodulin-binding protein P-57) (Growth-associated protein 43),Gap43 Basp2,Mus musculus (Mouse),227,astrocyte differentiation [GO:0048708]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; cell fate commitment [GO:0045165]; radial glial cell differentiation [GO:0060019]; regulation of filopodium assembly [GO:0051489]; regulation of growth [GO:0040008]; regulation of postsynaptic specialization assembly [GO:0099150]; tissue regeneration [GO:0042246],axon [GO:0030424]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium membrane [GO:0031527]; GABA-ergic synapse [GO:0098982]; growth cone membrane [GO:0032584]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793],axon [GO:0030424]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium membrane [GO:0031527]; GABA-ergic synapse [GO:0098982]; growth cone membrane [GO:0032584]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; calmodulin binding [GO:0005516]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylserine binding [GO:0001786]; astrocyte differentiation [GO:0048708]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; cell fate commitment [GO:0045165]; radial glial cell differentiation [GO:0060019]; regulation of filopodium assembly [GO:0051489]; regulation of growth [GO:0040008]; regulation of postsynaptic specialization assembly [GO:0099150]; tissue regeneration [GO:0042246],calmodulin binding [GO:0005516]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylserine binding [GO:0001786],GO:0001786; GO:0005516; GO:0005737; GO:0005886; GO:0007411; GO:0014069; GO:0016198; GO:0030424; GO:0030425; GO:0031103; GO:0031527; GO:0032584; GO:0035727; GO:0040008; GO:0042246; GO:0043204; GO:0045165; GO:0048708; GO:0051489; GO:0060019; GO:0071944; GO:0098793; GO:0098982; GO:0099150; GO:1901981,"LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:27875292""; LIPID 4; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:27875292"""
P08103,reviewed,HCK_MOUSE,Tyrosine-protein kinase HCK (EC 2.7.10.2) (B-cell/myeloid kinase) (BMK) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p56-HCK/p59-HCK),Hck,Mus musculus (Mouse),524,cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; exocytosis [GO:0006887]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; localization [GO:0051179]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],actin filament [GO:0005884]; caveola [GO:0005901]; cell projection [GO:0042995]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133],actin filament [GO:0005884]; caveola [GO:0005901]; cell projection [GO:0042995]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; exocytosis [GO:0006887]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; localization [GO:0051179]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],ATP binding [GO:0005524]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102],GO:0001784; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005901; GO:0005925; GO:0006887; GO:0006909; GO:0006954; GO:0007169; GO:0008284; GO:0008289; GO:0008360; GO:0018108; GO:0030133; GO:0030154; GO:0031234; GO:0032956; GO:0042995; GO:0043066; GO:0043231; GO:0045087; GO:0046777; GO:0050764; GO:0050830; GO:0051090; GO:0051179; GO:0071801; GO:2000251,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250""; LIPID P08103-2:2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:P08631""; LIPID P08103-2:3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P08631"""
P08228,reviewed,SODC_MOUSE,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),Sod1,Mus musculus (Mouse),154,anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; auditory receptor cell stereocilium organization [GO:0060088]; determination of adult lifespan [GO:0008340]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; intracellular iron ion homeostasis [GO:0006879]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of developmental process [GO:0051093]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reproductive process [GO:2000242]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to axon injury [GO:0048678]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226],axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141],axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ion binding [GO:0043167]; protein phosphatase 2B binding [GO:0030346]; protein-folding chaperone binding [GO:0051087]; small GTPase binding [GO:0031267]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; auditory receptor cell stereocilium organization [GO:0060088]; determination of adult lifespan [GO:0008340]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; intracellular iron ion homeostasis [GO:0006879]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of developmental process [GO:0051093]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reproductive process [GO:2000242]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to axon injury [GO:0048678]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226],copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ion binding [GO:0043167]; protein phosphatase 2B binding [GO:0030346]; protein-folding chaperone binding [GO:0051087]; small GTPase binding [GO:0031267]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270],GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0002262; GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006915; GO:0006979; GO:0007283; GO:0007566; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0008340; GO:0009408; GO:0009410; GO:0010033; GO:0019226; GO:0019430; GO:0019899; GO:0030141; GO:0030346; GO:0031045; GO:0031267; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0032991; GO:0035234; GO:0040014; GO:0042542; GO:0042554; GO:0042802; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043167; GO:0043209; GO:0043410; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046688; GO:0046716; GO:0048678; GO:0050665; GO:0050728; GO:0050766; GO:0051087; GO:0051093; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0072593; GO:1902177; GO:1904115; GO:2000242,"LIPID 7; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P08556,reviewed,RASN_MOUSE,GTPase NRas (EC 3.6.5.2) (Transforming protein N-Ras),Nras,Mus musculus (Mouse),189,defense response to protozoan [GO:0042832]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of type II interferon production [GO:0032729]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of protein phosphorylation [GO:0001932]; T cell receptor signaling pathway [GO:0050852],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; defense response to protozoan [GO:0042832]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of type II interferon production [GO:0032729]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of protein phosphorylation [GO:0001932]; T cell receptor signaling pathway [GO:0050852],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877],GO:0000139; GO:0001932; GO:0001938; GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0005886; GO:0007265; GO:0010468; GO:0016020; GO:0019003; GO:0032729; GO:0042832; GO:0044877; GO:0045766; GO:0048146; GO:0048642; GO:0050852; GO:0051726,"LIPID 181; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P01111""; LIPID 186; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P01111"""
P08752,reviewed,GNAI2_MOUSE,Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein),Gnai2 Gnai-2,Mus musculus (Mouse),355,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of calcium ion transport [GO:0051924],cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; neuronal dense core vesicle [GO:0098992]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; neuronal dense core vesicle [GO:0098992]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of calcium ion transport [GO:0051924],G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0001664; GO:0001973; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005834; GO:0005886; GO:0007049; GO:0007186; GO:0007189; GO:0007193; GO:0007213; GO:0007214; GO:0008283; GO:0008284; GO:0016020; GO:0030335; GO:0030425; GO:0030496; GO:0031683; GO:0032930; GO:0033864; GO:0035810; GO:0035815; GO:0044297; GO:0045121; GO:0045202; GO:0045955; GO:0046628; GO:0046872; GO:0050805; GO:0051301; GO:0051924; GO:0070374; GO:0098992; GO:0140199; GO:1903614; GO:1904707; GO:2000179; GO:2001234,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:P04899""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P10404,reviewed,ENV1_MOUSE,MLV-related proviral Env polyprotein [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],,Mus musculus (Mouse),641,,plasma membrane [GO:0005886],plasma membrane [GO:0005886]; metal ion binding [GO:0046872],metal ion binding [GO:0046872],GO:0005886; GO:0046872,"LIPID 601; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P10833,reviewed,RRAS_MOUSE,Ras-related protein R-Ras (EC 3.6.5.-) (p23),Rras,Mus musculus (Mouse),218,cell migration [GO:0016477]; face morphogenesis [GO:0060325]; leukocyte differentiation [GO:0002521]; negative regulation of Schwann cell migration [GO:1900148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein kinase B signaling [GO:0051896]; Schwann cell migration [GO:0036135]; signal transduction [GO:0007165],cytosol [GO:0005829]; plasma membrane [GO:0005886],cytosol [GO:0005829]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; cell migration [GO:0016477]; face morphogenesis [GO:0060325]; leukocyte differentiation [GO:0002521]; negative regulation of Schwann cell migration [GO:1900148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein kinase B signaling [GO:0051896]; Schwann cell migration [GO:0036135]; signal transduction [GO:0007165],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877],GO:0002521; GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0007165; GO:0010595; GO:0016477; GO:0019003; GO:0036135; GO:0044877; GO:0045766; GO:0051896; GO:0060325; GO:0070372; GO:1900148; GO:1904906; GO:2001214,"LIPID 215; /note=""S-geranylgeranyl cysteine""; /evidence=""ECO:0000250"""
P11881,reviewed,ITPR1_MOUSE,"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Inositol 1,4,5-trisphosphate-binding protein P400) (Protein PCD-6) (Purkinje cell protein 1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)",Itpr1 Insp3r Pcd6 Pcp1,Mus musculus (Mouse),2749,"calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; cellular response to cAMP [GO:0071320]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; liver regeneration [GO:0097421]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of neuron death [GO:1901215]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; post-embryonic development [GO:0009791]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; voluntary musculoskeletal movement [GO:0050882]",calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum membrane [GO:0030868]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; transport vesicle membrane [GO:0030658],"calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum membrane [GO:0030868]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; transport vesicle membrane [GO:0030658]; calcium channel inhibitor activity [GO:0019855]; calcium-release channel activity [GO:0015278]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]; calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; cellular response to cAMP [GO:0071320]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; liver regeneration [GO:0097421]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of neuron death [GO:1901215]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; post-embryonic development [GO:0009791]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; voluntary musculoskeletal movement [GO:0050882]","calcium channel inhibitor activity [GO:0019855]; calcium-release channel activity [GO:0015278]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]",GO:0000902; GO:0001666; GO:0005220; GO:0005635; GO:0005637; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005955; GO:0006816; GO:0007200; GO:0007204; GO:0007207; GO:0009791; GO:0010976; GO:0014069; GO:0015278; GO:0016020; GO:0016529; GO:0019855; GO:0019903; GO:0019904; GO:0030425; GO:0030658; GO:0030667; GO:0030868; GO:0031088; GO:0031094; GO:0032024; GO:0032469; GO:0032991; GO:0035091; GO:0042045; GO:0042802; GO:0043025; GO:0043065; GO:0043231; GO:0044325; GO:0044877; GO:0045121; GO:0045202; GO:0048471; GO:0050849; GO:0050882; GO:0051209; GO:0051928; GO:0070059; GO:0070679; GO:0071320; GO:0097060; GO:0097421; GO:0098685; GO:0098695; GO:0098793; GO:0098794; GO:0098982; GO:0099105; GO:1901215; GO:1990806; GO:2000347,"LIPID 56; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:25368151""; LIPID 849; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:25368151"""
P13808,reviewed,B3A2_MOUSE,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Band 3-related protein) (B3RP) (Non-erythroid band 3-like protein) (Solute carrier family 4 member 2),Slc4a2 Ae2,Mus musculus (Mouse),1237,"amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; positive regulation of enamel mineralization [GO:0070175]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085]",apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886],"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; enzyme binding [GO:0019899]; transmembrane transporter activity [GO:0022857]; amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; positive regulation of enamel mineralization [GO:0070175]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085]",chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; enzyme binding [GO:0019899]; transmembrane transporter activity [GO:0022857],GO:0005886; GO:0006821; GO:0007283; GO:0015108; GO:0015701; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0022857; GO:0030316; GO:0032956; GO:0043377; GO:0045124; GO:0051453; GO:0055085; GO:0070175; GO:0097186; GO:0140900; GO:2000565,"LIPID 1169; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P14142,reviewed,GLUT4_MOUSE,"Solute carrier family 2, facilitated glucose transporter member 4 (GT2) (Glucose transporter type 4, insulin-responsive) (GLUT-4)",Slc2a4 Glut4,Mus musculus (Mouse),509,amylopectin biosynthetic process [GO:0010021]; brown fat cell differentiation [GO:0050873]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to osmotic stress [GO:0071470]; cellular response to tumor necrosis factor [GO:0071356]; dehydroascorbic acid transport [GO:0070837]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; glucose import in response to insulin stimulus [GO:0044381]; glucose transmembrane transport [GO:1904659]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; positive regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031550]; regulation of synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0098694]; response to ethanol [GO:0045471]; short-term memory [GO:0007614],cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; vesicle [GO:0031982]; vesicle membrane [GO:0012506],cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; glucose uniporter activity [GO:0015304]; insulin-responsive glucose:proton symporter activity [GO:0005360]; amylopectin biosynthetic process [GO:0010021]; brown fat cell differentiation [GO:0050873]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to osmotic stress [GO:0071470]; cellular response to tumor necrosis factor [GO:0071356]; dehydroascorbic acid transport [GO:0070837]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; glucose import in response to insulin stimulus [GO:0044381]; glucose transmembrane transport [GO:1904659]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; positive regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031550]; regulation of synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0098694]; response to ethanol [GO:0045471]; short-term memory [GO:0007614],D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; glucose uniporter activity [GO:0015304]; insulin-responsive glucose:proton symporter activity [GO:0005360],GO:0005355; GO:0005360; GO:0005737; GO:0005768; GO:0005771; GO:0005802; GO:0005829; GO:0005886; GO:0005905; GO:0007611; GO:0007614; GO:0007616; GO:0009897; GO:0009986; GO:0010021; GO:0012505; GO:0012506; GO:0015304; GO:0016020; GO:0016529; GO:0030136; GO:0030140; GO:0030315; GO:0030659; GO:0031550; GO:0031982; GO:0032593; GO:0032869; GO:0042383; GO:0042593; GO:0043231; GO:0044381; GO:0045121; GO:0045471; GO:0046323; GO:0048471; GO:0050873; GO:0055056; GO:0070062; GO:0070837; GO:0071356; GO:0071456; GO:0071470; GO:0098694; GO:0098793; GO:1904659,"LIPID 223; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P14672"""
P14234,reviewed,FGR_MOUSE,Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr),Fgr,Mus musculus (Mouse),517,bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; myoblast proliferation [GO:0051450]; negative regulation of natural killer cell activation [GO:0032815]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production [GO:0001819]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of innate immune response [GO:0045088]; regulation of phagocytosis [GO:0050764]; regulation of protein kinase activity [GO:0045859]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],aggresome [GO:0016235]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],aggresome [GO:0016235]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; Fc-gamma receptor I complex binding [GO:0034988]; immunoglobulin receptor binding [GO:0034987]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; myoblast proliferation [GO:0051450]; negative regulation of natural killer cell activation [GO:0032815]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production [GO:0001819]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of innate immune response [GO:0045088]; regulation of phagocytosis [GO:0050764]; regulation of protein kinase activity [GO:0045859]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],ATP binding [GO:0005524]; Fc-gamma receptor I complex binding [GO:0034988]; immunoglobulin receptor binding [GO:0034987]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102],GO:0001784; GO:0001819; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005743; GO:0005758; GO:0005829; GO:0005856; GO:0005886; GO:0007169; GO:0007229; GO:0008360; GO:0014068; GO:0016235; GO:0018108; GO:0019901; GO:0030154; GO:0030282; GO:0030335; GO:0031234; GO:0032587; GO:0032815; GO:0032956; GO:0034987; GO:0034988; GO:0043306; GO:0043552; GO:0045087; GO:0045088; GO:0045859; GO:0046777; GO:0048705; GO:0050764; GO:0050830; GO:0051450,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000305|PubMed:15561106""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:15561106""; LIPID 6; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:15561106"""
P15409,reviewed,OPSD_MOUSE,Rhodopsin,Rho,Mus musculus (Mouse),348,"absorption of visible light [GO:0016038]; cellular response to light stimulus [GO:0071482]; detection of light stimulus [GO:0009583]; detection of temperature stimulus involved in thermoception [GO:0050960]; G protein-coupled receptor signaling pathway [GO:0007186]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein phosphorylation [GO:0006468]; red, far-red light phototransduction [GO:0009585]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of light stimulus [GO:0050953]; thermotaxis [GO:0043052]; visual perception [GO:0007601]",cell-cell junction [GO:0005911]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; rough endoplasmic reticulum membrane [GO:0030867]; sperm head plasma membrane [GO:1990913]; sperm midpiece [GO:0097225],"cell-cell junction [GO:0005911]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; rough endoplasmic reticulum membrane [GO:0030867]; sperm head plasma membrane [GO:1990913]; sperm midpiece [GO:0097225]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; metal ion binding [GO:0046872]; retinal binding [GO:0016918]; spectrin binding [GO:0030507]; absorption of visible light [GO:0016038]; cellular response to light stimulus [GO:0071482]; detection of light stimulus [GO:0009583]; detection of temperature stimulus involved in thermoception [GO:0050960]; G protein-coupled receptor signaling pathway [GO:0007186]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein phosphorylation [GO:0006468]; red, far-red light phototransduction [GO:0009585]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of light stimulus [GO:0050953]; thermotaxis [GO:0043052]; visual perception [GO:0007601]",11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; metal ion binding [GO:0046872]; retinal binding [GO:0016918]; spectrin binding [GO:0030507],GO:0001750; GO:0001917; GO:0005502; GO:0005794; GO:0005886; GO:0005911; GO:0006468; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0009416; GO:0009583; GO:0009585; GO:0016020; GO:0016038; GO:0016056; GO:0016918; GO:0030507; GO:0030867; GO:0042622; GO:0043052; GO:0045494; GO:0046872; GO:0050953; GO:0050960; GO:0060041; GO:0060342; GO:0071482; GO:0097225; GO:0097381; GO:0120200; GO:1990913,"LIPID 322; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P02699""; LIPID 323; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P02699"""
P16283,reviewed,B3A3_MOUSE,Anion exchange protein 3 (AE 3) (Anion exchanger 3) (Neuronal band 3-like protein) (Solute carrier family 4 member 3),Slc4a3 Ae3,Mus musculus (Mouse),1227,bicarbonate transport [GO:0015701]; cardiac conduction [GO:0061337]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085],external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886],external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride:bicarbonate antiporter activity [GO:0140900]; enzyme binding [GO:0019899]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; cardiac conduction [GO:0061337]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085],bicarbonate transmembrane transporter activity [GO:0015106]; chloride:bicarbonate antiporter activity [GO:0140900]; enzyme binding [GO:0019899]; transmembrane transporter activity [GO:0022857],GO:0005886; GO:0009897; GO:0015106; GO:0015701; GO:0019899; GO:0022857; GO:0051453; GO:0055085; GO:0061337; GO:0140900,"LIPID 1160; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P16388,reviewed,KCNA1_MOUSE,Potassium voltage-gated channel subfamily A member 1 (MBK1) (MKI) (Voltage-gated potassium channel subunit Kv1.1),Kcna1,Mus musculus (Mouse),495,axon development [GO:0061564]; brain development [GO:0007420]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; optic nerve development [GO:0021554]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; potassium channel complex [GO:0034705]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; potassium channel complex [GO:0034705]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]; axon development [GO:0061564]; brain development [GO:0007420]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; optic nerve development [GO:0021554]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249],GO:0001964; GO:0005249; GO:0005251; GO:0005783; GO:0005829; GO:0005886; GO:0006937; GO:0007405; GO:0007420; GO:0008076; GO:0008104; GO:0009986; GO:0010644; GO:0010960; GO:0016324; GO:0019228; GO:0021554; GO:0021766; GO:0021987; GO:0022038; GO:0023041; GO:0030054; GO:0030424; GO:0030425; GO:0031410; GO:0033270; GO:0034705; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045202; GO:0045211; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0061564; GO:0070161; GO:0071286; GO:0071805; GO:0097718; GO:0098978; GO:0099508; GO:1903818; GO:1905030,"LIPID 243; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q09470"""
P16390,reviewed,KCNA3_MOUSE,Potassium voltage-gated channel subfamily A member 3 (MK3) (Voltage-gated potassium channel subunit Kv1.3),Kcna3,Mus musculus (Mouse),528,corpus callosum development [GO:0022038]; optic nerve development [GO:0021554]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of monoatomic ion transmembrane transport [GO:0034765],axon [GO:0030424]; calyx of Held [GO:0044305]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],axon [GO:0030424]; calyx of Held [GO:0044305]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]; corpus callosum development [GO:0022038]; optic nerve development [GO:0021554]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of monoatomic ion transmembrane transport [GO:0034765],delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249],GO:0005249; GO:0005251; GO:0005886; GO:0008076; GO:0015271; GO:0021554; GO:0022038; GO:0030424; GO:0034765; GO:0042734; GO:0044305; GO:0045121; GO:0045211; GO:0051260; GO:0071805; GO:0098978,"LIPID 270; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P18762,reviewed,ADRB2_MOUSE,Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor),Adrb2 Adrb2r,Mus musculus (Mouse),418,"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenergic receptor signaling pathway [GO:0071875]; associative learning [GO:0008306]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; cellular response to hypoxia [GO:0071456]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; diaphragm contraction [GO:0002086]; diet induced thermogenesis [GO:0002024]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled receptor signaling pathway [GO:0007186]; heat generation [GO:0031649]; negative regulation of angiogenesis [GO:0016525]; negative regulation of inflammatory response [GO:0050728]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of ossification [GO:0030279]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of urine volume [GO:0035811]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of heart contraction [GO:0045823]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of the force of heart contraction by epinephrine [GO:0003059]; positive regulation of transcription by RNA polymerase II [GO:0045944]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; receptor-mediated endocytosis [GO:0006898]; regulation of calcium ion transport [GO:0051924]; regulation of sensory perception of pain [GO:0051930]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by norepinephrine-epinephrine [GO:0001993]; response to catecholamine [GO:0071869]; response to cold [GO:0009409]; smooth muscle contraction [GO:0006939]; synaptic transmission, glutamatergic [GO:0035249]; transcription by RNA polymerase II [GO:0006366]; vasodilation [GO:0042311]; wound healing [GO:0042060]",apical plasma membrane [GO:0016324]; axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; neuronal dense core vesicle [GO:0098992]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; receptor complex [GO:0043235]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685],"apical plasma membrane [GO:0016324]; axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; neuronal dense core vesicle [GO:0098992]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; receptor complex [GO:0043235]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; B2 bradykinin receptor binding [GO:0031713]; beta2-adrenergic receptor activity [GO:0004941]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenergic receptor signaling pathway [GO:0071875]; associative learning [GO:0008306]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; cellular response to hypoxia [GO:0071456]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; diaphragm contraction [GO:0002086]; diet induced thermogenesis [GO:0002024]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled receptor signaling pathway [GO:0007186]; heat generation [GO:0031649]; negative regulation of angiogenesis [GO:0016525]; negative regulation of inflammatory response [GO:0050728]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of ossification [GO:0030279]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of urine volume [GO:0035811]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of heart contraction [GO:0045823]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of the force of heart contraction by epinephrine [GO:0003059]; positive regulation of transcription by RNA polymerase II [GO:0045944]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; receptor-mediated endocytosis [GO:0006898]; regulation of calcium ion transport [GO:0051924]; regulation of sensory perception of pain [GO:0051930]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by norepinephrine-epinephrine [GO:0001993]; response to catecholamine [GO:0071869]; response to cold [GO:0009409]; smooth muscle contraction [GO:0006939]; synaptic transmission, glutamatergic [GO:0035249]; transcription by RNA polymerase II [GO:0006366]; vasodilation [GO:0042311]; wound healing [GO:0042060]",adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; B2 bradykinin receptor binding [GO:0031713]; beta2-adrenergic receptor activity [GO:0004941]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722],GO:0001540; GO:0001965; GO:0001993; GO:0002024; GO:0002025; GO:0002028; GO:0002032; GO:0002086; GO:0003059; GO:0004941; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005901; GO:0006366; GO:0006898; GO:0006939; GO:0007186; GO:0007189; GO:0007190; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0010739; GO:0010765; GO:0015459; GO:0016020; GO:0016324; GO:0016525; GO:0019899; GO:0030279; GO:0030424; GO:0030425; GO:0030501; GO:0031649; GO:0031713; GO:0032781; GO:0032809; GO:0035249; GO:0035255; GO:0035811; GO:0040015; GO:0042060; GO:0042311; GO:0042383; GO:0042802; GO:0042803; GO:0043065; GO:0043197; GO:0043231; GO:0043235; GO:0043268; GO:0043410; GO:0044877; GO:0045211; GO:0045453; GO:0045823; GO:0045944; GO:0045986; GO:0048633; GO:0050728; GO:0050873; GO:0051380; GO:0051721; GO:0051924; GO:0051930; GO:0060079; GO:0061885; GO:0071456; GO:0071869; GO:0071875; GO:0071880; GO:0071902; GO:0090331; GO:0090722; GO:0098685; GO:0098793; GO:0098978; GO:0098992; GO:0099171; GO:0120162; GO:1901098; GO:1904504; GO:1904646; GO:1905665; GO:2000969,"LIPID 265; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P07550""; LIPID 341; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P07550"""
P18872,reviewed,GNAO_MOUSE,Guanine nucleotide-binding protein G(o) subunit alpha,Gnao1 Gna0 Gnao,Mus musculus (Mouse),354,adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; aging [GO:0007568]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of insulin secretion [GO:0046676]; positive regulation of GTPase activity [GO:0043547]; regulation of heart contraction [GO:0008016]; response to organonitrogen compound [GO:0010243]; vesicle docking involved in exocytosis [GO:0006904],cell body [GO:0044297]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],cell body [GO:0044297]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; signaling receptor binding [GO:0005102]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; aging [GO:0007568]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of insulin secretion [GO:0046676]; positive regulation of GTPase activity [GO:0043547]; regulation of heart contraction [GO:0008016]; response to organonitrogen compound [GO:0010243]; vesicle docking involved in exocytosis [GO:0006904],corticotropin-releasing hormone receptor 1 binding [GO:0051430]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; signaling receptor binding [GO:0005102],GO:0003924; GO:0005102; GO:0005525; GO:0005834; GO:0005886; GO:0006904; GO:0007186; GO:0007188; GO:0007212; GO:0007568; GO:0007626; GO:0008016; GO:0010243; GO:0016020; GO:0030425; GO:0031683; GO:0031821; GO:0031852; GO:0032794; GO:0043005; GO:0043209; GO:0043547; GO:0044297; GO:0046676; GO:0046872; GO:0051430; GO:0051926,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:P09471""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P19437,reviewed,CD20_MOUSE,B-lymphocyte antigen CD20 (B-cell differentiation antigen Ly-44) (Lymphocyte antigen 44) (Membrane-spanning 4-domains subfamily A member 1) (CD antigen CD20),Ms4a1 Cd20 Ly-44 Ms4a2,Mus musculus (Mouse),291,B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium ion import into cytosol [GO:1902656]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; protein tetramerization [GO:0051262]; response to bacterium [GO:0009617]; store-operated calcium entry [GO:0002115],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium ion import into cytosol [GO:1902656]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; protein tetramerization [GO:0051262]; response to bacterium [GO:0009617]; store-operated calcium entry [GO:0002115],epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865],GO:0002115; GO:0005154; GO:0005654; GO:0005886; GO:0007166; GO:0009617; GO:0009897; GO:0009986; GO:0019865; GO:0030183; GO:0042113; GO:0042802; GO:0044853; GO:0050853; GO:0051262; GO:1902656; GO:1905665,"LIPID 214; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P19785,reviewed,ESR1_MOUSE,Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1),Esr1 Esr Estr Estra Nr3a1,Mus musculus (Mouse),599,androgen metabolic process [GO:0008209]; antral ovarian follicle growth [GO:0001547]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; epithelial cell development [GO:0002064]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; fibroblast proliferation [GO:0048144]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; male gonad development [GO:0008584]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in pregnancy [GO:0060745]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neuron death [GO:1901215]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of triglyceride metabolic process [GO:0090209]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; protein localization to chromatin [GO:0071168]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell apoptotic process [GO:1904035]; regulation of inflammatory response [GO:0050727]; regulation of neuron apoptotic process [GO:0043523]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; RNA polymerase II preinitiation complex assembly [GO:0051123]; Sertoli cell proliferation [GO:0060011]; stem cell differentiation [GO:0048863]; steroid hormone mediated signaling pathway [GO:0043401]; transcription by RNA polymerase II [GO:0006366]; uterus development [GO:0060065]; vagina development [GO:0060068],chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; terminal bouton [GO:0043195]; transcription regulator complex [GO:0005667],"chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; terminal bouton [GO:0043195]; transcription regulator complex [GO:0005667]; 14-3-3 protein binding [GO:0071889]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen response element binding [GO:0034056]; G protein-coupled estrogen receptor activity [GO:0038054]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; nuclear estrogen receptor activity [GO:0030284]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; nucleic acid binding [GO:0003676]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; promoter-specific chromatin binding [GO:1990841]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; TBP-class protein binding [GO:0017025]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]; transcription factor binding [GO:0008134]; type 1 metabotropic glutamate receptor binding [GO:0031798]; zinc ion binding [GO:0008270]; androgen metabolic process [GO:0008209]; antral ovarian follicle growth [GO:0001547]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; epithelial cell development [GO:0002064]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; fibroblast proliferation [GO:0048144]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; male gonad development [GO:0008584]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in pregnancy [GO:0060745]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neuron death [GO:1901215]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of triglyceride metabolic process [GO:0090209]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; protein localization to chromatin [GO:0071168]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell apoptotic process [GO:1904035]; regulation of inflammatory response [GO:0050727]; regulation of neuron apoptotic process [GO:0043523]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; RNA polymerase II preinitiation complex assembly [GO:0051123]; Sertoli cell proliferation [GO:0060011]; stem cell differentiation [GO:0048863]; steroid hormone mediated signaling pathway [GO:0043401]; transcription by RNA polymerase II [GO:0006366]; uterus development [GO:0060065]; vagina development [GO:0060068]","14-3-3 protein binding [GO:0071889]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen response element binding [GO:0034056]; G protein-coupled estrogen receptor activity [GO:0038054]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; nuclear estrogen receptor activity [GO:0030284]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; nucleic acid binding [GO:0003676]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; promoter-specific chromatin binding [GO:1990841]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; TBP-class protein binding [GO:0017025]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]; transcription factor binding [GO:0008134]; type 1 metabotropic glutamate receptor binding [GO:0031798]; zinc ion binding [GO:0008270]",GO:0000122; GO:0000785; GO:0000791; GO:0000978; GO:0001093; GO:0001221; GO:0001222; GO:0001223; GO:0001228; GO:0001547; GO:0002064; GO:0003676; GO:0003677; GO:0003682; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005667; GO:0005737; GO:0005739; GO:0005794; GO:0005886; GO:0006355; GO:0006357; GO:0006366; GO:0007200; GO:0007204; GO:0008013; GO:0008134; GO:0008209; GO:0008270; GO:0008584; GO:0010629; GO:0010863; GO:0017025; GO:0019899; GO:0019901; GO:0030284; GO:0030315; GO:0030331; GO:0030518; GO:0030520; GO:0031798; GO:0032355; GO:0032991; GO:0034056; GO:0034121; GO:0036312; GO:0038054; GO:0042562; GO:0042802; GO:0043005; GO:0043124; GO:0043195; GO:0043204; GO:0043401; GO:0043433; GO:0043523; GO:0043565; GO:0043627; GO:0044877; GO:0045429; GO:0045742; GO:0045839; GO:0045893; GO:0045944; GO:0046325; GO:0048144; GO:0048146; GO:0048471; GO:0048662; GO:0048863; GO:0050679; GO:0050727; GO:0051000; GO:0051091; GO:0051117; GO:0051123; GO:0060011; GO:0060065; GO:0060068; GO:0060523; GO:0060527; GO:0060687; GO:0060745; GO:0060749; GO:0060750; GO:0070374; GO:0071168; GO:0071391; GO:0071392; GO:0071889; GO:0090209; GO:1901215; GO:1902894; GO:1904035; GO:1990837; GO:1990841,"LIPID 451; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:22031296"""
P20352,reviewed,TF_MOUSE,Tissue factor (TF) (Coagulation factor III) (CD antigen CD142),F3 Cf-3 Cf3,Mus musculus (Mouse),294,"activation of blood coagulation via clotting cascade [GO:0002543]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of plasma proteins involved in acute inflammatory response [GO:0002541]; blood coagulation [GO:0007596]; blood coagulation, extrinsic pathway [GO:0007598]; blood coagulation, fibrin clot formation [GO:0072378]; blood coagulation, intrinsic pathway [GO:0007597]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell migration [GO:0014911]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to wounding [GO:0009611]",cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; serine-type endopeptidase complex [GO:1905370]; serine-type peptidase complex [GO:1905286],"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; serine-type endopeptidase complex [GO:1905370]; serine-type peptidase complex [GO:1905286]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; activation of blood coagulation via clotting cascade [GO:0002543]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of plasma proteins involved in acute inflammatory response [GO:0002541]; blood coagulation [GO:0007596]; blood coagulation, extrinsic pathway [GO:0007598]; blood coagulation, fibrin clot formation [GO:0072378]; blood coagulation, intrinsic pathway [GO:0007597]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell migration [GO:0014911]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to wounding [GO:0009611]",phospholipid binding [GO:0005543]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252],GO:0001938; GO:0002020; GO:0002541; GO:0002543; GO:0004252; GO:0005543; GO:0005615; GO:0005737; GO:0006508; GO:0006919; GO:0007596; GO:0007597; GO:0007598; GO:0009611; GO:0009986; GO:0010628; GO:0010641; GO:0014911; GO:0016020; GO:0016485; GO:0032757; GO:0045766; GO:0051897; GO:0062023; GO:0072378; GO:1905286; GO:1905370,"LIPID 275; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P20693,reviewed,FCER2_MOUSE,Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23),Fcer2 Fcer2a,Mus musculus (Mouse),331,B cell antigen processing and presentation [GO:0002450]; Fc receptor-mediated immune complex endocytosis [GO:0160006]; immune response [GO:0006955]; macrophage activation [GO:0042116]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; sequestering of metal ion [GO:0051238],external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886],external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; low-affinity IgE receptor activity [GO:0019769]; metal ion binding [GO:0046872]; B cell antigen processing and presentation [GO:0002450]; Fc receptor-mediated immune complex endocytosis [GO:0160006]; immune response [GO:0006955]; macrophage activation [GO:0042116]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; sequestering of metal ion [GO:0051238],carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; low-affinity IgE receptor activity [GO:0019769]; metal ion binding [GO:0046872],GO:0002450; GO:0002925; GO:0005886; GO:0006955; GO:0009897; GO:0019769; GO:0019863; GO:0030246; GO:0042116; GO:0046872; GO:0051000; GO:0051238; GO:0051712; GO:0051770; GO:0160006,"LIPID 17; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 18; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P20917,reviewed,MAG_MOUSE,Myelin-associated glycoprotein (Siglec-4a),Mag,Mus musculus (Mouse),627,axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to mechanical stimulus [GO:0071260]; central nervous system myelin formation [GO:0032289]; central nervous system myelination [GO:0022010]; myelination [GO:0042552]; negative regulation of axon extension [GO:0030517]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of myelination [GO:0031643]; transmission of nerve impulse [GO:0019226],compact myelin [GO:0043218]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; mesaxon [GO:0097453]; myelin sheath [GO:0043209]; myelin sheath adaxonal region [GO:0035749]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220],compact myelin [GO:0043218]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; mesaxon [GO:0097453]; myelin sheath [GO:0043209]; myelin sheath adaxonal region [GO:0035749]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; carbohydrate binding [GO:0030246]; ganglioside GT1b binding [GO:1905576]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to mechanical stimulus [GO:0071260]; central nervous system myelin formation [GO:0032289]; central nervous system myelination [GO:0022010]; myelination [GO:0042552]; negative regulation of axon extension [GO:0030517]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of myelination [GO:0031643]; transmission of nerve impulse [GO:0019226],carbohydrate binding [GO:0030246]; ganglioside GT1b binding [GO:1905576]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102],GO:0005102; GO:0005737; GO:0005886; GO:0007155; GO:0010977; GO:0019226; GO:0019901; GO:0022010; GO:0030246; GO:0030517; GO:0031103; GO:0031643; GO:0032289; GO:0033270; GO:0033691; GO:0035749; GO:0042552; GO:0042803; GO:0043209; GO:0043218; GO:0043220; GO:0043524; GO:0045121; GO:0045665; GO:0048711; GO:0071260; GO:0097453; GO:0098742; GO:1905576,"LIPID 531; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P07722"""
P21278,reviewed,GNA11_MOUSE,Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (G-protein subunit alpha-11),Gna11 Gna-11,Mus musculus (Mouse),359,"action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to pH [GO:0071467]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; endothelin receptor signaling pathway [GO:0086100]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion [GO:0032024]; regulation of blood pressure [GO:0008217]; regulation of melanocyte differentiation [GO:0045634]; skeletal system development [GO:0001501]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; synapse [GO:0045202],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; synapse [GO:0045202]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipase activator activity [GO:0016004]; protein-containing complex binding [GO:0044877]; action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to pH [GO:0071467]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; endothelin receptor signaling pathway [GO:0086100]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion [GO:0032024]; regulation of blood pressure [GO:0008217]; regulation of melanocyte differentiation [GO:0045634]; skeletal system development [GO:0001501]",alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipase activator activity [GO:0016004]; protein-containing complex binding [GO:0044877],GO:0001501; GO:0001508; GO:0001664; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007200; GO:0007207; GO:0007507; GO:0008217; GO:0016004; GO:0031683; GO:0032024; GO:0044877; GO:0045202; GO:0045634; GO:0046872; GO:0047391; GO:0048066; GO:0060158; GO:0071467; GO:0086100; GO:0099105; GO:1904888; GO:1990806,"LIPID 9; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P29992""; LIPID 10; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P29992"""
P21279,reviewed,GNAQ_MOUSE,Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q),Gnaq,Mus musculus (Mouse),359,"action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; endothelin receptor signaling pathway [GO:0086100]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of protein kinase activity [GO:0006469]; neuron remodeling [GO:0016322]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion [GO:0032024]; positive regulation of smooth muscle cell proliferation [GO:0048661]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of blood pressure [GO:0008217]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; regulation of platelet activation [GO:0010543]; skeletal system development [GO:0001501]",caveola [GO:0005901]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synapse [GO:0045202],"caveola [GO:0005901]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synapse [GO:0045202]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipase activator activity [GO:0016004]; protein-containing complex binding [GO:0044877]; action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; endothelin receptor signaling pathway [GO:0086100]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of protein kinase activity [GO:0006469]; neuron remodeling [GO:0016322]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion [GO:0032024]; positive regulation of smooth muscle cell proliferation [GO:0048661]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of blood pressure [GO:0008217]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; regulation of platelet activation [GO:0010543]; skeletal system development [GO:0001501]",alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipase activator activity [GO:0016004]; protein-containing complex binding [GO:0044877],GO:0001501; GO:0001508; GO:0001664; GO:0003924; GO:0003925; GO:0005096; GO:0005525; GO:0005794; GO:0005829; GO:0005834; GO:0005886; GO:0005901; GO:0006469; GO:0007186; GO:0007189; GO:0007200; GO:0007202; GO:0007207; GO:0007215; GO:0007507; GO:0008217; GO:0009791; GO:0010543; GO:0016004; GO:0016020; GO:0016322; GO:0021884; GO:0030425; GO:0031683; GO:0031965; GO:0032024; GO:0042711; GO:0042733; GO:0043066; GO:0043267; GO:0044297; GO:0044877; GO:0045202; GO:0045634; GO:0046872; GO:0047391; GO:0048066; GO:0048661; GO:0050821; GO:0060158; GO:0060828; GO:0086100; GO:0099105; GO:1904888; GO:1990806,"LIPID 9; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:8227063""; LIPID 10; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:8227063"""
P21729,reviewed,GRPR_MOUSE,Gastrin-releasing peptide receptor (GRP-R) (GRP-preferring bombesin receptor),Grpr,Mus musculus (Mouse),384,G protein-coupled receptor signaling pathway [GO:0007186]; learning or memory [GO:0007611]; motor behavior [GO:0061744]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of respiratory gaseous exchange [GO:1903942]; psychomotor behavior [GO:0036343]; regulation of cell population proliferation [GO:0042127]; response to external biotic stimulus [GO:0043207]; social behavior [GO:0035176],membrane [GO:0016020]; plasma membrane [GO:0005886],membrane [GO:0016020]; plasma membrane [GO:0005886]; bombesin receptor activity [GO:0004946]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; learning or memory [GO:0007611]; motor behavior [GO:0061744]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of respiratory gaseous exchange [GO:1903942]; psychomotor behavior [GO:0036343]; regulation of cell population proliferation [GO:0042127]; response to external biotic stimulus [GO:0043207]; social behavior [GO:0035176],bombesin receptor activity [GO:0004946]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188],GO:0004930; GO:0004946; GO:0005886; GO:0007186; GO:0007200; GO:0007611; GO:0008188; GO:0008528; GO:0016020; GO:0035176; GO:0036343; GO:0042127; GO:0042923; GO:0043207; GO:0061744; GO:1903942; GO:2000987,"LIPID 340; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P23818,reviewed,GRIA1_MOUSE,"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)",Gria1 Glur1,Mus musculus (Mouse),907,"cellular response to ammonium ion [GO:0071242]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; modulation of chemical synaptic transmission [GO:0050804]; neuronal action potential [GO:0019228]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of synaptic transmission [GO:0050806]; receptor internalization [GO:0031623]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of receptor recycling [GO:0001919]; regulation of synaptic plasticity [GO:0048167]; response to toxic substance [GO:0009636]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249]",AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; axonal spine [GO:0044308]; cell body [GO:0044297]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],"AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; axonal spine [GO:0044308]; cell body [GO:0044297]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; adenylate cyclase binding [GO:0008179]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; beta-2 adrenergic receptor binding [GO:0031698]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor activity [GO:0004970]; ionotropic glutamate receptor binding [GO:0035255]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; myosin V binding [GO:0031489]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; small GTPase binding [GO:0031267]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to ammonium ion [GO:0071242]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; modulation of chemical synaptic transmission [GO:0050804]; neuronal action potential [GO:0019228]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of synaptic transmission [GO:0050806]; receptor internalization [GO:0031623]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of receptor recycling [GO:0001919]; regulation of synaptic plasticity [GO:0048167]; response to toxic substance [GO:0009636]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249]",adenylate cyclase binding [GO:0008179]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; beta-2 adrenergic receptor binding [GO:0031698]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor activity [GO:0004970]; ionotropic glutamate receptor binding [GO:0035255]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; myosin V binding [GO:0031489]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; small GTPase binding [GO:0031267]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0001540; GO:0001919; GO:0001965; GO:0004970; GO:0004971; GO:0005737; GO:0005769; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0005911; GO:0007268; GO:0007416; GO:0007616; GO:0008021; GO:0008179; GO:0008328; GO:0009636; GO:0009986; GO:0010628; GO:0014069; GO:0016020; GO:0019228; GO:0019865; GO:0019901; GO:0019904; GO:0030165; GO:0030425; GO:0030672; GO:0031267; GO:0031489; GO:0031594; GO:0031623; GO:0031681; GO:0031698; GO:0031901; GO:0032279; GO:0032281; GO:0032590; GO:0032591; GO:0032809; GO:0032991; GO:0035249; GO:0035254; GO:0035255; GO:0036477; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044297; GO:0044308; GO:0044309; GO:0045202; GO:0045211; GO:0045838; GO:0048167; GO:0048787; GO:0050804; GO:0050806; GO:0051018; GO:0055037; GO:0055038; GO:0060076; GO:0060078; GO:0060292; GO:0071242; GO:0097060; GO:0097110; GO:0098793; GO:0098794; GO:0098839; GO:0098978; GO:0099507; GO:0099544; GO:0099583; GO:1904315; GO:1990416,"LIPID 603; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:16129400""; LIPID 829; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:16129400"""
P23819,reviewed,GRIA2_MOUSE,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)",Gria2 Glur2,Mus musculus (Mouse),883,"cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to glycine [GO:1905430]; chemical synaptic transmission [GO:0007268]; establishment of protein localization [GO:0045184]; ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic transmission [GO:0050806]; protein tetramerization [GO:0051262]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]",AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; somatodendritic compartment [GO:0036477]; spine synapse [GO:0106033]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195],"AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; somatodendritic compartment [GO:0036477]; spine synapse [GO:0106033]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor activity [GO:0004970]; ionotropic glutamate receptor binding [GO:0035255]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; SNARE binding [GO:0000149]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to glycine [GO:1905430]; chemical synaptic transmission [GO:0007268]; establishment of protein localization [GO:0045184]; ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic transmission [GO:0050806]; protein tetramerization [GO:0051262]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]",AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor activity [GO:0004970]; ionotropic glutamate receptor binding [GO:0035255]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; SNARE binding [GO:0000149]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0000149; GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005234; GO:0005783; GO:0005789; GO:0005886; GO:0007268; GO:0008021; GO:0008092; GO:0009986; GO:0014069; GO:0015277; GO:0016020; GO:0019865; GO:0019901; GO:0030165; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031623; GO:0032279; GO:0032281; GO:0032590; GO:0032839; GO:0032991; GO:0035235; GO:0035249; GO:0035254; GO:0035255; GO:0036477; GO:0038023; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0044326; GO:0044327; GO:0044877; GO:0045184; GO:0045202; GO:0045211; GO:0048787; GO:0050804; GO:0050806; GO:0051117; GO:0051262; GO:0051966; GO:0097060; GO:0097110; GO:0098685; GO:0098793; GO:0098839; GO:0098978; GO:0099507; GO:0099544; GO:0106033; GO:1904315; GO:1905430; GO:1990416,"LIPID 610; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:16129400""; LIPID 836; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:16129400"""
P24721,reviewed,ASGR2_MOUSE,Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (Hepatic lectin 2) (HL-2) (mHL-2),Asgr2 Asgr-2,Mus musculus (Mouse),301,bone mineralization [GO:0030282]; endocytosis [GO:0006897]; glycoprotein metabolic process [GO:0009100]; lipid homeostasis [GO:0055088]; regulation of protein stability [GO:0031647],endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; perinuclear region of cytoplasm [GO:0048471],endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; perinuclear region of cytoplasm [GO:0048471]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; bone mineralization [GO:0030282]; endocytosis [GO:0006897]; glycoprotein metabolic process [GO:0009100]; lipid homeostasis [GO:0055088]; regulation of protein stability [GO:0031647],fucose binding [GO:0042806]; mannose binding [GO:0005537],GO:0005537; GO:0006897; GO:0009100; GO:0009897; GO:0030282; GO:0031647; GO:0042806; GO:0044322; GO:0048471; GO:0055088,"LIPID 54; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P25446,reviewed,TNR6_MOUSE,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),Fas Apt1 Tnfrsf6,Mus musculus (Mouse),327,activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell mediated immunity [GO:0019724]; cellular response to amino acid starvation [GO:0034198]; cellular response to hyperoxia [GO:0071455]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fas signaling pathway [GO:0036337]; gene expression [GO:0010467]; hepatocyte apoptotic process [GO:0097284]; inflammatory cell apoptotic process [GO:0006925]; lymphocyte apoptotic process [GO:0070227]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell activation [GO:0050869]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative thymic T cell selection [GO:0045060]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell death [GO:0010942]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of myeloid cell differentiation [GO:0045637]; regulation of stress-activated MAPK cascade [GO:0032872]; regulation of T cell differentiation [GO:0045580]; response to glucocorticoid [GO:0051384]; response to toxic substance [GO:0009636]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029],apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; CD95 death-inducing signaling complex [GO:0031265]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; secretory granule [GO:0030141],apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; CD95 death-inducing signaling complex [GO:0031265]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; tumor necrosis factor receptor activity [GO:0005031]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell mediated immunity [GO:0019724]; cellular response to amino acid starvation [GO:0034198]; cellular response to hyperoxia [GO:0071455]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fas signaling pathway [GO:0036337]; gene expression [GO:0010467]; hepatocyte apoptotic process [GO:0097284]; inflammatory cell apoptotic process [GO:0006925]; lymphocyte apoptotic process [GO:0070227]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell activation [GO:0050869]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative thymic T cell selection [GO:0045060]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell death [GO:0010942]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of myeloid cell differentiation [GO:0045637]; regulation of stress-activated MAPK cascade [GO:0032872]; regulation of T cell differentiation [GO:0045580]; response to glucocorticoid [GO:0051384]; response to toxic substance [GO:0009636]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029],calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; tumor necrosis factor receptor activity [GO:0005031],GO:0001934; GO:0002020; GO:0005031; GO:0005516; GO:0005576; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0006924; GO:0006925; GO:0007623; GO:0008625; GO:0009636; GO:0009897; GO:0009986; GO:0010467; GO:0010468; GO:0010626; GO:0010942; GO:0016324; GO:0016604; GO:0019724; GO:0019900; GO:0030141; GO:0031104; GO:0031264; GO:0031265; GO:0031334; GO:0032872; GO:0034198; GO:0036337; GO:0042127; GO:0042383; GO:0042802; GO:0042981; GO:0043005; GO:0043025; GO:0043029; GO:0043065; GO:0043066; GO:0043280; GO:0043525; GO:0044877; GO:0045060; GO:0045121; GO:0045577; GO:0045580; GO:0045637; GO:0048471; GO:0048536; GO:0050869; GO:0051384; GO:0051402; GO:0070227; GO:0071285; GO:0071455; GO:0090200; GO:0097049; GO:0097190; GO:0097191; GO:0097192; GO:0097284; GO:0097440; GO:0097527; GO:1900148; GO:1901532; GO:2001235; GO:2001269,"LIPID 194; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P25445"""
P25911,reviewed,LYN_MOUSE,Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn),Lyn,Mus musculus (Mouse),512,adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; C-X-C chemokine receptor CXCR4 signaling pathway [GO:0038159]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; dendritic cell differentiation [GO:0097028]; DNA damage response [GO:0006974]; eosinophil differentiation [GO:0030222]; erythrocyte differentiation [GO:0030218]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; hematopoietic progenitor cell differentiation [GO:0002244]; hemoglobin biosynthetic process [GO:0042541]; hemopoiesis [GO:0030097]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; interleukin-5-mediated signaling pathway [GO:0038043]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cytokine production [GO:0001817]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of inflammatory response [GO:0050727]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],"adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; protein-containing complex [GO:0032991]","adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; ephrin receptor binding [GO:0046875]; erythropoietin receptor binding [GO:0005128]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; C-X-C chemokine receptor CXCR4 signaling pathway [GO:0038159]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; dendritic cell differentiation [GO:0097028]; DNA damage response [GO:0006974]; eosinophil differentiation [GO:0030222]; erythrocyte differentiation [GO:0030218]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; hematopoietic progenitor cell differentiation [GO:0002244]; hemoglobin biosynthetic process [GO:0042541]; hemopoiesis [GO:0030097]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; interleukin-5-mediated signaling pathway [GO:0038043]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cytokine production [GO:0001817]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of inflammatory response [GO:0050727]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; ephrin receptor binding [GO:0046875]; erythropoietin receptor binding [GO:0005128]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625],GO:0001782; GO:0001817; GO:0001933; GO:0001934; GO:0002244; GO:0002250; GO:0002431; GO:0002513; GO:0002553; GO:0002576; GO:0002762; GO:0002768; GO:0002774; GO:0002902; GO:0004672; GO:0004713; GO:0004715; GO:0004857; GO:0005102; GO:0005128; GO:0005161; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005758; GO:0005794; GO:0005829; GO:0005886; GO:0005912; GO:0006468; GO:0006974; GO:0006991; GO:0007165; GO:0007169; GO:0008284; GO:0008285; GO:0009410; GO:0009636; GO:0009725; GO:0009743; GO:0009898; GO:0009986; GO:0010976; GO:0014003; GO:0014069; GO:0014070; GO:0016020; GO:0017124; GO:0018108; GO:0019899; GO:0030061; GO:0030097; GO:0030218; GO:0030222; GO:0030335; GO:0030889; GO:0031175; GO:0031234; GO:0031625; GO:0031663; GO:0031668; GO:0031966; GO:0032868; GO:0032991; GO:0033003; GO:0033628; GO:0034136; GO:0034142; GO:0034144; GO:0034605; GO:0034666; GO:0035556; GO:0038043; GO:0038159; GO:0042327; GO:0042531; GO:0042541; GO:0043015; GO:0043200; GO:0043208; GO:0043231; GO:0043304; GO:0043407; GO:0043552; GO:0044325; GO:0044877; GO:0045087; GO:0045121; GO:0045646; GO:0046777; GO:0046875; GO:0048471; GO:0048678; GO:0050727; GO:0050853; GO:0050855; GO:0051219; GO:0051279; GO:0060252; GO:0060369; GO:0070304; GO:0070372; GO:0070373; GO:0070447; GO:0070667; GO:0070668; GO:0071300; GO:0090025; GO:0090330; GO:0097028; GO:0097110; GO:0098978; GO:0099091; GO:0140031; GO:1902532; GO:1902961; GO:2000670,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:P07948""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P25962,reviewed,ADRB3_MOUSE,Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor),Adrb3 Adrb3r B3bar,Mus musculus (Mouse),400,activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; eating behavior [GO:0042755]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; response to antibiotic [GO:0046677]; response to cold [GO:0009409],membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; beta-3 adrenergic receptor binding [GO:0031699]; beta-adrenergic receptor activity [GO:0004939]; beta3-adrenergic receptor activity [GO:0015052]; epinephrine binding [GO:0051379]; norepinephrine binding [GO:0051380]; protein homodimerization activity [GO:0042803]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; eating behavior [GO:0042755]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; response to antibiotic [GO:0046677]; response to cold [GO:0009409],beta-3 adrenergic receptor binding [GO:0031699]; beta-adrenergic receptor activity [GO:0004939]; beta3-adrenergic receptor activity [GO:0015052]; epinephrine binding [GO:0051379]; norepinephrine binding [GO:0051380]; protein homodimerization activity [GO:0042803],GO:0002024; GO:0002025; GO:0004939; GO:0005634; GO:0005886; GO:0007189; GO:0007190; GO:0007568; GO:0009409; GO:0015052; GO:0016020; GO:0031649; GO:0031699; GO:0040015; GO:0042755; GO:0042803; GO:0043235; GO:0043410; GO:0046677; GO:0050873; GO:0051379; GO:0051380; GO:0071880; GO:0120162,"LIPID 358; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P26361,reviewed,CFTR_MOUSE,Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel),Cftr Abcc7,Mus musculus (Mouse),1476,amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; enamel mineralization [GO:0070166]; establishment of localization in cell [GO:0051649]; intracellular pH elevation [GO:0051454]; lung development [GO:0030324]; membrane hyperpolarization [GO:0060081]; multicellular organismal-level water homeostasis [GO:0050891]; negative regulation of type B pancreatic cell development [GO:2000077]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mast cell activation [GO:0033005]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]; sperm capacitation [GO:0048240]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]; vasodilation [GO:0042311]; vesicle docking involved in exocytosis [GO:0006904]; water transport [GO:0006833],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microvillus [GO:0005902]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microvillus [GO:0005902]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; protein-folding chaperone binding [GO:0051087]; Sec61 translocon complex binding [GO:0106138]; amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; enamel mineralization [GO:0070166]; establishment of localization in cell [GO:0051649]; intracellular pH elevation [GO:0051454]; lung development [GO:0030324]; membrane hyperpolarization [GO:0060081]; multicellular organismal-level water homeostasis [GO:0050891]; negative regulation of type B pancreatic cell development [GO:2000077]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mast cell activation [GO:0033005]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]; sperm capacitation [GO:0048240]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]; vasodilation [GO:0042311]; vesicle docking involved in exocytosis [GO:0006904]; water transport [GO:0006833],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; protein-folding chaperone binding [GO:0051087]; Sec61 translocon complex binding [GO:0106138],GO:0005254; GO:0005260; GO:0005524; GO:0005634; GO:0005737; GO:0005769; GO:0005789; GO:0005829; GO:0005886; GO:0005902; GO:0006695; GO:0006821; GO:0006833; GO:0006904; GO:0009410; GO:0009986; GO:0015106; GO:0015108; GO:0015701; GO:0016020; GO:0016323; GO:0016324; GO:0016853; GO:0016887; GO:0019869; GO:0019899; GO:0030165; GO:0030301; GO:0030321; GO:0030324; GO:0030425; GO:0030659; GO:0031901; GO:0032991; GO:0033005; GO:0034707; GO:0034976; GO:0035377; GO:0035725; GO:0035774; GO:0042311; GO:0042626; GO:0043025; GO:0045921; GO:0048240; GO:0050891; GO:0051087; GO:0051454; GO:0051649; GO:0055037; GO:0055038; GO:0060081; GO:0070166; GO:0070175; GO:0071320; GO:0097186; GO:0106138; GO:0140359; GO:1902161; GO:1902476; GO:1902943; GO:1904322; GO:1904446; GO:1905460; GO:2000077,"LIPID 524; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P13569""; LIPID 1391; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P13569"""
P27600,reviewed,GNA12_MOUSE,Guanine nucleotide-binding protein subunit alpha-12 (G alpha-12) (G-protein subunit alpha-12),Gna12 Gna-12,Mus musculus (Mouse),379,adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266],brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266],D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888],GO:0001701; GO:0003924; GO:0005525; GO:0005737; GO:0005834; GO:0007186; GO:0007188; GO:0007266; GO:0008217; GO:0008360; GO:0009410; GO:0010762; GO:0016328; GO:0019888; GO:0030154; GO:0031526; GO:0031683; GO:0031752; GO:0032006; GO:0032434; GO:0032516; GO:0035556; GO:0042733; GO:0043005; GO:0043025; GO:0046872; GO:0051721; GO:1904706; GO:1904753,"LIPID 11; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:9485474"""
P27601,reviewed,GNA13_MOUSE,Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13),Gna13 Gna-13,Mus musculus (Mouse),377,activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; Rho protein signal transduction [GO:0007266],brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886],brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; Rho protein signal transduction [GO:0007266],D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0001525; GO:0001569; GO:0001701; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007189; GO:0007204; GO:0007266; GO:0008217; GO:0008360; GO:0010762; GO:0030154; GO:0030168; GO:0031526; GO:0031584; GO:0031683; GO:0031752; GO:0035556; GO:0042470; GO:0046872; GO:1904706; GO:1904753,"LIPID 14; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q14344""; LIPID 18; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q14344"""
P28334,reviewed,5HT1B_MOUSE,5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B),Htr1b 5ht1b,Mus musculus (Mouse),386,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to temperature stimulus [GO:0071502]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; drinking behavior [GO:0042756]; feeding behavior [GO:0007631]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to mineralocorticoid [GO:0051385]; vasoconstriction [GO:0042310]",calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; G protein-coupled serotonin receptor complex [GO:0098666]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; serotonergic synapse [GO:0099154],"calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; G protein-coupled serotonin receptor complex [GO:0098666]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; serotonergic synapse [GO:0099154]; G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to temperature stimulus [GO:0071502]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; drinking behavior [GO:0042756]; feeding behavior [GO:0007631]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to mineralocorticoid [GO:0051385]; vasoconstriction [GO:0042310]",G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626],GO:0002031; GO:0004993; GO:0005737; GO:0005783; GO:0005886; GO:0007187; GO:0007193; GO:0007198; GO:0007205; GO:0007268; GO:0007631; GO:0014053; GO:0014059; GO:0014063; GO:0030425; GO:0030594; GO:0032229; GO:0042220; GO:0042310; GO:0042734; GO:0042756; GO:0044305; GO:0045471; GO:0046849; GO:0050795; GO:0051378; GO:0051385; GO:0051967; GO:0071312; GO:0071466; GO:0071502; GO:0098666; GO:0099154; GO:0099171; GO:0099626; GO:1901363; GO:1904707; GO:2000300,"LIPID 384; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P29754,reviewed,AGTRA_MOUSE,Type-1 angiotensin II receptor A (Angiotensin II type-1 receptor A) (AT1 receptor A),Agtr1a Agtr1,Mus musculus (Mouse),359,activation of Janus kinase activity [GO:0042976]; aging [GO:0007568]; angiotensin-activated signaling pathway [GO:0038166]; blood vessel development [GO:0001568]; brain renin-angiotensin system [GO:0002035]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to dexamethasone stimulus [GO:0071549]; dopamine biosynthetic process [GO:0042416]; drinking behavior [GO:0042756]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; heart development [GO:0007507]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neuron apoptotic process [GO:0051402]; phospholipase C-activating angiotensin-activated signaling pathway [GO:0086097]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood pressure [GO:0045777]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of receptor recycling [GO:0001921]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of blood pressure [GO:0008217]; regulation of pH [GO:0006885]; regulation of renal output by angiotensin [GO:0002019]; regulation of systemic arterial blood pressure by circulatory renin-angiotensin [GO:0001991]; regulation of vascular associated smooth muscle cell apoptotic process [GO:1905459]; regulation of vasoconstriction [GO:0019229]; renin secretion into blood stream [GO:0002001]; renin-angiotensin regulation of aldosterone production [GO:0002018]; response to activity [GO:0014823]; response to corticosterone [GO:0051412]; response to estrogen [GO:0043627]; response to salt stress [GO:0009651]; Rho protein signal transduction [GO:0007266]; vascular associated smooth muscle cell proliferation [GO:1990874]; vasoconstriction [GO:0042310]; viral entry into host cell [GO:0046718],basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; organelle outer membrane [GO:0031968]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; organelle outer membrane [GO:0031968]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; angiotensin type I receptor activity [GO:0001596]; angiotensin type II receptor activity [GO:0004945]; bradykinin receptor binding [GO:0031711]; D1 dopamine receptor binding [GO:0031748]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; activation of Janus kinase activity [GO:0042976]; aging [GO:0007568]; angiotensin-activated signaling pathway [GO:0038166]; blood vessel development [GO:0001568]; brain renin-angiotensin system [GO:0002035]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to dexamethasone stimulus [GO:0071549]; dopamine biosynthetic process [GO:0042416]; drinking behavior [GO:0042756]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; heart development [GO:0007507]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neuron apoptotic process [GO:0051402]; phospholipase C-activating angiotensin-activated signaling pathway [GO:0086097]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood pressure [GO:0045777]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of receptor recycling [GO:0001921]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of blood pressure [GO:0008217]; regulation of pH [GO:0006885]; regulation of renal output by angiotensin [GO:0002019]; regulation of systemic arterial blood pressure by circulatory renin-angiotensin [GO:0001991]; regulation of vascular associated smooth muscle cell apoptotic process [GO:1905459]; regulation of vasoconstriction [GO:0019229]; renin secretion into blood stream [GO:0002001]; renin-angiotensin regulation of aldosterone production [GO:0002018]; response to activity [GO:0014823]; response to corticosterone [GO:0051412]; response to estrogen [GO:0043627]; response to salt stress [GO:0009651]; Rho protein signal transduction [GO:0007266]; vascular associated smooth muscle cell proliferation [GO:1990874]; vasoconstriction [GO:0042310]; viral entry into host cell [GO:0046718],angiotensin type I receptor activity [GO:0001596]; angiotensin type II receptor activity [GO:0004945]; bradykinin receptor binding [GO:0031711]; D1 dopamine receptor binding [GO:0031748]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0001568; GO:0001596; GO:0001819; GO:0001822; GO:0001921; GO:0001991; GO:0002001; GO:0002018; GO:0002019; GO:0002034; GO:0002035; GO:0004945; GO:0005737; GO:0005768; GO:0005794; GO:0005886; GO:0006885; GO:0006954; GO:0007186; GO:0007200; GO:0007204; GO:0007266; GO:0007507; GO:0007568; GO:0008217; GO:0008284; GO:0009651; GO:0010467; GO:0010744; GO:0012505; GO:0014823; GO:0016020; GO:0016323; GO:0019229; GO:0019722; GO:0019901; GO:0030425; GO:0031410; GO:0031711; GO:0031748; GO:0031968; GO:0032430; GO:0032930; GO:0034392; GO:0038166; GO:0042310; GO:0042416; GO:0042756; GO:0042976; GO:0043627; GO:0045766; GO:0045777; GO:0046718; GO:0046982; GO:0051247; GO:0051402; GO:0051412; GO:0051482; GO:0055037; GO:0060326; GO:0071549; GO:0086097; GO:0090190; GO:1903589; GO:1904707; GO:1905459; GO:1905665; GO:1905920; GO:1990874,"LIPID 355; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P29755,reviewed,AGTRB_MOUSE,Type-1 angiotensin II receptor B (AT3) (Angiotensin II type-1 receptor B) (AT1 receptor B),Agtr1b,Mus musculus (Mouse),359,angiotensin-activated signaling pathway [GO:0038166]; blood vessel development [GO:0001568]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to dexamethasone stimulus [GO:0071549]; drinking behavior [GO:0042756]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; neuron apoptotic process [GO:0051402]; phospholipase C-activating angiotensin-activated signaling pathway [GO:0086097]; positive regulation of blood pressure [GO:0045777]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of protein metabolic process [GO:0051247]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by circulatory renin-angiotensin [GO:0001991]; regulation of vasoconstriction [GO:0019229]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; response to salt stress [GO:0009651]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; viral entry into host cell [GO:0046718],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; angiotensin type I receptor activity [GO:0001596]; angiotensin type II receptor activity [GO:0004945]; bradykinin receptor binding [GO:0031711]; protein heterodimerization activity [GO:0046982]; angiotensin-activated signaling pathway [GO:0038166]; blood vessel development [GO:0001568]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to dexamethasone stimulus [GO:0071549]; drinking behavior [GO:0042756]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; neuron apoptotic process [GO:0051402]; phospholipase C-activating angiotensin-activated signaling pathway [GO:0086097]; positive regulation of blood pressure [GO:0045777]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of protein metabolic process [GO:0051247]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by circulatory renin-angiotensin [GO:0001991]; regulation of vasoconstriction [GO:0019229]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; response to salt stress [GO:0009651]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; viral entry into host cell [GO:0046718],angiotensin type I receptor activity [GO:0001596]; angiotensin type II receptor activity [GO:0004945]; bradykinin receptor binding [GO:0031711]; protein heterodimerization activity [GO:0046982],GO:0001568; GO:0001596; GO:0001666; GO:0001822; GO:0001991; GO:0002034; GO:0004945; GO:0005886; GO:0006954; GO:0007186; GO:0007204; GO:0007266; GO:0007584; GO:0008217; GO:0009410; GO:0009651; GO:0010744; GO:0019229; GO:0019722; GO:0031711; GO:0032430; GO:0035094; GO:0035902; GO:0038166; GO:0042756; GO:0043627; GO:0045777; GO:0046718; GO:0046982; GO:0051247; GO:0051402; GO:0051482; GO:0060326; GO:0071549; GO:0086097; GO:0090190; GO:1903589; GO:1905920,"LIPID 355; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P30545,reviewed,ADA2B_MOUSE,Alpha-2B adrenergic receptor (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR),Adra2b,Mus musculus (Mouse),453,activation of protein kinase B activity [GO:0032148]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; angiogenesis [GO:0001525]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; MAPK cascade [GO:0000165]; platelet activation [GO:0030168]; positive regulation of blood pressure [GO:0045777]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of uterine smooth muscle contraction [GO:0070474]; receptor transactivation [GO:0035624]; regulation of vascular associated smooth muscle contraction [GO:0003056],cell surface [GO:0009986]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],cell surface [GO:0009986]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; activation of protein kinase B activity [GO:0032148]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; angiogenesis [GO:0001525]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; MAPK cascade [GO:0000165]; platelet activation [GO:0030168]; positive regulation of blood pressure [GO:0045777]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of uterine smooth muscle contraction [GO:0070474]; receptor transactivation [GO:0035624]; regulation of vascular associated smooth muscle contraction [GO:0003056],adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379],GO:0000165; GO:0001525; GO:0003056; GO:0004935; GO:0004938; GO:0005829; GO:0005886; GO:0007186; GO:0007565; GO:0009986; GO:0030168; GO:0032148; GO:0035624; GO:0043231; GO:0043410; GO:0045666; GO:0045777; GO:0051379; GO:0070474; GO:0071875; GO:0071880,"LIPID 445; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P30548,reviewed,NK1R_MOUSE,Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1),Tacr1 Tac1r,Mus musculus (Mouse),407,"acute inflammatory response [GO:0002526]; aggressive behavior [GO:0002118]; angiotensin-mediated drinking behavior [GO:0003051]; associative learning [GO:0008306]; behavioral response to pain [GO:0048266]; eating behavior [GO:0042755]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; operant conditioning [GO:0035106]; positive regulation of action potential [GO:0045760]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of hormone secretion [GO:0046887]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of ossification [GO:0045778]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of saliva secretion [GO:0046878]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of uterine smooth muscle contraction [GO:0070472]; response to auditory stimulus [GO:0010996]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to ozone [GO:0010193]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; sensory perception of pain [GO:0019233]; smooth muscle contraction involved in micturition [GO:0060083]; sperm ejaculation [GO:0042713]; tachykinin receptor signaling pathway [GO:0007217]",cell body [GO:0044297]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225],"cell body [GO:0044297]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; substance P receptor activity [GO:0016496]; acute inflammatory response [GO:0002526]; aggressive behavior [GO:0002118]; angiotensin-mediated drinking behavior [GO:0003051]; associative learning [GO:0008306]; behavioral response to pain [GO:0048266]; eating behavior [GO:0042755]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; operant conditioning [GO:0035106]; positive regulation of action potential [GO:0045760]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of hormone secretion [GO:0046887]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of ossification [GO:0045778]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of saliva secretion [GO:0046878]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of uterine smooth muscle contraction [GO:0070472]; response to auditory stimulus [GO:0010996]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to ozone [GO:0010193]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; sensory perception of pain [GO:0019233]; smooth muscle contraction involved in micturition [GO:0060083]; sperm ejaculation [GO:0042713]; tachykinin receptor signaling pathway [GO:0007217]",substance P receptor activity [GO:0016496],GO:0002118; GO:0002526; GO:0002687; GO:0003051; GO:0005737; GO:0005886; GO:0007204; GO:0007217; GO:0007611; GO:0007616; GO:0008217; GO:0008306; GO:0009408; GO:0009725; GO:0009986; GO:0010193; GO:0010634; GO:0010996; GO:0014070; GO:0014910; GO:0016496; GO:0019233; GO:0030425; GO:0032224; GO:0032230; GO:0032355; GO:0032570; GO:0035094; GO:0035106; GO:0035815; GO:0036126; GO:0042713; GO:0042755; GO:0043117; GO:0043278; GO:0044297; GO:0045471; GO:0045760; GO:0045777; GO:0045778; GO:0045907; GO:0046878; GO:0046887; GO:0048265; GO:0048266; GO:0048660; GO:0050671; GO:0050679; GO:0051496; GO:0051602; GO:0060083; GO:0061827; GO:0070472; GO:0070474; GO:0071944; GO:0097225; GO:1902093,"LIPID 322; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P30549,reviewed,NK2R_MOUSE,Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2),Tacr2 Tac2r,Mus musculus (Mouse),384,"intestine smooth muscle contraction [GO:0014827]; negative regulation of luteinizing hormone secretion [GO:0033685]; operant conditioning [GO:0035106]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of monoatomic ion transport [GO:0043270]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; prolactin secretion [GO:0070459]; regulation of uterine smooth muscle contraction [GO:0070472]; response to electrical stimulus [GO:0051602]",membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225],"membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; substance K receptor activity [GO:0016497]; intestine smooth muscle contraction [GO:0014827]; negative regulation of luteinizing hormone secretion [GO:0033685]; operant conditioning [GO:0035106]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of monoatomic ion transport [GO:0043270]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; prolactin secretion [GO:0070459]; regulation of uterine smooth muscle contraction [GO:0070472]; response to electrical stimulus [GO:0051602]",substance K receptor activity [GO:0016497],GO:0005886; GO:0014057; GO:0014827; GO:0016020; GO:0016497; GO:0033685; GO:0035106; GO:0036126; GO:0043117; GO:0043270; GO:0051602; GO:0061827; GO:0070459; GO:0070472; GO:0070474; GO:0097225; GO:1902093,"LIPID 324; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P30730,reviewed,LSHR_MOUSE,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Lhcgr Lhr,Mus musculus (Mouse),700,activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; arachidonic acid secretion [GO:0050482]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to luteinizing hormone stimulus [GO:0071373]; central nervous system development [GO:0007417]; cognition [GO:0050890]; development of secondary male sexual characteristics [GO:0046544]; female gonad development [GO:0008585]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; protein targeting to lysosome [GO:0006622]; regulation of steroid hormone biosynthetic process [GO:0090030]; response to luteinizing hormone [GO:0034699]; response to xenobiotic stimulus [GO:0009410]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]; uterus development [GO:0060065],centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATPase binding [GO:0051117]; choriogonadotropin hormone binding [GO:0038106]; choriogonadotropin hormone receptor activity [GO:0035472]; G protein-coupled peptide receptor activity [GO:0008528]; identical protein binding [GO:0042802]; luteinizing hormone receptor activity [GO:0004964]; peptide hormone binding [GO:0017046]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; arachidonic acid secretion [GO:0050482]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to luteinizing hormone stimulus [GO:0071373]; central nervous system development [GO:0007417]; cognition [GO:0050890]; development of secondary male sexual characteristics [GO:0046544]; female gonad development [GO:0008585]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; protein targeting to lysosome [GO:0006622]; regulation of steroid hormone biosynthetic process [GO:0090030]; response to luteinizing hormone [GO:0034699]; response to xenobiotic stimulus [GO:0009410]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]; uterus development [GO:0060065],ATPase binding [GO:0051117]; choriogonadotropin hormone binding [GO:0038106]; choriogonadotropin hormone receptor activity [GO:0035472]; G protein-coupled peptide receptor activity [GO:0008528]; identical protein binding [GO:0042802]; luteinizing hormone receptor activity [GO:0004964]; peptide hormone binding [GO:0017046],GO:0001541; GO:0004964; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0006622; GO:0007188; GO:0007189; GO:0007190; GO:0007200; GO:0007283; GO:0007417; GO:0008528; GO:0008584; GO:0008585; GO:0009410; GO:0009755; GO:0010524; GO:0016020; GO:0017046; GO:0022602; GO:0032962; GO:0034451; GO:0034699; GO:0035472; GO:0038106; GO:0042700; GO:0042802; GO:0043235; GO:0046544; GO:0046886; GO:0050482; GO:0050850; GO:0050890; GO:0051117; GO:0051281; GO:0060065; GO:0071371; GO:0071373; GO:0072520; GO:0090030,"LIPID 647; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 648; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P30873,reviewed,SSR1_MOUSE,Somatostatin receptor type 1 (SS-1-R) (SS1-R) (SS1R) (SRIF-2),Sstr1 Smstr1,Mus musculus (Mouse),391,cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; neuropeptide signaling pathway [GO:0007218]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; somatostatin receptor activity [GO:0004994]; cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; neuropeptide signaling pathway [GO:0007218]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283],somatostatin receptor activity [GO:0004994],GO:0004994; GO:0005737; GO:0005886; GO:0007186; GO:0007215; GO:0007218; GO:0007283; GO:0016020; GO:0021549; GO:0030900; GO:0042594; GO:0043005; GO:0071392; GO:1990830,"LIPID 339; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P30875,reviewed,SSR2_MOUSE,Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SRIF-1),Sstr2 Smstr2 Sst2,Mus musculus (Mouse),369,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; peristalsis [GO:0030432]; regulation of muscle contraction [GO:0006937]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; somatostatin receptor activity [GO:0004994]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; peristalsis [GO:0030432]; regulation of muscle contraction [GO:0006937]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283],PDZ domain binding [GO:0030165]; somatostatin receptor activity [GO:0004994],GO:0004994; GO:0005737; GO:0005829; GO:0005886; GO:0006937; GO:0007186; GO:0007193; GO:0007218; GO:0007283; GO:0016020; GO:0021549; GO:0030165; GO:0030432; GO:0030900; GO:0042594; GO:0043005; GO:0071385; GO:0071392,"LIPID 328; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P32299,reviewed,BKRB2_MOUSE,B2 bradykinin receptor (B2R) (BK-2 receptor),Bdkrb2,Mus musculus (Mouse),392,acute inflammatory response to antigenic stimulus [GO:0002438]; arachidonic acid secretion [GO:0050482]; G protein-coupled receptor signaling pathway [GO:0007186]; intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator [GO:1990127]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator [GO:1902239]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to salt stress [GO:0009651]; smooth muscle contraction [GO:0006939]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; beta-2 adrenergic receptor binding [GO:0031698]; bradykinin receptor activity [GO:0004947]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; type 1 angiotensin receptor binding [GO:0031702]; acute inflammatory response to antigenic stimulus [GO:0002438]; arachidonic acid secretion [GO:0050482]; G protein-coupled receptor signaling pathway [GO:0007186]; intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator [GO:1990127]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator [GO:1902239]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to salt stress [GO:0009651]; smooth muscle contraction [GO:0006939]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311],beta-2 adrenergic receptor binding [GO:0031698]; bradykinin receptor activity [GO:0004947]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; type 1 angiotensin receptor binding [GO:0031702],GO:0002020; GO:0002438; GO:0004947; GO:0005768; GO:0005794; GO:0005886; GO:0006939; GO:0007186; GO:0007204; GO:0008285; GO:0009651; GO:0031698; GO:0031702; GO:0033137; GO:0035633; GO:0042310; GO:0042311; GO:0043231; GO:0045776; GO:0046982; GO:0050482; GO:1902219; GO:1902239; GO:1990127,"LIPID 352; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P32300,reviewed,OPRD_MOUSE,Delta-type opioid receptor (D-OR-1) (DOR-1) (K56) (MSL-2),Oprd1,Mus musculus (Mouse),372,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cellular response to toxic substance [GO:0097237]; eating behavior [GO:0042755]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of gene expression [GO:0010629]; negative regulation of protein-containing complex assembly [GO:0031333]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of sensory perception of pain [GO:0051930],axon terminus [GO:0043679]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal dense core vesicle [GO:0098992]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; spine apparatus [GO:0097444]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982],axon terminus [GO:0043679]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal dense core vesicle [GO:0098992]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; spine apparatus [GO:0097444]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; G protein-coupled enkephalin receptor activity [GO:0038046]; G protein-coupled opioid receptor activity [GO:0004985]; receptor serine/threonine kinase binding [GO:0033612]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cellular response to toxic substance [GO:0097237]; eating behavior [GO:0042755]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of gene expression [GO:0010629]; negative regulation of protein-containing complex assembly [GO:0031333]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of sensory perception of pain [GO:0051930],G protein-coupled enkephalin receptor activity [GO:0038046]; G protein-coupled opioid receptor activity [GO:0004985]; receptor serine/threonine kinase binding [GO:0033612],GO:0004985; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007200; GO:0007218; GO:0008344; GO:0010629; GO:0016020; GO:0030672; GO:0031333; GO:0031982; GO:0032590; GO:0033138; GO:0033612; GO:0038003; GO:0038046; GO:0042734; GO:0042755; GO:0043005; GO:0043679; GO:0045121; GO:0045211; GO:0051881; GO:0051924; GO:0051930; GO:0071363; GO:0071456; GO:0097237; GO:0097444; GO:0098839; GO:0098992,"LIPID 333; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P32304,reviewed,5HT7R_MOUSE,5-hydroxytryptamine receptor 7 (5-HT-7) (5-HT7) (5-HT-X) (Serotonin receptor 7),Htr7,Mus musculus (Mouse),448,"adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; behavioral response to pain [GO:0048266]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; dopaminergic neuron differentiation [GO:0071542]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; micturition [GO:0060073]; negative regulation of circadian sleep/wake cycle, REM sleep [GO:0042322]; negative regulation of serotonin secretion [GO:0014063]; positive regulation of neuron projection development [GO:0010976]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of vein smooth muscle contraction [GO:0062086]; response to corticosterone [GO:0051412]; serotonin receptor signaling pathway [GO:0007210]; urinary bladder smooth muscle contraction [GO:0014832]; vasoconstriction [GO:0042310]",axon terminus [GO:0043679]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; rough endoplasmic reticulum [GO:0005791]; synaptic vesicle [GO:0008021],"axon terminus [GO:0043679]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; rough endoplasmic reticulum [GO:0005791]; synaptic vesicle [GO:0008021]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; behavioral response to pain [GO:0048266]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; dopaminergic neuron differentiation [GO:0071542]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; micturition [GO:0060073]; negative regulation of circadian sleep/wake cycle, REM sleep [GO:0042322]; negative regulation of serotonin secretion [GO:0014063]; positive regulation of neuron projection development [GO:0010976]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of vein smooth muscle contraction [GO:0062086]; response to corticosterone [GO:0051412]; serotonin receptor signaling pathway [GO:0007210]; urinary bladder smooth muscle contraction [GO:0014832]; vasoconstriction [GO:0042310]",G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594],GO:0004993; GO:0005791; GO:0007187; GO:0007192; GO:0007210; GO:0007268; GO:0007613; GO:0007623; GO:0008021; GO:0010976; GO:0014063; GO:0014832; GO:0030425; GO:0030594; GO:0042310; GO:0042322; GO:0042734; GO:0043025; GO:0043679; GO:0045211; GO:0048266; GO:0050966; GO:0051412; GO:0060073; GO:0060291; GO:0062086; GO:0071542; GO:0099171,"LIPID 404; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P32883,reviewed,RASK_MOUSE,"GTPase KRas (EC 3.6.5.2) (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]",Kras Kras2,Mus musculus (Mouse),189,"actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; cytokine-mediated signaling pathway [GO:0019221]; endocrine signaling [GO:0038002]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain astrocyte development [GO:0021897]; glial cell proliferation [GO:0014009]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic transmission, GABAergic [GO:0032228]; skeletal muscle cell differentiation [GO:0035914]; striated muscle cell differentiation [GO:0051146]; type I pneumocyte differentiation [GO:0060509]; visual learning [GO:0008542]",cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GMP binding [GO:0019002]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; cytokine-mediated signaling pathway [GO:0019221]; endocrine signaling [GO:0038002]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain astrocyte development [GO:0021897]; glial cell proliferation [GO:0014009]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic transmission, GABAergic [GO:0032228]; skeletal muscle cell differentiation [GO:0035914]; striated muscle cell differentiation [GO:0051146]; type I pneumocyte differentiation [GO:0060509]; visual learning [GO:0008542]",G protein activity [GO:0003925]; GDP binding [GO:0019003]; GMP binding [GO:0019002]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495],GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005739; GO:0005886; GO:0007265; GO:0008283; GO:0008284; GO:0008542; GO:0010628; GO:0012505; GO:0014009; GO:0016020; GO:0016601; GO:0019002; GO:0019003; GO:0019221; GO:0021897; GO:0030036; GO:0030275; GO:0030857; GO:0031234; GO:0032228; GO:0035022; GO:0035914; GO:0038002; GO:0042802; GO:0043406; GO:0043495; GO:0043524; GO:0043539; GO:0044877; GO:0045121; GO:0048009; GO:0048169; GO:0048873; GO:0051000; GO:0051092; GO:0051146; GO:0051402; GO:0060252; GO:0060441; GO:0060509; GO:2000774,"LIPID 180; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P01116""; LIPID 182; /note=""N6-palmitoyl lysine""; /evidence=""ECO:0000250|UniProtKB:P01116""; LIPID 184; /note=""N6-palmitoyl lysine""; /evidence=""ECO:0000250|UniProtKB:P01116""; LIPID 185; /note=""N6-palmitoyl lysine""; /evidence=""ECO:0000250|UniProtKB:P01116""; LIPID 186; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P01116"""
P33033,reviewed,MC3R_MOUSE,Melanocortin receptor 3 (MC3-R),Mc3r,Mus musculus (Mouse),323,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; circadian regulation of gene expression [GO:0032922]; homoiothermy [GO:0042309]; locomotor rhythm [GO:0045475]; regulation of blood pressure [GO:0008217]; regulation of feeding behavior [GO:0060259]; regulation of heart rate [GO:0002027]; sodium ion homeostasis [GO:0055078],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; circadian regulation of gene expression [GO:0032922]; homoiothermy [GO:0042309]; locomotor rhythm [GO:0045475]; regulation of blood pressure [GO:0008217]; regulation of feeding behavior [GO:0060259]; regulation of heart rate [GO:0002027]; sodium ion homeostasis [GO:0055078],melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046],GO:0002027; GO:0004977; GO:0004980; GO:0005886; GO:0007188; GO:0007189; GO:0008217; GO:0017046; GO:0032922; GO:0042309; GO:0042923; GO:0045475; GO:0055078; GO:0060259,"LIPID 315; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P33534,reviewed,OPRK_MOUSE,Kappa-type opioid receptor (K-OR-1) (KOR-1) (MSL-1),Oprk1,Mus musculus (Mouse),380,adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to cocaine [GO:0048148]; cellular response to glucose stimulus [GO:0071333]; conditioned place preference [GO:1990708]; defense response to virus [GO:0051607]; eating behavior [GO:0042755]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; immune response [GO:0006955]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; negative regulation of luteinizing hormone secretion [GO:0033685]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of eating behavior [GO:1904000]; positive regulation of locomotion [GO:0040017]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of saliva secretion [GO:0046877]; regulation of sensory perception of pain [GO:0051930]; response to insulin [GO:0032868]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951],axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; dynorphin receptor activity [GO:0038048]; G protein-coupled opioid receptor activity [GO:0004985]; receptor serine/threonine kinase binding [GO:0033612]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to cocaine [GO:0048148]; cellular response to glucose stimulus [GO:0071333]; conditioned place preference [GO:1990708]; defense response to virus [GO:0051607]; eating behavior [GO:0042755]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; immune response [GO:0006955]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; negative regulation of luteinizing hormone secretion [GO:0033685]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of eating behavior [GO:1904000]; positive regulation of locomotion [GO:0040017]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of saliva secretion [GO:0046877]; regulation of sensory perception of pain [GO:0051930]; response to insulin [GO:0032868]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951],dynorphin receptor activity [GO:0038048]; G protein-coupled opioid receptor activity [GO:0004985]; receptor serine/threonine kinase binding [GO:0033612],GO:0004985; GO:0005654; GO:0005829; GO:0005886; GO:0006955; GO:0007200; GO:0007218; GO:0007626; GO:0016020; GO:0019233; GO:0030425; GO:0030672; GO:0031635; GO:0032868; GO:0033603; GO:0033612; GO:0033685; GO:0038003; GO:0038048; GO:0040017; GO:0042711; GO:0042734; GO:0042755; GO:0043005; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046877; GO:0048148; GO:0050951; GO:0051607; GO:0051930; GO:0071333; GO:1900745; GO:1901381; GO:1904000; GO:1990708,"LIPID 345; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P34927,reviewed,ASGR1_MOUSE,Asialoglycoprotein receptor 1 (ASGP-R 1) (ASGPR 1) (Hepatic lectin 1) (HL-1) (mHL-1),Asgr1 Asgr-1,Mus musculus (Mouse),284,cellular response to extracellular stimulus [GO:0031668],external side of plasma membrane [GO:0009897],external side of plasma membrane [GO:0009897]; asialoglycoprotein receptor activity [GO:0004873]; fucose binding [GO:0042806]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; cellular response to extracellular stimulus [GO:0031668],asialoglycoprotein receptor activity [GO:0004873]; fucose binding [GO:0042806]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872],GO:0004873; GO:0005537; GO:0009897; GO:0031668; GO:0042802; GO:0042806; GO:0046872,"LIPID 35; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P34971,reviewed,ADRB1_MOUSE,Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor),Adrb1 Adrb1r,Mus musculus (Mouse),466,"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic process [GO:0006915]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; fear response [GO:0042596]; G protein-coupled receptor signaling pathway [GO:0007186]; glycogen catabolic process [GO:0005980]; heat generation [GO:0031649]; inhibitory postsynaptic potential [GO:0060080]; lipid homeostasis [GO:0055088]; memory [GO:0007613]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of urine volume [GO:0035811]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart rate [GO:0010460]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of renin secretion into blood stream [GO:1900135]; positive regulation of saliva secretion [GO:0046878]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of the force of heart contraction by norepinephrine [GO:0003061]; protein localization to organelle [GO:0033365]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to cold [GO:0009409]; Rho protein signal transduction [GO:0007266]; sensory perception of pain [GO:0019233]; wound healing [GO:0042060]",cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal dense core vesicle [GO:0098992]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685],"cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal dense core vesicle [GO:0098992]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; alpha-2A adrenergic receptor binding [GO:0031694]; amine binding [GO:0043176]; beta1-adrenergic receptor activity [GO:0004940]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic process [GO:0006915]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; fear response [GO:0042596]; G protein-coupled receptor signaling pathway [GO:0007186]; glycogen catabolic process [GO:0005980]; heat generation [GO:0031649]; inhibitory postsynaptic potential [GO:0060080]; lipid homeostasis [GO:0055088]; memory [GO:0007613]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of urine volume [GO:0035811]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart rate [GO:0010460]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of renin secretion into blood stream [GO:1900135]; positive regulation of saliva secretion [GO:0046878]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of the force of heart contraction by norepinephrine [GO:0003061]; protein localization to organelle [GO:0033365]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to cold [GO:0009409]; Rho protein signal transduction [GO:0007266]; sensory perception of pain [GO:0019233]; wound healing [GO:0042060]",alpha-2A adrenergic receptor binding [GO:0031694]; amine binding [GO:0043176]; beta1-adrenergic receptor activity [GO:0004940]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982],GO:0001996; GO:0001997; GO:0002024; GO:0002025; GO:0003061; GO:0003084; GO:0004940; GO:0005085; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0005980; GO:0006915; GO:0007186; GO:0007189; GO:0007266; GO:0007613; GO:0009409; GO:0010460; GO:0016020; GO:0019233; GO:0030165; GO:0031649; GO:0031694; GO:0033365; GO:0035811; GO:0040015; GO:0042060; GO:0042596; GO:0043065; GO:0043176; GO:0043231; GO:0043547; GO:0045187; GO:0045762; GO:0045986; GO:0046878; GO:0046982; GO:0050873; GO:0051924; GO:0055088; GO:0060080; GO:0061051; GO:0071880; GO:0086004; GO:0098685; GO:0098794; GO:0098992; GO:0099579; GO:0106071; GO:0120162; GO:1900135; GO:1900273; GO:1905665; GO:2001259,"LIPID 381; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P35293,reviewed,RAB18_MOUSE,Ras-related protein Rab-18,Rab18,Mus musculus (Mouse),206,brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389],apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; synapse [GO:0045202],apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; synapse [GO:0045202]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0001654; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0005811; GO:0006886; GO:0007420; GO:0012505; GO:0016324; GO:0019003; GO:0034389; GO:0045202; GO:0051170; GO:0071782; GO:0071786,"LIPID 199; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 203; /note=""S-geranylgeranyl cysteine""; /evidence=""ECO:0000250"""
P35377,reviewed,OPRX_MOUSE,Nociceptin receptor (K3 opiate receptor) (Kappa-type 3 opioid receptor) (KOR-3) (ORGC) (Orphanin FQ receptor),Oprl1 Oor Oprl,Mus musculus (Mouse),367,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; conditioned place preference [GO:1990708]; eating behavior [GO:0042755]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of blood pressure [GO:0045776]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of urine volume [GO:0035810]; regulation of locomotor rhythm [GO:1904059]; regulation of sensory perception of pain [GO:0051930]; sensory perception of pain [GO:0019233],cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; nociceptin receptor activity [GO:0001626]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; conditioned place preference [GO:1990708]; eating behavior [GO:0042755]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of blood pressure [GO:0045776]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of urine volume [GO:0035810]; regulation of locomotor rhythm [GO:1904059]; regulation of sensory perception of pain [GO:0051930]; sensory perception of pain [GO:0019233],G protein-coupled receptor activity [GO:0004930]; nociceptin receptor activity [GO:0001626],GO:0001626; GO:0004930; GO:0005886; GO:0007193; GO:0007218; GO:0016020; GO:0019233; GO:0031410; GO:0035810; GO:0038003; GO:0042755; GO:0043005; GO:0043951; GO:0045776; GO:0051482; GO:0051930; GO:0060454; GO:0106072; GO:1901386; GO:1904058; GO:1904059; GO:1990708,"LIPID 331; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P35564,reviewed,CALX_MOUSE,Calnexin,Canx,Mus musculus (Mouse),591,aging [GO:0007568]; clathrin-dependent endocytosis [GO:0072583]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488]; ubiquitin-dependent ERAD pathway [GO:0030433],axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; glutamatergic synapse [GO:0098978]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790],axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; glutamatergic synapse [GO:0098978]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; unfolded protein binding [GO:0051082]; aging [GO:0007568]; clathrin-dependent endocytosis [GO:0072583]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488]; ubiquitin-dependent ERAD pathway [GO:0030433],apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; unfolded protein binding [GO:0051082],GO:0005509; GO:0005737; GO:0005783; GO:0005789; GO:0005790; GO:0005791; GO:0005840; GO:0006457; GO:0007568; GO:0016020; GO:0030246; GO:0030424; GO:0030433; GO:0031965; GO:0032839; GO:0032991; GO:0034185; GO:0035255; GO:0042470; GO:0043025; GO:0043197; GO:0043209; GO:0044233; GO:0044322; GO:0045211; GO:0048488; GO:0048787; GO:0051082; GO:0072583; GO:0098553; GO:0098978,"LIPID 503; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 504; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P39688,reviewed,FYN_MOUSE,Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn),Fyn,Mus musculus (Mouse),537,activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to glycine [GO:1905430]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamate [GO:1905232]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendrite morphogenesis [GO:0048813]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; forebrain development [GO:0030900]; heart process [GO:0003015]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; modulation of chemical synaptic transmission [GO:0050804]; myelination [GO:0042552]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell shape [GO:0008360]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to amyloid-beta [GO:1904645]; response to ethanol [GO:0045471]; response to singlet oxygen [GO:0000304]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],"actin filament [GO:0005884]; cell body [GO:0044297]; cell periphery [GO:0071944]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]","actin filament [GO:0005884]; cell body [GO:0044297]; cell periphery [GO:0071944]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; tau protein binding [GO:0048156]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631]; type 5 metabotropic glutamate receptor binding [GO:0031802]; activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to glycine [GO:1905430]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamate [GO:1905232]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendrite morphogenesis [GO:0048813]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; forebrain development [GO:0030900]; heart process [GO:0003015]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; modulation of chemical synaptic transmission [GO:0050804]; myelination [GO:0042552]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell shape [GO:0008360]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to amyloid-beta [GO:1904645]; response to ethanol [GO:0045471]; response to singlet oxygen [GO:0000304]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]",alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; tau protein binding [GO:0048156]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631]; type 5 metabotropic glutamate receptor binding [GO:0031802],GO:0000304; GO:0001664; GO:0001764; GO:0002250; GO:0003015; GO:0004672; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005739; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0006468; GO:0007166; GO:0007169; GO:0007249; GO:0008360; GO:0010629; GO:0010730; GO:0010976; GO:0014068; GO:0014069; GO:0015631; GO:0016004; GO:0016020; GO:0016567; GO:0018108; GO:0019899; GO:0030154; GO:0030163; GO:0030425; GO:0030900; GO:0031175; GO:0031234; GO:0031397; GO:0031802; GO:0035556; GO:0036120; GO:0042177; GO:0042531; GO:0042552; GO:0042608; GO:0042609; GO:0042610; GO:0042802; GO:0043014; GO:0043123; GO:0043204; GO:0043231; GO:0043274; GO:0043524; GO:0043548; GO:0044297; GO:0044325; GO:0044877; GO:0045087; GO:0045121; GO:0045471; GO:0046777; GO:0046872; GO:0046875; GO:0048156; GO:0048471; GO:0048813; GO:0050730; GO:0050798; GO:0050804; GO:0050852; GO:0050966; GO:0051428; GO:0070301; GO:0070851; GO:0071560; GO:0071944; GO:0090314; GO:0097038; GO:0097110; GO:0097386; GO:0097718; GO:0098685; GO:0098978; GO:0099092; GO:1900182; GO:1900449; GO:1901216; GO:1902951; GO:1903202; GO:1904645; GO:1904646; GO:1905232; GO:1905430; GO:1905664; GO:2001056; GO:2001240,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000269|PubMed:8655574""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:7980442, ECO:0000269|PubMed:8413237, ECO:0000269|PubMed:9201723""; LIPID 6; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:7980442, ECO:0000305|PubMed:8413237"""
P40240,reviewed,CD9_MOUSE,CD9 antigen (CD antigen CD9),Cd9,Mus musculus (Mouse),226,cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; glial cell migration [GO:0008347]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; glial cell migration [GO:0008347]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036],integrin binding [GO:0005178],GO:0005178; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0008283; GO:0008285; GO:0008347; GO:0009897; GO:0009986; GO:0014905; GO:0016020; GO:0016324; GO:0030913; GO:0031623; GO:0032991; GO:0035036; GO:0070062; GO:0071404; GO:0090331; GO:1905521,"LIPID 9; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21926""; LIPID 76; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21926""; LIPID 77; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21926""; LIPID 85; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21926""; LIPID 216; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21926""; LIPID 217; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21926"""
P41233,reviewed,ABCA1_MOUSE,Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1),Abca1 Abc1,Mus musculus (Mouse),2261,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; establishment of localization in cell [GO:0051649]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]",basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886],"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; establishment of localization in cell [GO:0051649]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]",ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905],GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016020; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0051649; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359,"LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 23; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 1110; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 1111; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P42866,reviewed,OPRM_MOUSE,Mu-type opioid receptor (M-OR-1) (MOR-1),Oprm1 Mor Oprm,Mus musculus (Mouse),398,adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to ethanol [GO:0048149]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of Wnt protein secretion [GO:0061358]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of appetite [GO:0032100]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of cellular response to stress [GO:0080135]; regulation of NMDA receptor activity [GO:2000310]; regulation of sensory perception of pain [GO:0051930]; response to ethanol [GO:0045471]; sensory perception of pain [GO:0019233],axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; endosome [GO:0005768]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; spine apparatus [GO:0097444],axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; endosome [GO:0005768]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; spine apparatus [GO:0097444]; beta-endorphin receptor activity [GO:0004979]; filamin binding [GO:0031005]; G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; morphine receptor activity [GO:0038047]; protein domain specific binding [GO:0019904]; voltage-gated calcium channel activity [GO:0005245]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to ethanol [GO:0048149]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of Wnt protein secretion [GO:0061358]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of appetite [GO:0032100]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of cellular response to stress [GO:0080135]; regulation of NMDA receptor activity [GO:2000310]; regulation of sensory perception of pain [GO:0051930]; response to ethanol [GO:0045471]; sensory perception of pain [GO:0019233],beta-endorphin receptor activity [GO:0004979]; filamin binding [GO:0031005]; G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; morphine receptor activity [GO:0038047]; protein domain specific binding [GO:0019904]; voltage-gated calcium channel activity [GO:0005245],GO:0001965; GO:0004930; GO:0004979; GO:0004985; GO:0005245; GO:0005737; GO:0005768; GO:0005886; GO:0005925; GO:0007186; GO:0007191; GO:0007193; GO:0007197; GO:0007200; GO:0007204; GO:0007218; GO:0007626; GO:0016020; GO:0019233; GO:0019904; GO:0030424; GO:0030425; GO:0031005; GO:0031635; GO:0031681; GO:0032100; GO:0032590; GO:0032839; GO:0038003; GO:0038047; GO:0042383; GO:0042734; GO:0042755; GO:0043005; GO:0043204; GO:0043950; GO:0043951; GO:0045019; GO:0045121; GO:0045211; GO:0045429; GO:0045471; GO:0048149; GO:0050769; GO:0051481; GO:0051930; GO:0060079; GO:0061358; GO:0070374; GO:0080135; GO:0097444; GO:0098982; GO:0099171; GO:0106072; GO:2000310,"LIPID 351; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P43006,reviewed,EAA2_MOUSE,Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2),Slc1a2 Eaat2 Glt1,Mus musculus (Mouse),572,adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; monoatomic anion transmembrane transport [GO:0098656]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; visual behavior [GO:0007632],astrocyte projection [GO:0097449]; axolemma [GO:0030673]; axon [GO:0030424]; cell body [GO:0044297]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; vesicle [GO:0031982],astrocyte projection [GO:0097449]; axolemma [GO:0030673]; axon [GO:0030424]; cell body [GO:0044297]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; vesicle [GO:0031982]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; monoatomic anion transmembrane transporter activity [GO:0008509]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; monoatomic anion transmembrane transport [GO:0098656]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; visual behavior [GO:0007632],cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; monoatomic anion transmembrane transporter activity [GO:0008509]; neutral L-amino acid transmembrane transporter activity [GO:0015175],GO:0005313; GO:0005314; GO:0005886; GO:0006750; GO:0007399; GO:0007632; GO:0008509; GO:0009410; GO:0009416; GO:0009611; GO:0009986; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031668; GO:0031982; GO:0033229; GO:0035264; GO:0042734; GO:0043005; GO:0043197; GO:0043198; GO:0043200; GO:0044297; GO:0044306; GO:0045121; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070779; GO:0071314; GO:0097449; GO:0098656; GO:0098712; GO:0098796; GO:0098810; GO:0098978; GO:0140009,"LIPID 38; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:20685337"""
P46096,reviewed,SYT1_MOUSE,Synaptotagmin-1 (Synaptotagmin I) (SytI) (p65),Syt1,Mus musculus (Mouse),421,"brain development [GO:0007420]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; fast, calcium ion-dependent exocytosis of neurotransmitter [GO:0098746]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of vesicle fusion [GO:0031340]; protein heterooligomerization [GO:0051291]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of regulated secretory pathway [GO:1903305]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to calcium ion [GO:0051592]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synchronous neurotransmitter secretion [GO:0071911]; vesicle docking [GO:0048278]",axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; dense core granule [GO:0031045]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intracellular organelle [GO:0043229]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],"axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; dense core granule [GO:0031045]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intracellular organelle [GO:0043229]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]; brain development [GO:0007420]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; fast, calcium ion-dependent exocytosis of neurotransmitter [GO:0098746]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of vesicle fusion [GO:0031340]; protein heterooligomerization [GO:0051291]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of regulated secretory pathway [GO:1903305]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to calcium ion [GO:0051592]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synchronous neurotransmitter secretion [GO:0071911]; vesicle docking [GO:0048278]","calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]",GO:0000149; GO:0001786; GO:0005509; GO:0005513; GO:0005516; GO:0005543; GO:0005544; GO:0005546; GO:0005737; GO:0005794; GO:0005886; GO:0007269; GO:0007420; GO:0008021; GO:0014059; GO:0016079; GO:0017075; GO:0017158; GO:0019905; GO:0030141; GO:0030154; GO:0030276; GO:0030348; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0033603; GO:0042584; GO:0042734; GO:0042802; GO:0043005; GO:0043229; GO:0044306; GO:0045956; GO:0046982; GO:0048278; GO:0048306; GO:0048488; GO:0048791; GO:0050750; GO:0050806; GO:0051291; GO:0051592; GO:0051966; GO:0060076; GO:0061669; GO:0061891; GO:0071277; GO:0071911; GO:0098686; GO:0098746; GO:0098978; GO:0099502; GO:1903235; GO:1903305; GO:1903861; GO:2000300,"LIPID 74; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21707""; LIPID 75; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21707""; LIPID 77; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21707""; LIPID 79; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21707""; LIPID 82; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21707"""
P47746,reviewed,CNR1_MOUSE,Cannabinoid receptor 1 (CB-R) (CB1) (Brain-type cannabinoid receptor),Cnr1,Mus musculus (Mouse),473,"adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; aging [GO:0007568]; axonal fasciculation [GO:0007413]; cannabinoid signaling pathway [GO:0038171]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; learning or memory [GO:0007611]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of action potential [GO:0045759]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of mast cell activation [GO:0033004]; negative regulation of monoatomic ion transport [GO:0043271]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of serotonin secretion [GO:0014063]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of fever generation [GO:0031622]; positive regulation of neuron projection development [GO:0010976]; regulation of feeding behavior [GO:0060259]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of penile erection [GO:0060405]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]",actin cytoskeleton [GO:0015629]; axon [GO:0030424]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],"actin cytoskeleton [GO:0015629]; axon [GO:0030424]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; cannabinoid receptor activity [GO:0004949]; identical protein binding [GO:0042802]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; aging [GO:0007568]; axonal fasciculation [GO:0007413]; cannabinoid signaling pathway [GO:0038171]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; learning or memory [GO:0007611]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of action potential [GO:0045759]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of mast cell activation [GO:0033004]; negative regulation of monoatomic ion transport [GO:0043271]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of serotonin secretion [GO:0014063]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of fever generation [GO:0031622]; positive regulation of neuron projection development [GO:0010976]; regulation of feeding behavior [GO:0060259]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of penile erection [GO:0060405]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]",cannabinoid receptor activity [GO:0004949]; identical protein binding [GO:0042802],GO:0002866; GO:0004949; GO:0005739; GO:0005741; GO:0005886; GO:0007186; GO:0007188; GO:0007283; GO:0007413; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0010976; GO:0014063; GO:0015629; GO:0019216; GO:0019233; GO:0030424; GO:0030426; GO:0031622; GO:0031999; GO:0032228; GO:0032496; GO:0033004; GO:0033602; GO:0035094; GO:0038171; GO:0042220; GO:0042593; GO:0042734; GO:0042802; GO:0043065; GO:0043231; GO:0043271; GO:0043278; GO:0045121; GO:0045471; GO:0045759; GO:0045776; GO:0045777; GO:0050796; GO:0051001; GO:0051966; GO:0060135; GO:0060259; GO:0060405; GO:0098921; GO:0098978; GO:0098982; GO:0099509; GO:0099553,"LIPID 416; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21554"""
P47937,reviewed,NK3R_MOUSE,Neuromedin-K receptor (NKR) (NK-3 receptor) (NK-3R) (Neurokinin B receptor) (Tachykinin receptor 3),Tacr3 Tac3r,Mus musculus (Mouse),452,aging [GO:0007568]; hyperosmotic salinity response [GO:0042538]; positive regulation of blood pressure [GO:0045777]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of heart rate [GO:0010460]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of dopamine metabolic process [GO:0042053]; regulation of feeding behavior [GO:0060259]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to morphine [GO:0043278],cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225],cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; tachykinin receptor activity [GO:0004995]; aging [GO:0007568]; hyperosmotic salinity response [GO:0042538]; positive regulation of blood pressure [GO:0045777]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of heart rate [GO:0010460]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of dopamine metabolic process [GO:0042053]; regulation of feeding behavior [GO:0060259]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to morphine [GO:0043278],tachykinin receptor activity [GO:0004995],GO:0004995; GO:0005634; GO:0005737; GO:0005886; GO:0007568; GO:0010460; GO:0016020; GO:0032355; GO:0032590; GO:0032809; GO:0042053; GO:0042220; GO:0042538; GO:0043278; GO:0045777; GO:0060259; GO:0070474; GO:0097225; GO:1902093,"LIPID 361; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P48030,reviewed,TGFA_MOUSE,Protransforming growth factor alpha [Cleaved into: Transforming growth factor alpha (TGF-alpha) (EGF-like TGF) (ETGF) (TGF type 1)],Tgfa,Mus musculus (Mouse),159,angiogenesis [GO:0001525]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-EGFR signaling pathway [GO:0038134]; hepatocyte proliferation [GO:0072574]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; response to xenobiotic stimulus [GO:0009410]; wound healing [GO:0042060],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; angiogenesis [GO:0001525]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-EGFR signaling pathway [GO:0038134]; hepatocyte proliferation [GO:0072574]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; response to xenobiotic stimulus [GO:0009410]; wound healing [GO:0042060],epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018],GO:0001525; GO:0005154; GO:0005615; GO:0005634; GO:0005886; GO:0007173; GO:0008083; GO:0008284; GO:0009410; GO:0009986; GO:0016323; GO:0031410; GO:0038134; GO:0042060; GO:0043066; GO:0043406; GO:0045741; GO:0045840; GO:0048018; GO:0048471; GO:0050679; GO:0050731; GO:0051781; GO:0060749; GO:0072574,"LIPID 152; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 153; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P48302,reviewed,EDNRB_MOUSE,Endothelin receptor type B (ET-B) (ET-BR) (Endothelin receptor non-selective type),Ednrb,Mus musculus (Mouse),442,aging [GO:0007568]; aldosterone metabolic process [GO:0032341]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to lipopolysaccharide [GO:0071222]; cGMP-mediated signaling [GO:0019934]; developmental pigmentation [GO:0048066]; endothelin receptor signaling pathway [GO:0086100]; enteric nervous system development [GO:0048484]; enteric smooth muscle cell differentiation [GO:0035645]; epithelial fluid transport [GO:0042045]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; macrophage chemotaxis [GO:0048246]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron maturation [GO:0014043]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast migration [GO:0097402]; peripheral nervous system development [GO:0007422]; pharynx development [GO:0060465]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pigmentation [GO:0043473]; podocyte differentiation [GO:0072112]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of penile erection [GO:0060406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; posterior midgut development [GO:0007497]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fever generation [GO:0031620]; regulation of heart rate [GO:0002027]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; renal albumin absorption [GO:0097018]; renal sodium excretion [GO:0035812]; renal sodium ion absorption [GO:0070294]; renin secretion into blood stream [GO:0002001]; response to endothelin [GO:1990839]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to sodium phosphate [GO:1904383]; sensory perception of pain [GO:0019233]; sodium ion homeostasis [GO:0055078]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311]; vein smooth muscle contraction [GO:0014826],membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; endothelin receptor activity [GO:0004962]; peptide hormone binding [GO:0017046]; type 1 angiotensin receptor binding [GO:0031702]; aging [GO:0007568]; aldosterone metabolic process [GO:0032341]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to lipopolysaccharide [GO:0071222]; cGMP-mediated signaling [GO:0019934]; developmental pigmentation [GO:0048066]; endothelin receptor signaling pathway [GO:0086100]; enteric nervous system development [GO:0048484]; enteric smooth muscle cell differentiation [GO:0035645]; epithelial fluid transport [GO:0042045]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; macrophage chemotaxis [GO:0048246]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron maturation [GO:0014043]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast migration [GO:0097402]; peripheral nervous system development [GO:0007422]; pharynx development [GO:0060465]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pigmentation [GO:0043473]; podocyte differentiation [GO:0072112]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of penile erection [GO:0060406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; posterior midgut development [GO:0007497]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fever generation [GO:0031620]; regulation of heart rate [GO:0002027]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; renal albumin absorption [GO:0097018]; renal sodium excretion [GO:0035812]; renal sodium ion absorption [GO:0070294]; renin secretion into blood stream [GO:0002001]; response to endothelin [GO:1990839]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to sodium phosphate [GO:1904383]; sensory perception of pain [GO:0019233]; sodium ion homeostasis [GO:0055078]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311]; vein smooth muscle contraction [GO:0014826],endothelin receptor activity [GO:0004962]; peptide hormone binding [GO:0017046]; type 1 angiotensin receptor binding [GO:0031702],GO:0000122; GO:0001755; GO:0001934; GO:0002001; GO:0002027; GO:0004962; GO:0005886; GO:0006885; GO:0007186; GO:0007200; GO:0007204; GO:0007249; GO:0007422; GO:0007497; GO:0007568; GO:0008217; GO:0008284; GO:0010033; GO:0010467; GO:0014043; GO:0014070; GO:0014826; GO:0016020; GO:0017046; GO:0019233; GO:0019722; GO:0019934; GO:0030202; GO:0030318; GO:0031620; GO:0031702; GO:0031965; GO:0032341; GO:0032496; GO:0035645; GO:0035810; GO:0035812; GO:0035815; GO:0042045; GO:0042310; GO:0042311; GO:0043066; GO:0043473; GO:0045121; GO:0048066; GO:0048246; GO:0048265; GO:0048484; GO:0050678; GO:0051248; GO:0051930; GO:0055078; GO:0060070; GO:0060406; GO:0060465; GO:0061028; GO:0070294; GO:0070588; GO:0071222; GO:0071806; GO:0072112; GO:0086100; GO:0097018; GO:0097402; GO:1904383; GO:1990839,"LIPID 402; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 403; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 405; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P48320,reviewed,DCE2_MOUSE,Glutamate decarboxylase 2 (EC 4.1.1.15) (65 kDa glutamic acid decarboxylase) (GAD-65) (Glutamate decarboxylase 65 kDa isoform),Gad2 Gad65,Mus musculus (Mouse),585,gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate decarboxylation to succinate [GO:0006540]; neurotransmitter biosynthetic process [GO:0042136]; response to xenobiotic stimulus [GO:0009410],axon [GO:0030424]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],axon [GO:0030424]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; glutamate binding [GO:0016595]; glutamate decarboxylase activity [GO:0004351]; protein-containing complex binding [GO:0044877]; pyridoxal phosphate binding [GO:0030170]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate decarboxylation to succinate [GO:0006540]; neurotransmitter biosynthetic process [GO:0042136]; response to xenobiotic stimulus [GO:0009410],glutamate binding [GO:0016595]; glutamate decarboxylase activity [GO:0004351]; protein-containing complex binding [GO:0044877]; pyridoxal phosphate binding [GO:0030170],GO:0000139; GO:0004351; GO:0005737; GO:0005829; GO:0006540; GO:0009410; GO:0009449; GO:0016595; GO:0030170; GO:0030424; GO:0030672; GO:0031410; GO:0042136; GO:0042734; GO:0044877; GO:0045202; GO:0048471; GO:0060077; GO:0061202; GO:0098793; GO:0098982,"LIPID 30; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 45; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P49817,reviewed,CAV1_MOUSE,Caveolin-1,Cav1 Cav,Mus musculus (Mouse),178,angiogenesis [GO:0001525]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; apoptotic signaling pathway [GO:0097190]; basement membrane organization [GO:0071711]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to hyperoxia [GO:0071455]; cellular response to mechanical stimulus [GO:0071260]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cytokine-mediated signaling pathway [GO:0019221]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; establishment of localization in cell [GO:0051649]; fibroblast proliferation [GO:0048144]; glandular epithelial cell differentiation [GO:0002067]; insulin receptor internalization [GO:0038016]; intracellular calcium ion homeostasis [GO:0006874]; intracellular nitric oxide homeostasis [GO:0033484]; lactation [GO:0007595]; lipid storage [GO:0019915]; maintenance of protein location in cell [GO:0032507]; mammary gland development [GO:0030879]; mammary gland involution [GO:0060056]; MAPK cascade [GO:0000165]; membrane depolarization [GO:0051899]; microtubule polymerization [GO:0046785]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of anoikis [GO:2000811]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-tyrosine autophosphorylation [GO:1900085]; negative regulation of pinocytosis [GO:0048550]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of protein binding [GO:0032091]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of signal transduction [GO:0009968]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell migration [GO:0030335]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction [GO:0009967]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; protein localization [GO:0008104]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of blood coagulation [GO:0030193]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of peptidase activity [GO:0052547]; regulation of ruffle assembly [GO:1900027]; regulation of smooth muscle contraction [GO:0006940]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by chemical signal [GO:0003057]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; response to bacterium [GO:0009617]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; skeletal muscle tissue development [GO:0007519]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]; tyrosine phosphorylation of STAT protein [GO:0007260]; vasculogenesis [GO:0001570]; vasoconstriction [GO:0042310]; wound healing [GO:0042060],acrosomal membrane [GO:0002080]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; caveolar macromolecular signaling complex [GO:0002095]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],acrosomal membrane [GO:0002080]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; caveolar macromolecular signaling complex [GO:0002095]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inward rectifier potassium channel inhibitor activity [GO:0070320]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; peptidase activator activity [GO:0016504]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; receptor serine/threonine kinase binding [GO:0033612]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; transmembrane transporter binding [GO:0044325]; angiogenesis [GO:0001525]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; apoptotic signaling pathway [GO:0097190]; basement membrane organization [GO:0071711]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to hyperoxia [GO:0071455]; cellular response to mechanical stimulus [GO:0071260]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cytokine-mediated signaling pathway [GO:0019221]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; establishment of localization in cell [GO:0051649]; fibroblast proliferation [GO:0048144]; glandular epithelial cell differentiation [GO:0002067]; insulin receptor internalization [GO:0038016]; intracellular calcium ion homeostasis [GO:0006874]; intracellular nitric oxide homeostasis [GO:0033484]; lactation [GO:0007595]; lipid storage [GO:0019915]; maintenance of protein location in cell [GO:0032507]; mammary gland development [GO:0030879]; mammary gland involution [GO:0060056]; MAPK cascade [GO:0000165]; membrane depolarization [GO:0051899]; microtubule polymerization [GO:0046785]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of anoikis [GO:2000811]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-tyrosine autophosphorylation [GO:1900085]; negative regulation of pinocytosis [GO:0048550]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of protein binding [GO:0032091]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of signal transduction [GO:0009968]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell migration [GO:0030335]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction [GO:0009967]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; protein localization [GO:0008104]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of blood coagulation [GO:0030193]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of peptidase activity [GO:0052547]; regulation of ruffle assembly [GO:1900027]; regulation of smooth muscle contraction [GO:0006940]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by chemical signal [GO:0003057]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; response to bacterium [GO:0009617]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; skeletal muscle tissue development [GO:0007519]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]; tyrosine phosphorylation of STAT protein [GO:0007260]; vasculogenesis [GO:0001570]; vasoconstriction [GO:0042310]; wound healing [GO:0042060],ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inward rectifier potassium channel inhibitor activity [GO:0070320]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; peptidase activator activity [GO:0016504]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; receptor serine/threonine kinase binding [GO:0033612]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; transmembrane transporter binding [GO:0044325],GO:0000122; GO:0000139; GO:0000149; GO:0000165; GO:0001525; GO:0001570; GO:0001666; GO:0001935; GO:0001937; GO:0001938; GO:0001960; GO:0002026; GO:0002067; GO:0002080; GO:0002095; GO:0002931; GO:0003057; GO:0005102; GO:0005737; GO:0005739; GO:0005768; GO:0005778; GO:0005783; GO:0005794; GO:0005811; GO:0005829; GO:0005886; GO:0005901; GO:0005925; GO:0005929; GO:0005938; GO:0006641; GO:0006809; GO:0006816; GO:0006874; GO:0006897; GO:0006940; GO:0007260; GO:0007519; GO:0007595; GO:0008104; GO:0008283; GO:0008285; GO:0009612; GO:0009617; GO:0009925; GO:0009967; GO:0009968; GO:0009986; GO:0010524; GO:0010608; GO:0010628; GO:0010656; GO:0010875; GO:0014912; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0016504; GO:0019065; GO:0019217; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0019905; GO:0019915; GO:0030154; GO:0030193; GO:0030335; GO:0030512; GO:0030514; GO:0030674; GO:0030857; GO:0030879; GO:0031116; GO:0031267; GO:0031295; GO:0031397; GO:0031398; GO:0031410; GO:0031623; GO:0032091; GO:0032092; GO:0032507; GO:0032570; GO:0032991; GO:0033137; GO:0033138; GO:0033344; GO:0033484; GO:0033612; GO:0034141; GO:0038016; GO:0042060; GO:0042310; GO:0042532; GO:0042632; GO:0042802; GO:0043085; GO:0043407; GO:0043409; GO:0043627; GO:0044325; GO:0044877; GO:0045019; GO:0045121; GO:0045665; GO:0045807; GO:0045907; GO:0046426; GO:0046716; GO:0046785; GO:0046982; GO:0048144; GO:0048147; GO:0048471; GO:0048550; GO:0048662; GO:0050998; GO:0051001; GO:0051092; GO:0051117; GO:0051480; GO:0051592; GO:0051649; GO:0051899; GO:0052547; GO:0055074; GO:0060056; GO:0060090; GO:0060355; GO:0060546; GO:0061099; GO:0070320; GO:0070373; GO:0070836; GO:0071260; GO:0071360; GO:0071375; GO:0071455; GO:0071560; GO:0071711; GO:0072584; GO:0086091; GO:0086098; GO:0090090; GO:0090263; GO:0090398; GO:0097190; GO:0098903; GO:0098911; GO:0120162; GO:1900027; GO:1900085; GO:1901380; GO:1901844; GO:1903071; GO:1903598; GO:1903609; GO:1904706; GO:1905949; GO:2000286; GO:2000535; GO:2000811; GO:2001238; GO:2001244; GO:2001258,"LIPID 133; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 143; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 156; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P51436,reviewed,DRD4_MOUSE,D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor),Drd4,Mus musculus (Mouse),387,"adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; adult locomotory behavior [GO:0008344]; arachidonic acid secretion [GO:0050482]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; chemical synaptic transmission [GO:0007268]; dopamine receptor signaling pathway [GO:0007212]; fear response [GO:0042596]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inhibitory postsynaptic potential [GO:0060080]; negative regulation of protein secretion [GO:0050709]; negative regulation of synaptic transmission [GO:0050805]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; olfactory learning [GO:0008355]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of penile erection [GO:0060406]; positive regulation of sodium:proton antiporter activity [GO:0032417]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of calcium-mediated signaling [GO:0050848]; regulation of circadian rhythm [GO:0042752]; regulation of dopamine metabolic process [GO:0042053]; regulation of neurotransmitter secretion [GO:0046928]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to amphetamine [GO:0001975]; response to histamine [GO:0034776]; rhythmic process [GO:0048511]; short-term memory [GO:0007614]; synaptic transmission, dopaminergic [GO:0001963]",axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506],"axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; epinephrine binding [GO:0051379]; G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; norepinephrine binding [GO:0051380]; serotonin binding [GO:0051378]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; adult locomotory behavior [GO:0008344]; arachidonic acid secretion [GO:0050482]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; chemical synaptic transmission [GO:0007268]; dopamine receptor signaling pathway [GO:0007212]; fear response [GO:0042596]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inhibitory postsynaptic potential [GO:0060080]; negative regulation of protein secretion [GO:0050709]; negative regulation of synaptic transmission [GO:0050805]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; olfactory learning [GO:0008355]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of penile erection [GO:0060406]; positive regulation of sodium:proton antiporter activity [GO:0032417]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of calcium-mediated signaling [GO:0050848]; regulation of circadian rhythm [GO:0042752]; regulation of dopamine metabolic process [GO:0042053]; regulation of neurotransmitter secretion [GO:0046928]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to amphetamine [GO:0001975]; response to histamine [GO:0034776]; rhythmic process [GO:0048511]; short-term memory [GO:0007614]; synaptic transmission, dopaminergic [GO:0001963]","dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; epinephrine binding [GO:0051379]; G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; norepinephrine binding [GO:0051380]; serotonin binding [GO:0051378]; SH3 domain binding [GO:0017124]",GO:0001591; GO:0001662; GO:0001963; GO:0001975; GO:0004952; GO:0004993; GO:0005737; GO:0005813; GO:0005886; GO:0005938; GO:0007187; GO:0007195; GO:0007198; GO:0007212; GO:0007268; GO:0007614; GO:0008306; GO:0008344; GO:0008355; GO:0012506; GO:0016020; GO:0017124; GO:0030424; GO:0030425; GO:0030594; GO:0032417; GO:0033674; GO:0034776; GO:0035240; GO:0042053; GO:0042596; GO:0042734; GO:0042752; GO:0042802; GO:0043025; GO:0043195; GO:0043197; GO:0043406; GO:0043679; GO:0045211; GO:0046872; GO:0046928; GO:0048148; GO:0048511; GO:0050482; GO:0050709; GO:0050805; GO:0050848; GO:0051378; GO:0051379; GO:0051380; GO:0060080; GO:0060406; GO:0098978; GO:0098982; GO:0099072; GO:0099149; GO:0099171; GO:1901363; GO:1901386; GO:1904706; GO:1904753; GO:2000463,"LIPID 387; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P21917"""
P51682,reviewed,CCR5_MOUSE,C-C chemokine receptor type 5 (C-C CKR-5) (CC-CKR-5) (CCR-5) (MIP-1 alpha receptor) (CD antigen CD195),Ccr5 Cmkbr5,Mus musculus (Mouse),354,calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; defense response [GO:0006952]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of axon extension [GO:0030517]; negative regulation of cell migration [GO:0030336]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of neural precursor cell proliferation [GO:2000178]; neuron death [GO:0070997]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fever generation [GO:0031622]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of tumor necrosis factor production [GO:0032760]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to cholesterol [GO:0070723],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine (C-C motif) ligand 5 binding [GO:0071791]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; defense response [GO:0006952]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of axon extension [GO:0030517]; negative regulation of cell migration [GO:0030336]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of neural precursor cell proliferation [GO:2000178]; neuron death [GO:0070997]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fever generation [GO:0031622]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of tumor necrosis factor production [GO:0032760]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to cholesterol [GO:0070723],actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine (C-C motif) ligand 5 binding [GO:0071791]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901],GO:0003779; GO:0005737; GO:0005768; GO:0006816; GO:0006935; GO:0006952; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0007267; GO:0009897; GO:0009986; GO:0010628; GO:0014808; GO:0016493; GO:0019722; GO:0019901; GO:0019957; GO:0022409; GO:0030336; GO:0030517; GO:0031622; GO:0032731; GO:0032755; GO:0032760; GO:0042802; GO:0045666; GO:0050729; GO:0070723; GO:0070997; GO:0071791; GO:2000110; GO:2000178,"LIPID 323; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P51681""; LIPID 326; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P51681"""
P52592,reviewed,S1PR2_MOUSE,Sphingosine 1-phosphate receptor 2 (S1P receptor 2) (S1P2) (Endothelial differentiation G-protein coupled receptor 5) (Lysophospholipid receptor B2) (Sphingosine 1-phosphate receptor Edg-5) (S1P receptor Edg-5),S1pr2 Edg5 Gpcr13 Lpb2,Mus musculus (Mouse),352,actin cytoskeleton reorganization [GO:0031532]; excitatory postsynaptic potential [GO:0060079]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376],plasma membrane [GO:0005886]; postsynapse [GO:0098794],plasma membrane [GO:0005886]; postsynapse [GO:0098794]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]; sphingosine-1-phosphate receptor activity [GO:0038036]; actin cytoskeleton reorganization [GO:0031532]; excitatory postsynaptic potential [GO:0060079]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]; sphingosine-1-phosphate receptor activity [GO:0038036],GO:0001664; GO:0003376; GO:0004930; GO:0005178; GO:0005886; GO:0007186; GO:0008528; GO:0010800; GO:0014912; GO:0031532; GO:0038036; GO:0046847; GO:0060079; GO:0090394; GO:0098794; GO:1903142; GO:1904706,"LIPID 305; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P54116,reviewed,STOM_MOUSE,Stomatin (Erythrocyte band 7 integral membrane protein) (Erythrocyte membrane protein band 7.2) (Protein 7.2b),Stom Epb7.2 Epb72,Mus musculus (Mouse),284,positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of viral process [GO:0048524]; regulation of acid-sensing ion channel activity [GO:1901585]; regulation of monoatomic ion transmembrane transport [GO:0034765],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of viral process [GO:0048524]; regulation of acid-sensing ion channel activity [GO:1901585]; regulation of monoatomic ion transmembrane transport [GO:0034765],identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063],GO:0005737; GO:0005739; GO:0005783; GO:0005856; GO:0005886; GO:0034765; GO:0042470; GO:0042802; GO:0042803; GO:0044829; GO:0045121; GO:0048471; GO:0048524; GO:0070063; GO:0090314; GO:1901585,"LIPID 30; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 87; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P55086,reviewed,PAR2_MOUSE,Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1),F2rl1 Gpcr11 Gpr11 Par2,Mus musculus (Mouse),399,"blood coagulation [GO:0007596]; cell-cell junction maintenance [GO:0045217]; defense response to virus [GO:0051607]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; leukocyte proliferation [GO:0070661]; mature conventional dendritic cell differentiation [GO:0097029]; negative regulation of chemokine production [GO:0032682]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JNK cascade [GO:0046329]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neutrophil activation [GO:0042119]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of eosinophil degranulation [GO:0043311]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070963]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of renin secretion into blood stream [GO:1900135]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type II interferon production [GO:0032729]; potassium channel activating, G protein-coupled receptor signaling pathway [GO:0099109]; regulation of blood coagulation [GO:0030193]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of JNK cascade [GO:0046328]; T cell activation involved in immune response [GO:0002286]; vasodilation [GO:0042311]",early endosome [GO:0005769]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],"early endosome [GO:0005769]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; heterotrimeric G-protein binding [GO:0032795]; molecular function activator activity [GO:0140677]; protease binding [GO:0002020]; proteinase-activated receptor activity [GO:0001648]; thrombin-activated receptor activity [GO:0015057]; blood coagulation [GO:0007596]; cell-cell junction maintenance [GO:0045217]; defense response to virus [GO:0051607]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; leukocyte proliferation [GO:0070661]; mature conventional dendritic cell differentiation [GO:0097029]; negative regulation of chemokine production [GO:0032682]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JNK cascade [GO:0046329]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neutrophil activation [GO:0042119]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of eosinophil degranulation [GO:0043311]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070963]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of renin secretion into blood stream [GO:1900135]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type II interferon production [GO:0032729]; potassium channel activating, G protein-coupled receptor signaling pathway [GO:0099109]; regulation of blood coagulation [GO:0030193]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of JNK cascade [GO:0046328]; T cell activation involved in immune response [GO:0002286]; vasodilation [GO:0042311]",G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; heterotrimeric G-protein binding [GO:0032795]; molecular function activator activity [GO:0140677]; protease binding [GO:0002020]; proteinase-activated receptor activity [GO:0001648]; thrombin-activated receptor activity [GO:0015057],GO:0001648; GO:0001965; GO:0002020; GO:0002286; GO:0002690; GO:0002720; GO:0003104; GO:0004930; GO:0005769; GO:0005886; GO:0006954; GO:0007186; GO:0007204; GO:0007596; GO:0010804; GO:0014068; GO:0015057; GO:0030193; GO:0030335; GO:0030836; GO:0031143; GO:0031274; GO:0031681; GO:0032682; GO:0032722; GO:0032729; GO:0032731; GO:0032733; GO:0032755; GO:0032757; GO:0032795; GO:0032930; GO:0034137; GO:0034140; GO:0034141; GO:0034145; GO:0035025; GO:0042119; GO:0042311; GO:0043122; GO:0043123; GO:0043311; GO:0043547; GO:0045087; GO:0045217; GO:0045944; GO:0046328; GO:0046329; GO:0046330; GO:0046676; GO:0050900; GO:0050921; GO:0050927; GO:0051482; GO:0051607; GO:0060100; GO:0061028; GO:0070374; GO:0070661; GO:0070963; GO:0097029; GO:0099109; GO:0140677; GO:1900135; GO:2000341,"LIPID 363; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P55088,reviewed,AQP4_MOUSE,Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4),Aqp4,Mus musculus (Mouse),323,carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to glucose stimulus [GO:0071333]; cellular response to type II interferon [GO:0071346]; cerebrospinal fluid circulation [GO:0090660]; cerebrospinal fluid secretion [GO:0033326]; establishment of localization in cell [GO:0051649]; intracellular water homeostasis [GO:0009992]; multicellular organismal-level water homeostasis [GO:0050891]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water absorption [GO:0070295]; sensory perception of sound [GO:0007605]; water transport [GO:0006833],astrocyte end-foot [GO:0097450]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315],astrocyte end-foot [GO:0097450]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; identical protein binding [GO:0042802]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to glucose stimulus [GO:0071333]; cellular response to type II interferon [GO:0071346]; cerebrospinal fluid circulation [GO:0090660]; cerebrospinal fluid secretion [GO:0033326]; establishment of localization in cell [GO:0051649]; intracellular water homeostasis [GO:0009992]; multicellular organismal-level water homeostasis [GO:0050891]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water absorption [GO:0070295]; sensory perception of sound [GO:0007605]; water transport [GO:0006833],identical protein binding [GO:0042802]; water channel activity [GO:0015250],GO:0005576; GO:0005737; GO:0005886; GO:0005911; GO:0006833; GO:0007605; GO:0009897; GO:0009925; GO:0009992; GO:0010008; GO:0010574; GO:0015250; GO:0015670; GO:0016020; GO:0016323; GO:0030315; GO:0031253; GO:0032691; GO:0032715; GO:0032991; GO:0033326; GO:0042383; GO:0042802; GO:0050891; GO:0051289; GO:0051649; GO:0060354; GO:0070295; GO:0071333; GO:0071346; GO:0090660; GO:0097450; GO:0098609,"LIPID 13; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P47863""; LIPID 17; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P47863"""
P55821,reviewed,STMN2_MOUSE,Stathmin-2 (Superior cervical ganglion-10 protein) (Protein SCG10),Stmn2 Scg10 Scgn10 Stmb2,Mus musculus (Mouse),179,cellular response to nerve growth factor stimulus [GO:1990090]; microtubule depolymerization [GO:0007019]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; regulation of microtubule polymerization or depolymerization [GO:0031110],cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982],cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]; calcium-dependent protein binding [GO:0048306]; tubulin binding [GO:0015631]; cellular response to nerve growth factor stimulus [GO:1990090]; microtubule depolymerization [GO:0007019]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; regulation of microtubule polymerization or depolymerization [GO:0031110],calcium-dependent protein binding [GO:0048306]; tubulin binding [GO:0015631],GO:0005737; GO:0005768; GO:0005794; GO:0007019; GO:0007026; GO:0010976; GO:0010977; GO:0015631; GO:0016020; GO:0030027; GO:0030426; GO:0031110; GO:0031115; GO:0031117; GO:0031175; GO:0031982; GO:0043005; GO:0043025; GO:0048306; GO:0048471; GO:1990090,"LIPID 22; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 24; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P56450,reviewed,MC4R_MOUSE,Melanocortin receptor 4 (MC4-R),Mc4r,Mus musculus (Mouse),332,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; diet induced thermogenesis [GO:0002024]; energy reserve metabolic process [GO:0006112]; feeding behavior [GO:0007631]; insulin secretion [GO:0030073]; negative regulation of feeding behavior [GO:2000252]; positive regulation of bone resorption [GO:0045780]; regulation of eating behavior [GO:1903998]; regulation of feeding behavior [GO:0060259]; regulation of grooming behavior [GO:2000821]; regulation of metabolic process [GO:0019222]; response to insulin [GO:0032868]; response to melanocyte-stimulating hormone [GO:1990680],nucleus [GO:0005634]; plasma membrane [GO:0005886],nucleus [GO:0005634]; plasma membrane [GO:0005886]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; diet induced thermogenesis [GO:0002024]; energy reserve metabolic process [GO:0006112]; feeding behavior [GO:0007631]; insulin secretion [GO:0030073]; negative regulation of feeding behavior [GO:2000252]; positive regulation of bone resorption [GO:0045780]; regulation of eating behavior [GO:1903998]; regulation of feeding behavior [GO:0060259]; regulation of grooming behavior [GO:2000821]; regulation of metabolic process [GO:0019222]; response to insulin [GO:0032868]; response to melanocyte-stimulating hormone [GO:1990680],hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; ubiquitin protein ligase binding [GO:0031625],GO:0002024; GO:0004977; GO:0004980; GO:0005634; GO:0005886; GO:0006112; GO:0007189; GO:0007631; GO:0017046; GO:0019222; GO:0030073; GO:0031625; GO:0032868; GO:0042562; GO:0042923; GO:0045780; GO:0060259; GO:1903998; GO:1990680; GO:2000252; GO:2000821,"LIPID 318; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P56481,reviewed,GASR_MOUSE,Gastrin/cholecystokinin type B receptor (CCK-B receptor) (CCK-BR) (Cholecystokinin-2 receptor) (CCK2-R),Cckbr,Mus musculus (Mouse),453,"apoptotic process [GO:0006915]; behavioral defense response [GO:0002209]; cholecystokinin signaling pathway [GO:0038188]; digestive tract development [GO:0048565]; ERK1 and ERK2 cascade [GO:0070371]; estrous cycle [GO:0044849]; gastric acid secretion [GO:0001696]; gland development [GO:0048732]; histamine secretion [GO:0001821]; pH reduction [GO:0045851]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of somatostatin secretion [GO:0090274]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of sensory perception of pain [GO:0051930]",cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cholecystokinin receptor activity [GO:0004951]; gastrin receptor activity [GO:0015054]; peptide hormone binding [GO:0017046]; type B gastrin/cholecystokinin receptor binding [GO:0031741]; apoptotic process [GO:0006915]; behavioral defense response [GO:0002209]; cholecystokinin signaling pathway [GO:0038188]; digestive tract development [GO:0048565]; ERK1 and ERK2 cascade [GO:0070371]; estrous cycle [GO:0044849]; gastric acid secretion [GO:0001696]; gland development [GO:0048732]; histamine secretion [GO:0001821]; pH reduction [GO:0045851]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of somatostatin secretion [GO:0090274]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of sensory perception of pain [GO:0051930]",cholecystokinin receptor activity [GO:0004951]; gastrin receptor activity [GO:0015054]; peptide hormone binding [GO:0017046]; type B gastrin/cholecystokinin receptor binding [GO:0031741],GO:0001696; GO:0001821; GO:0002209; GO:0004951; GO:0005634; GO:0005737; GO:0005886; GO:0006915; GO:0007200; GO:0007204; GO:0008284; GO:0015054; GO:0016020; GO:0017046; GO:0031741; GO:0032230; GO:0038188; GO:0043231; GO:0044849; GO:0045851; GO:0048565; GO:0048732; GO:0050806; GO:0051930; GO:0051968; GO:0070371; GO:0090274; GO:2000987,"LIPID 414; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P17124"""
P56818,reviewed,BACE1_MOUSE,Beta-secretase 1 (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2),Bace1 Bace,Mus musculus (Mouse),501,amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; cellular response to amyloid-beta [GO:1904646]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane protein ectodomain proteolysis [GO:0006509]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of synaptic plasticity [GO:0048167]; response to lead ion [GO:0010288]; response to radiation [GO:0009314]; signaling receptor ligand precursor processing [GO:0140448],axon [GO:0030424]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802],axon [GO:0030424]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; cellular response to amyloid-beta [GO:1904646]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane protein ectodomain proteolysis [GO:0006509]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of synaptic plasticity [GO:0048167]; response to lead ion [GO:0010288]; response to radiation [GO:0009314]; signaling receptor ligand precursor processing [GO:0140448],amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233],GO:0001540; GO:0004175; GO:0004190; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006508; GO:0006509; GO:0007613; GO:0008021; GO:0008233; GO:0009314; GO:0009986; GO:0010288; GO:0016020; GO:0016485; GO:0019899; GO:0030424; GO:0030425; GO:0030659; GO:0031410; GO:0034205; GO:0042987; GO:0043025; GO:0043525; GO:0045121; GO:0048167; GO:0050435; GO:0050804; GO:0050966; GO:0055037; GO:0060134; GO:0071280; GO:0071287; GO:0098686; GO:0098793; GO:0099171; GO:0140448; GO:1904646,"LIPID 474; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19074428""; LIPID 478; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19074428""; LIPID 482; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19074428""; LIPID 485; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19074428"""
P60202,reviewed,MYPR_MOUSE,Myelin proteolipid protein (PLP) (Lipophilin),Plp1 Plp,Mus musculus (Mouse),277,AMPA selective glutamate receptor signaling pathway [GO:0098990]; astrocyte development [GO:0014002]; axon development [GO:0061564]; axon ensheathment [GO:0008366]; central nervous system myelination [GO:0022010]; glial cell differentiation [GO:0010001]; inflammatory response [GO:0006954]; long-chain fatty acid biosynthetic process [GO:0042759]; myelination [GO:0042552]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628],integrin alphav-beta3 complex [GO:0034683]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],integrin alphav-beta3 complex [GO:0034683]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of myelin sheath [GO:0019911]; AMPA selective glutamate receptor signaling pathway [GO:0098990]; astrocyte development [GO:0014002]; axon development [GO:0061564]; axon ensheathment [GO:0008366]; central nervous system myelination [GO:0022010]; glial cell differentiation [GO:0010001]; inflammatory response [GO:0006954]; long-chain fatty acid biosynthetic process [GO:0042759]; myelination [GO:0042552]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628],identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of myelin sheath [GO:0019911],GO:0005886; GO:0006954; GO:0008366; GO:0010001; GO:0010628; GO:0014002; GO:0019911; GO:0022010; GO:0030335; GO:0034683; GO:0042552; GO:0042759; GO:0042802; GO:0043209; GO:0044877; GO:0061564; GO:0098990; GO:1904427,"LIPID 6; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 7; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 10; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 109; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 139; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 141; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 199; /note=""O-palmitoyl serine""; /evidence=""ECO:0000250"""
P60879,reviewed,SNP25_MOUSE,Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein),Snap25 Snap,Mus musculus (Mouse),206,associative learning [GO:0008306]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; endosomal transport [GO:0016197]; establishment of localization in cell [GO:0051649]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; localization [GO:0051179]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter secretion [GO:0007269]; positive regulation of hormone secretion [GO:0046887]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of establishment of protein localization [GO:0070201]; regulation of neuron projection development [GO:0010975]; sleep [GO:0030431]; SNARE complex assembly [GO:0035493]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; BLOC-1 complex [GO:0031083]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of presynaptic membrane [GO:0098888]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular organelle [GO:0043229]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; BLOC-1 complex [GO:0031083]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of presynaptic membrane [GO:0098888]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular organelle [GO:0043229]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; calcium-dependent protein binding [GO:0048306]; lipid binding [GO:0008289]; molecular adaptor activity [GO:0060090]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; associative learning [GO:0008306]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; endosomal transport [GO:0016197]; establishment of localization in cell [GO:0051649]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; localization [GO:0051179]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter secretion [GO:0007269]; positive regulation of hormone secretion [GO:0046887]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of establishment of protein localization [GO:0070201]; regulation of neuron projection development [GO:0010975]; sleep [GO:0030431]; SNARE complex assembly [GO:0035493]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082],calcium-dependent protein binding [GO:0048306]; lipid binding [GO:0008289]; molecular adaptor activity [GO:0060090]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249],GO:0000149; GO:0001917; GO:0005249; GO:0005484; GO:0005737; GO:0005768; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006887; GO:0007269; GO:0007616; GO:0007626; GO:0008021; GO:0008076; GO:0008289; GO:0008306; GO:0010975; GO:0015629; GO:0016020; GO:0016079; GO:0016082; GO:0016197; GO:0017022; GO:0017075; GO:0019904; GO:0030027; GO:0030073; GO:0030175; GO:0030424; GO:0030426; GO:0030431; GO:0031083; GO:0031201; GO:0031629; GO:0031982; GO:0035493; GO:0036477; GO:0042734; GO:0043005; GO:0043025; GO:0043209; GO:0043229; GO:0044295; GO:0044325; GO:0045121; GO:0045202; GO:0046887; GO:0048306; GO:0048471; GO:0048787; GO:0048791; GO:0051179; GO:0051649; GO:0060090; GO:0060291; GO:0070032; GO:0070033; GO:0070044; GO:0070201; GO:0097470; GO:0098794; GO:0098888; GO:0098967; GO:0098978; GO:0099525; GO:0099590,"LIPID 85; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:9349529""; LIPID 88; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:9349529""; LIPID 90; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:9349529""; LIPID 92; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:9349529"""
P61014,reviewed,PPLA_MOUSE,Cardiac phospholamban (PLB),Pln,Mus musculus (Mouse),52,acrosome assembly [GO:0001675]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; calcium ion transport [GO:0006816]; cardiac muscle tissue development [GO:0048738]; intracellular calcium ion homeostasis [GO:0006874]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of calcium ion binding [GO:1901877]; negative regulation of calcium ion import into sarcoplasmic reticulum [GO:1902081]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of heart contraction [GO:0045822]; negative regulation of heart rate [GO:0010459]; Notch signaling pathway [GO:0007219]; regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901894]; regulation of calcium ion import [GO:0090279]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart contraction [GO:0008016]; regulation of relaxation of muscle [GO:1901077]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to testosterone [GO:0033574]; response to zinc ion [GO:0010043],calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; vesicle [GO:0031982],calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; vesicle [GO:0031982]; ATPase inhibitor activity [GO:0042030]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; acrosome assembly [GO:0001675]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; calcium ion transport [GO:0006816]; cardiac muscle tissue development [GO:0048738]; intracellular calcium ion homeostasis [GO:0006874]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of calcium ion binding [GO:1901877]; negative regulation of calcium ion import into sarcoplasmic reticulum [GO:1902081]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of heart contraction [GO:0045822]; negative regulation of heart rate [GO:0010459]; Notch signaling pathway [GO:0007219]; regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901894]; regulation of calcium ion import [GO:0090279]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart contraction [GO:0008016]; regulation of relaxation of muscle [GO:1901077]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to testosterone [GO:0033574]; response to zinc ion [GO:0010043],ATPase inhibitor activity [GO:0042030]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],GO:0001675; GO:0002026; GO:0005789; GO:0006816; GO:0006874; GO:0007219; GO:0008016; GO:0010043; GO:0010459; GO:0010880; GO:0010881; GO:0016020; GO:0016529; GO:0031966; GO:0031982; GO:0032780; GO:0032991; GO:0033017; GO:0033574; GO:0042030; GO:0042802; GO:0042803; GO:0045822; GO:0046716; GO:0048738; GO:0051924; GO:0051926; GO:0060314; GO:0086004; GO:0086023; GO:0086092; GO:0090279; GO:0090534; GO:1901020; GO:1901077; GO:1901877; GO:1901894; GO:1901895; GO:1902081,"LIPID 36; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:26644582"""
P61168,reviewed,DRD2_MOUSE,D(2) dopamine receptor (Dopamine D2 receptor),Drd2,Mus musculus (Mouse),444,"acid secretion [GO:0046717]; activation of protein kinase activity [GO:0032147]; adenohypophysis development [GO:0021984]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adult behavior [GO:0030534]; adult walking behavior [GO:0007628]; arachidonic acid secretion [GO:0050482]; associative learning [GO:0008306]; auditory behavior [GO:0031223]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; branching morphogenesis of a nerve [GO:0048755]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cerebral cortex GABAergic interneuron migration [GO:0021853]; circadian regulation of gene expression [GO:0032922]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; dopamine uptake involved in synaptic transmission [GO:0051583]; drinking behavior [GO:0042756]; epithelial cell proliferation [GO:0050673]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; hyaloid vascular plexus regression [GO:1990384]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of innate immune response [GO:0045824]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron migration [GO:2001223]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein secretion [GO:0050709]; negative regulation of synaptic transmission [GO:0050805]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; neuron-neuron synaptic transmission [GO:0007270]; orbitofrontal cortex development [GO:0021769]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; pigmentation [GO:0043473]; positive regulation of cytokinesis [GO:0032467]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of receptor internalization [GO:0002092]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of heart rate [GO:0002027]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of neurotransmitter uptake [GO:0051580]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of potassium ion transport [GO:0043266]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209]; response to amphetamine [GO:0001975]; response to axon injury [GO:0048678]; response to cocaine [GO:0042220]; response to histamine [GO:0034776]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to iron ion [GO:0010039]; response to light stimulus [GO:0009416]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; sensory perception of smell [GO:0007608]; startle response [GO:0001964]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; temperature homeostasis [GO:0001659]; visual learning [GO:0008542]; Wnt signaling pathway [GO:0016055]",acrosomal vesicle [GO:0001669]; axon [GO:0030424]; axon terminus [GO:0043679]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dopaminergic synapse [GO:0098691]; endocytic vesicle [GO:0030139]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; sperm flagellum [GO:0036126]; synaptic vesicle membrane [GO:0030672],"acrosomal vesicle [GO:0001669]; axon [GO:0030424]; axon terminus [GO:0043679]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dopaminergic synapse [GO:0098691]; endocytic vesicle [GO:0030139]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; sperm flagellum [GO:0036126]; synaptic vesicle membrane [GO:0030672]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; G protein-coupled receptor activity [GO:0004930]; heterocyclic compound binding [GO:1901363]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; organic cyclic compound binding [GO:0097159]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; acid secretion [GO:0046717]; activation of protein kinase activity [GO:0032147]; adenohypophysis development [GO:0021984]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adult behavior [GO:0030534]; adult walking behavior [GO:0007628]; arachidonic acid secretion [GO:0050482]; associative learning [GO:0008306]; auditory behavior [GO:0031223]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; branching morphogenesis of a nerve [GO:0048755]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cerebral cortex GABAergic interneuron migration [GO:0021853]; circadian regulation of gene expression [GO:0032922]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; dopamine uptake involved in synaptic transmission [GO:0051583]; drinking behavior [GO:0042756]; epithelial cell proliferation [GO:0050673]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; hyaloid vascular plexus regression [GO:1990384]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of innate immune response [GO:0045824]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron migration [GO:2001223]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein secretion [GO:0050709]; negative regulation of synaptic transmission [GO:0050805]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; neuron-neuron synaptic transmission [GO:0007270]; orbitofrontal cortex development [GO:0021769]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; pigmentation [GO:0043473]; positive regulation of cytokinesis [GO:0032467]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of receptor internalization [GO:0002092]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of heart rate [GO:0002027]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of neurotransmitter uptake [GO:0051580]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of potassium ion transport [GO:0043266]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209]; response to amphetamine [GO:0001975]; response to axon injury [GO:0048678]; response to cocaine [GO:0042220]; response to histamine [GO:0034776]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to iron ion [GO:0010039]; response to light stimulus [GO:0009416]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; sensory perception of smell [GO:0007608]; startle response [GO:0001964]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; temperature homeostasis [GO:0001659]; visual learning [GO:0008542]; Wnt signaling pathway [GO:0016055]","dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; G protein-coupled receptor activity [GO:0004930]; heterocyclic compound binding [GO:1901363]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; organic cyclic compound binding [GO:0097159]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]",GO:0000139; GO:0001591; GO:0001659; GO:0001666; GO:0001669; GO:0001764; GO:0001933; GO:0001964; GO:0001975; GO:0001976; GO:0002027; GO:0002028; GO:0002031; GO:0002052; GO:0002092; GO:0004930; GO:0004952; GO:0005102; GO:0005886; GO:0005929; GO:0006914; GO:0007186; GO:0007188; GO:0007194; GO:0007195; GO:0007212; GO:0007270; GO:0007405; GO:0007409; GO:0007416; GO:0007608; GO:0007616; GO:0007625; GO:0007626; GO:0007628; GO:0007631; GO:0008104; GO:0008283; GO:0008285; GO:0008306; GO:0008542; GO:0009410; GO:0009416; GO:0009636; GO:0010039; GO:0014069; GO:0014854; GO:0016020; GO:0016055; GO:0016328; GO:0016477; GO:0021756; GO:0021769; GO:0021853; GO:0021984; GO:0030139; GO:0030424; GO:0030425; GO:0030432; GO:0030534; GO:0030672; GO:0030900; GO:0031223; GO:0031410; GO:0032147; GO:0032228; GO:0032467; GO:0032922; GO:0033602; GO:0034776; GO:0035094; GO:0035240; GO:0035255; GO:0035556; GO:0035810; GO:0035815; GO:0036126; GO:0040018; GO:0042220; GO:0042321; GO:0042417; GO:0042734; GO:0042756; GO:0042802; GO:0043197; GO:0043204; GO:0043266; GO:0043278; GO:0043408; GO:0043473; GO:0043491; GO:0043666; GO:0043679; GO:0044877; GO:0045211; GO:0045745; GO:0045776; GO:0045824; GO:0045944; GO:0046676; GO:0046717; GO:0048148; GO:0048149; GO:0048169; GO:0048678; GO:0048755; GO:0050482; GO:0050673; GO:0050680; GO:0050709; GO:0050769; GO:0050804; GO:0050805; GO:0051209; GO:0051481; GO:0051482; GO:0051580; GO:0051583; GO:0051584; GO:0051586; GO:0051823; GO:0051898; GO:0051967; GO:0060124; GO:0060134; GO:0060158; GO:0060160; GO:0060170; GO:0060548; GO:0070374; GO:0071880; GO:0090325; GO:0097159; GO:0097730; GO:0098691; GO:0098978; GO:0098982; GO:0099170; GO:0099171; GO:1900168; GO:1900273; GO:1901363; GO:1901386; GO:1990384; GO:2001223,"LIPID 444; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P14416"""
P61226,reviewed,RAP2B_MOUSE,Ras-related protein Rap-2b (EC 3.6.5.2),Rap2b,Mus musculus (Mouse),183,negative regulation of cell migration [GO:0030336]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of protein tyrosine kinase activity [GO:0061097],bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; negative regulation of cell migration [GO:0030336]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of protein tyrosine kinase activity [GO:0061097],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904],GO:0003924; GO:0003925; GO:0005525; GO:0005829; GO:0005886; GO:0005923; GO:0016020; GO:0019003; GO:0019904; GO:0030168; GO:0030336; GO:0031954; GO:0032486; GO:0044291; GO:0045121; GO:0055037; GO:0055038; GO:0061097; GO:0070062; GO:0070527,"LIPID 176; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19061864""; LIPID 177; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19061864""; LIPID 180; /note=""S-geranylgeranyl cysteine""; /evidence=""ECO:0000269|PubMed:19061864"""
P62071,reviewed,RRAS2_MOUSE,Ras-related protein R-Ras2 (EC 3.6.5.-),Rras2,Mus musculus (Mouse),204,cell migration [GO:0016477]; positive regulation of Schwann cell migration [GO:1900149]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; Schwann cell migration [GO:0036135],Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell migration [GO:0016477]; positive regulation of Schwann cell migration [GO:1900149]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; Schwann cell migration [GO:0036135],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0000139; GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0016477; GO:0019003; GO:0036135; GO:1900149; GO:1901214,"LIPID 192; /note=""N6-palmitoyl lysine""; /evidence=""ECO:0000250|UniProtKB:P62070""; LIPID 194; /note=""N6-palmitoyl lysine""; /evidence=""ECO:0000250|UniProtKB:P62070""; LIPID 196; /note=""N6-palmitoyl lysine""; /evidence=""ECO:0000250|UniProtKB:P62070""; LIPID 197; /note=""N6-palmitoyl lysine""; /evidence=""ECO:0000250|UniProtKB:P62070""; LIPID 199; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P62070""; LIPID 201; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P62070"""
P62281,reviewed,RS11_MOUSE,Small ribosomal subunit protein uS17 (40S ribosomal protein S11),Rps11,Mus musculus (Mouse),158,cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0019843; GO:0022626; GO:0022627; GO:0032040; GO:0042274; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242,"LIPID 60; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P62280"""
P62746,reviewed,RHOB_MOUSE,Rho-related GTP-binding protein RhoB,Rhob Arhb,Mus musculus (Mouse),196,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; endosome to lysosome transport [GO:0008333]; endothelial tube morphogenesis [GO:0061154]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; regulation of cell migration [GO:0030334]; regulation of modification of postsynaptic structure [GO:0099159]; small GTPase mediated signal transduction [GO:0007264],cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202],cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; endosome to lysosome transport [GO:0008333]; endothelial tube morphogenesis [GO:0061154]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; regulation of cell migration [GO:0030334]; regulation of modification of postsynaptic structure [GO:0099159]; small GTPase mediated signal transduction [GO:0007264],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0000281; GO:0001525; GO:0003924; GO:0005525; GO:0005634; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0006886; GO:0006915; GO:0007155; GO:0007264; GO:0008333; GO:0010008; GO:0010595; GO:0016020; GO:0019003; GO:0030154; GO:0030334; GO:0030336; GO:0031902; GO:0032154; GO:0043065; GO:0045202; GO:0045766; GO:0045786; GO:0061154; GO:0070301; GO:0071479; GO:0098685; GO:0099159,"LIPID 189; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 192; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 193; /note=""S-farnesyl cysteine; in plasma membrane form""; /evidence=""ECO:0000250""; LIPID 193; /note=""S-geranylgeranyl cysteine; in endosomal form""; /evidence=""ECO:0000250"""
P63094,reviewed,GNAS2_MOUSE,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein),Gnas Gnas1 MNCb-5546,Mus musculus (Mouse),394,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone development [GO:0060348]; calcium ion homeostasis [GO:0055074]; cartilage development [GO:0051216]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to glucagon stimulus [GO:0071377]; cellular response to prostaglandin E stimulus [GO:0071380]; cognition [GO:0050890]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; G protein-coupled receptor signaling pathway [GO:0007186]; genomic imprinting [GO:0071514]; hair follicle placode formation [GO:0060789]; multicellular organism growth [GO:0035264]; negative regulation of blood pressure [GO:0045776]; negative regulation of renal sodium excretion [GO:0035814]; platelet aggregation [GO:0070527]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of insulin secretion [GO:0032024]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sodium ion transport [GO:0010765]; post-embryonic body morphogenesis [GO:0040032]; post-embryonic development [GO:0009791]; regulation of parathyroid hormone secretion [GO:2000828]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; response to parathyroid hormone [GO:0071107]; response to xenobiotic stimulus [GO:0009410]; sensory perception of chemical stimulus [GO:0007606]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tissue homeostasis [GO:0001894],COPI-coated Golgi to ER transport vesicle [GO:0030142]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; trans-Golgi network membrane [GO:0032588],COPI-coated Golgi to ER transport vesicle [GO:0030142]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; trans-Golgi network membrane [GO:0032588]; adenylate cyclase activator activity [GO:0010856]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; alpha-tubulin binding [GO:0043014]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein activity [GO:0003925]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; protein domain specific binding [GO:0019904]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone development [GO:0060348]; calcium ion homeostasis [GO:0055074]; cartilage development [GO:0051216]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to glucagon stimulus [GO:0071377]; cellular response to prostaglandin E stimulus [GO:0071380]; cognition [GO:0050890]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; G protein-coupled receptor signaling pathway [GO:0007186]; genomic imprinting [GO:0071514]; hair follicle placode formation [GO:0060789]; multicellular organism growth [GO:0035264]; negative regulation of blood pressure [GO:0045776]; negative regulation of renal sodium excretion [GO:0035814]; platelet aggregation [GO:0070527]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of insulin secretion [GO:0032024]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sodium ion transport [GO:0010765]; post-embryonic body morphogenesis [GO:0040032]; post-embryonic development [GO:0009791]; regulation of parathyroid hormone secretion [GO:2000828]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; response to parathyroid hormone [GO:0071107]; response to xenobiotic stimulus [GO:0009410]; sensory perception of chemical stimulus [GO:0007606]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tissue homeostasis [GO:0001894],adenylate cyclase activator activity [GO:0010856]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; alpha-tubulin binding [GO:0043014]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein activity [GO:0003925]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; protein domain specific binding [GO:0019904],GO:0001501; GO:0001726; GO:0001894; GO:0001934; GO:0001958; GO:0001965; GO:0003924; GO:0003925; GO:0005159; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005834; GO:0005886; GO:0006112; GO:0006306; GO:0006357; GO:0007186; GO:0007189; GO:0007191; GO:0007606; GO:0008284; GO:0009410; GO:0009791; GO:0009966; GO:0010765; GO:0010856; GO:0016020; GO:0019904; GO:0030142; GO:0030425; GO:0031681; GO:0031683; GO:0031698; GO:0031748; GO:0031852; GO:0032024; GO:0032588; GO:0035116; GO:0035255; GO:0035264; GO:0035814; GO:0040032; GO:0042383; GO:0043014; GO:0043025; GO:0043547; GO:0043588; GO:0043950; GO:0045121; GO:0045669; GO:0045672; GO:0045776; GO:0046872; GO:0047391; GO:0048471; GO:0048589; GO:0048701; GO:0050890; GO:0051216; GO:0051430; GO:0055037; GO:0055074; GO:0060348; GO:0060789; GO:0070527; GO:0071107; GO:0071377; GO:0071380; GO:0071514; GO:0071870; GO:0071880; GO:0120162; GO:2000828,"LIPID 2; /note=""N-palmitoyl glycine""; /evidence=""ECO:0000250|UniProtKB:P04896""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:8227063"""
P63141,reviewed,KCNA2_MOUSE,Potassium voltage-gated channel subfamily A member 2 (MK2) (Voltage-gated potassium channel subunit Kv1.2),Kcna2,Mus musculus (Mouse),499,"cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; neuronal action potential [GO:0019228]; optic nerve structural organization [GO:0021633]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; regulation of monoatomic ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]",axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; neuronal cell body membrane [GO:0032809]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; potassium channel complex [GO:0034705]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],"axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; neuronal cell body membrane [GO:0032809]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; potassium channel complex [GO:0034705]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; neuronal action potential [GO:0019228]; optic nerve structural organization [GO:0021633]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; regulation of monoatomic ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]",delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249],GO:0005249; GO:0005251; GO:0005789; GO:0005886; GO:0008076; GO:0014059; GO:0015271; GO:0019228; GO:0019233; GO:0019894; GO:0021633; GO:0021987; GO:0022038; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0034705; GO:0034765; GO:0042734; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045188; GO:0045211; GO:0051260; GO:0071805; GO:0097623; GO:0098978; GO:0099508; GO:1905030,"LIPID 244; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P70310,reviewed,NTR2_MOUSE,Neurotensin receptor type 2 (NT-R-2) (NTR2) (Low-affinity levocabastine-sensitive neurotensin receptor) (NTRL),Ntsr2,Mus musculus (Mouse),416,neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; regulation of membrane potential [GO:0042391],cell surface [GO:0009986]; dendritic shaft [GO:0043198]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],cell surface [GO:0009986]; dendritic shaft [GO:0043198]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; G protein-coupled neurotensin receptor activity [GO:0016492]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; regulation of membrane potential [GO:0042391],G protein-coupled neurotensin receptor activity [GO:0016492]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877],GO:0005802; GO:0005886; GO:0007200; GO:0007218; GO:0009986; GO:0016020; GO:0016492; GO:0042391; GO:0042802; GO:0043198; GO:0043204; GO:0043410; GO:0044877; GO:0070374,"LIPID 377; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P70313,reviewed,NOS3_MOUSE,"Nitric oxide synthase 3 (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (NOS type III) (NOSIII) (Nitric oxide synthase, endothelial) (Endothelial NOS) (eNOS)",Nos3 Ecnos,Mus musculus (Mouse),1202,angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; calcium ion transport [GO:0006816]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; establishment of localization in cell [GO:0051649]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of guanylate cyclase activity [GO:0031284]; potassium ion transport [GO:0006813]; pulmonary valve morphogenesis [GO:0003184]; regulation of nervous system process [GO:0031644]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to estradiol [GO:0032355]; response to fluid shear stress [GO:0034405]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; smooth muscle hyperplasia [GO:0014806]; ventricular septum morphogenesis [GO:0060412],apical part of cell [GO:0045177]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; vesicle membrane [GO:0012506],apical part of cell [GO:0045177]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; actin monomer binding [GO:0003785]; arginine binding [GO:0034618]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; scaffold protein binding [GO:0097110]; tetrahydrobiopterin binding [GO:0034617]; angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; calcium ion transport [GO:0006816]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; establishment of localization in cell [GO:0051649]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of guanylate cyclase activity [GO:0031284]; potassium ion transport [GO:0006813]; pulmonary valve morphogenesis [GO:0003184]; regulation of nervous system process [GO:0031644]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to estradiol [GO:0032355]; response to fluid shear stress [GO:0034405]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; smooth muscle hyperplasia [GO:0014806]; ventricular septum morphogenesis [GO:0060412],actin binding [GO:0003779]; actin monomer binding [GO:0003785]; arginine binding [GO:0034618]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; scaffold protein binding [GO:0097110]; tetrahydrobiopterin binding [GO:0034617],GO:0001525; GO:0001542; GO:0001701; GO:0001974; GO:0002028; GO:0003057; GO:0003100; GO:0003180; GO:0003184; GO:0003203; GO:0003779; GO:0003785; GO:0004517; GO:0005516; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0006527; GO:0006809; GO:0006813; GO:0006816; GO:0007165; GO:0007263; GO:0008013; GO:0008285; GO:0009725; GO:0010181; GO:0010628; GO:0012506; GO:0014740; GO:0014806; GO:0019430; GO:0020037; GO:0030324; GO:0031284; GO:0031644; GO:0031663; GO:0032355; GO:0032496; GO:0034405; GO:0034617; GO:0034618; GO:0042383; GO:0043065; GO:0043267; GO:0043536; GO:0043542; GO:0045121; GO:0045177; GO:0045296; GO:0045766; GO:0045776; GO:0046872; GO:0048662; GO:0048873; GO:0050660; GO:0050661; GO:0050998; GO:0051346; GO:0051649; GO:0051879; GO:0051926; GO:0060412; GO:0070168; GO:0071260; GO:0071560; GO:0097110; GO:0097746,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250""; LIPID 15; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 26; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P84228,reviewed,H32_MOUSE,Histone H3.2 (H3-clustered histone 13) (H3-clustered histone 14) (H3-clustered histone 15) (H3-clustered histone 2) (H3-clustered histone 3) (H3-clustered histone 4) (H3-clustered histone 6) (H3-clustered histone 7),H3c2 H3-53 H3.2 H3b Hist1h3b; H3c3 H3-143 Hist1h3c; H3c4 H3-B Hist1h3d; H3c6 H3-F Hist1h3e; H3c7 H3.2-221 H3f Hist1h3f; H3c13 H3.2-616 Hist2h3b; H3c14 H3.2-615 Hist2h3c1 Hist2h3ca1; H3c15 H3.2-614 Hist2h3c2 Hist2h3ca2,Mus musculus (Mouse),136,epigenetic regulation of gene expression [GO:0040029]; gene expression [GO:0010467]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; epigenetic regulation of gene expression [GO:0040029]; gene expression [GO:0010467]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527],GO:0000122; GO:0000785; GO:0000786; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006334; GO:0010467; GO:0030527; GO:0032991; GO:0040029; GO:0046982,"LIPID 19; /note=""N6-decanoyllysine""; /evidence=""ECO:0000250|UniProtKB:Q71DI3""; LIPID 111; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q71DI3"""
P97288,reviewed,5HT4R_MOUSE,5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4),Htr4,Mus musculus (Mouse),388,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; large intestinal transit [GO:0120056]; maintenance of gastrointestinal epithelium [GO:0030277]; mucus secretion [GO:0070254]; regulation of appetite [GO:0032098]",cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202],"cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin receptor activity [GO:0099589]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; large intestinal transit [GO:0120056]; maintenance of gastrointestinal epithelium [GO:0030277]; mucus secretion [GO:0070254]; regulation of appetite [GO:0032098]",G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin receptor activity [GO:0099589],GO:0004993; GO:0005737; GO:0005768; GO:0005886; GO:0007186; GO:0007187; GO:0007189; GO:0007214; GO:0007268; GO:0016020; GO:0030277; GO:0030425; GO:0030594; GO:0032098; GO:0045202; GO:0070254; GO:0099589; GO:0120056,"LIPID 329; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P97292,reviewed,HRH2_MOUSE,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),Hrh2,Mus musculus (Mouse),397,"chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]",dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202],"dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]",G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594],GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998,"LIPID 304; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P97295,reviewed,NPY2R_MOUSE,Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor),Npy2r,Mus musculus (Mouse),381,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; behavioral fear response [GO:0001662]; cardiac left ventricle morphogenesis [GO:0003214]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of feeding behavior [GO:2000252]; negative regulation of nervous system process [GO:0031645]; negative regulation of secretion [GO:0051048]; negative regulation of synaptic transmission [GO:0050805]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; nitric oxide mediated signal transduction [GO:0007263]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of peptide secretion [GO:0002793]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of sensory perception of pain [GO:0051930]; secretion [GO:0046903]",cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],"cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; behavioral fear response [GO:0001662]; cardiac left ventricle morphogenesis [GO:0003214]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of feeding behavior [GO:2000252]; negative regulation of nervous system process [GO:0031645]; negative regulation of secretion [GO:0051048]; negative regulation of synaptic transmission [GO:0050805]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; nitric oxide mediated signal transduction [GO:0007263]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of peptide secretion [GO:0002793]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of sensory perception of pain [GO:0051930]; secretion [GO:0046903]",neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601],GO:0001601; GO:0001662; GO:0002793; GO:0003151; GO:0003214; GO:0004983; GO:0005886; GO:0005929; GO:0007186; GO:0007193; GO:0007204; GO:0007263; GO:0010811; GO:0016020; GO:0031645; GO:0033603; GO:0043951; GO:0045987; GO:0046010; GO:0046903; GO:0050805; GO:0051048; GO:0051930; GO:0051967; GO:0090394; GO:0097730; GO:2000252,"LIPID 342; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P97428,reviewed,RGS16_MOUSE,Regulator of G-protein signaling 16 (RGS16) (A28-RGS14P) (Retinal-specific RGS) (RGS-r) (Retinally abundant regulator of G-protein signaling),Rgs16 Rgsr,Mus musculus (Mouse),201,G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547],cytoplasm [GO:0005737]; membrane [GO:0016020]; membrane raft [GO:0045121],cytoplasm [GO:0005737]; membrane [GO:0016020]; membrane raft [GO:0045121]; GTPase activator activity [GO:0005096]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547],GTPase activator activity [GO:0005096],GO:0005096; GO:0005737; GO:0007186; GO:0009968; GO:0016020; GO:0043547; GO:0045121,"LIPID 2; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:10373502""; LIPID 12; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:10373502"""
P97714,reviewed,ADA1D_MOUSE,Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor),Adra1d Adra1a Gpcr8,Mus musculus (Mouse),562,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; aging [GO:0007568]; cell-cell signaling [GO:0007267]; micturition [GO:0060073]; negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001986]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217],cytosol [GO:0005829]; plasma membrane [GO:0005886],cytosol [GO:0005829]; plasma membrane [GO:0005886]; alpha1-adrenergic receptor activity [GO:0004937]; identical protein binding [GO:0042802]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; aging [GO:0007568]; cell-cell signaling [GO:0007267]; micturition [GO:0060073]; negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001986]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217],alpha1-adrenergic receptor activity [GO:0004937]; identical protein binding [GO:0042802],GO:0001986; GO:0001994; GO:0004937; GO:0005829; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0007568; GO:0008217; GO:0042802; GO:0045907; GO:0060073; GO:0071880; GO:0150099,"LIPID 413; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P97717,reviewed,ADA1B_MOUSE,Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor),Adra1b,Mus musculus (Mouse),514,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; behavioral response to cocaine [GO:0048148]; blood vessel remodeling [GO:0001974]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; locomotory behavior [GO:0007626]; negative regulation of glycogen catabolic process [GO:0045818]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229]; response to amphetamine [GO:0001975]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to steroid hormone [GO:0048545]; vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [GO:0001987]; visual learning [GO:0008542],caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315],caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; behavioral response to cocaine [GO:0048148]; blood vessel remodeling [GO:0001974]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; locomotory behavior [GO:0007626]; negative regulation of glycogen catabolic process [GO:0045818]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229]; response to amphetamine [GO:0001975]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to steroid hormone [GO:0048545]; vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [GO:0001987]; visual learning [GO:0008542],alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982],GO:0001974; GO:0001975; GO:0001987; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005901; GO:0005980; GO:0007200; GO:0007204; GO:0007267; GO:0007512; GO:0007626; GO:0008217; GO:0008542; GO:0009725; GO:0014704; GO:0016020; GO:0019229; GO:0030315; GO:0031965; GO:0035024; GO:0035265; GO:0042593; GO:0043278; GO:0043410; GO:0045818; GO:0045819; GO:0046982; GO:0048148; GO:0048545; GO:0055117; GO:0061049; GO:0071880; GO:0150099,"LIPID 364; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P97718,reviewed,ADA1A_MOUSE,Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor),Adra1a Adra1c,Mus musculus (Mouse),466,"activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; aging [GO:0007568]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; MAPK cascade [GO:0000165]; micturition [GO:0060073]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate [GO:0010460]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of blood pressure [GO:0008217]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]",caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; T-tubule [GO:0030315]; Z disc [GO:0030018],"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; T-tubule [GO:0030315]; Z disc [GO:0030018]; alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; aging [GO:0007568]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; MAPK cascade [GO:0000165]; micturition [GO:0060073]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate [GO:0010460]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of blood pressure [GO:0008217]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]",alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982],GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0003084; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007202; GO:0007204; GO:0007267; GO:0007512; GO:0007568; GO:0008217; GO:0009410; GO:0009725; GO:0010460; GO:0010507; GO:0010613; GO:0016020; GO:0030018; GO:0030315; GO:0031965; GO:0032230; GO:0035024; GO:0035265; GO:0042734; GO:0043231; GO:0043410; GO:0045211; GO:0045760; GO:0045907; GO:0045987; GO:0046982; GO:0060073; GO:0060402; GO:0060452; GO:0061049; GO:0070374; GO:0071880; GO:0090037; GO:0097195; GO:0098691; GO:0098978; GO:0098982; GO:0099171; GO:0150099; GO:1903997,"LIPID 345; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P97792,reviewed,CXAR_MOUSE,Coxsackievirus and adenovirus receptor homolog (CAR) (mCAR),Cxadr Car,Mus musculus (Mouse),365,actin cytoskeleton reorganization [GO:0031532]; AV node cell to bundle of His cell communication [GO:0086067]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; cardiac muscle cell development [GO:0055013]; cardiac muscle cell proliferation [GO:0060038]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; neutrophil chemotaxis [GO:0030593]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; regulation of AV node cell action potential [GO:0098904]; transepithelial transport [GO:0070633],acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; actin cytoskeleton reorganization [GO:0031532]; AV node cell to bundle of His cell communication [GO:0086067]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; cardiac muscle cell development [GO:0055013]; cardiac muscle cell proliferation [GO:0060038]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; neutrophil chemotaxis [GO:0030593]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; regulation of AV node cell action potential [GO:0098904]; transepithelial transport [GO:0070633],beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102],GO:0001669; GO:0005102; GO:0005178; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007005; GO:0007157; GO:0007507; GO:0008013; GO:0008354; GO:0010669; GO:0014704; GO:0016323; GO:0016327; GO:0030054; GO:0030165; GO:0030175; GO:0030426; GO:0030593; GO:0031532; GO:0031594; GO:0032991; GO:0034109; GO:0042802; GO:0043005; GO:0044297; GO:0045121; GO:0045216; GO:0046629; GO:0050839; GO:0051607; GO:0055013; GO:0060038; GO:0060044; GO:0060054; GO:0070633; GO:0071253; GO:0086067; GO:0086072; GO:0086082; GO:0098609; GO:0098904,"LIPID 259; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 260; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P97812,reviewed,IHH_MOUSE,Indian hedgehog protein (IHH) (EC 3.1.-.-) (HHG-2) [Cleaved into: Indian hedgehog protein N-product],Ihh,Mus musculus (Mouse),411,bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye development [GO:0043010]; camera-type eye photoreceptor cell fate commitment [GO:0060220]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte proliferation [GO:0035988]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint development [GO:0072498]; endochondral bone morphogenesis [GO:0060350]; epithelial cell morphogenesis [GO:0003382]; epithelial cell-cell adhesion [GO:0090136]; head morphogenesis [GO:0060323]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; intein-mediated protein splicing [GO:0016539]; liver regeneration [GO:0097421]; maternal process involved in female pregnancy [GO:0060135]; morphogenesis of a branching structure [GO:0001763]; multicellular organism growth [GO:0035264]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of eye pigmentation [GO:0048074]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell differentiation in thymus [GO:0033085]; neuron development [GO:0048666]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; proteoglycan metabolic process [GO:0006029]; regulation of growth [GO:0040008]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; retinal pigment epithelium development [GO:0003406]; self proteolysis [GO:0097264]; skeletal system development [GO:0001501]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; vasculature development [GO:0001944]; vitelline membrane formation [GO:0030704],endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; very-low-density lipoprotein particle binding [GO:0034189]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye development [GO:0043010]; camera-type eye photoreceptor cell fate commitment [GO:0060220]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte proliferation [GO:0035988]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint development [GO:0072498]; endochondral bone morphogenesis [GO:0060350]; epithelial cell morphogenesis [GO:0003382]; epithelial cell-cell adhesion [GO:0090136]; head morphogenesis [GO:0060323]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; intein-mediated protein splicing [GO:0016539]; liver regeneration [GO:0097421]; maternal process involved in female pregnancy [GO:0060135]; morphogenesis of a branching structure [GO:0001763]; multicellular organism growth [GO:0035264]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of eye pigmentation [GO:0048074]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell differentiation in thymus [GO:0033085]; neuron development [GO:0048666]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; proteoglycan metabolic process [GO:0006029]; regulation of growth [GO:0040008]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; retinal pigment epithelium development [GO:0003406]; self proteolysis [GO:0097264]; skeletal system development [GO:0001501]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; vasculature development [GO:0001944]; vitelline membrane formation [GO:0030704],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; very-low-density lipoprotein particle binding [GO:0034189],GO:0000139; GO:0001501; GO:0001503; GO:0001569; GO:0001649; GO:0001701; GO:0001708; GO:0001763; GO:0001944; GO:0001947; GO:0002053; GO:0002062; GO:0003382; GO:0003406; GO:0003413; GO:0005113; GO:0005509; GO:0005576; GO:0005789; GO:0005886; GO:0006029; GO:0007224; GO:0007267; GO:0007389; GO:0008233; GO:0008283; GO:0008284; GO:0009612; GO:0009880; GO:0016539; GO:0016540; GO:0030704; GO:0031012; GO:0031016; GO:0032331; GO:0032355; GO:0032967; GO:0033085; GO:0033088; GO:0033089; GO:0034189; GO:0035264; GO:0035988; GO:0040008; GO:0042733; GO:0043010; GO:0043066; GO:0045453; GO:0045880; GO:0045944; GO:0046638; GO:0046639; GO:0048074; GO:0048469; GO:0048557; GO:0048596; GO:0048666; GO:0048745; GO:0050679; GO:0051216; GO:0060135; GO:0060220; GO:0060323; GO:0060350; GO:0061053; GO:0072498; GO:0090136; GO:0097264; GO:0097421; GO:0140853,"LIPID 28; /note=""N-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q14623""; LIPID 202; /note=""Cholesterol glycine ester""; /evidence=""ECO:0000250|UniProtKB:Q02936"""
P99029,reviewed,PRDX5_MOUSE,"Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 2D-0014IV) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)",Prdx5 Prdx6,Mus musculus (Mouse),210,cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; thioredoxin-dependent peroxiredoxin activity [GO:0140824]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979],antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; thioredoxin-dependent peroxiredoxin activity [GO:0140824],GO:0001016; GO:0004601; GO:0005102; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0042802; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0048471; GO:0051354; GO:0060785; GO:0070995; GO:0072541; GO:0140824; GO:2001057,"LIPID 96; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P30044"""
Q00LT2,reviewed,PRCD_MOUSE,Photoreceptor disk component PRCD (Progressive rod-cone degeneration protein homolog),Prcd Gm11744,Mus musculus (Mouse),53,response to stimulus [GO:0050896]; visual perception [GO:0007601],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; opsin binding [GO:0002046]; response to stimulus [GO:0050896]; visual perception [GO:0007601],opsin binding [GO:0002046],GO:0001750; GO:0002046; GO:0005576; GO:0005737; GO:0005783; GO:0005794; GO:0007601; GO:0042622; GO:0050896,"LIPID 2; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:27509380, ECO:0000305|PubMed:27613864"""
Q01102,reviewed,LYAM3_MOUSE,P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140) (GMP-140) (Leukocyte-endothelial cell adhesion molecule 3) (LECAM3) (Platelet activation dependent granule-external membrane protein) (PADGEM) (CD antigen CD62P),Selp Grmp,Mus musculus (Mouse),768,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell-cell adhesion [GO:0098609]; cellular response to interleukin-6 [GO:0071354]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; positive regulation of cell adhesion [GO:0045785]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet activation [GO:0010572]; regulation of cellular extravasation [GO:0002691]; regulation of integrin activation [GO:0033623]; response to cytokine [GO:0034097],external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092],external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; fucose binding [GO:0042806]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; oligosaccharide binding [GO:0070492]; sialic acid binding [GO:0033691]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell-cell adhesion [GO:0098609]; cellular response to interleukin-6 [GO:0071354]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; positive regulation of cell adhesion [GO:0045785]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet activation [GO:0010572]; regulation of cellular extravasation [GO:0002691]; regulation of integrin activation [GO:0033623]; response to cytokine [GO:0034097],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; fucose binding [GO:0042806]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; oligosaccharide binding [GO:0070492]; sialic acid binding [GO:0033691],GO:0001530; GO:0002687; GO:0002691; GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007157; GO:0007159; GO:0008201; GO:0009897; GO:0010572; GO:0014068; GO:0016020; GO:0016339; GO:0031092; GO:0033623; GO:0033691; GO:0034097; GO:0035584; GO:0042806; GO:0045785; GO:0048306; GO:0050900; GO:0050901; GO:0070492; GO:0071354; GO:0098609; GO:1903238,"LIPID 745; /note=""S-palmitoyl cysteine; alternate""; /evidence=""ECO:0000250|UniProtKB:P16109""; LIPID 745; /note=""S-stearoyl cysteine; alternate""; /evidence=""ECO:0000250|UniProtKB:P16109"""
Q01279,reviewed,EGFR_MOUSE,Epidermal growth factor receptor (EC 2.7.10.1),Egfr,Mus musculus (Mouse),1210,"astrocyte activation [GO:0048143]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cellular response to xenobiotic stimulus [GO:0071466]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis development [GO:0008544]; epithelial cell proliferation [GO:0050673]; ERBB2-EGFR signaling pathway [GO:0038134]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; magnesium ion homeostasis [GO:0010960]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; neuron projection morphogenesis [GO:0048812]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of inflammatory response [GO:0050729]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mucus secretion [GO:0070257]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; regulation of cell population proliferation [GO:0042127]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to osmotic stress [GO:0006970]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasodilation [GO:0042311]; wound healing [GO:0042060]","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; synapse [GO:0045202]","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; astrocyte activation [GO:0048143]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cellular response to xenobiotic stimulus [GO:0071466]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis development [GO:0008544]; epithelial cell proliferation [GO:0050673]; ERBB2-EGFR signaling pathway [GO:0038134]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; magnesium ion homeostasis [GO:0010960]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; neuron projection morphogenesis [GO:0048812]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of inflammatory response [GO:0050729]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mucus secretion [GO:0070257]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; regulation of cell population proliferation [GO:0042127]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to osmotic stress [GO:0006970]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasodilation [GO:0042311]; wound healing [GO:0042060]",actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625],GO:0000139; GO:0000902; GO:0001892; GO:0001934; GO:0001942; GO:0003682; GO:0004713; GO:0004714; GO:0004888; GO:0005006; GO:0005102; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005789; GO:0005886; GO:0006412; GO:0006970; GO:0007165; GO:0007166; GO:0007169; GO:0007173; GO:0007435; GO:0007494; GO:0007611; GO:0007623; GO:0008283; GO:0008284; GO:0008544; GO:0009925; GO:0009986; GO:0010008; GO:0010750; GO:0010960; GO:0014066; GO:0016020; GO:0016101; GO:0016301; GO:0016323; GO:0016324; GO:0018108; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021795; GO:0022008; GO:0030054; GO:0030139; GO:0030235; GO:0030297; GO:0030307; GO:0030324; GO:0030335; GO:0031625; GO:0031901; GO:0031965; GO:0032587; GO:0032930; GO:0032991; GO:0033138; GO:0033590; GO:0033594; GO:0033674; GO:0034614; GO:0035556; GO:0038083; GO:0038134; GO:0042060; GO:0042127; GO:0042177; GO:0042311; GO:0042327; GO:0042698; GO:0042743; GO:0042802; GO:0043066; GO:0043235; GO:0043406; GO:0043410; GO:0043586; GO:0044877; GO:0045121; GO:0045202; GO:0045737; GO:0045739; GO:0045740; GO:0045780; GO:0045893; GO:0045907; GO:0045930; GO:0045944; GO:0046328; GO:0046777; GO:0048143; GO:0048146; GO:0048408; GO:0048471; GO:0048546; GO:0048661; GO:0048812; GO:0050673; GO:0050679; GO:0050729; GO:0050730; GO:0050999; GO:0051015; GO:0051592; GO:0051897; GO:0051968; GO:0060252; GO:0060571; GO:0061029; GO:0070141; GO:0070257; GO:0070372; GO:0070374; GO:0071230; GO:0071260; GO:0071276; GO:0071363; GO:0071364; GO:0071392; GO:0071466; GO:0071549; GO:0090263; GO:0097421; GO:0097489; GO:0097708; GO:0098609; GO:1900020; GO:1900087; GO:1901224; GO:1902722; GO:1902895; GO:1902966; GO:1903078; GO:1905208,"LIPID 1051; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P00533""; LIPID 1146; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P00533"""
Q01338,reviewed,ADA2A_MOUSE,Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR),Adra2a,Mus musculus (Mouse),465,activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adrenergic receptor signaling pathway [GO:0071875]; cellular response to hormone stimulus [GO:0032870]; DNA replication [GO:0006260]; fear response [GO:0042596]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of uterine smooth muscle contraction [GO:0070473]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production [GO:0001819]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of wound healing [GO:0090303]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; receptor transactivation [GO:0035624]; regulation of vasoconstriction [GO:0019229]; thermoception [GO:0050955]; vasodilation [GO:0042311],axon terminus [GO:0043679]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; receptor complex [GO:0043235]; synapse [GO:0045202],axon terminus [GO:0043679]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; receptor complex [GO:0043235]; synapse [GO:0045202]; adrenergic receptor activity [GO:0004935]; alpha-2C adrenergic receptor binding [GO:0031696]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; heterotrimeric G-protein binding [GO:0032795]; molecular function activator activity [GO:0140677]; norepinephrine binding [GO:0051380]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adrenergic receptor signaling pathway [GO:0071875]; cellular response to hormone stimulus [GO:0032870]; DNA replication [GO:0006260]; fear response [GO:0042596]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of uterine smooth muscle contraction [GO:0070473]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production [GO:0001819]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of wound healing [GO:0090303]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; receptor transactivation [GO:0035624]; regulation of vasoconstriction [GO:0019229]; thermoception [GO:0050955]; vasodilation [GO:0042311],adrenergic receptor activity [GO:0004935]; alpha-2C adrenergic receptor binding [GO:0031696]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; heterotrimeric G-protein binding [GO:0032795]; molecular function activator activity [GO:0140677]; norepinephrine binding [GO:0051380]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996],GO:0001819; GO:0002526; GO:0004935; GO:0004938; GO:0005737; GO:0005886; GO:0006260; GO:0007186; GO:0007565; GO:0019229; GO:0019901; GO:0030168; GO:0030335; GO:0031696; GO:0031996; GO:0032147; GO:0032148; GO:0032795; GO:0032870; GO:0035624; GO:0042311; GO:0042593; GO:0042596; GO:0042803; GO:0043025; GO:0043235; GO:0043406; GO:0043410; GO:0043679; GO:0045202; GO:0045211; GO:0045741; GO:0045955; GO:0046676; GO:0046982; GO:0048787; GO:0050955; GO:0050995; GO:0051044; GO:0051379; GO:0051380; GO:0061179; GO:0070473; GO:0071875; GO:0071880; GO:0071881; GO:0071882; GO:0090303; GO:0098691; GO:0098839; GO:0098978; GO:0098982; GO:0099171; GO:0140677,"LIPID 457; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q01727,reviewed,MSHR_MOUSE,Melanocyte-stimulating hormone receptor (MSH-R) (Melanocortin receptor 1) (MC1-R),Mc1r Msh-r,Mus musculus (Mouse),315,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of feeding behavior [GO:2000253]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory perception of pain [GO:0019233]; UV-damage excision repair [GO:0070914],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of feeding behavior [GO:2000253]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory perception of pain [GO:0019233]; UV-damage excision repair [GO:0070914],hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625],GO:0004977; GO:0004980; GO:0005886; GO:0007189; GO:0010739; GO:0019233; GO:0031625; GO:0032720; GO:0035556; GO:0042438; GO:0042562; GO:0045944; GO:0051897; GO:0070914; GO:0090037; GO:2000253,"LIPID 313; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q02152,reviewed,5HT2B_MOUSE,5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (NP75 protein) (Serotonin receptor 2B),Htr2b,Mus musculus (Mouse),479,"activation of phospholipase C activity [GO:0007202]; behavior [GO:0007610]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy [GO:0003300]; cellular response to amine stimulus [GO:0071418]; cellular response to serotonin [GO:1904015]; cellular response to temperature stimulus [GO:0071502]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; embryonic morphogenesis [GO:0048598]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; G protein-coupled serotonin receptor signaling pathway [GO:0098664]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; intestine smooth muscle contraction [GO:0014827]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; neural crest cell differentiation [GO:0014033]; neural crest cell migration [GO:0001755]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; phosphorylation [GO:0016310]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310]",cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled serotonin receptor complex [GO:0098666]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202],"cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled serotonin receptor complex [GO:0098666]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; G-protein alpha-subunit binding [GO:0001965]; Gq/11-coupled serotonin receptor activity [GO:0001587]; GTPase activator activity [GO:0005096]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; activation of phospholipase C activity [GO:0007202]; behavior [GO:0007610]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy [GO:0003300]; cellular response to amine stimulus [GO:0071418]; cellular response to serotonin [GO:1904015]; cellular response to temperature stimulus [GO:0071502]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; embryonic morphogenesis [GO:0048598]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; G protein-coupled serotonin receptor signaling pathway [GO:0098664]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; intestine smooth muscle contraction [GO:0014827]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; neural crest cell differentiation [GO:0014033]; neural crest cell migration [GO:0001755]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; phosphorylation [GO:0016310]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310]",G protein-coupled serotonin receptor activity [GO:0004993]; G-protein alpha-subunit binding [GO:0001965]; Gq/11-coupled serotonin receptor activity [GO:0001587]; GTPase activator activity [GO:0005096]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378],GO:0001587; GO:0001755; GO:0001819; GO:0001938; GO:0001965; GO:0002031; GO:0003007; GO:0003300; GO:0004993; GO:0005096; GO:0005654; GO:0005737; GO:0005886; GO:0006874; GO:0007186; GO:0007187; GO:0007200; GO:0007202; GO:0007205; GO:0007208; GO:0007268; GO:0007507; GO:0007610; GO:0008284; GO:0009410; GO:0010507; GO:0010513; GO:0014033; GO:0014065; GO:0014827; GO:0016020; GO:0016310; GO:0019722; GO:0019934; GO:0030425; GO:0030594; GO:0034220; GO:0042310; GO:0043025; GO:0043066; GO:0043123; GO:0043406; GO:0045202; GO:0048598; GO:0050795; GO:0051000; GO:0051209; GO:0051378; GO:0051781; GO:0060548; GO:0070371; GO:0070374; GO:0070528; GO:0071418; GO:0071502; GO:0098664; GO:0098666; GO:1904015,"LIPID 396; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q02496,reviewed,MUC1_MOUSE,Mucin-1 (MUC-1) (Episialin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)],Muc1 Muc-1,Mus musculus (Mouse),630,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; localization [GO:0051179]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]",apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; localization [GO:0051179]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]",p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712],GO:0000785; GO:0000978; GO:0002039; GO:0003712; GO:0005634; GO:0005737; GO:0005886; GO:0006977; GO:0006978; GO:0009986; GO:0010944; GO:0016324; GO:0033629; GO:0036003; GO:0043618; GO:0051179; GO:0062023; GO:0070062; GO:0090240; GO:1902166,"LIPID 559; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 561; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q04573,reviewed,NPY1R_MOUSE,Neuropeptide Y receptor type 1 (NPY1-R),Npy1r,Mus musculus (Mouse),382,feeding behavior [GO:0007631]; glucose metabolic process [GO:0006006]; locomotory behavior [GO:0007626]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of hormone secretion [GO:0046888]; outflow tract morphogenesis [GO:0003151]; peristalsis [GO:0030432]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of multicellular organism growth [GO:0040014]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300]; sensory perception of pain [GO:0019233]; synaptic signaling via neuropeptide [GO:0099538],axon [GO:0030424]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal dense core vesicle [GO:0098992]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021],axon [GO:0030424]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal dense core vesicle [GO:0098992]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601]; feeding behavior [GO:0007631]; glucose metabolic process [GO:0006006]; locomotory behavior [GO:0007626]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of hormone secretion [GO:0046888]; outflow tract morphogenesis [GO:0003151]; peristalsis [GO:0030432]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of multicellular organism growth [GO:0040014]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300]; sensory perception of pain [GO:0019233]; synaptic signaling via neuropeptide [GO:0099538],neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601],GO:0001601; GO:0001602; GO:0003151; GO:0004983; GO:0005829; GO:0005886; GO:0006006; GO:0007626; GO:0007631; GO:0008021; GO:0008188; GO:0008217; GO:0019233; GO:0030424; GO:0030432; GO:0040014; GO:0042734; GO:0042923; GO:0043005; GO:0045907; GO:0046888; GO:0051481; GO:0098978; GO:0098992; GO:0099509; GO:0099538; GO:2000300,"LIPID 337; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q04736,reviewed,YES_MOUSE,Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes),Yes1 Yes,Mus musculus (Mouse),541,cell differentiation [GO:0030154]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; innate immune response [GO:0045087]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of glucose transmembrane transport [GO:0010827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],"actin filament [GO:0005884]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]","actin filament [GO:0005884]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; cell differentiation [GO:0030154]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; innate immune response [GO:0045087]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of glucose transmembrane transport [GO:0010827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325],GO:0001784; GO:0004713; GO:0004715; GO:0005102; GO:0005154; GO:0005524; GO:0005794; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0007169; GO:0010827; GO:0019899; GO:0030154; GO:0031234; GO:0036120; GO:0044325; GO:0045087; GO:0045944; GO:0046777; GO:0050731; GO:0071300; GO:0071560; GO:0098978; GO:0099091,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250""; LIPID 3; /note=""S-palmitoyl cysteine; in membrane form""; /evidence=""ECO:0000250"""
Q08460,reviewed,KCMA1_MOUSE,"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (mSlo1) (Slowpoke homolog) (Slo homolog) (mSlo)",Kcnma1 Kcnma,Mus musculus (Mouse),1209,adult walking behavior [GO:0007628]; blood vessel diameter maintenance [GO:0097746]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; columnar/cuboidal epithelial cell maturation [GO:0002069]; eye blink reflex [GO:0060082]; inner ear auditory receptor cell differentiation [GO:0042491]; intracellular potassium ion homeostasis [GO:0030007]; locomotor rhythm [GO:0045475]; micturition [GO:0060073]; negative regulation of cell volume [GO:0045794]; negative regulation of small intestine smooth muscle contraction [GO:1904348]; neuromuscular process controlling balance [GO:0050885]; neuron maturation [GO:0042551]; neuronal action potential [GO:0019228]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; potassium ion transport [GO:0006813]; regulation of aldosterone metabolic process [GO:0032344]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; relaxation of vascular associated smooth muscle [GO:0060087]; response to calcium ion [GO:0051592]; response to carbon monoxide [GO:0034465]; response to corticosteroid [GO:0031960]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to osmotic stress [GO:0006970]; response to pH [GO:0009268]; saliva secretion [GO:0046541]; sensory perception of sound [GO:0007605]; smooth muscle contraction involved in micturition [GO:0060083]; vasodilation [GO:0042311],apical plasma membrane [GO:0016324]; caveola [GO:0005901]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528]; terminal bouton [GO:0043195]; voltage-gated potassium channel complex [GO:0008076],apical plasma membrane [GO:0016324]; caveola [GO:0005901]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528]; terminal bouton [GO:0043195]; voltage-gated potassium channel complex [GO:0008076]; actin binding [GO:0003779]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; large conductance calcium-activated potassium channel activity [GO:0060072]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]; adult walking behavior [GO:0007628]; blood vessel diameter maintenance [GO:0097746]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; columnar/cuboidal epithelial cell maturation [GO:0002069]; eye blink reflex [GO:0060082]; inner ear auditory receptor cell differentiation [GO:0042491]; intracellular potassium ion homeostasis [GO:0030007]; locomotor rhythm [GO:0045475]; micturition [GO:0060073]; negative regulation of cell volume [GO:0045794]; negative regulation of small intestine smooth muscle contraction [GO:1904348]; neuromuscular process controlling balance [GO:0050885]; neuron maturation [GO:0042551]; neuronal action potential [GO:0019228]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; potassium ion transport [GO:0006813]; regulation of aldosterone metabolic process [GO:0032344]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; relaxation of vascular associated smooth muscle [GO:0060087]; response to calcium ion [GO:0051592]; response to carbon monoxide [GO:0034465]; response to corticosteroid [GO:0031960]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to osmotic stress [GO:0006970]; response to pH [GO:0009268]; saliva secretion [GO:0046541]; sensory perception of sound [GO:0007605]; smooth muscle contraction involved in micturition [GO:0060083]; vasodilation [GO:0042311],actin binding [GO:0003779]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; large conductance calcium-activated potassium channel activity [GO:0060072]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249],GO:0001666; GO:0002069; GO:0003779; GO:0005249; GO:0005267; GO:0005739; GO:0005783; GO:0005886; GO:0005901; GO:0006813; GO:0006970; GO:0007268; GO:0007605; GO:0007623; GO:0007628; GO:0008076; GO:0009268; GO:0009897; GO:0015269; GO:0016020; GO:0016324; GO:0016528; GO:0019228; GO:0030007; GO:0030425; GO:0031960; GO:0032344; GO:0032991; GO:0034465; GO:0034765; GO:0042311; GO:0042391; GO:0042491; GO:0042551; GO:0042802; GO:0043025; GO:0043065; GO:0043195; GO:0043525; GO:0043627; GO:0044877; GO:0045211; GO:0045475; GO:0045794; GO:0046541; GO:0046872; GO:0048471; GO:0048787; GO:0050885; GO:0051592; GO:0060072; GO:0060073; GO:0060082; GO:0060083; GO:0060087; GO:0097746; GO:0098978; GO:0099507; GO:1904348,"LIPID 118; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 119; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 121; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q08481,reviewed,PECA1_MOUSE,Platelet endothelial cell adhesion molecule (PECAM-1) (CD antigen CD31),Pecam1 Pecam Pecam-1,Mus musculus (Mouse),727,angiogenesis [GO:0001525]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diapedesis [GO:0050904]; endothelial cell migration [GO:0043542]; endothelial cell morphogenesis [GO:0001886]; endothelial cell-matrix adhesion [GO:0090673]; establishment of endothelial barrier [GO:0061028]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte cell-cell adhesion [GO:0007159]; monocyte extravasation [GO:0035696]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; neutrophil extravasation [GO:0072672]; phagocytosis [GO:0006909]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein localization to cell-cell junction [GO:0150107]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell migration [GO:0030334]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060],cell periphery [GO:0071944]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; smooth muscle contractile fiber [GO:0030485],cell periphery [GO:0071944]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; smooth muscle contractile fiber [GO:0030485]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane signaling receptor activity [GO:0004888]; angiogenesis [GO:0001525]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diapedesis [GO:0050904]; endothelial cell migration [GO:0043542]; endothelial cell morphogenesis [GO:0001886]; endothelial cell-matrix adhesion [GO:0090673]; establishment of endothelial barrier [GO:0061028]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte cell-cell adhesion [GO:0007159]; monocyte extravasation [GO:0035696]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; neutrophil extravasation [GO:0072672]; phagocytosis [GO:0006909]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein localization to cell-cell junction [GO:0150107]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell migration [GO:0030334]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060],protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane signaling receptor activity [GO:0004888],GO:0001525; GO:0001726; GO:0001886; GO:0001934; GO:0002687; GO:0002693; GO:0004888; GO:0005615; GO:0005737; GO:0005886; GO:0005911; GO:0006909; GO:0007155; GO:0007156; GO:0007159; GO:0007166; GO:0007266; GO:0009897; GO:0009986; GO:0016020; GO:0019903; GO:0030334; GO:0030335; GO:0030485; GO:0030837; GO:0032991; GO:0034260; GO:0035696; GO:0042060; GO:0042531; GO:0042803; GO:0043542; GO:0044291; GO:0045121; GO:0050731; GO:0050732; GO:0050904; GO:0061028; GO:0070830; GO:0071944; GO:0072672; GO:0090673; GO:0098609; GO:0098742; GO:0150107,"LIPID 611; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q08857,reviewed,CD36_MOUSE,Platelet glycoprotein 4 (Glycoprotein IIIb) (GPIIIB) (PAS IV) (PAS-4) (Platelet glycoprotein IV) (GPIV) (CD antigen CD36),Cd36,Mus musculus (Mouse),472,"amyloid fibril formation [GO:1990000]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to hydroperoxide [GO:0071447]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cGMP-mediated signaling [GO:0019934]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; defense response to Gram-positive bacterium [GO:0050830]; energy homeostasis [GO:0097009]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; lipid storage [GO:0019915]; lipid transport across blood-brain barrier [GO:1990379]; lipoprotein transport [GO:0042953]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle mediated signaling [GO:0055096]; MAPK cascade [GO:0000165]; negative regulation of gene expression [GO:0010629]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitric oxide mediated signal transduction [GO:0007263]; oxidised low-density lipoprotein particle clearance [GO:0150024]; phagocytosis, recognition [GO:0006910]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood microparticle formation [GO:2000334]; positive regulation of cell death [GO:0010942]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of tumor necrosis factor production [GO:0032760]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of action potential [GO:0098900]; regulation of protein-containing complex assembly [GO:0043254]; regulation of removal of superoxide radicals [GO:2000121]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to bacterium [GO:0009617]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; response to stilbenoid [GO:0035634]; sensory perception of taste [GO:0050909]; short-chain fatty acid transport [GO:0015912]; triglyceride transport [GO:0034197]",apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; caveola [GO:0005901]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; sarcolemma [GO:0042383],"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; caveola [GO:0005901]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; sarcolemma [GO:0042383]; amyloid-beta binding [GO:0001540]; fatty acid binding [GO:0005504]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid immune receptor activity [GO:0070892]; long-chain fatty acid transporter activity [GO:0005324]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; oleate transmembrane transporter activity [GO:1901480]; oleic acid binding [GO:0070538]; oxidised low-density lipoprotein particle receptor activity [GO:0150025]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; scavenger receptor activity [GO:0005044]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; thrombospondin receptor activity [GO:0070053]; Toll-like receptor binding [GO:0035325]; transforming growth factor beta binding [GO:0050431]; amyloid fibril formation [GO:1990000]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to hydroperoxide [GO:0071447]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cGMP-mediated signaling [GO:0019934]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; defense response to Gram-positive bacterium [GO:0050830]; energy homeostasis [GO:0097009]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; lipid storage [GO:0019915]; lipid transport across blood-brain barrier [GO:1990379]; lipoprotein transport [GO:0042953]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle mediated signaling [GO:0055096]; MAPK cascade [GO:0000165]; negative regulation of gene expression [GO:0010629]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitric oxide mediated signal transduction [GO:0007263]; oxidised low-density lipoprotein particle clearance [GO:0150024]; phagocytosis, recognition [GO:0006910]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood microparticle formation [GO:2000334]; positive regulation of cell death [GO:0010942]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of tumor necrosis factor production [GO:0032760]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of action potential [GO:0098900]; regulation of protein-containing complex assembly [GO:0043254]; regulation of removal of superoxide radicals [GO:2000121]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to bacterium [GO:0009617]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; response to stilbenoid [GO:0035634]; sensory perception of taste [GO:0050909]; short-chain fatty acid transport [GO:0015912]; triglyceride transport [GO:0034197]",amyloid-beta binding [GO:0001540]; fatty acid binding [GO:0005504]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid immune receptor activity [GO:0070892]; long-chain fatty acid transporter activity [GO:0005324]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; oleate transmembrane transporter activity [GO:1901480]; oleic acid binding [GO:0070538]; oxidised low-density lipoprotein particle receptor activity [GO:0150025]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; scavenger receptor activity [GO:0005044]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; thrombospondin receptor activity [GO:0070053]; Toll-like receptor binding [GO:0035325]; transforming growth factor beta binding [GO:0050431],GO:0000122; GO:0000165; GO:0001540; GO:0001954; GO:0005041; GO:0005044; GO:0005324; GO:0005504; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005886; GO:0005901; GO:0006898; GO:0006910; GO:0007155; GO:0007166; GO:0007204; GO:0007263; GO:0008035; GO:0008289; GO:0009617; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010744; GO:0010886; GO:0010942; GO:0015636; GO:0015909; GO:0015911; GO:0015912; GO:0016020; GO:0016324; GO:0019915; GO:0019934; GO:0030169; GO:0030194; GO:0030296; GO:0030299; GO:0030301; GO:0031526; GO:0031623; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0032991; GO:0033993; GO:0034121; GO:0034197; GO:0034381; GO:0034383; GO:0035325; GO:0035634; GO:0042308; GO:0042383; GO:0042953; GO:0043123; GO:0043231; GO:0043235; GO:0043254; GO:0043277; GO:0043410; GO:0043619; GO:0044539; GO:0044877; GO:0045121; GO:0045177; GO:0045429; GO:0050431; GO:0050731; GO:0050830; GO:0050892; GO:0050909; GO:0051092; GO:0055096; GO:0060100; GO:0060907; GO:0070053; GO:0070374; GO:0070508; GO:0070538; GO:0070542; GO:0070543; GO:0070892; GO:0071221; GO:0071222; GO:0071223; GO:0071404; GO:0071447; GO:0071726; GO:0071813; GO:0071944; GO:0097009; GO:0098900; GO:0120162; GO:0140052; GO:0150024; GO:0150025; GO:0150094; GO:1900227; GO:1901480; GO:1903428; GO:1904646; GO:1990000; GO:1990379; GO:2000121; GO:2000334; GO:2000379,"LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 7; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 464; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 466; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q0QWG9,reviewed,GRD2I_MOUSE,"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)",Grid2ip,Mus musculus (Mouse),1203,actin cytoskeleton organization [GO:0030036]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],"cerebellar granule cell to Purkinje cell synapse [GO:0150048]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]","cerebellar granule cell to Purkinje cell synapse [GO:0150048]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; actin cytoskeleton organization [GO:0030036]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]",,GO:0007216; GO:0030036; GO:0043197; GO:0045202; GO:0045211; GO:0060292; GO:0098688; GO:0098978; GO:0099072; GO:0099092; GO:0099566; GO:0150048,"LIPID Q0QWG9-2:3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:16835239"""
Q14BB9,reviewed,MA6D1_MOUSE,MAP6 domain-containing protein 1 (21 kDa STOP-like protein) (SL21),Map6d1,Mus musculus (Mouse),191,cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule cytoskeleton organization [GO:0000226]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of microtubule cytoskeleton organization [GO:0070507],cis-Golgi network [GO:0005801]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874],cis-Golgi network [GO:0005801]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule cytoskeleton organization [GO:0000226]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of microtubule cytoskeleton organization [GO:0070507],calmodulin binding [GO:0005516]; microtubule binding [GO:0008017],GO:0000226; GO:0005516; GO:0005798; GO:0005801; GO:0005874; GO:0007026; GO:0008017; GO:0018009; GO:0030705; GO:0070507,"LIPID 5; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 10; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 11; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q2TBE6,reviewed,P4K2A_MOUSE,Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha),Pi4k2a,Mus musculus (Mouse),479,basophil degranulation [GO:0002561]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854],BLOC-1 complex [GO:0031083]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; Golgi membrane [GO:0000139]; growing cell tip [GO:0035838]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802],BLOC-1 complex [GO:0031083]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; Golgi membrane [GO:0000139]; growing cell tip [GO:0035838]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; basophil degranulation [GO:0002561]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854],1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877],GO:0000139; GO:0002561; GO:0004430; GO:0005524; GO:0005739; GO:0005768; GO:0005802; GO:0005886; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0030425; GO:0030672; GO:0031083; GO:0031410; GO:0031901; GO:0032991; GO:0035651; GO:0035838; GO:0042734; GO:0043005; GO:0043025; GO:0043204; GO:0043231; GO:0044877; GO:0045121; GO:0046854; GO:0070382,"LIPID 174; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9BTU6""; LIPID 175; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9BTU6""; LIPID 177; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9BTU6""; LIPID 178; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9BTU6"""
Q3TBT3,reviewed,STING_MOUSE,Stimulator of interferon genes protein (mSTING) (Endoplasmic reticulum interferon stimulator) (ERIS) (Mediator of IRF3 activation) (MMITA) (Transmembrane protein 173),Sting1 Eris Mita Mpys Sting Tmem173,Mus musculus (Mouse),378,activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; cytosolic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein complex oligomerization [GO:0051259]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; reticulophagy [GO:0061709],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; STING complex [GO:1990231],"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; STING complex [GO:1990231]; 2',3'-cyclic GMP-AMP binding [GO:0061507]; cyclic-di-GMP binding [GO:0035438]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; cytosolic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein complex oligomerization [GO:0051259]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; reticulophagy [GO:0061709]","2',3'-cyclic GMP-AMP binding [GO:0061507]; cyclic-di-GMP binding [GO:0035438]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591]; ubiquitin protein ligase binding [GO:0031625]",GO:0000045; GO:0000139; GO:0000421; GO:0002218; GO:0002221; GO:0002230; GO:0002753; GO:0005654; GO:0005737; GO:0005741; GO:0005768; GO:0005776; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0010468; GO:0016239; GO:0019901; GO:0031625; GO:0032092; GO:0032481; GO:0032728; GO:0033116; GO:0035438; GO:0035458; GO:0035591; GO:0042802; GO:0042803; GO:0043539; GO:0045087; GO:0045944; GO:0048471; GO:0050727; GO:0051091; GO:0051259; GO:0051607; GO:0060340; GO:0061507; GO:0061629; GO:0061709; GO:0071360; GO:0071407; GO:0140374; GO:0140677; GO:1990231,"LIPID 88; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:27324217""; LIPID 91; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:27324217"""
Q3U1F9,reviewed,PHAG1_MOUSE,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane phosphoprotein Cbp),Pag1 Cbp Pag,Mus musculus (Mouse),429,adaptive immune response [GO:0002250]; intracellular signal transduction [GO:0035556]; negative regulation of T cell activation [GO:0050868]; regulation of T cell activation [GO:0050863],membrane raft [GO:0045121]; plasma membrane [GO:0005886],membrane raft [GO:0045121]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; adaptive immune response [GO:0002250]; intracellular signal transduction [GO:0035556]; negative regulation of T cell activation [GO:0050868]; regulation of T cell activation [GO:0050863],SH2 domain binding [GO:0042169],GO:0002250; GO:0005886; GO:0035556; GO:0042169; GO:0045121; GO:0050863; GO:0050868,"LIPID 39; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 42; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q3UNH4,reviewed,GRIN1_MOUSE,G protein-regulated inducer of neurite outgrowth 1 (GRIN1),Gprin1,Mus musculus (Mouse),932,neuron projection development [GO:0031175],growth cone [GO:0030426]; plasma membrane [GO:0005886],growth cone [GO:0030426]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; neuron projection development [GO:0031175],phosphoprotein binding [GO:0051219],GO:0005886; GO:0030426; GO:0031175; GO:0051219,"LIPID 923; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:15585744""; LIPID 924; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:15585744"""
Q3UU41,reviewed,SCIMP_MOUSE,SLP adapter and CSK-interacting membrane protein,Scimp,Mus musculus (Mouse),150,cellular response to molecule of fungal origin [GO:0071226]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of stress-activated MAPK cascade [GO:0032874]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor TLR1:TLR2 signaling pathway [GO:0038123],filopodium [GO:0030175]; immunological synapse [GO:0001772]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; receptor complex [GO:0043235]; ruffle [GO:0001726]; tetraspanin-enriched microdomain [GO:0097197]; uropod membrane [GO:0031259],filopodium [GO:0030175]; immunological synapse [GO:0001772]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; receptor complex [GO:0043235]; ruffle [GO:0001726]; tetraspanin-enriched microdomain [GO:0097197]; uropod membrane [GO:0031259]; molecular adaptor activity [GO:0060090]; cellular response to molecule of fungal origin [GO:0071226]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of stress-activated MAPK cascade [GO:0032874]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor TLR1:TLR2 signaling pathway [GO:0038123],molecular adaptor activity [GO:0060090],GO:0001726; GO:0001772; GO:0002720; GO:0002732; GO:0016020; GO:0030175; GO:0031256; GO:0031259; GO:0031666; GO:0032735; GO:0032755; GO:0032874; GO:0034138; GO:0034142; GO:0034154; GO:0038123; GO:0043235; GO:0045335; GO:0060090; GO:0070374; GO:0071226; GO:0097197,"LIPID 29; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q6UWF3""; LIPID 31; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q6UWF3"""
Q60612,reviewed,AA1R_MOUSE,Adenosine receptor A1,Adora1,Mus musculus (Mouse),326,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cognition [GO:0050890]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; excitatory postsynaptic potential [GO:0060079]; fatty acid homeostasis [GO:0055089]; G protein-coupled receptor signaling pathway [GO:0007186]; inhibition of non-skeletal tissue mineralization [GO:0140928]; leukocyte migration [GO:0050900]; lipid catabolic process [GO:0016042]; long-term synaptic depression [GO:0060292]; mucus secretion [GO:0070254]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of circadian sleep/wake cycle, non-REM sleep [GO:0042323]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of heart contraction [GO:0045822]; negative regulation of hormone secretion [GO:0046888]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mucus secretion [GO:0070256]; negative regulation of neurotrophin production [GO:0032900]; negative regulation of renal sodium excretion [GO:0035814]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of blood pressure [GO:0045777]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron death [GO:1901216]; positive regulation of nucleoside transport [GO:0032244]; positive regulation of peptide secretion [GO:0002793]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of systemic arterial blood pressure [GO:0003084]; protein targeting to membrane [GO:0006612]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of glomerular filtration [GO:0003093]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of sensory perception of pain [GO:0051930]; relaxation of vascular associated smooth muscle [GO:0060087]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; triglyceride homeostasis [GO:0070328]; vasodilation [GO:0042311]",asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; calyx of Held [GO:0044305]; cell body [GO:0044297]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195],"asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; calyx of Held [GO:0044305]; cell body [GO:0044297]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heat shock protein binding [GO:0031072]; heterotrimeric G-protein binding [GO:0032795]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; purine nucleoside binding [GO:0001883]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cognition [GO:0050890]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; excitatory postsynaptic potential [GO:0060079]; fatty acid homeostasis [GO:0055089]; G protein-coupled receptor signaling pathway [GO:0007186]; inhibition of non-skeletal tissue mineralization [GO:0140928]; leukocyte migration [GO:0050900]; lipid catabolic process [GO:0016042]; long-term synaptic depression [GO:0060292]; mucus secretion [GO:0070254]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of circadian sleep/wake cycle, non-REM sleep [GO:0042323]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of heart contraction [GO:0045822]; negative regulation of hormone secretion [GO:0046888]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mucus secretion [GO:0070256]; negative regulation of neurotrophin production [GO:0032900]; negative regulation of renal sodium excretion [GO:0035814]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of blood pressure [GO:0045777]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron death [GO:1901216]; positive regulation of nucleoside transport [GO:0032244]; positive regulation of peptide secretion [GO:0002793]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of systemic arterial blood pressure [GO:0003084]; protein targeting to membrane [GO:0006612]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of glomerular filtration [GO:0003093]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of sensory perception of pain [GO:0051930]; relaxation of vascular associated smooth muscle [GO:0060087]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; triglyceride homeostasis [GO:0070328]; vasodilation [GO:0042311]",G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heat shock protein binding [GO:0031072]; heterotrimeric G-protein binding [GO:0032795]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; purine nucleoside binding [GO:0001883],GO:0001609; GO:0001659; GO:0001664; GO:0001666; GO:0001883; GO:0002087; GO:0002674; GO:0002686; GO:0002793; GO:0003084; GO:0003085; GO:0003093; GO:0005783; GO:0005886; GO:0006612; GO:0007186; GO:0007193; GO:0008285; GO:0010035; GO:0012505; GO:0014050; GO:0014069; GO:0014074; GO:0016042; GO:0016323; GO:0030425; GO:0030673; GO:0031072; GO:0031683; GO:0032229; GO:0032244; GO:0032279; GO:0032795; GO:0032900; GO:0035307; GO:0035814; GO:0042311; GO:0042321; GO:0042323; GO:0042734; GO:0043025; GO:0043066; GO:0043195; GO:0043197; GO:0043268; GO:0043410; GO:0044297; GO:0044305; GO:0044877; GO:0045202; GO:0045211; GO:0045741; GO:0045776; GO:0045777; GO:0045822; GO:0046888; GO:0046982; GO:0048786; GO:0050728; GO:0050890; GO:0050900; GO:0050965; GO:0050995; GO:0050996; GO:0051930; GO:0051967; GO:0055089; GO:0055117; GO:0060079; GO:0060087; GO:0060292; GO:0070254; GO:0070256; GO:0070328; GO:0086004; GO:0099509; GO:0140928; GO:1900272; GO:1900453; GO:1901216,"LIPID 309; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q60614,reviewed,AA2BR_MOUSE,Adenosine receptor A2b,Adora2b,Mus musculus (Mouse),332,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to extracellular stimulus [GO:0031668]; cGMP-mediated signaling [GO:0019934]; mast cell degranulation [GO:0043303]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen biosynthetic process [GO:0032966]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose metabolic process [GO:0010906]; relaxation of vascular associated smooth muscle [GO:0060087]; response to angiotensin [GO:1990776]; vasodilation [GO:0042311],cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202],cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to extracellular stimulus [GO:0031668]; cGMP-mediated signaling [GO:0019934]; mast cell degranulation [GO:0043303]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen biosynthetic process [GO:0032966]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose metabolic process [GO:0010906]; relaxation of vascular associated smooth muscle [GO:0060087]; response to angiotensin [GO:1990776]; vasodilation [GO:0042311],G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930],GO:0001609; GO:0001938; GO:0002882; GO:0004930; GO:0005886; GO:0007189; GO:0008284; GO:0008285; GO:0009986; GO:0010575; GO:0010595; GO:0010701; GO:0010753; GO:0010893; GO:0010906; GO:0019934; GO:0031284; GO:0031668; GO:0032722; GO:0032755; GO:0032966; GO:0033605; GO:0042311; GO:0043303; GO:0043306; GO:0043950; GO:0045202; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171; GO:1990776,"LIPID 311; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q60634,reviewed,FLOT2_MOUSE,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1 homolog),Flot2 Esa1 M17s1,Mus musculus (Mouse),428,anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; flotillin complex [GO:0016600]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; synapse [GO:0045202]; uropod [GO:0001931]; vesicle [GO:0031982],acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; flotillin complex [GO:0016600]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; synapse [GO:0045202]; uropod [GO:0001931]; vesicle [GO:0031982]; ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020]; anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020],GO:0001931; GO:0002020; GO:0002080; GO:0005768; GO:0005886; GO:0005901; GO:0005912; GO:0007155; GO:0010629; GO:0016020; GO:0016323; GO:0016600; GO:0030027; GO:0030139; GO:0030864; GO:0031410; GO:0031982; GO:0032839; GO:0035255; GO:0043231; GO:0044291; GO:0044860; GO:0045121; GO:0045202; GO:0045661; GO:0048471; GO:0048787; GO:0050821; GO:0051092; GO:0072659; GO:0098937; GO:0098978; GO:0099072; GO:1902992; GO:1903905,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:Q14254""; LIPID 4; /note=""S-palmitoyl cysteine; by ZDHHC5""; /evidence=""ECO:0000250""; LIPID 19; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 20; /note=""S-palmitoyl cysteine; by ZDHHC5""; /evidence=""ECO:0000250"""
Q61009,reviewed,SCRB1_MOUSE,Scavenger receptor class B member 1 (SRB1) (SR-BI),Scarb1 Srb1,Mus musculus (Mouse),509,"adhesion of symbiont to host [GO:0044406]; androgen biosynthetic process [GO:0006702]; blood vessel endothelial cell migration [GO:0043534]; carotenoid transport [GO:0046867]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal lipid absorption [GO:0098856]; lipid transport [GO:0006869]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phagocytosis, recognition [GO:0006910]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phagocytosis [GO:0050764]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]",caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886],"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; scavenger receptor activity [GO:0005044]; adhesion of symbiont to host [GO:0044406]; androgen biosynthetic process [GO:0006702]; blood vessel endothelial cell migration [GO:0043534]; carotenoid transport [GO:0046867]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal lipid absorption [GO:0098856]; lipid transport [GO:0006869]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phagocytosis, recognition [GO:0006910]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phagocytosis [GO:0050764]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]",amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; scavenger receptor activity [GO:0005044],GO:0001530; GO:0001540; GO:0001786; GO:0001875; GO:0001935; GO:0005044; GO:0005737; GO:0005764; GO:0005886; GO:0005901; GO:0006702; GO:0006707; GO:0006869; GO:0006910; GO:0008035; GO:0008289; GO:0009986; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0016020; GO:0030169; GO:0030301; GO:0031528; GO:0032497; GO:0033344; GO:0034185; GO:0034186; GO:0034375; GO:0034381; GO:0034383; GO:0034384; GO:0035461; GO:0042632; GO:0042802; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0046867; GO:0050764; GO:0051000; GO:0070328; GO:0070506; GO:0070508; GO:0098856,"LIPID 462; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:9614139"""
Q61411,reviewed,RASH_MOUSE,"GTPase HRas (EC 3.6.5.2) (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed]",Hras Hras1,Mus musculus (Mouse),189,adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; fibroblast proliferation [GO:0048144]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oncogene-induced cell senescence [GO:0090402]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type II interferon production [GO:0032729]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAP kinase activity [GO:0043405]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of transcription by RNA polymerase II [GO:0006357]; small GTPase mediated signal transduction [GO:0007264]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTPase complex [GO:1905360]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTPase complex [GO:1905360]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; fibroblast proliferation [GO:0048144]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oncogene-induced cell senescence [GO:0090402]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type II interferon production [GO:0032729]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAP kinase activity [GO:0043405]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of transcription by RNA polymerase II [GO:0006357]; small GTPase mediated signal transduction [GO:0007264]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495],GO:0000139; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0006357; GO:0006897; GO:0006915; GO:0007264; GO:0007265; GO:0008284; GO:0008285; GO:0008286; GO:0010628; GO:0010629; GO:0010863; GO:0019003; GO:0030335; GO:0032729; GO:0034260; GO:0042088; GO:0042127; GO:0042832; GO:0043231; GO:0043405; GO:0043406; GO:0043410; GO:0043495; GO:0043524; GO:0043539; GO:0043547; GO:0044877; GO:0045740; GO:0045944; GO:0046330; GO:0046579; GO:0048009; GO:0048144; GO:0048146; GO:0048169; GO:0050679; GO:0050852; GO:0051402; GO:0051726; GO:0060612; GO:0070374; GO:0071480; GO:0090303; GO:0090314; GO:0090398; GO:0090402; GO:0097193; GO:0098696; GO:0098978; GO:1900029; GO:1905360; GO:2000251; GO:2000630,"LIPID 181; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P01112""; LIPID 184; /note=""S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine; alternate""; /evidence=""ECO:0000250|UniProtKB:P01112""; LIPID 184; /note=""S-palmitoyl cysteine; alternate""; /evidence=""ECO:0000250|UniProtKB:P01112""; LIPID 186; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P01112"""
Q61488,reviewed,DHH_MOUSE,Desert hedgehog protein (DHH) (EC 3.1.-.-) (HHG-3) [Cleaved into: Desert hedgehog protein N-product],Dhh,Mus musculus (Mouse),396,cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; Leydig cell differentiation [GO:0033327]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; paracrine signaling [GO:0038001]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell development [GO:0014044]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283],endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; Leydig cell differentiation [GO:0033327]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; paracrine signaling [GO:0038001]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell development [GO:0014044]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0000139; GO:0001649; GO:0001708; GO:0005113; GO:0005509; GO:0005576; GO:0005789; GO:0005886; GO:0007224; GO:0007267; GO:0007283; GO:0007286; GO:0008233; GO:0008270; GO:0008584; GO:0014044; GO:0016539; GO:0016540; GO:0030238; GO:0032355; GO:0033327; GO:0038001; GO:0042552; GO:0043627; GO:0045880; GO:0050810; GO:0097264; GO:0140853,"LIPID 23; /note=""N-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O43323""; LIPID 198; /note=""Cholesterol glycine ester""; /evidence=""ECO:0000250|UniProtKB:Q62226"""
Q61616,reviewed,DRD1_MOUSE,D(1A) dopamine receptor (Dopamine D1 receptor),Drd1 Drd1a Gpcr15,Mus musculus (Mouse),446,"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult walking behavior [GO:0007628]; associative learning [GO:0008306]; astrocyte development [GO:0014002]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to dopamine [GO:1903351]; cerebral cortex GABAergic interneuron migration [GO:0021853]; conditioned taste aversion [GO:0001661]; dentate gyrus development [GO:0021542]; dopamine receptor signaling pathway [GO:0007212]; dopamine transport [GO:0015872]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose import [GO:0046323]; grooming behavior [GO:0007625]; habituation [GO:0046959]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; maternal behavior [GO:0042711]; mating behavior [GO:0007617]; memory [GO:0007613]; modification of postsynaptic structure [GO:0099010]; muscle contraction [GO:0006936]; negative regulation of cell death [GO:0060548]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of synaptic transmission [GO:0050805]; neuron migration [GO:0001764]; neuronal action potential [GO:0019228]; operant conditioning [GO:0035106]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of feeding behavior [GO:2000253]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of membrane potential [GO:0045838]; positive regulation of neuron migration [GO:2001224]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; regulation of dopamine metabolic process [GO:0042053]; regulation of monoatomic ion transport [GO:0043269]; regulation of protein phosphorylation [GO:0001932]; regulation of vasoconstriction [GO:0019229]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; response to xenobiotic stimulus [GO:0009410]; sensitization [GO:0046960]; social behavior [GO:0035176]; striatum development [GO:0021756]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; temperature homeostasis [GO:0001659]; transmission of nerve impulse [GO:0019226]; vasodilation [GO:0042311]; visual learning [GO:0008542]",axon [GO:0030424]; axon terminus [GO:0043679]; caveola [GO:0005901]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],"axon [GO:0030424]; axon terminus [GO:0043679]; caveola [GO:0005901]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; angiotensin receptor binding [GO:0031701]; ATPase binding [GO:0051117]; D3 dopamine receptor binding [GO:0031750]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; heterocyclic compound binding [GO:1901363]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult walking behavior [GO:0007628]; associative learning [GO:0008306]; astrocyte development [GO:0014002]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to dopamine [GO:1903351]; cerebral cortex GABAergic interneuron migration [GO:0021853]; conditioned taste aversion [GO:0001661]; dentate gyrus development [GO:0021542]; dopamine receptor signaling pathway [GO:0007212]; dopamine transport [GO:0015872]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose import [GO:0046323]; grooming behavior [GO:0007625]; habituation [GO:0046959]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; maternal behavior [GO:0042711]; mating behavior [GO:0007617]; memory [GO:0007613]; modification of postsynaptic structure [GO:0099010]; muscle contraction [GO:0006936]; negative regulation of cell death [GO:0060548]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of synaptic transmission [GO:0050805]; neuron migration [GO:0001764]; neuronal action potential [GO:0019228]; operant conditioning [GO:0035106]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of feeding behavior [GO:2000253]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of membrane potential [GO:0045838]; positive regulation of neuron migration [GO:2001224]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; regulation of dopamine metabolic process [GO:0042053]; regulation of monoatomic ion transport [GO:0043269]; regulation of protein phosphorylation [GO:0001932]; regulation of vasoconstriction [GO:0019229]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; response to xenobiotic stimulus [GO:0009410]; sensitization [GO:0046960]; social behavior [GO:0035176]; striatum development [GO:0021756]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; temperature homeostasis [GO:0001659]; transmission of nerve impulse [GO:0019226]; vasodilation [GO:0042311]; visual learning [GO:0008542]","angiotensin receptor binding [GO:0031701]; ATPase binding [GO:0051117]; D3 dopamine receptor binding [GO:0031750]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; heterocyclic compound binding [GO:1901363]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]",GO:0001588; GO:0001659; GO:0001661; GO:0001662; GO:0001764; GO:0001932; GO:0001934; GO:0001963; GO:0001965; GO:0001975; GO:0004930; GO:0004952; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005901; GO:0005929; GO:0006468; GO:0006469; GO:0006606; GO:0006886; GO:0006936; GO:0007186; GO:0007187; GO:0007189; GO:0007190; GO:0007191; GO:0007212; GO:0007612; GO:0007613; GO:0007617; GO:0007625; GO:0007626; GO:0007628; GO:0007631; GO:0008306; GO:0008542; GO:0009410; GO:0009986; GO:0010628; GO:0012505; GO:0014002; GO:0015872; GO:0016020; GO:0016477; GO:0019226; GO:0019228; GO:0019229; GO:0019722; GO:0019903; GO:0021542; GO:0021756; GO:0021766; GO:0021853; GO:0030336; GO:0030424; GO:0030425; GO:0030432; GO:0031701; GO:0031750; GO:0035106; GO:0035176; GO:0035240; GO:0035249; GO:0042053; GO:0042220; GO:0042311; GO:0042321; GO:0042711; GO:0042734; GO:0042755; GO:0043025; GO:0043197; GO:0043198; GO:0043269; GO:0043679; GO:0044326; GO:0044327; GO:0044877; GO:0045211; GO:0045838; GO:0046323; GO:0046959; GO:0046960; GO:0048148; GO:0050805; GO:0051117; GO:0051281; GO:0051482; GO:0051968; GO:0060158; GO:0060170; GO:0060291; GO:0060292; GO:0060548; GO:0071870; GO:0071880; GO:0097730; GO:0098978; GO:0098982; GO:0099010; GO:0099170; GO:0099171; GO:1900273; GO:1901363; GO:1903351; GO:2000253; GO:2001224,"LIPID 347; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 351; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q61618,reviewed,AA3R_MOUSE,Adenosine receptor A3 (A3AR),Adora3 Gpcr2,Mus musculus (Mouse),319,calcium-mediated signaling [GO:0019722]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion by mast cell [GO:0002553]; mast cell degranulation [GO:0043303]; mucus secretion [GO:0070254]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of mucus secretion [GO:0070257]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of norepinephrine secretion [GO:0014061],dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202],dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; G protein-coupled adenosine receptor activity [GO:0001609]; calcium-mediated signaling [GO:0019722]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion by mast cell [GO:0002553]; mast cell degranulation [GO:0043303]; mucus secretion [GO:0070254]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of mucus secretion [GO:0070257]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of norepinephrine secretion [GO:0014061],G protein-coupled adenosine receptor activity [GO:0001609],GO:0001609; GO:0001973; GO:0002553; GO:0002687; GO:0005886; GO:0007186; GO:0008285; GO:0014061; GO:0014065; GO:0014068; GO:0019722; GO:0030336; GO:0030425; GO:0031594; GO:0032088; GO:0042734; GO:0043303; GO:0043306; GO:0045202; GO:0050729; GO:0050850; GO:0070254; GO:0070257; GO:0098685; GO:0099171,"LIPID 304; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q61739,reviewed,ITA6_MOUSE,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)],Itga6,Mus musculus (Mouse),1091,brown fat cell differentiation [GO:0050873]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to extracellular stimulus [GO:0031668]; filopodium assembly [GO:0046847]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lymphoid lineage cell migration [GO:0097534]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skin morphogenesis [GO:0043589],adherens junction [GO:0005912]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; filopodium [GO:0030175]; hemidesmosome [GO:0030056]; integrin alpha6-beta4 complex [GO:0034676]; integrin complex [GO:0008305]; plasma membrane [GO:0005886],adherens junction [GO:0005912]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; filopodium [GO:0030175]; hemidesmosome [GO:0030056]; integrin alpha6-beta4 complex [GO:0034676]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; insulin-like growth factor I binding [GO:0031994]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]; protein-containing complex binding [GO:0044877]; brown fat cell differentiation [GO:0050873]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to extracellular stimulus [GO:0031668]; filopodium assembly [GO:0046847]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lymphoid lineage cell migration [GO:0097534]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skin morphogenesis [GO:0043589],insulin-like growth factor I binding [GO:0031994]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]; protein-containing complex binding [GO:0044877],GO:0005178; GO:0005604; GO:0005886; GO:0005912; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009925; GO:0009986; GO:0010811; GO:0010976; GO:0016323; GO:0022409; GO:0030056; GO:0030175; GO:0030335; GO:0031589; GO:0031668; GO:0031994; GO:0033627; GO:0034676; GO:0035878; GO:0038132; GO:0042327; GO:0042475; GO:0043065; GO:0043236; GO:0043547; GO:0043589; GO:0044877; GO:0045178; GO:0045944; GO:0046847; GO:0046872; GO:0050873; GO:0050900; GO:0097534; GO:0098609; GO:2001237,"LIPID 1039; /note=""S-palmitoyl cysteine; by DHHC3""; /evidence=""ECO:0000250"""
Q61762,reviewed,KCNA5_MOUSE,Potassium voltage-gated channel subfamily A member 5 (Voltage-gated potassium channel subunit Kv1.5) (KV1-5),Kcna5,Mus musculus (Mouse),602,atrial cardiac muscle cell action potential [GO:0086014]; membrane hyperpolarization [GO:0060081]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during bundle of His cell action potential [GO:0086050]; membrane repolarization during SA node cell action potential [GO:0086052]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of myoblast proliferation [GO:2000288]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of potassium ion transport [GO:0043266]; regulation of vasoconstriction [GO:0019229]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; intracellular canaliculus [GO:0046691]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; Z disc [GO:0030018],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; intracellular canaliculus [GO:0046691]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization [GO:0086087]; voltage-gated potassium channel activity involved in SA node cell action potential repolarization [GO:0086090]; atrial cardiac muscle cell action potential [GO:0086014]; membrane hyperpolarization [GO:0060081]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during bundle of His cell action potential [GO:0086050]; membrane repolarization during SA node cell action potential [GO:0086052]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of myoblast proliferation [GO:2000288]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of potassium ion transport [GO:0043266]; regulation of vasoconstriction [GO:0019229]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612],alpha-actinin binding [GO:0051393]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization [GO:0086087]; voltage-gated potassium channel activity involved in SA node cell action potential repolarization [GO:0086090],GO:0001666; GO:0005102; GO:0005251; GO:0005783; GO:0005794; GO:0005886; GO:0006813; GO:0007219; GO:0008076; GO:0009612; GO:0009986; GO:0014704; GO:0015271; GO:0016020; GO:0019229; GO:0019901; GO:0030018; GO:0034705; GO:0034765; GO:0042391; GO:0042542; GO:0043266; GO:0045121; GO:0046691; GO:0048471; GO:0051259; GO:0051260; GO:0051393; GO:0051481; GO:0055075; GO:0055093; GO:0060081; GO:0060372; GO:0071805; GO:0086014; GO:0086050; GO:0086052; GO:0086087; GO:0086089; GO:0086090; GO:0086091; GO:0097110; GO:0097623; GO:0098914; GO:1900087; GO:2000288,"LIPID 337; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q61831,reviewed,MK10_MOUSE,Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3),Mapk10 Jnk3 Prkm10 Serk2,Mus musculus (Mouse),464,JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; response to light stimulus [GO:0009416]; vesicle-mediated transport in synapse [GO:0099003],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic Golgi apparatus [GO:0150051],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic Golgi apparatus [GO:0150051]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; protein serine kinase activity [GO:0106310]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; response to light stimulus [GO:0009416]; vesicle-mediated transport in synapse [GO:0099003],ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; protein serine kinase activity [GO:0106310],GO:0000122; GO:0004705; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005886; GO:0006468; GO:0007254; GO:0007258; GO:0009416; GO:0014069; GO:0042752; GO:0043005; GO:0043204; GO:0045475; GO:0098969; GO:0098978; GO:0099003; GO:0106310; GO:0150051,"LIPID 462; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 463; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q62083,reviewed,PICK1_MOUSE,PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein),Pick1 Prkcabp,Mus musculus (Mouse),416,cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synapse structure or activity [GO:0050803],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; postsynaptic endocytic zone [GO:0098843]; postsynaptic specialization [GO:0099572]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; postsynaptic endocytic zone [GO:0098843]; postsynaptic specialization [GO:0099572]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; G protein-coupled glutamate receptor binding [GO:0035256]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]; SNAP receptor activity [GO:0005484]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synapse structure or activity [GO:0050803],actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; G protein-coupled glutamate receptor binding [GO:0035256]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]; SNAP receptor activity [GO:0005484],GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005484; GO:0005543; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006605; GO:0006886; GO:0007205; GO:0008021; GO:0008092; GO:0010629; GO:0014069; GO:0015844; GO:0016020; GO:0019904; GO:0021782; GO:0030425; GO:0032588; GO:0032991; GO:0034315; GO:0034316; GO:0035255; GO:0035256; GO:0035556; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043113; GO:0043197; GO:0045202; GO:0046872; GO:0048471; GO:0050796; GO:0050803; GO:0051015; GO:0060292; GO:0060548; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0098843; GO:0098978; GO:0099149; GO:0099572; GO:0140090; GO:2000312,"LIPID 414; /note=""S-palmitoyl cysteine; by DHHC8""; /evidence=""ECO:0000269|PubMed:24068808"""
Q62108,reviewed,DLG4_MOUSE,Disks large homolog 4 (Postsynaptic density protein 95) (PSD-95) (Synapse-associated protein 90) (SAP-90) (SAP90),Dlg4 Dlgh4 Psd95,Mus musculus (Mouse),724,AMPA glutamate receptor clustering [GO:0097113]; cellular response to potassium ion [GO:0035865]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; dendritic spine morphogenesis [GO:0060997]; dendritic spine organization [GO:0097061]; establishment of protein localization [GO:0045184]; locomotory behavior [GO:0007626]; locomotory exploration behavior [GO:0035641]; negative regulation of receptor internalization [GO:0002091]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic transmission [GO:0050806]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; receptor localization to synapse [GO:0097120]; regulation of grooming behavior [GO:2000821]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; response to cocaine [GO:0042220]; social behavior [GO:0035176]; synaptic vesicle maturation [GO:0016188]; vocalization behavior [GO:0071625],AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; cerebellar mossy fiber [GO:0044300]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; proximal dendrite [GO:1990635]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; voltage-gated potassium channel complex [GO:0008076],AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; cerebellar mossy fiber [GO:0044300]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; proximal dendrite [GO:1990635]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; voltage-gated potassium channel complex [GO:0008076]; acetylcholine receptor binding [GO:0033130]; beta-1 adrenergic receptor binding [GO:0031697]; beta-2 adrenergic receptor binding [GO:0031698]; D1 dopamine receptor binding [GO:0031748]; frizzled binding [GO:0005109]; glutamate receptor binding [GO:0035254]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; neurexin family protein binding [GO:0042043]; neuroligin family protein binding [GO:0097109]; P2Y1 nucleotide receptor binding [GO:0031812]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; structural constituent of postsynaptic density [GO:0098919]; structural molecule activity [GO:0005198]; AMPA glutamate receptor clustering [GO:0097113]; cellular response to potassium ion [GO:0035865]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; dendritic spine morphogenesis [GO:0060997]; dendritic spine organization [GO:0097061]; establishment of protein localization [GO:0045184]; locomotory behavior [GO:0007626]; locomotory exploration behavior [GO:0035641]; negative regulation of receptor internalization [GO:0002091]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic transmission [GO:0050806]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; receptor localization to synapse [GO:0097120]; regulation of grooming behavior [GO:2000821]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; response to cocaine [GO:0042220]; social behavior [GO:0035176]; synaptic vesicle maturation [GO:0016188]; vocalization behavior [GO:0071625],acetylcholine receptor binding [GO:0033130]; beta-1 adrenergic receptor binding [GO:0031697]; beta-2 adrenergic receptor binding [GO:0031698]; D1 dopamine receptor binding [GO:0031748]; frizzled binding [GO:0005109]; glutamate receptor binding [GO:0035254]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; neurexin family protein binding [GO:0042043]; neuroligin family protein binding [GO:0097109]; P2Y1 nucleotide receptor binding [GO:0031812]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; structural constituent of postsynaptic density [GO:0098919]; structural molecule activity [GO:0005198],GO:0002091; GO:0005102; GO:0005109; GO:0005198; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0007204; GO:0007268; GO:0007626; GO:0008021; GO:0008076; GO:0014069; GO:0016020; GO:0016188; GO:0019865; GO:0019894; GO:0019900; GO:0019901; GO:0019903; GO:0021987; GO:0030054; GO:0030165; GO:0030425; GO:0030863; GO:0031594; GO:0031697; GO:0031698; GO:0031748; GO:0031812; GO:0032281; GO:0032839; GO:0033130; GO:0035176; GO:0035254; GO:0035255; GO:0035418; GO:0035641; GO:0035865; GO:0042043; GO:0042220; GO:0043005; GO:0043197; GO:0044224; GO:0044300; GO:0044306; GO:0044307; GO:0044309; GO:0044877; GO:0045184; GO:0045202; GO:0045211; GO:0048168; GO:0048169; GO:0050775; GO:0050806; GO:0050885; GO:0060076; GO:0060997; GO:0061098; GO:0065003; GO:0071625; GO:0071944; GO:0097060; GO:0097061; GO:0097109; GO:0097110; GO:0097113; GO:0097120; GO:0098794; GO:0098839; GO:0098919; GO:0098970; GO:0098978; GO:0099645; GO:0150012; GO:1904719; GO:1990635; GO:2000310; GO:2000463; GO:2000821,"LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P31016""; LIPID 5; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P31016"""
Q62226,reviewed,SHH_MOUSE,Sonic hedgehog protein (SHH) (EC 3.1.-.-) (HHG-1) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) [Cleaved into: Sonic hedgehog protein N-product (ShhN) (Shh N-terminal processed signaling domains) (ShhNp) (Sonic hedgehog protein 19 kDa product)],Shh Hhg1,Mus musculus (Mouse),437,"alpha-beta T cell differentiation [GO:0046632]; alpha-tubulin acetylation [GO:0071929]; anatomical structure development [GO:0048856]; anatomical structure formation involved in morphogenesis [GO:0048646]; androgen metabolic process [GO:0008209]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; anterior/posterior pattern specification [GO:0009952]; apoptotic signaling pathway [GO:0097190]; artery development [GO:0060840]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; blood coagulation [GO:0007596]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bud outgrowth involved in lung branching [GO:0060447]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell development [GO:0048468]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell proliferation in external granule layer [GO:0021924]; cell-cell signaling [GO:0007267]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; cerebellar granule cell precursor proliferation [GO:0021930]; commissural neuron axon guidance [GO:0071679]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; developmental growth [GO:0048589]; digestive tract mesoderm development [GO:0007502]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic morphogenesis [GO:0048598]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; endocytosis [GO:0006897]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; epithelial-mesenchymal cell signaling [GO:0060684]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; establishment of epithelial cell polarity [GO:0090162]; forebrain development [GO:0030900]; forebrain regionalization [GO:0021871]; formation of anatomical boundary [GO:0048859]; fungiform papilla development [GO:0061196]; fungiform papilla formation [GO:0061198]; fungiform papilla morphogenesis [GO:0061197]; gene expression [GO:0010467]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; intermediate filament organization [GO:0045109]; kidney development [GO:0001822]; left lung development [GO:0060459]; limb bud formation [GO:0060174]; limb development [GO:0060173]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung lobe morphogenesis [GO:0060463]; lung morphogenesis [GO:0060425]; lung-associated mesenchyme development [GO:0060484]; lymphoid progenitor cell differentiation [GO:0002320]; male genitalia development [GO:0030539]; male genitalia morphogenesis [GO:0048808]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal smoothened signaling pathway involved in prostate gland development [GO:0060783]; metanephric collecting duct development [GO:0072205]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephros development [GO:0001656]; midbrain development [GO:0030901]; myoblast differentiation [GO:0045445]; myotube differentiation [GO:0014902]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of kidney smooth muscle cell differentiation [GO:2000357]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of ureter smooth muscle cell differentiation [GO:2000062]; negative regulation of Wnt signaling pathway [GO:0030178]; negative thymic T cell selection [GO:0045060]; neural crest cell migration [GO:0001755]; neural tube formation [GO:0001841]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; osteoblast development [GO:0002076]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of kidney smooth muscle cell differentiation [GO:2000358]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neurotrophin production [GO:0032901]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of penile erection [GO:0060406]; positive regulation of photoreceptor cell differentiation [GO:0046534]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sclerotome development [GO:0061189]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureter smooth muscle cell differentiation [GO:2000063]; positive regulation of Wnt signaling pathway [GO:0030177]; positive thymic T cell selection [GO:0045059]; primary prostatic bud elongation [GO:0060516]; prostate epithelial cord elongation [GO:0060523]; prostate gland development [GO:0030850]; protein autoprocessing [GO:0016540]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of gene expression [GO:0010468]; regulation of glial cell proliferation [GO:0060251]; regulation of mesenchymal cell proliferation involved in prostate gland development [GO:0060782]; regulation of odontogenesis [GO:0042481]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to nucleus [GO:1900180]; regulation of proteolysis [GO:0030162]; regulation of stem cell proliferation [GO:0072091]; respiratory tube development [GO:0030323]; response to axon injury [GO:0048678]; response to ethanol [GO:0045471]; right lung development [GO:0060458]; roof of mouth development [GO:0060021]; salivary gland cavitation [GO:0060662]; self proteolysis [GO:0097264]; signal transduction [GO:0007165]; skeletal muscle cell proliferation [GO:0014856]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; skin development [GO:0043588]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; striated muscle cell differentiation [GO:0051146]; striated muscle tissue development [GO:0014706]; T cell differentiation in thymus [GO:0033077]; T cell proliferation [GO:0042098]; telencephalon regionalization [GO:0021978]; thalamus development [GO:0021794]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue development [GO:0043586]; tongue morphogenesis [GO:0043587]; trachea development [GO:0060438]; trachea morphogenesis [GO:0060439]; tracheoesophageal septum formation [GO:1905327]; trunk neural crest cell migration [GO:0036484]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventral spinal cord interneuron specification [GO:0021521]; zona limitans intrathalamica formation [GO:0022006]",axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; transport vesicle [GO:0030133],"axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; glycosaminoglycan binding [GO:0005539]; laminin-1 binding [GO:0043237]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; alpha-beta T cell differentiation [GO:0046632]; alpha-tubulin acetylation [GO:0071929]; anatomical structure development [GO:0048856]; anatomical structure formation involved in morphogenesis [GO:0048646]; androgen metabolic process [GO:0008209]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; anterior/posterior pattern specification [GO:0009952]; apoptotic signaling pathway [GO:0097190]; artery development [GO:0060840]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; blood coagulation [GO:0007596]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bud outgrowth involved in lung branching [GO:0060447]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell development [GO:0048468]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell proliferation in external granule layer [GO:0021924]; cell-cell signaling [GO:0007267]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; cerebellar granule cell precursor proliferation [GO:0021930]; commissural neuron axon guidance [GO:0071679]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; developmental growth [GO:0048589]; digestive tract mesoderm development [GO:0007502]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic morphogenesis [GO:0048598]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; endocytosis [GO:0006897]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; epithelial-mesenchymal cell signaling [GO:0060684]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; establishment of epithelial cell polarity [GO:0090162]; forebrain development [GO:0030900]; forebrain regionalization [GO:0021871]; formation of anatomical boundary [GO:0048859]; fungiform papilla development [GO:0061196]; fungiform papilla formation [GO:0061198]; fungiform papilla morphogenesis [GO:0061197]; gene expression [GO:0010467]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; intermediate filament organization [GO:0045109]; kidney development [GO:0001822]; left lung development [GO:0060459]; limb bud formation [GO:0060174]; limb development [GO:0060173]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung lobe morphogenesis [GO:0060463]; lung morphogenesis [GO:0060425]; lung-associated mesenchyme development [GO:0060484]; lymphoid progenitor cell differentiation [GO:0002320]; male genitalia development [GO:0030539]; male genitalia morphogenesis [GO:0048808]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal smoothened signaling pathway involved in prostate gland development [GO:0060783]; metanephric collecting duct development [GO:0072205]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephros development [GO:0001656]; midbrain development [GO:0030901]; myoblast differentiation [GO:0045445]; myotube differentiation [GO:0014902]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of kidney smooth muscle cell differentiation [GO:2000357]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of ureter smooth muscle cell differentiation [GO:2000062]; negative regulation of Wnt signaling pathway [GO:0030178]; negative thymic T cell selection [GO:0045060]; neural crest cell migration [GO:0001755]; neural tube formation [GO:0001841]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; osteoblast development [GO:0002076]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of kidney smooth muscle cell differentiation [GO:2000358]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neurotrophin production [GO:0032901]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of penile erection [GO:0060406]; positive regulation of photoreceptor cell differentiation [GO:0046534]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sclerotome development [GO:0061189]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureter smooth muscle cell differentiation [GO:2000063]; positive regulation of Wnt signaling pathway [GO:0030177]; positive thymic T cell selection [GO:0045059]; primary prostatic bud elongation [GO:0060516]; prostate epithelial cord elongation [GO:0060523]; prostate gland development [GO:0030850]; protein autoprocessing [GO:0016540]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of gene expression [GO:0010468]; regulation of glial cell proliferation [GO:0060251]; regulation of mesenchymal cell proliferation involved in prostate gland development [GO:0060782]; regulation of odontogenesis [GO:0042481]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to nucleus [GO:1900180]; regulation of proteolysis [GO:0030162]; regulation of stem cell proliferation [GO:0072091]; respiratory tube development [GO:0030323]; response to axon injury [GO:0048678]; response to ethanol [GO:0045471]; right lung development [GO:0060458]; roof of mouth development [GO:0060021]; salivary gland cavitation [GO:0060662]; self proteolysis [GO:0097264]; signal transduction [GO:0007165]; skeletal muscle cell proliferation [GO:0014856]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; skin development [GO:0043588]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; striated muscle cell differentiation [GO:0051146]; striated muscle tissue development [GO:0014706]; T cell differentiation in thymus [GO:0033077]; T cell proliferation [GO:0042098]; telencephalon regionalization [GO:0021978]; thalamus development [GO:0021794]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue development [GO:0043586]; tongue morphogenesis [GO:0043587]; trachea development [GO:0060438]; trachea morphogenesis [GO:0060439]; tracheoesophageal septum formation [GO:1905327]; trunk neural crest cell migration [GO:0036484]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventral spinal cord interneuron specification [GO:0021521]; zona limitans intrathalamica formation [GO:0022006]",calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; glycosaminoglycan binding [GO:0005539]; laminin-1 binding [GO:0043237]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0000122; GO:0000139; GO:0001525; GO:0001569; GO:0001570; GO:0001656; GO:0001658; GO:0001708; GO:0001755; GO:0001822; GO:0001841; GO:0001942; GO:0001944; GO:0001947; GO:0002052; GO:0002053; GO:0002076; GO:0002320; GO:0003140; GO:0005113; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006355; GO:0006606; GO:0006897; GO:0007165; GO:0007224; GO:0007228; GO:0007267; GO:0007368; GO:0007389; GO:0007398; GO:0007405; GO:0007411; GO:0007417; GO:0007442; GO:0007502; GO:0007507; GO:0007519; GO:0007596; GO:0008021; GO:0008209; GO:0008233; GO:0008270; GO:0008283; GO:0008284; GO:0009949; GO:0009952; GO:0009953; GO:0009986; GO:0010463; GO:0010467; GO:0010468; GO:0010628; GO:0010629; GO:0014003; GO:0014706; GO:0014856; GO:0014858; GO:0014902; GO:0016020; GO:0016477; GO:0016539; GO:0016540; GO:0021513; GO:0021521; GO:0021522; GO:0021794; GO:0021871; GO:0021904; GO:0021924; GO:0021930; GO:0021938; GO:0021940; GO:0021978; GO:0022006; GO:0030133; GO:0030162; GO:0030177; GO:0030178; GO:0030182; GO:0030323; GO:0030324; GO:0030326; GO:0030336; GO:0030424; GO:0030425; GO:0030539; GO:0030850; GO:0030878; GO:0030900; GO:0030901; GO:0030902; GO:0031012; GO:0031016; GO:0031069; GO:0032091; GO:0032435; GO:0032901; GO:0033077; GO:0033085; GO:0033089; GO:0033092; GO:0034244; GO:0034504; GO:0035115; GO:0035116; GO:0036484; GO:0042098; GO:0042127; GO:0042130; GO:0042177; GO:0042307; GO:0042475; GO:0042476; GO:0042481; GO:0042733; GO:0043010; GO:0043025; GO:0043066; GO:0043237; GO:0043369; GO:0043586; GO:0043587; GO:0043588; GO:0045059; GO:0045060; GO:0045109; GO:0045121; GO:0045165; GO:0045445; GO:0045471; GO:0045665; GO:0045666; GO:0045880; GO:0045893; GO:0045944; GO:0046534; GO:0046632; GO:0046638; GO:0046639; GO:0048468; GO:0048538; GO:0048546; GO:0048557; GO:0048568; GO:0048589; GO:0048598; GO:0048617; GO:0048643; GO:0048645; GO:0048646; GO:0048663; GO:0048678; GO:0048706; GO:0048708; GO:0048709; GO:0048711; GO:0048714; GO:0048745; GO:0048754; GO:0048808; GO:0048839; GO:0048856; GO:0048859; GO:0048864; GO:0050673; GO:0050679; GO:0051146; GO:0051155; GO:0051781; GO:0060020; GO:0060021; GO:0060070; GO:0060173; GO:0060174; GO:0060251; GO:0060406; GO:0060425; GO:0060428; GO:0060438; GO:0060439; GO:0060441; GO:0060442; GO:0060445; GO:0060447; GO:0060458; GO:0060459; GO:0060463; GO:0060484; GO:0060516; GO:0060523; GO:0060662; GO:0060664; GO:0060684; GO:0060685; GO:0060738; GO:0060767; GO:0060768; GO:0060769; GO:0060782; GO:0060783; GO:0060840; GO:0060916; GO:0060979; GO:0061053; GO:0061189; GO:0061196; GO:0061197; GO:0061198; GO:0070447; GO:0071285; GO:0071542; GO:0071679; GO:0071929; GO:0072089; GO:0072091; GO:0072136; GO:0072205; GO:0090090; GO:0090162; GO:0090370; GO:0097152; GO:0097190; GO:0097264; GO:0098528; GO:0140853; GO:1900180; GO:1901215; GO:1903672; GO:1904339; GO:1905327; GO:2000062; GO:2000063; GO:2000357; GO:2000358; GO:2000729; GO:2001028; GO:2001054,"LIPID 25; /note=""N-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:11486055, ECO:0000269|PubMed:15075292""; LIPID 198; /note=""Cholesterol glycine ester""; /evidence=""ECO:0000269|PubMed:8824192"""
Q62351,reviewed,TFR1_MOUSE,Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (CD antigen CD71),Tfrc Trfr,Mus musculus (Mouse),763,acute-phase response [GO:0006953]; aging [GO:0007568]; cellular response to extracellular stimulus [GO:0031668]; cellular response to iron ion [GO:0071281]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; HFE-transferrin receptor complex [GO:1990712]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; HFE-transferrin receptor complex [GO:1990712]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transferrin receptor activity [GO:0004998]; acute-phase response [GO:0006953]; aging [GO:0007568]; cellular response to extracellular stimulus [GO:0031668]; cellular response to iron ion [GO:0071281]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572],double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transferrin receptor activity [GO:0004998],GO:0001666; GO:0001934; GO:0003725; GO:0004998; GO:0005381; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005768; GO:0005769; GO:0005886; GO:0005905; GO:0006826; GO:0006879; GO:0006953; GO:0007568; GO:0007584; GO:0009897; GO:0009986; GO:0010008; GO:0010042; GO:0010628; GO:0010637; GO:0016020; GO:0016323; GO:0019901; GO:0030316; GO:0030544; GO:0030890; GO:0031334; GO:0031410; GO:0031623; GO:0031668; GO:0032526; GO:0033138; GO:0033572; GO:0035556; GO:0042102; GO:0042470; GO:0042802; GO:0042803; GO:0043066; GO:0043123; GO:0043231; GO:0044877; GO:0045780; GO:0045830; GO:0046688; GO:0048471; GO:0051087; GO:0051092; GO:0055037; GO:0055038; GO:0070062; GO:0071281; GO:0071466; GO:1900182; GO:1990712; GO:1990830,"LIPID 67; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q62463,reviewed,V1AR_MOUSE,Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor),Avpr1a,Mus musculus (Mouse),423,calcium-mediated signaling [GO:0019722]; cellular response to hormone stimulus [GO:0032870]; cellular response to water deprivation [GO:0042631]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; myotube differentiation [GO:0014902]; negative regulation of female receptivity [GO:0007621]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of heart rate [GO:0010460]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to corticosterone [GO:0051412]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; telencephalon development [GO:0021537],cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886],cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; V1A vasopressin receptor binding [GO:0031894]; vasopressin receptor activity [GO:0005000]; calcium-mediated signaling [GO:0019722]; cellular response to hormone stimulus [GO:0032870]; cellular response to water deprivation [GO:0042631]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; myotube differentiation [GO:0014902]; negative regulation of female receptivity [GO:0007621]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of heart rate [GO:0010460]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to corticosterone [GO:0051412]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; telencephalon development [GO:0021537],peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; V1A vasopressin receptor binding [GO:0031894]; vasopressin receptor activity [GO:0005000],GO:0001992; GO:0002125; GO:0003084; GO:0005000; GO:0005768; GO:0005886; GO:0007186; GO:0007204; GO:0007621; GO:0007625; GO:0008217; GO:0008284; GO:0010033; GO:0010035; GO:0010460; GO:0014049; GO:0014902; GO:0017046; GO:0019722; GO:0021537; GO:0030139; GO:0030307; GO:0031394; GO:0031410; GO:0031894; GO:0032849; GO:0032870; GO:0035176; GO:0035815; GO:0042277; GO:0042631; GO:0042711; GO:0042713; GO:0043084; GO:0045777; GO:0045907; GO:0051412; GO:0051970,"LIPID 370; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 371; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q62470,reviewed,ITA3_MOUSE,Integrin alpha-3 (CD49 antigen-like family member C) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain],Itga3,Mus musculus (Mouse),1053,cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; dendritic spine maintenance [GO:0097062]; exploration behavior [GO:0035640]; heart development [GO:0007507]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lung development [GO:0030324]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; negative regulation of cell projection organization [GO:0031345]; negative regulation of Rho protein signal transduction [GO:0035024]; nephron development [GO:0072006]; neuron migration [GO:0001764]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; postsynapse organization [GO:0099173]; regulation of BMP signaling pathway [GO:0030510]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of Wnt signaling pathway [GO:0030111]; renal filtration [GO:0097205]; response to gonadotropin [GO:0034698]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skin development [GO:0043588]; synaptic membrane adhesion [GO:0099560],anchoring junction [GO:0070161]; basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; integrin alpha3-beta1 complex [GO:0034667]; integrin complex [GO:0008305]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; receptor complex [GO:0043235]; synapse [GO:0045202]; synaptic membrane [GO:0097060],anchoring junction [GO:0070161]; basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; integrin alpha3-beta1 complex [GO:0034667]; integrin complex [GO:0008305]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; receptor complex [GO:0043235]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; dendritic spine maintenance [GO:0097062]; exploration behavior [GO:0035640]; heart development [GO:0007507]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lung development [GO:0030324]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; negative regulation of cell projection organization [GO:0031345]; negative regulation of Rho protein signal transduction [GO:0035024]; nephron development [GO:0072006]; neuron migration [GO:0001764]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; postsynapse organization [GO:0099173]; regulation of BMP signaling pathway [GO:0030510]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of Wnt signaling pathway [GO:0030111]; renal filtration [GO:0097205]; response to gonadotropin [GO:0034698]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skin development [GO:0043588]; synaptic membrane adhesion [GO:0099560],collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877],GO:0001764; GO:0001968; GO:0002020; GO:0005178; GO:0005518; GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0007266; GO:0007507; GO:0007613; GO:0008305; GO:0009410; GO:0009897; GO:0009986; GO:0010628; GO:0010634; GO:0010811; GO:0010976; GO:0016323; GO:0017015; GO:0019904; GO:0030111; GO:0030324; GO:0030426; GO:0030510; GO:0031345; GO:0031527; GO:0031594; GO:0033627; GO:0034667; GO:0034698; GO:0035024; GO:0035640; GO:0043235; GO:0043236; GO:0043588; GO:0044877; GO:0045202; GO:0045211; GO:0046982; GO:0048333; GO:0048471; GO:0048787; GO:0050900; GO:0060076; GO:0060135; GO:0070161; GO:0071944; GO:0072006; GO:0097060; GO:0097062; GO:0097205; GO:0098609; GO:0098978; GO:0099173; GO:0099560; GO:1903078; GO:1990812,"LIPID 1018; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q640N2,reviewed,AR13B_MOUSE,ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein hennin),Arl13b Arl2l1,Mus musculus (Mouse),427,cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224],axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730],axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0001947; GO:0003924; GO:0005525; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0007368; GO:0009953; GO:0010226; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0060170; GO:0060271; GO:0070986; GO:0097500; GO:0097730; GO:1905515,"LIPID 8; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:20231383""; LIPID 9; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:20231383"""
Q64299,reviewed,CCN3_MOUSE,CCN family member 3 (Cellular communication network factor 3) (Nephroblastoma-overexpressed gene protein homolog) (Protein NOV homolog) (NovH),Ccn3 Nov,Mus musculus (Mouse),354,angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell chemotaxis [GO:0060326]; chondrocyte differentiation [GO:0002062]; endothelial cell chemotaxis [GO:0035767]; endothelial cell-cell adhesion [GO:0071603]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342],axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025],axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell chemotaxis [GO:0060326]; chondrocyte differentiation [GO:0002062]; endothelial cell chemotaxis [GO:0035767]; endothelial cell-cell adhesion [GO:0071603]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342],growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; Notch binding [GO:0005112],GO:0001525; GO:0002062; GO:0005112; GO:0005178; GO:0005576; GO:0005615; GO:0005737; GO:0005921; GO:0007155; GO:0007165; GO:0008083; GO:0008201; GO:0010468; GO:0010761; GO:0010832; GO:0014909; GO:0030308; GO:0030424; GO:0030425; GO:0031012; GO:0033627; GO:0035767; GO:0043025; GO:0043231; GO:0044342; GO:0045747; GO:0046676; GO:0048659; GO:0050728; GO:0060326; GO:0060392; GO:0060548; GO:0061484; GO:0062023; GO:0071603; GO:0090027; GO:1901223; GO:1902731; GO:1904057; GO:1990523,"LIPID 241; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:29287726"""
Q64343,reviewed,ABCG1_MOUSE,ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog),Abcg1 Abc8 Wht1,Mus musculus (Mouse),666,amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein secretion [GO:0050714]; positive regulation of secretory granule organization [GO:1904411]; regulation of cholesterol metabolic process [GO:0090181]; response to lipid [GO:0033993]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085],endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ABC-type sterol transporter activity [GO:0034041]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534]; amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein secretion [GO:0050714]; positive regulation of secretory granule organization [GO:1904411]; regulation of cholesterol metabolic process [GO:0090181]; response to lipid [GO:0033993]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085],ABC-type sterol transporter activity [GO:0034041]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534],GO:0000139; GO:0005524; GO:0005739; GO:0005768; GO:0005789; GO:0005886; GO:0008203; GO:0009897; GO:0010745; GO:0010875; GO:0010888; GO:0016887; GO:0019534; GO:0030301; GO:0032367; GO:0033344; GO:0033700; GO:0033993; GO:0034041; GO:0034374; GO:0034375; GO:0034436; GO:0035774; GO:0042632; GO:0042803; GO:0042987; GO:0043531; GO:0043691; GO:0045542; GO:0046982; GO:0050714; GO:0055037; GO:0055085; GO:0055091; GO:0071403; GO:0090181; GO:0090554; GO:0120020; GO:0140328; GO:1902004; GO:1904411,"LIPID 30; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 154; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 315; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 394; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q6A0D4,reviewed,RFTN1_MOUSE,Raftlin (Raft-linking protein),Rftn1 Kiaa0084,Mus musculus (Mouse),554,B cell receptor signaling pathway [GO:0050853]; dsRNA transport [GO:0033227]; membrane raft assembly [GO:0001765]; positive regulation of growth rate [GO:0040010]; positive regulation of interleukin-17 production [GO:0032740]; protein localization to membrane raft [GO:1903044]; protein transport into membrane raft [GO:0032596]; response to exogenous dsRNA [GO:0043330]; T cell antigen processing and presentation [GO:0002457]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 3 signaling pathway [GO:0034138],cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; double-stranded RNA binding [GO:0003725]; B cell receptor signaling pathway [GO:0050853]; dsRNA transport [GO:0033227]; membrane raft assembly [GO:0001765]; positive regulation of growth rate [GO:0040010]; positive regulation of interleukin-17 production [GO:0032740]; protein localization to membrane raft [GO:1903044]; protein transport into membrane raft [GO:0032596]; response to exogenous dsRNA [GO:0043330]; T cell antigen processing and presentation [GO:0002457]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 3 signaling pathway [GO:0034138],double-stranded RNA binding [GO:0003725],GO:0001765; GO:0002457; GO:0003725; GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0032596; GO:0032740; GO:0032991; GO:0033227; GO:0034138; GO:0040010; GO:0043330; GO:0045121; GO:0050852; GO:0050853; GO:1903044,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q6PAC4,reviewed,PCARE_MOUSE,Photoreceptor cilium actin regulator,Pcare,Mus musculus (Mouse),1279,detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to photoreceptor outer segment [GO:1903546],cilium [GO:0005929]; cone photoreceptor outer segment [GO:0120199]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750],cilium [GO:0005929]; cone photoreceptor outer segment [GO:0120199]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to photoreceptor outer segment [GO:1903546],,GO:0001750; GO:0001917; GO:0005929; GO:0035845; GO:0050908; GO:0120199; GO:1903546,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000255""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q6PHU5,reviewed,SORT_MOUSE,Sortilin (Neurotensin receptor 3) (NTR3) (mNTR3),Sort1,Mus musculus (Mouse),825,endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose import [GO:0046323]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; maintenance of synapse structure [GO:0099558]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of lipoprotein lipase activity [GO:0051005]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein targeting to lysosome [GO:0006622]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050],cell surface [GO:0009986]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140],"cell surface [GO:0009986]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140]; enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; retromer complex binding [GO:1905394]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose import [GO:0046323]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; maintenance of synapse structure [GO:0099558]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of lipoprotein lipase activity [GO:0051005]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein targeting to lysosome [GO:0006622]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050]","enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; retromer complex binding [GO:1905394]",GO:0001503; GO:0005764; GO:0005765; GO:0005769; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006622; GO:0006895; GO:0006897; GO:0007186; GO:0007218; GO:0008333; GO:0008625; GO:0009986; GO:0010008; GO:0010465; GO:0010468; GO:0014902; GO:0016020; GO:0016050; GO:0019899; GO:0030136; GO:0030140; GO:0030379; GO:0030425; GO:0030659; GO:0031410; GO:0031965; GO:0032509; GO:0032580; GO:0032868; GO:0043025; GO:0043231; GO:0045599; GO:0046323; GO:0048011; GO:0048227; GO:0048406; GO:0048471; GO:0051005; GO:0090160; GO:0099558; GO:0150053; GO:1904037; GO:1905394,"LIPID 781; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q99523"""
Q6VZZ7,reviewed,OPN5_MOUSE,Opsin-5 (G-protein coupled receptor 136) (G-protein coupled receptor PGR12) (Neuropsin),Opn5 Gpr136 Pgr12,Mus musculus (Mouse),377,"cellular response to light stimulus [GO:0071482]; cellular response to UV-A [GO:0071492]; entrainment of circadian clock by photoperiod [GO:0043153]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; phototransduction [GO:0007602]; phototransduction, UV [GO:0007604]; visual perception [GO:0007601]",cytoplasm [GO:0005737]; plasma membrane [GO:0005886],"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930]; cellular response to light stimulus [GO:0071482]; cellular response to UV-A [GO:0071492]; entrainment of circadian clock by photoperiod [GO:0043153]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; phototransduction [GO:0007602]; phototransduction, UV [GO:0007604]; visual perception [GO:0007601]",11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930],GO:0004930; GO:0005502; GO:0005737; GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0007604; GO:0008020; GO:0043153; GO:0071482; GO:0071492; GO:1990384,"LIPID 315; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 316; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q7TN89,reviewed,RASE_MOUSE,GTPase ERas (E-Ras) (EC 3.6.5.2) (Embryonic stem cell-expressed Ras),Eras,Mus musculus (Mouse),227,Ras protein signal transduction [GO:0007265],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0019003,"LIPID 220; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 222; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 224; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000250"""
Q7TSJ2,reviewed,MAP6_MOUSE,Microtubule-associated protein 6 (MAP-6) (Stable tubule-only polypeptide) (STOP),Map6 Mtap6,Mus musculus (Mouse),906,axonal transport of mitochondrion [GO:0019896]; cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of axonogenesis [GO:0050772]; regulation of microtubule cytoskeleton organization [GO:0070507],axon [GO:0030424]; axon cytoplasm [GO:1904115]; cis-Golgi network [GO:0005801]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; secretory vesicle [GO:0099503]; transport vesicle membrane [GO:0030658],axon [GO:0030424]; axon cytoplasm [GO:1904115]; cis-Golgi network [GO:0005801]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; secretory vesicle [GO:0099503]; transport vesicle membrane [GO:0030658]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; axonal transport of mitochondrion [GO:0019896]; cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of axonogenesis [GO:0050772]; regulation of microtubule cytoskeleton organization [GO:0070507],calmodulin binding [GO:0005516]; microtubule binding [GO:0008017],GO:0000226; GO:0005516; GO:0005794; GO:0005798; GO:0005801; GO:0005874; GO:0008017; GO:0019896; GO:0030424; GO:0030425; GO:0030658; GO:0030705; GO:0032418; GO:0043005; GO:0048471; GO:0048813; GO:0050772; GO:0070507; GO:0099503; GO:1904115,"LIPID 5; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q63560""; LIPID 10; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q63560""; LIPID 11; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q63560"""
Q80VQ0,reviewed,AL3B1_MOUSE,Aldehyde dehydrogenase family 3 member B1 (EC 1.2.1.28) (EC 1.2.1.5) (EC 1.2.1.7) (Aldehyde dehydrogenase 7),Aldh3b1 Aldh7,Mus musculus (Mouse),468,aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979],3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477],GO:0004028; GO:0004029; GO:0004030; GO:0005737; GO:0005829; GO:0005886; GO:0006068; GO:0006081; GO:0006629; GO:0006979; GO:0018477; GO:0018479; GO:0034599; GO:0046185,"LIPID 462; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:25286108""; LIPID 463; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:25286108""; LIPID 465; /note=""S-geranylgeranyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P43353"""
Q80ZJ1,reviewed,RAP2A_MOUSE,Ras-related protein Rap-2a (EC 3.6.5.2),Rap2a,Mus musculus (Mouse),183,actin cytoskeleton reorganization [GO:0031532]; cellular response to xenobiotic stimulus [GO:0071466]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse assembly [GO:0051963],cytosol [GO:0005829]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060],cytosol [GO:0005829]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; actin cytoskeleton reorganization [GO:0031532]; cellular response to xenobiotic stimulus [GO:0071466]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse assembly [GO:0051963],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287],GO:0000287; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005829; GO:0005886; GO:0008104; GO:0016020; GO:0019003; GO:0030033; GO:0030336; GO:0030496; GO:0031532; GO:0031954; GO:0032486; GO:0045184; GO:0045202; GO:0046328; GO:0048814; GO:0051963; GO:0055037; GO:0055038; GO:0071466; GO:0072659; GO:0097060; GO:0098685; GO:0099072,"LIPID 176; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19061864""; LIPID 177; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19061864""; LIPID 180; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000269|PubMed:19061864"""
Q8BHB0,reviewed,NOD1_MOUSE,Nucleotide-binding oligomerization domain-containing protein 1 (mNod1),Nod1,Mus musculus (Mouse),953,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to muramyl dipeptide [GO:0071225]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; ERK1 and ERK2 cascade [GO:0070371]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cell death [GO:0010942]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of xenophagy [GO:1904417]; regulation of apoptotic process [GO:0042981]; stress-activated MAPK cascade [GO:0051403]; xenophagy [GO:0098792],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to muramyl dipeptide [GO:0071225]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; ERK1 and ERK2 cascade [GO:0070371]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cell death [GO:0010942]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of xenophagy [GO:1904417]; regulation of apoptotic process [GO:0042981]; stress-activated MAPK cascade [GO:0051403]; xenophagy [GO:0098792],ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0002221; GO:0002606; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0006919; GO:0007249; GO:0007254; GO:0010942; GO:0016045; GO:0016323; GO:0016324; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0032874; GO:0035556; GO:0038187; GO:0042742; GO:0042802; GO:0042803; GO:0042981; GO:0043123; GO:0043280; GO:0044877; GO:0045087; GO:0045335; GO:0046330; GO:0050700; GO:0050830; GO:0051000; GO:0051092; GO:0051403; GO:0060907; GO:0070371; GO:0070374; GO:0071225; GO:0098792; GO:0140677; GO:1901224; GO:1904417,"LIPID 558; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9Y239""; LIPID 567; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9Y239""; LIPID 952; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9Y239"""
Q8BKT6,reviewed,TSN12_MOUSE,Tetraspanin-12 (Tspan-12) (Transmembrane 4 superfamily member 12),Tspan12 Tm4sf12,Mus musculus (Mouse),305,angiogenesis [GO:0001525]; cell surface receptor signaling pathway [GO:0007166]; maintenance of blood-brain barrier [GO:0035633]; Norrin signaling pathway [GO:0110135]; regulation of angiogenesis [GO:0045765]; retina layer formation [GO:0010842],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; cell surface receptor signaling pathway [GO:0007166]; maintenance of blood-brain barrier [GO:0035633]; Norrin signaling pathway [GO:0110135]; regulation of angiogenesis [GO:0045765]; retina layer formation [GO:0010842],,GO:0001525; GO:0005886; GO:0007166; GO:0010842; GO:0035633; GO:0045765; GO:0110135,"LIPID 9; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 12; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 83; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q8BLD9,reviewed,DRD5_MOUSE,D(1B) dopamine receptor (D(5) dopamine receptor) (Dopamine D5 receptor),Drd5,Mus musculus (Mouse),478,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; associative learning [GO:0008306]; cellular response to catecholamine stimulus [GO:0071870]; dopamine receptor signaling pathway [GO:0007212]; long-term synaptic depression [GO:0060292]; mating behavior [GO:0007617]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell migration [GO:0030336]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; negative regulation of protein kinase activity [GO:0006469]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; reactive oxygen species metabolic process [GO:0072593]; regulation of female receptivity [GO:0045924]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; sensitization [GO:0046960]; transmission of nerve impulse [GO:0019226]; visual learning [GO:0008542]; wound healing [GO:0042060],axon [GO:0030424]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839],"axon [GO:0030424]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; associative learning [GO:0008306]; cellular response to catecholamine stimulus [GO:0071870]; dopamine receptor signaling pathway [GO:0007212]; long-term synaptic depression [GO:0060292]; mating behavior [GO:0007617]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell migration [GO:0030336]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; negative regulation of protein kinase activity [GO:0006469]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; reactive oxygen species metabolic process [GO:0072593]; regulation of female receptivity [GO:0045924]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; sensitization [GO:0046960]; transmission of nerve impulse [GO:0019226]; visual learning [GO:0008542]; wound healing [GO:0042060]","dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]",GO:0001588; GO:0001965; GO:0001975; GO:0001992; GO:0001994; GO:0004930; GO:0004952; GO:0005886; GO:0005929; GO:0006469; GO:0007189; GO:0007191; GO:0007212; GO:0007617; GO:0008306; GO:0008542; GO:0019226; GO:0030336; GO:0030424; GO:0030425; GO:0031526; GO:0033861; GO:0035240; GO:0042060; GO:0042220; GO:0043025; GO:0043197; GO:0045776; GO:0045924; GO:0046960; GO:0060170; GO:0060292; GO:0071870; GO:0071880; GO:0072593; GO:0097730; GO:0098839; GO:0098978; GO:0099072,"LIPID 370; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q8BMK4,reviewed,CKAP4_MOUSE,Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63),Ckap4,Mus musculus (Mouse),575,,cell surface [GO:0009986]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791],cell surface [GO:0009986]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791],,GO:0005783; GO:0005789; GO:0005791; GO:0005811; GO:0005856; GO:0005886; GO:0009986; GO:0048471,"LIPID 79; /note=""S-palmitoyl cysteine; by ZDHHC2""; /evidence=""ECO:0000250"""
Q8BMT9,reviewed,HHAT_MOUSE,Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Skinny hedgehog protein),Hhat Skn,Mus musculus (Mouse),499,N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; palmitoyltransferase activity [GO:0016409]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224],GTP binding [GO:0005525]; palmitoyltransferase activity [GO:0016409],GO:0000139; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007224; GO:0016409; GO:0018009; GO:0018345,"LIPID 188; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9Y6R1""; LIPID 248; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9Y6R1""; LIPID 330; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9Y6R1""; LIPID 416; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9Y6R1"""
Q8BNJ3,reviewed,NMNA2_MOUSE,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 (NMN/NaMN adenylyltransferase 2) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide mononucleotide adenylyltransferase 2) (NMN adenylyltransferase 2) (Nicotinate-nucleotide adenylyltransferase 2) (NaMN adenylyltransferase 2) (Protein bloated bladder) (Blad),Nmnat2 Kiaa0479,Mus musculus (Mouse),307,NAD biosynthetic process [GO:0009435]; negative regulation of cytoplasmic translation [GO:2000766],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; synapse [GO:0045202]; trans-Golgi network [GO:0005802],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; translation regulator activity [GO:0045182]; NAD biosynthetic process [GO:0009435]; negative regulation of cytoplasmic translation [GO:2000766],ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; translation regulator activity [GO:0045182],GO:0000139; GO:0000309; GO:0004515; GO:0005524; GO:0005737; GO:0005770; GO:0005794; GO:0005802; GO:0005829; GO:0009435; GO:0030424; GO:0030659; GO:0045182; GO:0045202; GO:0140768; GO:2000766,"LIPID 164; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:23610559""; LIPID 165; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:23610559"""
Q8BQP9,reviewed,R7BP_MOUSE,Regulator of G-protein signaling 7-binding protein (R7 family-binding protein),Rgs7bp D13Bwg1146e R7bp,Mus musculus (Mouse),257,G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of postsynaptic membrane potential [GO:0060078],axon [GO:0030424]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734],axon [GO:0030424]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of postsynaptic membrane potential [GO:0060078],,GO:0005634; GO:0005737; GO:0005886; GO:0007186; GO:0009968; GO:0030424; GO:0042734; GO:0043005; GO:0043198; GO:0043204; GO:0044327; GO:0060078; GO:0098793; GO:0098794; GO:0098839; GO:0098978,"LIPID 252; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:15897264, ECO:0000305|PubMed:16574655""; LIPID 253; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:15897264, ECO:0000305|PubMed:16574655"""
Q8BU31,reviewed,RAP2C_MOUSE,Ras-related protein Rap-2c (EC 3.6.5.2),Rap2c,Mus musculus (Mouse),183,establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of protein tyrosine kinase activity [GO:0061097],bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; transcription coactivator activity [GO:0003713]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of protein tyrosine kinase activity [GO:0061097],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; transcription coactivator activity [GO:0003713],GO:0003713; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0016020; GO:0019003; GO:0030336; GO:0031954; GO:0032486; GO:0044291; GO:0055037; GO:0055038; GO:0061097; GO:0090557,"LIPID 176; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19061864""; LIPID 177; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:19061864""; LIPID 180; /note=""S-geranylgeranyl cysteine""; /evidence=""ECO:0000269|PubMed:19061864"""
Q8BUV3,reviewed,GEPH_MOUSE,Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)],Gphn,Mus musculus (Mouse),769,establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; maintenance of postsynaptic specialization structure [GO:0098880]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038],"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of plasma membrane [GO:0019897]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; postsynaptic specialization, intracellular component [GO:0099091]; synapse [GO:0045202]; synaptic membrane [GO:0097060]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of plasma membrane [GO:0019897]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; postsynaptic specialization, intracellular component [GO:0099091]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; signaling receptor binding [GO:0005102]; structural constituent of postsynaptic specialization [GO:0098879]; establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; maintenance of postsynaptic specialization structure [GO:0098880]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038]",ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; signaling receptor binding [GO:0005102]; structural constituent of postsynaptic specialization [GO:0098879],GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006777; GO:0007529; GO:0008092; GO:0008940; GO:0010038; GO:0014069; GO:0018315; GO:0019897; GO:0030425; GO:0031234; GO:0032324; GO:0042802; GO:0043025; GO:0043546; GO:0045184; GO:0045202; GO:0045211; GO:0046872; GO:0060077; GO:0060090; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098794; GO:0098879; GO:0098880; GO:0098970; GO:0098982; GO:0099091; GO:0099572; GO:0099634; GO:0099645,"LIPID 212; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9NQX3""; LIPID 284; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9NQX3"""
Q8C6L5,reviewed,CGAS_MOUSE,Cyclic GMP-AMP synthase (cGAMP synthase) (cGAS) (m-cGAS) (EC 2.7.7.86) (2'3'-cGAMP synthase) (Mab-21 domain-containing protein 1),Cgas Mb21d1,Mus musculus (Mouse),507,activation of innate immune response [GO:0002218]; cAMP-mediated signaling [GO:0019933]; cellular response to exogenous dsRNA [GO:0071360]; cGMP-mediated signaling [GO:0019934]; cytosolic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; negative regulation of DNA repair [GO:0045738]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of innate immune response [GO:0045824]; paracrine signaling [GO:0038001]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cellular senescence [GO:2000774]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of immune response [GO:0050776]; regulation of immunoglobulin production [GO:0002637]; regulation of innate immune response [GO:0045088]; regulation of T cell activation [GO:0050863]; regulation of type I interferon production [GO:0032479],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; 2',3'-cyclic GMP-AMP synthase activity [GO:0061501]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; molecular function inhibitor activity [GO:0140678]; nucleosome binding [GO:0031491]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004]; protein homodimerization activity [GO:0042803]; activation of innate immune response [GO:0002218]; cAMP-mediated signaling [GO:0019933]; cellular response to exogenous dsRNA [GO:0071360]; cGMP-mediated signaling [GO:0019934]; cytosolic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; negative regulation of DNA repair [GO:0045738]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of innate immune response [GO:0045824]; paracrine signaling [GO:0038001]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cellular senescence [GO:2000774]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of immune response [GO:0050776]; regulation of immunoglobulin production [GO:0002637]; regulation of innate immune response [GO:0045088]; regulation of T cell activation [GO:0050863]; regulation of type I interferon production [GO:0032479]","2',3'-cyclic GMP-AMP synthase activity [GO:0061501]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; molecular function inhibitor activity [GO:0140678]; nucleosome binding [GO:0031491]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004]; protein homodimerization activity [GO:0042803]",GO:0002218; GO:0002221; GO:0002230; GO:0002637; GO:0002753; GO:0003677; GO:0003682; GO:0003690; GO:0005524; GO:0005525; GO:0005546; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0008047; GO:0008340; GO:0016604; GO:0019933; GO:0019934; GO:0031491; GO:0032479; GO:0032481; GO:0035861; GO:0038001; GO:0042803; GO:0045087; GO:0045088; GO:0045738; GO:0045824; GO:0046872; GO:0050776; GO:0050863; GO:0051607; GO:0061501; GO:0071360; GO:0140677; GO:0140678; GO:0140693; GO:0160004; GO:2000042; GO:2000774,"LIPID 459; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q8N884"""
Q8CGK7,reviewed,GNAL_MOUSE,"Guanine nucleotide-binding protein G(olf) subunit alpha (Adenylate cyclase-stimulating G alpha protein, olfactory type)",Gnal,Mus musculus (Mouse),381,activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to dopamine [GO:1903351]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of long-term synaptic depression [GO:1900452]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; sensory perception of smell [GO:0007608],heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886],heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to dopamine [GO:1903351]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of long-term synaptic depression [GO:1900452]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; sensory perception of smell [GO:0007608],G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0001664; GO:0001975; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007189; GO:0007190; GO:0007191; GO:0007608; GO:0031000; GO:0031683; GO:0046872; GO:1900452; GO:1903351,"LIPID 2; /note=""N-palmitoyl glycine""; /evidence=""ECO:0000250|UniProtKB:P04896""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q8K1S3,reviewed,UNC5B_MOUSE,Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B),Unc5b Unc5h2,Mus musculus (Mouse),945,angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068],cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068],netrin receptor activity [GO:0005042],GO:0001525; GO:0005042; GO:0005829; GO:0005886; GO:0006915; GO:0007411; GO:0014068; GO:0033564; GO:0043524; GO:0045121; GO:2001240; GO:2001241,"LIPID 403; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O08722"""
Q8K3Z0,reviewed,NOD2_MOUSE,Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15),Nod2 Card15,Mus musculus (Mouse),1020,activation of immune response [GO:0002253]; biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0002815]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptidoglycan [GO:0071224]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; ERK1 and ERK2 cascade [GO:0070371]; establishment of localization in cell [GO:0051649]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; maintenance of gastrointestinal epithelium [GO:0030277]; MAPK cascade [GO:0000165]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; NIK/NF-kappaB signaling [GO:0038061]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; response to nutrient [GO:0007584]; response to peptidoglycan [GO:0032494]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; toll-like receptor 2 signaling pathway [GO:0034134]; xenophagy [GO:0098792],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin binding [GO:0003779]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; muramyl dipeptide binding [GO:0032500]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein kinase binding [GO:0019901]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; signaling receptor activator activity [GO:0030546]; activation of immune response [GO:0002253]; biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0002815]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptidoglycan [GO:0071224]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; ERK1 and ERK2 cascade [GO:0070371]; establishment of localization in cell [GO:0051649]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; maintenance of gastrointestinal epithelium [GO:0030277]; MAPK cascade [GO:0000165]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; NIK/NF-kappaB signaling [GO:0038061]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; response to nutrient [GO:0007584]; response to peptidoglycan [GO:0032494]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; toll-like receptor 2 signaling pathway [GO:0034134]; xenophagy [GO:0098792],actin binding [GO:0003779]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; muramyl dipeptide binding [GO:0032500]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein kinase binding [GO:0019901]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; signaling receptor activator activity [GO:0030546],GO:0000165; GO:0002221; GO:0002227; GO:0002253; GO:0002606; GO:0002710; GO:0002720; GO:0002732; GO:0002815; GO:0002830; GO:0002862; GO:0002925; GO:0003779; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006909; GO:0006952; GO:0006954; GO:0006963; GO:0006965; GO:0007165; GO:0007249; GO:0007254; GO:0007584; GO:0008284; GO:0009595; GO:0009986; GO:0010936; GO:0016045; GO:0016323; GO:0018108; GO:0019899; GO:0019901; GO:0030277; GO:0030296; GO:0030544; GO:0030546; GO:0031398; GO:0031982; GO:0032088; GO:0032494; GO:0032495; GO:0032496; GO:0032498; GO:0032500; GO:0032689; GO:0032695; GO:0032701; GO:0032703; GO:0032720; GO:0032731; GO:0032733; GO:0032735; GO:0032740; GO:0032755; GO:0032757; GO:0032760; GO:0032874; GO:0032991; GO:0034134; GO:0034136; GO:0035556; GO:0038061; GO:0038187; GO:0042742; GO:0042834; GO:0043123; GO:0043330; GO:0043406; GO:0043410; GO:0043552; GO:0044877; GO:0045087; GO:0045089; GO:0045335; GO:0045747; GO:0045944; GO:0046330; GO:0050679; GO:0050700; GO:0050727; GO:0050731; GO:0050766; GO:0050830; GO:0050871; GO:0051092; GO:0051353; GO:0051403; GO:0051649; GO:0051770; GO:0051879; GO:0060585; GO:0060907; GO:0070371; GO:0070374; GO:0070431; GO:0071222; GO:0071224; GO:0071225; GO:0071407; GO:0071639; GO:0090022; GO:0098792; GO:1900017; GO:1901224; GO:1902523; GO:1904417; GO:2000110; GO:2000363,"LIPID 375; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9HC29"""
Q8K558,reviewed,TRML1_MOUSE,Trem-like transcript 1 protein (TLT-1) (Triggering receptor expressed on myeloid cells-like protein 1),Treml1 Tlt1,Mus musculus (Mouse),317,calcium-mediated signaling [GO:0019722]; negative regulation of signal transduction [GO:0009968]; platelet activation [GO:0030168]; wound healing [GO:0042060],cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091],cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; calcium-mediated signaling [GO:0019722]; negative regulation of signal transduction [GO:0009968]; platelet activation [GO:0030168]; wound healing [GO:0042060],signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888],GO:0004888; GO:0005794; GO:0005829; GO:0005886; GO:0009968; GO:0009986; GO:0016607; GO:0019722; GO:0030168; GO:0031091; GO:0038023; GO:0042060,"LIPID 208; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q8QZZ8,reviewed,RAB38_MOUSE,Ras-related protein Rab-38,Rab38,Mus musculus (Mouse),211,endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of protein localization to cell periphery [GO:1904377]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192],cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982],cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of protein localization to cell periphery [GO:1904377]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192],AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924],GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0007005; GO:0012505; GO:0016020; GO:0016192; GO:0030670; GO:0030742; GO:0031410; GO:0031982; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0044297; GO:0045335; GO:0048023; GO:0048471; GO:0060155; GO:0072657; GO:0090383; GO:1903232; GO:1904377; GO:2001247,"LIPID 205; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 208; /note=""S-geranylgeranyl cysteine""; /evidence=""ECO:0000250"""
Q8R173,reviewed,ZDHC3_MOUSE,Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (GABA-A receptor-associated membrane protein 1) (Golgi-specific DHHC zinc finger protein) (Zinc finger DHHC domain-containing protein 3) (DHHC-3),Zdhhc3 Godz Gramp1,Mus musculus (Mouse),299,"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting [GO:0006605]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]",endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting [GO:0006605]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]",palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439],GO:0000139; GO:0005783; GO:0005794; GO:0006605; GO:0006612; GO:0008277; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:0140439; GO:1902685; GO:1903546,"LIPID 146; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:26487721"""
Q8R366,reviewed,IGSF8_MOUSE,Immunoglobulin superfamily member 8 (IgSF8) (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2) (EWI-2) (Keratinocyte-associated transmembrane protein 4) (KCT-4) (Prostaglandin regulatory-like protein) (PGRL) (CD antigen CD316),Igsf8 Ewi2 Kct4 Pgrl,Mus musculus (Mouse),611,regulation of cell motility [GO:2000145],axon [GO:0030424]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; synapse [GO:0045202],axon [GO:0030424]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; synapse [GO:0045202]; regulation of cell motility [GO:2000145],,GO:0005886; GO:0016020; GO:0030424; GO:0043209; GO:0043231; GO:0045202; GO:2000145,"LIPID 602; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:21609323""; LIPID 603; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:21609323"""
Q8R4B8,reviewed,NLRP3_MOUSE,"NACHT, LRR and PYD domains-containing protein 3 (EC 3.6.4.-) (Cold autoinflammatory syndrome 1 protein homolog) (Cryopyrin) (Mast cell maturation-associated-inducible protein 1) (PYRIN-containing APAF1-like protein 1)",Nlrp3 Cias1 Mmig1 Nalp3 Pypaf1,Mus musculus (Mouse),1033,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; acute inflammatory response [GO:0002526]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptidoglycan [GO:0071224]; cellular response to virus [GO:0098586]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; protein homooligomerization [GO:0051260]; protein maturation [GO:0051604]; pyroptosis [GO:0070269]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070],canonical inflammasome complex [GO:0061702]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; interphase microtubule organizing center [GO:0031021]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634],canonical inflammasome complex [GO:0061702]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; interphase microtubule organizing center [GO:0031021]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cysteine-type endopeptidase activator activity [GO:0140608]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; molecular condensate scaffold activity [GO:0140693]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-4-phosphate binding [GO:0070273]; sequence-specific DNA binding [GO:0043565]; signaling adaptor activity [GO:0035591]; small molecule sensor activity [GO:0140299]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; acute inflammatory response [GO:0002526]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptidoglycan [GO:0071224]; cellular response to virus [GO:0098586]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; protein homooligomerization [GO:0051260]; protein maturation [GO:0051604]; pyroptosis [GO:0070269]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070],ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cysteine-type endopeptidase activator activity [GO:0140608]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; molecular condensate scaffold activity [GO:0140693]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-4-phosphate binding [GO:0070273]; sequence-specific DNA binding [GO:0043565]; signaling adaptor activity [GO:0035591]; small molecule sensor activity [GO:0140299],GO:0000139; GO:0002221; GO:0002523; GO:0002526; GO:0002674; GO:0002720; GO:0002830; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005815; GO:0005829; GO:0006919; GO:0006954; GO:0007231; GO:0009595; GO:0014070; GO:0016020; GO:0016887; GO:0031021; GO:0032088; GO:0032691; GO:0032731; GO:0032736; GO:0032753; GO:0032754; GO:0035591; GO:0042802; GO:0043280; GO:0043531; GO:0043565; GO:0044546; GO:0045087; GO:0045471; GO:0045630; GO:0045944; GO:0050727; GO:0050728; GO:0050729; GO:0050830; GO:0051092; GO:0051260; GO:0051604; GO:0051607; GO:0060090; GO:0061702; GO:0070269; GO:0070273; GO:0071222; GO:0071224; GO:0072559; GO:0098586; GO:0140297; GO:0140299; GO:0140608; GO:0140693; GO:1901223; GO:1901224; GO:1901981; GO:2000321; GO:2000553,"LIPID 841; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q96P20"""
Q8VHQ3,reviewed,PP16B_MOUSE,Protein phosphatase 1 regulatory inhibitor subunit 16B (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein),Ppp1r16b,Mus musculus (Mouse),568,establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670],cell projection [GO:0042995]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],cell projection [GO:0042995]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase regulator activity [GO:0019888]; establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670],enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase regulator activity [GO:0019888],GO:0001938; GO:0004857; GO:0005634; GO:0005737; GO:0005886; GO:0014066; GO:0016607; GO:0017020; GO:0019888; GO:0035304; GO:0035307; GO:0035308; GO:0042995; GO:0048471; GO:0051489; GO:0061028; GO:1902309; GO:1903589; GO:1903670,"LIPID 564; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q923M0""; LIPID 565; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q923M0"""
Q8VIM4,reviewed,BSND_MOUSE,Barttin,Bsnd,Mus musculus (Mouse),307,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; intracellular chloride ion homeostasis [GO:0030644]; intracellular monoatomic ion homeostasis [GO:0006873]; intracellular potassium ion homeostasis [GO:0030007]; sensory perception of sound [GO:0007605],basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; chloride channel regulator activity [GO:0017081]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; intracellular chloride ion homeostasis [GO:0030644]; intracellular monoatomic ion homeostasis [GO:0006873]; intracellular potassium ion homeostasis [GO:0030007]; sensory perception of sound [GO:0007605],chloride channel regulator activity [GO:0017081],GO:0005886; GO:0006821; GO:0006873; GO:0007605; GO:0016020; GO:0016323; GO:0017081; GO:0030007; GO:0030644; GO:0032991; GO:1902476,"LIPID 54; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q8WZ55""; LIPID 56; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q8WZ55"""
Q91XM9,reviewed,DLG2_MOUSE,Disks large homolog 2 (Channel-associated protein of synapse-110) (Chapsyn-110) (Postsynaptic density protein PSD-93),Dlg2 Dlgh2,Mus musculus (Mouse),852,anterograde axonal protein transport [GO:0099641]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; clustering of voltage-gated potassium channels [GO:0045163]; neuronal ion channel clustering [GO:0045161]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; receptor clustering [GO:0043113]; retrograde axonal protein transport [GO:0099642]; sensory perception of pain [GO:0019233],axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synaptic vesicle membrane [GO:0030672],axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synaptic vesicle membrane [GO:0030672]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; structural constituent of postsynaptic density [GO:0098919]; anterograde axonal protein transport [GO:0099641]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; clustering of voltage-gated potassium channels [GO:0045163]; neuronal ion channel clustering [GO:0045161]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; receptor clustering [GO:0043113]; retrograde axonal protein transport [GO:0099642]; sensory perception of pain [GO:0019233],kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; structural constituent of postsynaptic density [GO:0098919],GO:0005737; GO:0007268; GO:0014069; GO:0016020; GO:0019233; GO:0019900; GO:0019903; GO:0030054; GO:0030165; GO:0030425; GO:0030672; GO:0031594; GO:0035865; GO:0043005; GO:0043025; GO:0043113; GO:0043194; GO:0043204; GO:0044224; GO:0044877; GO:0045161; GO:0045163; GO:0045211; GO:0098839; GO:0098919; GO:0098978; GO:0099641; GO:0099642; GO:0099645; GO:1904115,"LIPID 5; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 7; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q91YA2,reviewed,KPSH1_MOUSE,Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1),Pskh1,Mus musculus (Mouse),424,determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; protein phosphorylation [GO:0006468],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; protein phosphorylation [GO:0006468],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0004672; GO:0004674; GO:0005524; GO:0005789; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006468; GO:0007368; GO:0007507; GO:0016607; GO:0106310,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q91ZQ5,reviewed,RPE65_MOUSE,Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase),Rpe65,Mus musculus (Mouse),533,cellular response to electrical stimulus [GO:0071257]; circadian rhythm [GO:0007623]; detection of light stimulus involved in visual perception [GO:0050908]; insulin receptor signaling pathway [GO:0008286]; neural retina development [GO:0003407]; regulation of gene expression [GO:0010468]; retina development in camera-type eye [GO:0060041]; retina homeostasis [GO:0001895]; retina morphogenesis in camera-type eye [GO:0060042]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; zeaxanthin biosynthetic process [GO:1901827],cell body [GO:0044297]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"cell body [GO:0044297]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinol isomerase activity [GO:0050251]; cellular response to electrical stimulus [GO:0071257]; circadian rhythm [GO:0007623]; detection of light stimulus involved in visual perception [GO:0050908]; insulin receptor signaling pathway [GO:0008286]; neural retina development [GO:0003407]; regulation of gene expression [GO:0010468]; retina development in camera-type eye [GO:0060041]; retina homeostasis [GO:0001895]; retina morphogenesis in camera-type eye [GO:0060042]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; zeaxanthin biosynthetic process [GO:1901827]","all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinol isomerase activity [GO:0050251]",GO:0001523; GO:0001786; GO:0001895; GO:0003407; GO:0003834; GO:0005634; GO:0005737; GO:0005789; GO:0005886; GO:0007601; GO:0007623; GO:0008286; GO:0010468; GO:0016020; GO:0016853; GO:0031210; GO:0042572; GO:0042574; GO:0044297; GO:0046872; GO:0050251; GO:0050908; GO:0052884; GO:0052885; GO:0060041; GO:0060042; GO:0071257; GO:1901612; GO:1901827,"LIPID 112; /note=""S-palmitoyl cysteine; in membrane form""; /evidence=""ECO:0000250|UniProtKB:Q28175""; LIPID 231; /note=""S-palmitoyl cysteine; in membrane form""; /evidence=""ECO:0000250|UniProtKB:Q28175""; LIPID 329; /note=""S-palmitoyl cysteine; in membrane form""; /evidence=""ECO:0000250|UniProtKB:Q28175""; LIPID 330; /note=""S-palmitoyl cysteine; in membrane form""; /evidence=""ECO:0000250|UniProtKB:Q28175"""
Q922S4,reviewed,PDE2A_MOUSE,"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)",Pde2a,Mus musculus (Mouse),939,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cardiac septum development [GO:0003279]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; coronary vasculature development [GO:0060976]; establishment of endothelial barrier [GO:0061028]; heart development [GO:0007507]; heart valve development [GO:0003170]; intracellular signal transduction [GO:0035556]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell death [GO:0060548]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; regulation of nitric oxide mediated signal transduction [GO:0010749]; ventricular septum development [GO:0003281]",axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber [GO:0097457]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060],"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber [GO:0097457]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; GAF domain binding [GO:0036004]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cardiac septum development [GO:0003279]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; coronary vasculature development [GO:0060976]; establishment of endothelial barrier [GO:0061028]; heart development [GO:0007507]; heart valve development [GO:0003170]; intracellular signal transduction [GO:0035556]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell death [GO:0060548]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; regulation of nitric oxide mediated signal transduction [GO:0010749]; ventricular septum development [GO:0003281]","3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; GAF domain binding [GO:0036004]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]",GO:0000122; GO:0000287; GO:0003170; GO:0003279; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0007507; GO:0008270; GO:0010628; GO:0010749; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030424; GO:0030425; GO:0030552; GO:0030553; GO:0030911; GO:0035556; GO:0035904; GO:0036004; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0043949; GO:0043951; GO:0045121; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0060548; GO:0060976; GO:0061028; GO:0071222; GO:0071260; GO:0071320; GO:0071321; GO:0090324; GO:0097011; GO:0097060; GO:0097457; GO:1904613,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:O00408""; LIPID 5; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O00408""; LIPID 11; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O00408"""
Q925T6,reviewed,GRIP1_MOUSE,Glutamate receptor-interacting protein 1 (GRIP-1),Grip1,Mus musculus (Mouse),1127,"cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; dendrite arborization [GO:0140059]; negative regulation of AMPA receptor activity [GO:0061907]; nervous system development [GO:0007399]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of synaptic scaling [GO:0150092]; vesicle-mediated transport in synapse [GO:0099003]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; endoplasmic reticulum membrane [GO:0005789]; exocyst [GO:0000145]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; proximal dendrite [GO:1990635]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; spine synapse [GO:0106033]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; endoplasmic reticulum membrane [GO:0005789]; exocyst [GO:0000145]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; proximal dendrite [GO:1990635]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; spine synapse [GO:0106033]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; GTPase binding [GO:0051020]; ionotropic glutamate receptor binding [GO:0035255]; nuclear glucocorticoid receptor binding [GO:0035259]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; dendrite arborization [GO:0140059]; negative regulation of AMPA receptor activity [GO:0061907]; nervous system development [GO:0007399]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of synaptic scaling [GO:0150092]; vesicle-mediated transport in synapse [GO:0099003]",GTPase binding [GO:0051020]; ionotropic glutamate receptor binding [GO:0035255]; nuclear glucocorticoid receptor binding [GO:0035259]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102],GO:0000145; GO:0005102; GO:0005737; GO:0005739; GO:0005789; GO:0005791; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0007399; GO:0008104; GO:0014069; GO:0015031; GO:0016020; GO:0030165; GO:0030425; GO:0035255; GO:0035259; GO:0042734; GO:0043005; GO:0043025; GO:0043083; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0044326; GO:0044327; GO:0044877; GO:0045121; GO:0045202; GO:0045211; GO:0048471; GO:0048786; GO:0050775; GO:0051020; GO:0055037; GO:0061907; GO:0097060; GO:0098793; GO:0098794; GO:0098887; GO:0098978; GO:0098982; GO:0099003; GO:0106033; GO:0140059; GO:0150012; GO:0150092; GO:1903078; GO:1904628; GO:1990416; GO:1990635; GO:2000312,"LIPID Q925T6-2:11; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305"""
Q99J93,reviewed,IFM2_MOUSE,Interferon-induced transmembrane protein 2 (Dispanin subfamily A member 2c) (DSPA2c) (Fragilis protein 3),Ifitm2,Mus musculus (Mouse),144,cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; heart development [GO:0007507]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral transcription [GO:0032897]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to type II interferon [GO:0034341]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],cell junction [GO:0030054]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],cell junction [GO:0030054]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; heart development [GO:0007507]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral transcription [GO:0032897]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to type II interferon [GO:0034341]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],,GO:0005654; GO:0005765; GO:0005886; GO:0007507; GO:0009615; GO:0030054; GO:0031901; GO:0031902; GO:0032897; GO:0032991; GO:0034341; GO:0035455; GO:0035456; GO:0035458; GO:0045071; GO:0046597; GO:0051607; GO:0060337,"LIPID 70; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q01629""; LIPID 71; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q01629""; LIPID 104; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q01629"""
Q99JX3,reviewed,GORS2_MOUSE,Golgi reassembly-stacking protein 2 (GRS2) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55),Gorasp2,Mus musculus (Mouse),451,cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283],,GO:0000139; GO:0005789; GO:0005794; GO:0005797; GO:0006996; GO:0007030; GO:0007283; GO:0030154; GO:0034976; GO:0061951; GO:0070925,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:Q9H8Y8"""
Q99LX0,reviewed,PARK7_MOUSE,"Parkinson disease protein 7 homolog (Maillard deglycase) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)",Park7,Mus musculus (Mouse),189,"adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of hydrogen peroxide [GO:0061691]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of fertilization [GO:1905516]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]; synaptic transmission, dopaminergic [GO:0001963]",axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; sperm head [GO:0061827],"axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; sperm head [GO:0061827]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of hydrogen peroxide [GO:0061691]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of fertilization [GO:1905516]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]; synaptic transmission, dopaminergic [GO:0001963]","copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]",GO:0000785; GO:0001933; GO:0001963; GO:0002866; GO:0003713; GO:0003723; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0006281; GO:0006469; GO:0006508; GO:0006517; GO:0006914; GO:0006954; GO:0006979; GO:0007005; GO:0007338; GO:0008233; GO:0008344; GO:0010273; GO:0010628; GO:0010629; GO:0014912; GO:0016532; GO:0016605; GO:0016684; GO:0019249; GO:0019826; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031334; GO:0031397; GO:0032091; GO:0032435; GO:0032757; GO:0033138; GO:0033234; GO:0033864; GO:0034599; GO:0034614; GO:0036470; GO:0036471; GO:0036478; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042177; GO:0042542; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043005; GO:0043066; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0044877; GO:0045121; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051899; GO:0051920; GO:0060081; GO:0060548; GO:0060765; GO:0061691; GO:0061727; GO:0061827; GO:0070301; GO:0070994; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:0140297; GO:1900182; GO:1901215; GO:1901671; GO:1901984; GO:1902176; GO:1902177; GO:1902236; GO:1902958; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903202; GO:1903204; GO:1903206; GO:1903208; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1904706; GO:1904782; GO:1905259; GO:1905516; GO:1990381; GO:1990422; GO:2000157; GO:2000277; GO:2000679; GO:2000825; GO:2001237; GO:2001268,"LIPID 46; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q99497""; LIPID 53; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q99497""; LIPID 106; /note=""S-palmitoyl cysteine; alternate""; /evidence=""ECO:0000250|UniProtKB:Q99497"""
Q99PE8,reviewed,ABCG5_MOUSE,ATP-binding cassette sub-family G member 5 (EC 7.6.2.-) (Sterolin-1),Abcg5,Mus musculus (Mouse),652,bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]; triglyceride homeostasis [GO:0070328],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]; triglyceride homeostasis [GO:0070328],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982],GO:0005524; GO:0005886; GO:0007584; GO:0009410; GO:0010212; GO:0010949; GO:0014850; GO:0015918; GO:0016020; GO:0016324; GO:0016887; GO:0030299; GO:0033344; GO:0038183; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045177; GO:0045796; GO:0046872; GO:0046982; GO:0055085; GO:0070328; GO:0120020; GO:0140359,"LIPID 61; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:18402465"""
Q9CPV7,reviewed,ZDHC6_MOUSE,Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Stearoyltransferase ZDHHC6) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 6) (DHHC-6),Zdhhc6,Mus musculus (Mouse),413,peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of mitochondrial fusion [GO:0010636]; protein palmitoylation [GO:0018345]; protein stearoylation [GO:0140438]; protein targeting to membrane [GO:0006612],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of mitochondrial fusion [GO:0010636]; protein palmitoylation [GO:0018345]; protein stearoylation [GO:0140438]; protein targeting to membrane [GO:0006612],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439],GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0010636; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0140438; GO:0140439,"LIPID 328; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9H6R6""; LIPID 329; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9H6R6""; LIPID 343; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9H6R6"""
Q9CQW1,reviewed,YKT6_MOUSE,Synaptobrevin homolog YKT6 (EC 2.3.1.-),Ykt6,Mus musculus (Mouse),198,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]",apical dendrite [GO:0097440]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201],"apical dendrite [GO:0097440]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]",protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484],GO:0000139; GO:0005484; GO:0005737; GO:0005739; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0006903; GO:0006904; GO:0015031; GO:0016020; GO:0019706; GO:0030659; GO:0031201; GO:0042147; GO:0043025; GO:0097440; GO:0097441,"LIPID 194; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 195; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000250"""
Q9CQW9,reviewed,IFM3_MOUSE,Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b) (DSPA2b) (Fragilis protein) (Interferon-inducible protein 15) (Mouse ifitm-like protein 1) (Mil-1),Ifitm3,Mus musculus (Mouse),137,defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral transcription [GO:0032897]; receptor-mediated endocytosis [GO:0006898]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to type II interferon [GO:0034341]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral transcription [GO:0032897]; receptor-mediated endocytosis [GO:0006898]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to type II interferon [GO:0034341]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],,GO:0005634; GO:0005737; GO:0005765; GO:0005783; GO:0005886; GO:0006898; GO:0008285; GO:0009615; GO:0009986; GO:0031410; GO:0031901; GO:0031902; GO:0032897; GO:0032991; GO:0034341; GO:0035455; GO:0035456; GO:0045071; GO:0045177; GO:0046597; GO:0048471; GO:0051607; GO:0060337,"LIPID 71; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q01628""; LIPID 72; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q01628""; LIPID 105; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q01628"""
Q9CZA6,reviewed,NDE1_MOUSE,Nuclear distribution protein nudE homolog 1 (NudE) (mNudE),Nde1 Nude,Mus musculus (Mouse),344,cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; forebrain development [GO:0030900]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; vesicle transport along microtubule [GO:0047496],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; forebrain development [GO:0030900]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; vesicle transport along microtubule [GO:0047496],identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904],GO:0000132; GO:0000776; GO:0001764; GO:0005737; GO:0005813; GO:0005815; GO:0005819; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0007405; GO:0008017; GO:0016477; GO:0019904; GO:0021987; GO:0030900; GO:0031023; GO:0031616; GO:0032154; GO:0042802; GO:0045202; GO:0047496; GO:0051298; GO:0051301; GO:0051303; GO:0051642,"LIPID 274; /note=""S-palmitoyl cysteine; by ZDHHC2, ZDHHC3 and ZDHHC7""; /evidence=""ECO:0000250"""
Q9D103,reviewed,IFM1_MOUSE,Interferon-induced transmembrane protein 1 (Dispanin subfamily A member 2a) (DSPA2a) (Fragilis protein 2) (Mouse ifitm-like protein 2) (Mil-2),Ifitm1,Mus musculus (Mouse),106,anterior/posterior pattern specification [GO:0009952]; defense response to virus [GO:0051607]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to type II interferon [GO:0034341]; response to virus [GO:0009615]; somitogenesis [GO:0001756]; type I interferon-mediated signaling pathway [GO:0060337],early endosome [GO:0005769]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],early endosome [GO:0005769]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; anterior/posterior pattern specification [GO:0009952]; defense response to virus [GO:0051607]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to type II interferon [GO:0034341]; response to virus [GO:0009615]; somitogenesis [GO:0001756]; type I interferon-mediated signaling pathway [GO:0060337],,GO:0001503; GO:0001756; GO:0005765; GO:0005769; GO:0005886; GO:0008285; GO:0009615; GO:0009952; GO:0030336; GO:0032991; GO:0034341; GO:0035455; GO:0035456; GO:0045071; GO:0045669; GO:0046597; GO:0051607; GO:0060337,"LIPID 49; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P13164""; LIPID 50; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P13164""; LIPID 83; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P13164"""
Q9D1N4,reviewed,MYMK_MOUSE,Protein myomaker (Myoblast fusion maker) (Transmembrane protein 8C),Mymk Tmem8c,Mus musculus (Mouse),221,muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; plasma membrane fusion [GO:0045026]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; skeletal muscle tissue regeneration [GO:0043403],Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; plasma membrane fusion [GO:0045026]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; skeletal muscle tissue regeneration [GO:0043403],,GO:0000139; GO:0005886; GO:0007517; GO:0007520; GO:0014905; GO:0043403; GO:0045026; GO:1904206,"LIPID 217; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:28860190""; LIPID 218; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:28860190"""
Q9D4B1,reviewed,SMS2_MOUSE,Phosphatidylcholine:ceramide cholinephosphotransferase 2 (EC 2.7.8.27) (Sphingomyelin synthase 2),Sgms2,Mus musculus (Mouse),365,ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; phosphorylation [GO:0016310]; regulation of bone mineralization [GO:0030500]; sphingomyelin biosynthetic process [GO:0006686],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; phosphorylation [GO:0016310]; regulation of bone mineralization [GO:0030500]; sphingomyelin biosynthetic process [GO:0006686],ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188],GO:0000139; GO:0002950; GO:0005654; GO:0005794; GO:0005886; GO:0006686; GO:0016301; GO:0016310; GO:0030500; GO:0033188; GO:0046513; GO:0047493; GO:1905373,"LIPID 331; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 332; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 343; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 348; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9D8B7,reviewed,JAM3_MOUSE,Junctional adhesion molecule C (JAM-C) (JAM-2) (Junctional adhesion molecule 3) (JAM-3) [Cleaved into: Soluble form of JAM-C (sJAM-C)],Jam3,Mus musculus (Mouse),310,adaptive immune response [GO:0002250]; adherens junction assembly [GO:0034333]; angiogenesis [GO:0001525]; apical protein localization [GO:0045176]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of cell polarity [GO:0030010]; granulocyte migration [GO:0097530]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte migration involved in inflammatory response [GO:0002523]; myelination [GO:0042552]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of integrin activation [GO:0033624]; neutrophil homeostasis [GO:0001780]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of membrane permeability [GO:1905710]; protein localization to cell junction [GO:1902414]; protein localization to cell surface [GO:0034394]; regulation of actin cytoskeleton organization by cell-cell adhesion [GO:0090138]; regulation of neutrophil chemotaxis [GO:0090022]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transmission of nerve impulse [GO:0019226],bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160],bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; adaptive immune response [GO:0002250]; adherens junction assembly [GO:0034333]; angiogenesis [GO:0001525]; apical protein localization [GO:0045176]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of cell polarity [GO:0030010]; granulocyte migration [GO:0097530]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte migration involved in inflammatory response [GO:0002523]; myelination [GO:0042552]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of integrin activation [GO:0033624]; neutrophil homeostasis [GO:0001780]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of membrane permeability [GO:1905710]; protein localization to cell junction [GO:1902414]; protein localization to cell surface [GO:0034394]; regulation of actin cytoskeleton organization by cell-cell adhesion [GO:0090138]; regulation of neutrophil chemotaxis [GO:0090022]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transmission of nerve impulse [GO:0019226],cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0001525; GO:0001780; GO:0002250; GO:0002318; GO:0002523; GO:0002693; GO:0005178; GO:0005615; GO:0005794; GO:0005886; GO:0005902; GO:0005911; GO:0005923; GO:0007155; GO:0007160; GO:0007283; GO:0007286; GO:0009986; GO:0016477; GO:0019226; GO:0030010; GO:0030057; GO:0031941; GO:0033010; GO:0033624; GO:0033629; GO:0034113; GO:0034333; GO:0034394; GO:0042552; GO:0042802; GO:0042803; GO:0043220; GO:0044291; GO:0045176; GO:0046982; GO:0070160; GO:0090022; GO:0090138; GO:0097241; GO:0097530; GO:0098609; GO:0098632; GO:0098636; GO:1902414; GO:1905710,"LIPID 264; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9BX67""; LIPID 265; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9BX67"""
Q9DC51,reviewed,GNAI3_MOUSE,Guanine nucleotide-binding protein G(i) subunit alpha-3 (G(i) alpha-3),Gnai3,Mus musculus (Mouse),354,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; GTP metabolic process [GO:0046039]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; vesicle fusion [GO:0006906],centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588],centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; GTP metabolic process [GO:0046039]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; vesicle fusion [GO:0006906],G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904],GO:0000139; GO:0001664; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005813; GO:0005834; GO:0005886; GO:0006906; GO:0007049; GO:0007186; GO:0007188; GO:0007193; GO:0007212; GO:0016020; GO:0016239; GO:0019003; GO:0019904; GO:0030496; GO:0031683; GO:0031821; GO:0032794; GO:0032930; GO:0033864; GO:0042588; GO:0045121; GO:0046039; GO:0046872; GO:0051301; GO:1904707; GO:2001234,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:P08754""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9DCW2,reviewed,PLS2_MOUSE,Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2),Plscr2,Mus musculus (Mouse),307,cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]","calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]",GO:0000287; GO:0001228; GO:0001618; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006955; GO:0008270; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0032791; GO:0033003; GO:0042609; GO:0043231; GO:0045121; GO:0045340; GO:0048471; GO:0060368; GO:0062023; GO:0070782; GO:0071222,"LIPID 182; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162""; LIPID 183; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162""; LIPID 186; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162""; LIPID 187; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162"""
Q9EPK2,reviewed,XRP2_MOUSE,Protein XRP2,Rp2 Rp2h,Mus musculus (Mouse),347,post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031],centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886],centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031],GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287],GO:0000287; GO:0005096; GO:0005525; GO:0005654; GO:0005737; GO:0005794; GO:0005814; GO:0005886; GO:0005929; GO:0006892; GO:0015031; GO:0016604; GO:0031410; GO:0036064; GO:1990075,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:O75695""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9EPU5,reviewed,TNR21_MOUSE,Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358),Tnfrsf21 Dr6,Mus musculus (Mouse),655,adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell apoptotic process [GO:0001783]; cellular response to tumor necrosis factor [GO:0071356]; humoral immune response [GO:0006959]; myelination [GO:0042552]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of myelination [GO:0031642]; negative regulation of T cell proliferation [GO:0042130]; neuron apoptotic process [GO:0051402]; oligodendrocyte apoptotic process [GO:0097252]; regulation of oligodendrocyte differentiation [GO:0048713]; T cell receptor signaling pathway [GO:0050852],axon [GO:0030424]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],axon [GO:0030424]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell apoptotic process [GO:0001783]; cellular response to tumor necrosis factor [GO:0071356]; humoral immune response [GO:0006959]; myelination [GO:0042552]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of myelination [GO:0031642]; negative regulation of T cell proliferation [GO:0042130]; neuron apoptotic process [GO:0051402]; oligodendrocyte apoptotic process [GO:0097252]; regulation of oligodendrocyte differentiation [GO:0048713]; T cell receptor signaling pathway [GO:0050852],,GO:0001783; GO:0002250; GO:0005737; GO:0005886; GO:0006915; GO:0006959; GO:0007413; GO:0030424; GO:0030889; GO:0031642; GO:0032693; GO:0032696; GO:0032714; GO:0042130; GO:0042552; GO:0048713; GO:0050852; GO:0051402; GO:0071356; GO:0097252,"LIPID 368; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9EQ09,reviewed,OLR1_MOUSE,"Oxidized low-density lipoprotein receptor 1 (Ox-LDL receptor 1) (Lectin-like oxidized LDL receptor 1) (LOX-1) (Lectin-like oxLDL receptor 1) (Lectin-type oxidized LDL receptor 1) [Cleaved into: Oxidized low-density lipoprotein receptor 1, soluble form]",Olr1 Lox1,Mus musculus (Mouse),363,cell death [GO:0008219]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; lipoprotein metabolic process [GO:0042157]; negative regulation of gene expression [GO:0010629],extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor activity [GO:0005041]; cell death [GO:0008219]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; lipoprotein metabolic process [GO:0042157]; negative regulation of gene expression [GO:0010629],carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor activity [GO:0005041],GO:0002376; GO:0005041; GO:0005576; GO:0005654; GO:0005886; GO:0006954; GO:0007159; GO:0008219; GO:0010629; GO:0019897; GO:0030246; GO:0042157; GO:0042802; GO:0043231; GO:0043235; GO:0045121,"LIPID 45; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9EQ31,reviewed,LPAR3_MOUSE,Lysophosphatidic acid receptor 3 (LPA receptor 3) (LPA-3) (Lysophosphatidic acid receptor Edg-7),Lpar3 Edg7 Lpa3,Mus musculus (Mouse),354,bleb assembly [GO:0032060]; collateral sprouting [GO:0048668]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of MAPK cascade [GO:0043410],axon [GO:0030424]; plasma membrane [GO:0005886],axon [GO:0030424]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; lysophosphatidic acid receptor activity [GO:0070915]; phospholipid binding [GO:0005543]; bleb assembly [GO:0032060]; collateral sprouting [GO:0048668]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of MAPK cascade [GO:0043410],G-protein alpha-subunit binding [GO:0001965]; lysophosphatidic acid receptor activity [GO:0070915]; phospholipid binding [GO:0005543],GO:0001965; GO:0005543; GO:0005886; GO:0007186; GO:0010467; GO:0030424; GO:0032060; GO:0043410; GO:0048668; GO:0048672; GO:0051482; GO:0051928; GO:0070915,"LIPID 309; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9EQR5,reviewed,LIME1_MOUSE,Lck-interacting transmembrane adapter 1 (Lck-interacting molecule),Lime1 Lime,Mus musculus (Mouse),269,adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of MAP kinase activity [GO:0043405]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell receptor signaling pathway [GO:0050852],B cell receptor complex [GO:0019815],B cell receptor complex [GO:0019815]; protein kinase binding [GO:0019901]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of MAP kinase activity [GO:0043405]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell receptor signaling pathway [GO:0050852],protein kinase binding [GO:0019901],GO:0002250; GO:0006357; GO:0014066; GO:0019815; GO:0019901; GO:0043122; GO:0043405; GO:0050852; GO:0050853; GO:0051279; GO:1901222,"LIPID 28; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:14610044""; LIPID 31; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:14610044"""
Q9EQT3,reviewed,RHOU_MOUSE,Rho-related GTP-binding protein RhoU (Rho GTPase-like protein ARHU) (Wnt-1 responsive Cdc42 homolog 1) (WRCH-1),Rhou Arhu G28k Wrch1,Mus musculus (Mouse),261,actin cytoskeleton organization [GO:0030036]; Cdc42 protein signal transduction [GO:0032488]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; G1/S transition of mitotic cell cycle [GO:0000082]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360],cell projection [GO:0042995]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102],cell projection [GO:0042995]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; Cdc42 protein signal transduction [GO:0032488]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; G1/S transition of mitotic cell cycle [GO:0000082]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0000082; GO:0000139; GO:0002102; GO:0003924; GO:0005525; GO:0005886; GO:0005925; GO:0006897; GO:0007010; GO:0007163; GO:0008360; GO:0016601; GO:0030036; GO:0032488; GO:0042995; GO:0046872,"LIPID 259; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q7L0Q8"""
Q9ER71,reviewed,RHOJ_MOUSE,Rho-related GTP-binding protein RhoJ (Tc10-like GTP-binding protein),Rhoj Arhj Rhoi Rhot Tc10l Tcl,Mus musculus (Mouse),214,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; Rho protein signal transduction [GO:0007266],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; Rho protein signal transduction [GO:0007266],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0001525; GO:0003924; GO:0005525; GO:0005886; GO:0006897; GO:0007163; GO:0007266; GO:0008360; GO:0010594; GO:0030036; GO:0032488; GO:0061299; GO:0090050; GO:1903670,"LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9H4E5""; LIPID 11; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9H4E5""; LIPID 211; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P62745"""
Q9ERR1,reviewed,NDEL1_MOUSE,Nuclear distribution protein nudE-like 1 (Protein mNudE-like) (Protein Nudel) (mNudE-L),Ndel1 Nudel,Mus musculus (Mouse),345,activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; nuclear membrane disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; radial glia-guided pyramidal neuron migration [GO:0140650]; regulation of intracellular protein transport [GO:0033157]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496],axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell body [GO:0044297]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021],axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell body [GO:0044297]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; nuclear membrane disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; radial glia-guided pyramidal neuron migration [GO:0140650]; regulation of intracellular protein transport [GO:0033157]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496],alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877],GO:0000132; GO:0000226; GO:0000776; GO:0001764; GO:0001833; GO:0005635; GO:0005737; GO:0005813; GO:0005815; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005875; GO:0007020; GO:0007059; GO:0007100; GO:0008017; GO:0008021; GO:0008090; GO:0008286; GO:0010975; GO:0016477; GO:0021799; GO:0021955; GO:0030424; GO:0031175; GO:0031252; GO:0032418; GO:0033157; GO:0042802; GO:0043014; GO:0043203; GO:0043547; GO:0044297; GO:0044877; GO:0045773; GO:0047496; GO:0048487; GO:0048680; GO:0051081; GO:0051303; GO:0051642; GO:0060052; GO:0060053; GO:0070012; GO:0090630; GO:0090724; GO:0140650; GO:1900029; GO:1904115; GO:1990138,"LIPID 273; /note=""S-palmitoyl cysteine; by ZDHHC2, ZDHHC3 and ZDHHC7""; /evidence=""ECO:0000250"""
Q9JHL0,reviewed,NTAL_MOUSE,Linker for activation of T-cells family member 2 (Linker for activation of B-cells) (Membrane-associated adapter molecule) (Non-T-cell activation linker) (Williams-Beuren syndrome chromosomal region 15 protein homolog),Lat2 Lab Ntal Wbscr15 Wbscr5,Mus musculus (Mouse),203,adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; intracellular signal transduction [GO:0035556]; mast cell degranulation [GO:0043303],membrane raft [GO:0045121]; plasma membrane [GO:0005886],membrane raft [GO:0045121]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; intracellular signal transduction [GO:0035556]; mast cell degranulation [GO:0043303],SH2 domain binding [GO:0042169],GO:0002250; GO:0005886; GO:0019722; GO:0035556; GO:0042113; GO:0042169; GO:0043303; GO:0045121; GO:0050853,"LIPID 26; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 29; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9JIZ9,reviewed,PLS3_MOUSE,Phospholipid scramblase 3 (PL scramblase 3) (Ca(2+)-dependent phospholipid scramblase 3),Plscr3,Mus musculus (Mouse),296,apoptotic process [GO:0006915]; cardiolipin biosynthetic process [GO:0032049]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of apoptotic process [GO:0042981]; regulation of release of cytochrome c from mitochondria [GO:0090199],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; phospholipid scramblase activity [GO:0017128]; protein self-association [GO:0043621]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cardiolipin biosynthetic process [GO:0032049]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of apoptotic process [GO:0042981]; regulation of release of cytochrome c from mitochondria [GO:0090199],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; phospholipid scramblase activity [GO:0017128]; protein self-association [GO:0043621]; SH3 domain binding [GO:0017124],GO:0000287; GO:0005509; GO:0005634; GO:0005739; GO:0005743; GO:0005829; GO:0005886; GO:0006915; GO:0017121; GO:0017124; GO:0017128; GO:0032049; GO:0032791; GO:0042593; GO:0042632; GO:0042981; GO:0043621; GO:0045340; GO:0048306; GO:0071222; GO:0090199,"LIPID 159; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:21785166""; LIPID 161; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:21785166""; LIPID 163; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:21785166""; LIPID 164; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:21785166""; LIPID 166; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:21785166"""
Q9JJ00,reviewed,PLS1_MOUSE,Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (Transplantability-associated protein 1) (NOR1) (TRA1),Plscr1 Tra1b Tras1,Mus musculus (Mouse),328,acute-phase response [GO:0006953]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; acute-phase response [GO:0006953]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]","calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]",GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006659; GO:0006953; GO:0006955; GO:0008270; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030099; GO:0032091; GO:0032791; GO:0033003; GO:0035455; GO:0042609; GO:0043065; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0062023; GO:0070782; GO:0071222; GO:0071345; GO:0097193; GO:1902231; GO:1905820; GO:2000373,"LIPID 193; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162""; LIPID 194; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162""; LIPID 197; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162""; LIPID 198; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162"""
Q9JJ69,reviewed,KCIP2_MOUSE,Kv channel-interacting protein 2 (KChIP2) (A-type potassium channel modulatory protein 2) (Potassium channel-interacting protein 2),Kcnip2 Kchip2,Mus musculus (Mouse),270,clustering of voltage-gated potassium channels [GO:0045163]; membrane repolarization [GO:0086009]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; potassium ion export across plasma membrane [GO:0097623]; regulation of potassium ion transmembrane transport [GO:1901379],cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076],cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]; clustering of voltage-gated potassium channels [GO:0045163]; membrane repolarization [GO:0086009]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; potassium ion export across plasma membrane [GO:0097623]; regulation of potassium ion transmembrane transport [GO:1901379],A-type (transient outward) potassium channel activity [GO:0005250]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325],GO:0005250; GO:0005509; GO:0005737; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0042802; GO:0044325; GO:0044877; GO:0045163; GO:0086009; GO:0097623; GO:1901379; GO:1903766,"LIPID 45; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9JM59""; LIPID 46; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9JM59"""
Q9JJY3,reviewed,NSMA2_MOUSE,Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II),Smpd3,Mus musculus (Mouse),655,artery smooth muscle contraction [GO:0014824]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; bone growth [GO:0098868]; bone mineralization [GO:0030282]; cartilage development [GO:0051216]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to magnesium ion [GO:0071286]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to reactive oxygen species [GO:0034614]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; ceramide metabolic process [GO:0006672]; chondrocyte development [GO:0002063]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen metabolic process [GO:0032963]; dentinogenesis [GO:0097187]; DNA biosynthetic process [GO:0071897]; dopamine uptake [GO:0090494]; endochondral ossification [GO:0001958]; extracellular matrix assembly [GO:0085029]; G1 to G0 transition [GO:0070314]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; mitotic nuclear division [GO:0140014]; multicellular organism growth [GO:0035264]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; ossification [GO:0001503]; peptide hormone secretion [GO:0030072]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; polysaccharide transport [GO:0015774]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein kinase B signaling [GO:0043491]; regulation of cartilage development [GO:0061035]; regulation of hyaluronan biosynthetic process [GO:1900125]; regulation of leukocyte migration [GO:0002685]; regulation of protein phosphorylation [GO:0001932]; respiratory system development [GO:0060541]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; sphingolipid mediated signaling pathway [GO:0090520]; sphingolipid metabolic process [GO:0006665]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neutral sphingomyelin phosphodiesterase activity [GO:0061751]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; phospholipase activity [GO:0004620]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; artery smooth muscle contraction [GO:0014824]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; bone growth [GO:0098868]; bone mineralization [GO:0030282]; cartilage development [GO:0051216]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to magnesium ion [GO:0071286]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to reactive oxygen species [GO:0034614]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; ceramide metabolic process [GO:0006672]; chondrocyte development [GO:0002063]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen metabolic process [GO:0032963]; dentinogenesis [GO:0097187]; DNA biosynthetic process [GO:0071897]; dopamine uptake [GO:0090494]; endochondral ossification [GO:0001958]; extracellular matrix assembly [GO:0085029]; G1 to G0 transition [GO:0070314]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; mitotic nuclear division [GO:0140014]; multicellular organism growth [GO:0035264]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; ossification [GO:0001503]; peptide hormone secretion [GO:0030072]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; polysaccharide transport [GO:0015774]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein kinase B signaling [GO:0043491]; regulation of cartilage development [GO:0061035]; regulation of hyaluronan biosynthetic process [GO:1900125]; regulation of leukocyte migration [GO:0002685]; regulation of protein phosphorylation [GO:0001932]; respiratory system development [GO:0060541]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; sphingolipid mediated signaling pathway [GO:0090520]; sphingolipid metabolic process [GO:0006665]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684],identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neutral sphingomyelin phosphodiesterase activity [GO:0061751]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; phospholipase activity [GO:0004620]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767],GO:0000137; GO:0000139; GO:0001501; GO:0001503; GO:0001786; GO:0001932; GO:0001958; GO:0002063; GO:0002244; GO:0002685; GO:0003433; GO:0004620; GO:0004767; GO:0005576; GO:0005737; GO:0005794; GO:0005886; GO:0006665; GO:0006672; GO:0006684; GO:0006685; GO:0007165; GO:0008081; GO:0014824; GO:0015774; GO:0016020; GO:0030072; GO:0030282; GO:0030324; GO:0030509; GO:0032963; GO:0034614; GO:0035264; GO:0042802; GO:0043491; GO:0045429; GO:0045840; GO:0046872; GO:0048008; GO:0048286; GO:0048661; GO:0051216; GO:0051481; GO:0060348; GO:0060541; GO:0061035; GO:0061751; GO:0070300; GO:0070301; GO:0070314; GO:0071286; GO:0071356; GO:0071461; GO:0071897; GO:0085029; GO:0090494; GO:0090520; GO:0097187; GO:0098868; GO:0140014; GO:0140052; GO:1900125; GO:1900126; GO:1901224; GO:1901653; GO:1903543; GO:2000304,"LIPID 53; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:17272284""; LIPID 54; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:17272284""; LIPID 59; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:17272284""; LIPID 395; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:17272284""; LIPID 396; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:17272284"""
Q9JL06,reviewed,LPAR2_MOUSE,Lysophosphatidic acid receptor 2 (LPA receptor 2) (LPA-2) (Lysophosphatidic acid receptor Edg-4),Lpar2 Edg4 Lpa2,Mus musculus (Mouse),348,G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rho protein signal transduction [GO:0035025],cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; presynaptic active zone membrane [GO:0048787],cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; presynaptic active zone membrane [GO:0048787]; lysophosphatidic acid receptor activity [GO:0070915]; PDZ domain binding [GO:0030165]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rho protein signal transduction [GO:0035025],lysophosphatidic acid receptor activity [GO:0070915]; PDZ domain binding [GO:0030165],GO:0007186; GO:0009986; GO:0030139; GO:0030165; GO:0035025; GO:0043410; GO:0048787; GO:0070915; GO:0098978,"LIPID 308; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9JLK7,reviewed,CABP1_MOUSE,Calcium-binding protein 1 (CaBP1),Cabp1,Mus musculus (Mouse),227,modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of cell communication by electrical coupling [GO:0010651]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of postsynapse to nucleus signaling pathway [GO:1905539]; regulation of voltage-gated calcium channel activity [GO:1901385]; visual perception [GO:0007601],"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; subplasmalemmal coating [GO:0044280]","axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; subplasmalemmal coating [GO:0044280]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325]; type 3 metabotropic glutamate receptor binding [GO:0031800]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of cell communication by electrical coupling [GO:0010651]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of postsynapse to nucleus signaling pathway [GO:1905539]; regulation of voltage-gated calcium channel activity [GO:1901385]; visual perception [GO:0007601]",calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325]; type 3 metabotropic glutamate receptor binding [GO:0031800],GO:0000139; GO:0005246; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007601; GO:0008139; GO:0010651; GO:0014069; GO:0016020; GO:0019904; GO:0030141; GO:0030424; GO:0030425; GO:0031800; GO:0032991; GO:0042308; GO:0042802; GO:0043025; GO:0044280; GO:0044325; GO:0048306; GO:0048471; GO:0098885; GO:0098978; GO:0099092; GO:0099527; GO:1901385; GO:1901386; GO:1905539,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:Q9NZU7""; LIPID 4; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9NZU7""; LIPID Q9JLK7-2:2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000305""; LIPID Q9JLK7-2:4; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305"""
Q9QXT8,reviewed,CSEN_MOUSE,Calsenilin (A-type potassium channel modulatory protein 3) (DRE-antagonist modulator) (DREAM) (Kv channel-interacting protein 3) (KChIP3),Kcnip3 Csen Dream Kchip3,Mus musculus (Mouse),256,apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; intracellular protein transport [GO:0006886]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; potassium ion transport [GO:0006813]; protein localization to plasma membrane [GO:0072659]; regulation of neuron apoptotic process [GO:0043523]; regulation of potassium ion transmembrane transport [GO:1901379]; response to magnesium ion [GO:0032026]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233],axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; voltage-gated potassium channel complex [GO:0008076],"axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; ion binding [GO:0043167]; magnesium ion binding [GO:0000287]; molecular function activator activity [GO:0140677]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic ion channel activity [GO:0005244]; apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; intracellular protein transport [GO:0006886]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; potassium ion transport [GO:0006813]; protein localization to plasma membrane [GO:0072659]; regulation of neuron apoptotic process [GO:0043523]; regulation of potassium ion transmembrane transport [GO:1901379]; response to magnesium ion [GO:0032026]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]","calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; ion binding [GO:0043167]; magnesium ion binding [GO:0000287]; molecular function activator activity [GO:0140677]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic ion channel activity [GO:0005244]",GO:0000122; GO:0000287; GO:0000978; GO:0001046; GO:0001227; GO:0003677; GO:0005244; GO:0005267; GO:0005509; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006813; GO:0006886; GO:0006915; GO:0008076; GO:0015459; GO:0019233; GO:0030424; GO:0030425; GO:0032026; GO:0032993; GO:0043167; GO:0043523; GO:0043565; GO:0043679; GO:0044325; GO:0045892; GO:0048265; GO:0048266; GO:0048306; GO:0072659; GO:0140677; GO:1901379,"LIPID 45; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 46; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9QYK7,reviewed,RNF11_MOUSE,RING finger protein 11 (NEDD4 WW domain-binding protein 2) (Sid 1669),Rnf11 N4wbp2 Sid1669,Mus musculus (Mouse),154,protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],early endosome [GO:0005769]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; ubiquitin ligase complex [GO:0000151],early endosome [GO:0005769]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],GO:0000151; GO:0005634; GO:0005769; GO:0006511; GO:0046872; GO:0051865; GO:0055037; GO:0061630,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250""; LIPID 4; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9WTK7,reviewed,STK11_MOUSE,Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1 homolog) (LKB1) (mLKB1),Stk11 Lkb1,Mus musculus (Mouse),436,activation of protein kinase activity [GO:0032147]; anoikis [GO:0043276]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to UV-B [GO:0071493]; dendrite extension [GO:0097484]; DNA damage response [GO:0006974]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; establishment of cell polarity [GO:0030010]; G1 to G0 transition [GO:0070314]; glucose homeostasis [GO:0042593]; Golgi localization [GO:0051645]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vesicle transport along microtubule [GO:1901610]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of dendrite morphogenesis [GO:0048814]; regulation of protein kinase B signaling [GO:0051896]; regulation of Wnt signaling pathway [GO:0030111]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to ionizing radiation [GO:0010212]; response to lipid [GO:0033993]; response to thyroid hormone [GO:0097066]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; tissue homeostasis [GO:0001894]; vasculature development [GO:0001944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular protein-containing complex [GO:0140535]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; serine/threonine protein kinase complex [GO:1902554]; Z disc [GO:0030018],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular protein-containing complex [GO:0140535]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; serine/threonine protein kinase complex [GO:1902554]; Z disc [GO:0030018]; ATP binding [GO:0005524]; LRR domain binding [GO:0030275]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; activation of protein kinase activity [GO:0032147]; anoikis [GO:0043276]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to UV-B [GO:0071493]; dendrite extension [GO:0097484]; DNA damage response [GO:0006974]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; establishment of cell polarity [GO:0030010]; G1 to G0 transition [GO:0070314]; glucose homeostasis [GO:0042593]; Golgi localization [GO:0051645]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vesicle transport along microtubule [GO:1901610]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of dendrite morphogenesis [GO:0048814]; regulation of protein kinase B signaling [GO:0051896]; regulation of Wnt signaling pathway [GO:0030111]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to ionizing radiation [GO:0010212]; response to lipid [GO:0033993]; response to thyroid hormone [GO:0097066]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; tissue homeostasis [GO:0001894]; vasculature development [GO:0001944],ATP binding [GO:0005524]; LRR domain binding [GO:0030275]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877],GO:0000287; GO:0001558; GO:0001894; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0006470; GO:0006914; GO:0006974; GO:0007165; GO:0007283; GO:0007286; GO:0007409; GO:0008285; GO:0010212; GO:0010508; GO:0014823; GO:0016020; GO:0018107; GO:0030010; GO:0030018; GO:0030111; GO:0030275; GO:0030295; GO:0030308; GO:0030511; GO:0032147; GO:0032991; GO:0033762; GO:0033993; GO:0034504; GO:0042593; GO:0043276; GO:0044877; GO:0045059; GO:0045722; GO:0046777; GO:0048814; GO:0050772; GO:0050852; GO:0051645; GO:0051896; GO:0060767; GO:0060770; GO:0070314; GO:0071493; GO:0072332; GO:0090090; GO:0097066; GO:0097484; GO:0106310; GO:0120163; GO:0140535; GO:1900182; GO:1901610; GO:1902554; GO:1904262,"LIPID 422; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:10642527""; LIPID 433; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000269|PubMed:10642527, ECO:0000269|PubMed:11297520, ECO:0000269|PubMed:11853558"""
Q9WTL7,reviewed,LYPA2_MOUSE,Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase 2) (Lysophospholipase II) (LPL-II) (LysoPLA II) (mLyso II) (Palmitoyl-protein hydrolase) (EC 3.1.2.22),Lypla2,Mus musculus (Mouse),231,acylglycerol catabolic process [GO:0046464]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084],cytoplasm [GO:0005737]; Golgi stack [GO:0005795],cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; acylglycerol catabolic process [GO:0046464]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084],carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474],GO:0002084; GO:0004622; GO:0005737; GO:0005795; GO:0006631; GO:0008474; GO:0046464; GO:0052689; GO:1905344,"LIPID 2; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O95372"""
Q9WUK7,reviewed,OPN3_MOUSE,Opsin-3 (Encephalopsin) (Panopsin),Opn3 Ecpn,Mus musculus (Mouse),400,cellular response to UV-A [GO:0071492]; G protein-coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of melanin biosynthetic process [GO:0048022]; phototransduction [GO:0007602]; positive regulation of cellular respiration [GO:1901857]; positive regulation of glucose import [GO:0046326]; positive regulation of melanin biosynthetic process [GO:0048023]; response to blue light [GO:0009637],cytoplasm [GO:0005737]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; 11-cis retinal binding [GO:0005502]; all-trans retinal binding [GO:0005503]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; cellular response to UV-A [GO:0071492]; G protein-coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of melanin biosynthetic process [GO:0048022]; phototransduction [GO:0007602]; positive regulation of cellular respiration [GO:1901857]; positive regulation of glucose import [GO:0046326]; positive regulation of melanin biosynthetic process [GO:0048023]; response to blue light [GO:0009637],11-cis retinal binding [GO:0005502]; all-trans retinal binding [GO:0005503]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881],GO:0001750; GO:0004930; GO:0005502; GO:0005503; GO:0005737; GO:0005886; GO:0007186; GO:0007602; GO:0009637; GO:0009881; GO:0030216; GO:0043066; GO:0046326; GO:0048022; GO:0048023; GO:0071492; GO:1901857,"LIPID 323; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9Z0E0,reviewed,NCDN_MOUSE,Neurochondrin (M-Sema F-associating protein of 75 kDa) (Norbin),Ncdn Kiaa0607 Sfap75,Mus musculus (Mouse),729,bone resorption [GO:0045453]; neuron projection development [GO:0031175]; regulation of neuronal synaptic plasticity [GO:0048168],cytosol [GO:0005829]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynapse [GO:0098794],cytosol [GO:0005829]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; bone resorption [GO:0045453]; neuron projection development [GO:0031175]; regulation of neuronal synaptic plasticity [GO:0048168],,GO:0005829; GO:0010008; GO:0016020; GO:0030425; GO:0031175; GO:0043005; GO:0043025; GO:0043204; GO:0045453; GO:0048168; GO:0098794,"LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O35095""; LIPID 4; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O35095"""
Q9Z0P4,reviewed,PALM_MOUSE,Paralemmin-1 (Paralemmin),Palm,Mus musculus (Mouse),383,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to electrical stimulus [GO:0071257]; cytoskeleton organization [GO:0007010]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; synapse maturation [GO:0060074],apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; neuron spine [GO:0044309]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; neuron spine [GO:0044309]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; D3 dopamine receptor binding [GO:0031750]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to electrical stimulus [GO:0071257]; cytoskeleton organization [GO:0007010]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; synapse maturation [GO:0060074],D3 dopamine receptor binding [GO:0031750],GO:0005654; GO:0005737; GO:0005886; GO:0007010; GO:0007193; GO:0007194; GO:0008104; GO:0008360; GO:0014069; GO:0016323; GO:0016327; GO:0030175; GO:0030424; GO:0031527; GO:0031750; GO:0032590; GO:0032591; GO:0044309; GO:0051491; GO:0060074; GO:0060160; GO:0060999; GO:0071257; GO:0072659,"LIPID 377; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 379; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 380; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000255"""
Q9Z1B3,reviewed,PLCB1_MOUSE,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1)",Plcb1 Plcb,Mus musculus (Mouse),1216,"activation of meiosis involved in egg activation [GO:0060466]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; erythrocyte differentiation [GO:0030218]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; learning [GO:0007612]; ligand-gated ion channel signaling pathway [GO:1990806]; macrophage differentiation [GO:0030225]; memory [GO:0007613]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monocyte extravasation [GO:2000438]; oocyte maturation [GO:0001556]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 production [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of sodium:proton antiporter activity [GO:0032417]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; release of sequestered calcium ion into cytosol [GO:0051209]; response to monosaccharide [GO:0034284]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; myelin sheath [GO:0043209]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991],"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; myelin sheath [GO:0043209]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; ion channel regulator activity involved in G protein-coupled receptor signaling pathway [GO:0099107]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein serine/threonine kinase activator activity [GO:0043539]; activation of meiosis involved in egg activation [GO:0060466]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; erythrocyte differentiation [GO:0030218]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; learning [GO:0007612]; ligand-gated ion channel signaling pathway [GO:1990806]; macrophage differentiation [GO:0030225]; memory [GO:0007613]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monocyte extravasation [GO:2000438]; oocyte maturation [GO:0001556]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 production [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of sodium:proton antiporter activity [GO:0032417]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; release of sequestered calcium ion into cytosol [GO:0051209]; response to monosaccharide [GO:0034284]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]","calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; ion channel regulator activity involved in G protein-coupled receptor signaling pathway [GO:0099107]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein serine/threonine kinase activator activity [GO:0043539]",GO:0000086; GO:0000785; GO:0001556; GO:0004435; GO:0005096; GO:0005246; GO:0005509; GO:0005516; GO:0005521; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006397; GO:0007155; GO:0007165; GO:0007200; GO:0007207; GO:0007213; GO:0007215; GO:0007420; GO:0007612; GO:0007613; GO:0008277; GO:0008286; GO:0016020; GO:0016607; GO:0019899; GO:0021987; GO:0030218; GO:0030225; GO:0031161; GO:0031965; GO:0032024; GO:0032417; GO:0032735; GO:0032957; GO:0032991; GO:0034284; GO:0035722; GO:0035723; GO:0040019; GO:0042802; GO:0043209; GO:0043434; GO:0043539; GO:0045444; GO:0045663; GO:0045892; GO:0045893; GO:0046330; GO:0046488; GO:0048009; GO:0048015; GO:0048639; GO:0051209; GO:0060466; GO:0070498; GO:0080154; GO:0098978; GO:0098982; GO:0099103; GO:0099105; GO:0099107; GO:0099170; GO:0099178; GO:0099524; GO:1900087; GO:1902618; GO:1903140; GO:1904117; GO:1904637; GO:1905631; GO:1990806; GO:2000344; GO:2000438; GO:2000560,"LIPID 17; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:27653213"""
Q9Z239,reviewed,PLM_MOUSE,Phospholemman (FXYD domain-containing ion transport regulator 1) (Sodium/potassium-transporting ATPase subunit FXYD1),Fxyd1 Plm,Mus musculus (Mouse),92,negative regulation of protein glutathionylation [GO:0010734]; positive regulation of inorganic anion transmembrane transport [GO:1903797]; positive regulation of organic acid transport [GO:0032892]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion transport [GO:0006813]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; caveola [GO:0005901]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315],apical plasma membrane [GO:0016324]; caveola [GO:0005901]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315]; ATPase binding [GO:0051117]; myosin binding [GO:0017022]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; negative regulation of protein glutathionylation [GO:0010734]; positive regulation of inorganic anion transmembrane transport [GO:1903797]; positive regulation of organic acid transport [GO:0032892]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion transport [GO:0006813]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; sodium ion transport [GO:0006814],ATPase binding [GO:0051117]; myosin binding [GO:0017022]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325],GO:0005886; GO:0005890; GO:0005901; GO:0006813; GO:0006814; GO:0010734; GO:0014704; GO:0016324; GO:0017022; GO:0017080; GO:0030315; GO:0032892; GO:0042383; GO:0044325; GO:0051117; GO:0051480; GO:0086004; GO:0086036; GO:1903278; GO:1903797; GO:2000649,"LIPID 60; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O00168""; LIPID 62; /note=""S-palmitoyl cysteine; alternate""; /evidence=""ECO:0000250|UniProtKB:O00168"""
Q9Z280,reviewed,PLD1_MOUSE,Phospholipase D1 (PLD 1) (mPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1),Pld1,Mus musculus (Mouse),1074,defense response to Gram-positive bacterium [GO:0050830]; inositol lipid-mediated signaling [GO:0048017]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; phospholipid catabolic process [GO:0009395]; positive regulation of cell migration [GO:0030335]; positive regulation of translation [GO:0045727]; regulation of microvillus assembly [GO:0032534]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of vesicle-mediated transport [GO:0060627]; response to peptide hormone [GO:0043434],apical plasma membrane [GO:0016324]; cholinergic synapse [GO:0098981]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; vesicle [GO:0031982],apical plasma membrane [GO:0016324]; cholinergic synapse [GO:0098981]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; vesicle [GO:0031982]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; defense response to Gram-positive bacterium [GO:0050830]; inositol lipid-mediated signaling [GO:0048017]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; phospholipid catabolic process [GO:0009395]; positive regulation of cell migration [GO:0030335]; positive regulation of translation [GO:0045727]; regulation of microvillus assembly [GO:0032534]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of vesicle-mediated transport [GO:0060627]; response to peptide hormone [GO:0043434],N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630],GO:0000139; GO:0004630; GO:0005768; GO:0005789; GO:0005794; GO:0006654; GO:0008654; GO:0009395; GO:0016324; GO:0030027; GO:0030139; GO:0030335; GO:0031902; GO:0031982; GO:0031985; GO:0032534; GO:0035091; GO:0043231; GO:0043434; GO:0045202; GO:0045727; GO:0048017; GO:0048471; GO:0050830; GO:0060627; GO:0070290; GO:0098693; GO:0098981,"LIPID 240; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 241; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9Z2W8,reviewed,GRIA4_MOUSE,"Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4)",Gria4 Glur4,Mus musculus (Mouse),902,"chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; synaptic transmission, glutamatergic [GO:0035249]",AMPA glutamate receptor complex [GO:0032281]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; kainate selective glutamate receptor complex [GO:0032983]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; synapse [GO:0045202]; terminal bouton [GO:0043195],"AMPA glutamate receptor complex [GO:0032281]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; kainate selective glutamate receptor complex [GO:0032983]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; synapse [GO:0045202]; terminal bouton [GO:0043195]; AMPA glutamate receptor activity [GO:0004971]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; synaptic transmission, glutamatergic [GO:0035249]",AMPA glutamate receptor activity [GO:0004971]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0004970; GO:0004971; GO:0005886; GO:0007268; GO:0014069; GO:0030425; GO:0032281; GO:0032983; GO:0034392; GO:0035249; GO:0042802; GO:0043025; GO:0043195; GO:0043197; GO:0045202; GO:0048787; GO:0050804; GO:0051968; GO:0098839; GO:0098978; GO:0099507; GO:1904315,"LIPID 611; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 837; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:16129400"""
Q9Z2W9,reviewed,GRIA3_MOUSE,"Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3) (GluA3)",Gria3 Glur3 Kiaa4184,Mus musculus (Mouse),888,"modulation of chemical synaptic transmission [GO:0050804]; regulation of receptor recycling [GO:0001919]; synaptic transmission, glutamatergic [GO:0035249]",AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195],"AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; regulation of receptor recycling [GO:0001919]; synaptic transmission, glutamatergic [GO:0035249]",AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005886; GO:0014069; GO:0016020; GO:0030165; GO:0030425; GO:0032279; GO:0032281; GO:0032991; GO:0035249; GO:0042734; GO:0043025; GO:0043083; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0048787; GO:0050804; GO:0098688; GO:0098839; GO:0098978; GO:0099507; GO:1904315,"LIPID 615; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 841; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000269|PubMed:16129400"""
B2RQA1,reviewed,KCA10_MOUSE,Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8),Kcna10,Mus musculus (Mouse),511,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of monoatomic ion transmembrane transport [GO:0034765],plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076],plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of monoatomic ion transmembrane transport [GO:0034765],delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249],GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0034765; GO:0051260; GO:0071805,"LIPID 293; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q09470"""
O08899,reviewed,RGS4_MOUSE,Regulator of G-protein signaling 4 (RGS4),Rgs4,Mus musculus (Mouse),205,G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart rate [GO:0010460]; regulation of actin filament organization [GO:0110053]; regulation of calcium ion transport [GO:0051924]; regulation of potassium ion transmembrane transport [GO:1901379],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; protein kinase binding [GO:0019901]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart rate [GO:0010460]; regulation of actin filament organization [GO:0110053]; regulation of calcium ion transport [GO:0051924]; regulation of potassium ion transmembrane transport [GO:1901379],G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; protein kinase binding [GO:0019901],GO:0001965; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0010460; GO:0016020; GO:0019901; GO:0032991; GO:0043547; GO:0045744; GO:0051924; GO:0060160; GO:0061052; GO:0110053; GO:1900924; GO:1901379; GO:1901380; GO:2000463,"LIPID 2; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 12; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 95; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
O35566,reviewed,CD151_MOUSE,CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (CD antigen CD151),Cd151 Peta3,Mus musculus (Mouse),253,"cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]",basement membrane [GO:0005604]; cell surface [GO:0009986]; membrane [GO:0016020],"basement membrane [GO:0005604]; cell surface [GO:0009986]; membrane [GO:0016020]; integrin binding [GO:0005178]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]",integrin binding [GO:0005178],GO:0005178; GO:0005604; GO:0009986; GO:0016020; GO:0016477; GO:0030335; GO:0042098; GO:0044319; GO:0045807,"LIPID 11; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P48509""; LIPID 15; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P48509""; LIPID 242; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P48509""; LIPID 243; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:P48509"""
O88853,reviewed,GALR3_MOUSE,Galanin receptor type 3 (GAL3-R) (GALR-3),Galr3 Galnr3,Mus musculus (Mouse),370,"adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; galanin-activated signaling pathway [GO:0090663]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; positive regulation of transcription by RNA polymerase II [GO:0045944]",cilium [GO:0005929]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],"cilium [GO:0005929]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; galanin receptor activity [GO:0004966]; peptide hormone binding [GO:0017046]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; galanin-activated signaling pathway [GO:0090663]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; positive regulation of transcription by RNA polymerase II [GO:0045944]",galanin receptor activity [GO:0004966]; peptide hormone binding [GO:0017046],GO:0004966; GO:0005886; GO:0005929; GO:0007187; GO:0007188; GO:0007194; GO:0007218; GO:0017046; GO:0045944; GO:0090663; GO:0097730,"LIPID 308; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P21841,reviewed,PSPC_MOUSE,Pulmonary surfactant-associated protein C (SP-C) (Pulmonary surfactant-associated proteolipid SPL(Val)) (SP5),Sftpc Sftp2,Mus musculus (Mouse),193,respiratory gaseous exchange by respiratory system [GO:0007585],alveolar lamellar body [GO:0097208]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; multivesicular body [GO:0005771],alveolar lamellar body [GO:0097208]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; multivesicular body [GO:0005771]; identical protein binding [GO:0042802]; respiratory gaseous exchange by respiratory system [GO:0007585],identical protein binding [GO:0042802],GO:0005576; GO:0005615; GO:0005737; GO:0005771; GO:0007585; GO:0042802; GO:0097208,"LIPID 28; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 29; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P35412,reviewed,GPR12_MOUSE,G-protein coupled receptor 12 (GPCR01),Gpr12 Gpcr12,Mus musculus (Mouse),334,G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874],G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210],GO:0004930; GO:0005886; GO:0006874; GO:0007186; GO:0031210,"LIPID 317; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P35413,reviewed,GPR3_MOUSE,G-protein coupled receptor 3 (GPCR21),Gpr3 Gpcr3,Mus musculus (Mouse),330,positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of meiotic nuclear division [GO:0040020],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of meiotic nuclear division [GO:0040020],G protein-coupled receptor activity [GO:0004930],GO:0004930; GO:0005886; GO:0040020; GO:0043950; GO:0051480; GO:0120162,"LIPID 313; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P49660,reviewed,SSR4_MOUSE,Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R),Sstr4 Smstr4,Mus musculus (Mouse),385,cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; somatostatin receptor activity [GO:0004994]; cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],somatostatin receptor activity [GO:0004994],GO:0004994; GO:0005737; GO:0005886; GO:0007218; GO:0016477; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072,"LIPID 324; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P50283,reviewed,CD7_MOUSE,T-cell antigen CD7 (CD antigen CD7),Cd7,Mus musculus (Mouse),210,adaptive immune response [GO:0002250]; homeostasis of number of cells within a tissue [GO:0048873],membrane [GO:0016020],membrane [GO:0016020]; signaling receptor activity [GO:0038023]; adaptive immune response [GO:0002250]; homeostasis of number of cells within a tissue [GO:0048873],signaling receptor activity [GO:0038023],GO:0002250; GO:0016020; GO:0038023; GO:0048873,"LIPID 168; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P56479,reviewed,GALR1_MOUSE,Galanin receptor type 1 (GAL1-R) (GALR-1),Galr1 Galnr Galnr1,Mus musculus (Mouse),348,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transcription by RNA polymerase II [GO:0045944],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transcription by RNA polymerase II [GO:0045944],G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046],GO:0004966; GO:0005886; GO:0007186; GO:0007189; GO:0007194; GO:0007204; GO:0007218; GO:0008528; GO:0017046; GO:0042923; GO:0045944; GO:0051464,"LIPID 319; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P58196,reviewed,PLS4_MOUSE,Phospholipid scramblase 4 (PL scramblase 4) (Ca(2+)-dependent phospholipid scramblase 4),Plscr4,Mus musculus (Mouse),326,cellular response to lipopolysaccharide [GO:0071222]; plasma membrane phospholipid scrambling [GO:0017121],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; CD4 receptor binding [GO:0042609]; enzyme binding [GO:0019899]; phospholipid scramblase activity [GO:0017128]; cellular response to lipopolysaccharide [GO:0071222]; plasma membrane phospholipid scrambling [GO:0017121],CD4 receptor binding [GO:0042609]; enzyme binding [GO:0019899]; phospholipid scramblase activity [GO:0017128],GO:0005886; GO:0017121; GO:0017128; GO:0019899; GO:0042609; GO:0071222,"LIPID 193; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162""; LIPID 194; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162""; LIPID 195; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162""; LIPID 197; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162""; LIPID 198; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O15162"""
Q17ST2,reviewed,KCNA7_MOUSE,Potassium voltage-gated channel subfamily A member 7 (Voltage-gated potassium channel subunit Kv1.7),Kcna7 Kcnc7,Mus musculus (Mouse),489,potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of monoatomic ion transmembrane transport [GO:0034765],voltage-gated potassium channel complex [GO:0008076],voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of monoatomic ion transmembrane transport [GO:0034765],delayed rectifier potassium channel activity [GO:0005251],GO:0005251; GO:0008076; GO:0034765; GO:0051260; GO:0071805,"LIPID 264; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q61041,reviewed,NPY4R_MOUSE,Neuropeptide Y receptor type 4 (NPY4-R) (NPYR-D) (Pancreatic polypeptide receptor 1) (PP1),Npy4r Ppyr1,Mus musculus (Mouse),375,G protein-coupled receptor signaling pathway [GO:0007186],neuron projection [GO:0043005]; plasma membrane [GO:0005886],neuron projection [GO:0043005]; plasma membrane [GO:0005886]; neuropeptide binding [GO:0042923]; pancreatic polypeptide receptor activity [GO:0001602]; peptide binding [GO:0042277]; peptide YY receptor activity [GO:0001601]; G protein-coupled receptor signaling pathway [GO:0007186],neuropeptide binding [GO:0042923]; pancreatic polypeptide receptor activity [GO:0001602]; peptide binding [GO:0042277]; peptide YY receptor activity [GO:0001601],GO:0001601; GO:0001602; GO:0005886; GO:0007186; GO:0042277; GO:0042923; GO:0043005,"LIPID 340; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q61212,reviewed,NPY6R_MOUSE,Neuropeptide Y receptor type 6 (NPY6-R) (Pancreatic polypeptide receptor 2) (PP2),Npy6r Npy5r Ppyr2 Y2b,Mus musculus (Mouse),371,,neuron projection [GO:0043005]; plasma membrane [GO:0005886],neuron projection [GO:0043005]; plasma membrane [GO:0005886]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601],neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601],GO:0001601; GO:0004983; GO:0005886; GO:0008188; GO:0042923; GO:0043005,"LIPID 336; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q61923,reviewed,KCNA6_MOUSE,Potassium voltage-gated channel subfamily A member 6 (MK1.6) (Voltage-gated potassium channel subunit Kv1.6),Kcna6,Mus musculus (Mouse),529,potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of monoatomic ion transmembrane transport [GO:0034765],axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076],axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of monoatomic ion transmembrane transport [GO:0034765],delayed rectifier potassium channel activity [GO:0005251],GO:0005251; GO:0005829; GO:0005886; GO:0008076; GO:0030424; GO:0034705; GO:0034765; GO:0043231; GO:0043679; GO:0051260; GO:0071805,"LIPID 285; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q6YNI2,reviewed,GPR6_MOUSE,G-protein coupled receptor 6 (Sphingosine 1-phosphate receptor GPR6),Gpr6 Gm233,Mus musculus (Mouse),363,positive regulation of cytosolic calcium ion concentration [GO:0007204],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; sphingosine-1-phosphate receptor activity [GO:0038036]; positive regulation of cytosolic calcium ion concentration [GO:0007204],sphingosine-1-phosphate receptor activity [GO:0038036],GO:0005886; GO:0007204; GO:0038036,"LIPID 346; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q8BL86,reviewed,MBLC2_MOUSE,Acyl-coenzyme A thioesterase MBLAC2 (Acyl-CoA thioesterase MBLAC2) (EC 3.1.2.2) (Beta-lactamase MBLAC2) (EC 3.5.2.6) (Metallo-beta-lactamase domain-containing protein 2) (Palmitoyl-coenzyme A thioesterase MBLAC2),Mblac2,Mus musculus (Mouse),279,fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; beta-lactamase activity [GO:0008800]; metal ion binding [GO:0046872]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; fatty acid metabolic process [GO:0006631],beta-lactamase activity [GO:0008800]; metal ion binding [GO:0046872]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290],GO:0005789; GO:0005886; GO:0006631; GO:0008800; GO:0016290; GO:0046872; GO:0102991,"LIPID 254; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q68D91"""
Q8BMC0,reviewed,LPAR6_MOUSE,Lysophosphatidic acid receptor 6 (LPA receptor 6) (LPA-6) (Oleoyl-L-alpha-lysophosphatidic acid receptor) (P2Y purinoceptor 5) (P2Y5) (Purinergic receptor 5),Lpar6 P2ry5 P2y5,Mus musculus (Mouse),344,blastocyst hatching [GO:0001835]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; lysophosphatidic acid receptor activity [GO:0070915]; blastocyst hatching [GO:0001835]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025],lysophosphatidic acid receptor activity [GO:0070915],GO:0001835; GO:0005886; GO:0035025; GO:0051482; GO:0070915,"LIPID 284; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q8CHX7,reviewed,RFTN2_MOUSE,Raftlin-2 (Raft-linking protein 2),Rftn2,Mus musculus (Mouse),500,dsRNA transport [GO:0033227]; response to exogenous dsRNA [GO:0043330],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; dsRNA transport [GO:0033227]; response to exogenous dsRNA [GO:0043330],,GO:0005886; GO:0033227; GO:0043330,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q8VHP8,reviewed,RB40B_MOUSE,Ras-related protein Rab-40B (SOCS box-containing protein RAR),Rab40b,Mus musculus (Mouse),278,intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]; toxin transport [GO:1901998],cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021],cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]; toxin transport [GO:1901998],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003924; GO:0005525; GO:0005635; GO:0005737; GO:0005739; GO:0005768; GO:0005794; GO:0005811; GO:0005886; GO:0008021; GO:0016567; GO:0035556; GO:0048471; GO:0072659; GO:1901998,"LIPID 270; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 275; /note=""S-geranylgeranyl cysteine""; /evidence=""ECO:0000250"""
Q8VHQ4,reviewed,RB40C_MOUSE,Ras-related protein Rab-40C (SOCS box-containing protein RAR3),Rab40c,Mus musculus (Mouse),281,intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005811; GO:0005886; GO:0008021; GO:0016567; GO:0019003; GO:0035556; GO:0048471; GO:0072659,"LIPID 273; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 278; /note=""S-geranylgeranyl cysteine""; /evidence=""ECO:0000250"""
Q8VHV1,reviewed,BAALC_MOUSE,Brain and acute leukemia cytoplasmic protein,Baalc,Mus musculus (Mouse),145,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; sarcoplasm [GO:0016528],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; sarcoplasm [GO:0016528],,GO:0005654; GO:0005737; GO:0005829; GO:0014069; GO:0016528; GO:0043005; GO:0045121,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000250|UniProtKB:Q920K5""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q920K5"""
Q91X05,reviewed,PODO_MOUSE,Podocin,Nphs2,Mus musculus (Mouse),385,actin cytoskeleton reorganization [GO:0031532]; metanephric podocyte development [GO:0072249],cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057],cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; actin cytoskeleton reorganization [GO:0031532]; metanephric podocyte development [GO:0072249],,GO:0005886; GO:0005911; GO:0009898; GO:0031532; GO:0032991; GO:0036057; GO:0045121; GO:0072249,"LIPID 103; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q91X56,reviewed,S1PR5_MOUSE,Sphingosine 1-phosphate receptor 5 (S1P receptor 5) (S1P5) (Endothelial differentiation G-protein-coupled receptor 8) (Lysophospholipid receptor B4) (Sphingosine 1-phosphate receptor Edg-8) (S1P receptor Edg-8),S1pr5 Edg8 Lpb4,Mus musculus (Mouse),400,G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron differentiation [GO:0045664],membrane [GO:0016020]; plasma membrane [GO:0005886],membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sphingosine-1-phosphate receptor activity [GO:0038036]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron differentiation [GO:0045664],G protein-coupled receptor activity [GO:0004930]; sphingosine-1-phosphate receptor activity [GO:0038036],GO:0004930; GO:0005886; GO:0007186; GO:0016020; GO:0038036; GO:0045664,"LIPID 324; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q923M0,reviewed,PP16A_MOUSE,Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase targeting subunit 3),Ppp1r16a Mypt3,Mus musculus (Mouse),524,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020],enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020],GO:0004857; GO:0005737; GO:0005829; GO:0005886; GO:0017020,"LIPID 520; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305""; LIPID 521; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000305|PubMed:11336659"""
Q9CPU4,reviewed,MGST3_MOUSE,"Glutathione S-transferase 3, mitochondrial (EC 2.5.1.-) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (LTC4 synthase MGST3) (EC 4.4.1.20)",Mgst3,Mus musculus (Mouse),153,leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629],glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464],GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0016020; GO:0019370; GO:0042802; GO:0043231,"LIPID 151; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O14880"""
Q9CQE5,reviewed,RGS10_MOUSE,Regulator of G-protein signaling 10 (RGS10),Rgs10,Mus musculus (Mouse),181,G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to amphetamine [GO:0001975],axon terminus [GO:0043679]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],axon terminus [GO:0043679]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to amphetamine [GO:0001975],G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096],GO:0001965; GO:0001975; GO:0005096; GO:0005634; GO:0005654; GO:0005829; GO:0007213; GO:0008277; GO:0009968; GO:0016604; GO:0043025; GO:0043197; GO:0043547; GO:0043679,"LIPID 74; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:O43665"""
Q9CQS8,reviewed,SC61B_MOUSE,Protein transport protein Sec61 subunit beta,Sec61b,Mus musculus (Mouse),96,"post-translational protein targeting to membrane, translocation [GO:0031204]; retrograde protein transport, ER to cytosol [GO:0030970]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; ubiquitin-dependent ERAD pathway [GO:0030433]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784],"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784]; epidermal growth factor binding [GO:0048408]; ribosome binding [GO:0043022]; post-translational protein targeting to membrane, translocation [GO:0031204]; retrograde protein transport, ER to cytosol [GO:0030970]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; ubiquitin-dependent ERAD pathway [GO:0030433]",epidermal growth factor binding [GO:0048408]; ribosome binding [GO:0043022],GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0016020; GO:0030433; GO:0030970; GO:0031204; GO:0043022; GO:0044322; GO:0048408,"LIPID 39; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9Z0L1,reviewed,S1PR4_MOUSE,Sphingosine 1-phosphate receptor 4 (S1P receptor 4) (S1P4) (Endothelial differentiation G-protein coupled receptor 6) (Lysophospholipid receptor C1) (Sphingosine 1-phosphate receptor Edg-6) (S1P receptor Edg-6),S1pr4 Edg6 Lpc1 S1p4,Mus musculus (Mouse),386,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189],mitochondrion [GO:0005739]; plasma membrane [GO:0005886],mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sphingosine-1-phosphate receptor activity [GO:0038036]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189],G protein-coupled receptor activity [GO:0004930]; sphingosine-1-phosphate receptor activity [GO:0038036],GO:0004930; GO:0005739; GO:0005886; GO:0007189; GO:0038036,"LIPID 325; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
A2TJV2,reviewed,PALM3_MOUSE,Paralemmin-3,Palm3,Mus musculus (Mouse),734,negative regulation of cytokine-mediated signaling pathway [GO:0001960]; regulation of cell shape [GO:0008360]; response to lipopolysaccharide [GO:0032496]; Toll signaling pathway [GO:0008063],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; regulation of cell shape [GO:0008360]; response to lipopolysaccharide [GO:0032496]; Toll signaling pathway [GO:0008063],ATP binding [GO:0005524],GO:0001960; GO:0005524; GO:0005737; GO:0005886; GO:0008063; GO:0008360; GO:0032496,"LIPID 728; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 730; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 731; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000250"""
O54798,reviewed,BRS3_MOUSE,Bombesin receptor subtype-3 (BRS-3),Brs3,Mus musculus (Mouse),399,G protein-coupled receptor signaling pathway [GO:0007186],neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; bombesin receptor activity [GO:0004946]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186],bombesin receptor activity [GO:0004946]; neuropeptide receptor activity [GO:0008188],GO:0004946; GO:0005886; GO:0007186; GO:0008188; GO:0043005; GO:0043025,"LIPID 347; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
P41149,reviewed,MC5R_MOUSE,Melanocortin receptor 5 (MC5-R),Mc5r,Mus musculus (Mouse),325,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189],hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977],GO:0004977; GO:0005886; GO:0007189; GO:0042562,"LIPID 311; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 312; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
P63042,reviewed,STMN4_MOUSE,Stathmin-4 (Stathmin-like protein B3) (RB3),Stmn4,Mus musculus (Mouse),189,microtubule depolymerization [GO:0007019]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110],cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005],cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; microtubule depolymerization [GO:0007019]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110],tubulin binding [GO:0015631],GO:0005737; GO:0005794; GO:0007019; GO:0015631; GO:0030426; GO:0031110; GO:0031175; GO:0043005,"LIPID 20; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 22; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q4KL14,reviewed,TPC3L_MOUSE,Trafficking protein particle complex subunit 3-like protein (TRAPPC3-like protein) (BET3-like protein),Trappc3l Bet3l,Mus musculus (Mouse),181,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891],cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008],cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891],,GO:0005783; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106,"LIPID 68; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q544H9,unreviewed,Q544H9_MOUSE,Protein phosphatase 1 regulatory inhibitor subunit 16B,Ppp1r16b,Mus musculus (Mouse),568,establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066],cell projection [GO:0042995]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],cell projection [GO:0042995]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein phosphatase regulator activity [GO:0019888]; establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066],protein phosphatase regulator activity [GO:0019888],GO:0005886; GO:0014066; GO:0016607; GO:0019888; GO:0035307; GO:0042995; GO:0048471; GO:0061028; GO:1902309; GO:1903589,"LIPID 564; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000256|PIRSR:PIRSR038159-50""; LIPID 565; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000256|PIRSR:PIRSR038159-50"""
Q64326,reviewed,ACTHR_MOUSE,Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R),Mc2r Acthr,Mus musculus (Mouse),296,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; placenta development [GO:0001890],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; corticotropin receptor activity [GO:0004978]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; placenta development [GO:0001890],corticotropin receptor activity [GO:0004978],GO:0001890; GO:0004978; GO:0005737; GO:0005886; GO:0007189,"LIPID 293; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255"""
Q8BGH7,reviewed,C42S2_MOUSE,CDC42 small effector protein 2,Cdc42se2,Mus musculus (Mouse),84,phagocytosis [GO:0006909]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of signal transduction [GO:0009966],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; signaling adaptor activity [GO:0035591]; small GTPase binding [GO:0031267]; phagocytosis [GO:0006909]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of signal transduction [GO:0009966],signaling adaptor activity [GO:0035591]; small GTPase binding [GO:0031267],GO:0001891; GO:0005737; GO:0005856; GO:0005886; GO:0006909; GO:0008360; GO:0009966; GO:0031267; GO:0035023; GO:0035591; GO:0042995,"LIPID 10; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 11; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q8BHL7,reviewed,C42S1_MOUSE,CDC42 small effector protein 1,Cdc42se1,Mus musculus (Mouse),80,negative regulation of JNK cascade [GO:0046329]; phagocytosis [GO:0006909]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264],cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886],cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; small GTPase binding [GO:0031267]; negative regulation of JNK cascade [GO:0046329]; phagocytosis [GO:0006909]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264],small GTPase binding [GO:0031267],GO:0005856; GO:0005886; GO:0005938; GO:0006909; GO:0007264; GO:0008360; GO:0030054; GO:0031267; GO:0035023; GO:0046329,"LIPID 10; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 11; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q8BR26,reviewed,IFM10_MOUSE,Interferon-induced transmembrane protein 10 (Dispanin subfamily A member 3) (DSPA3),Ifitm10,Mus musculus (Mouse),201,,plasma membrane [GO:0005886],plasma membrane [GO:0005886],,GO:0005886,"LIPID 140; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 141; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q8VDU1,reviewed,RHOV_MOUSE,Rho-related GTP-binding protein RhoV,Rhov,Mus musculus (Mouse),236,actin cytoskeleton organization [GO:0030036]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; signal transduction [GO:0007165],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; signal transduction [GO:0007165],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0003924; GO:0005525; GO:0005886; GO:0006897; GO:0007163; GO:0007165; GO:0010008; GO:0030036; GO:0032488; GO:0046872,"LIPID 234; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250|UniProtKB:Q9Z1Y0"""
Q91W53,reviewed,GOGA7_MOUSE,Golgin subfamily A member 7,Golga7 MNCb-1213,Mus musculus (Mouse),137,Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612],Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; palmitoyltransferase complex [GO:0002178],Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; palmitoyltransferase complex [GO:0002178]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612],,GO:0000139; GO:0002178; GO:0005795; GO:0006612; GO:0006893; GO:0018230; GO:0043001; GO:0050821,"LIPID 69; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 72; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9D428,reviewed,GOG7B_MOUSE,Golgin subfamily A member 7B,GOLGA7B,Mus musculus (Mouse),167,peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612],Golgi membrane [GO:0000139]; palmitoyltransferase complex [GO:0002178]; plasma membrane [GO:0005886],Golgi membrane [GO:0000139]; palmitoyltransferase complex [GO:0002178]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612],enzyme binding [GO:0019899],GO:0000139; GO:0002178; GO:0005886; GO:0006612; GO:0018230; GO:0019899,"LIPID 78; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250""; LIPID 81; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q3TB53,unreviewed,Q3TB53_MOUSE,Uncharacterized protein,Ppp1r16a,Mus musculus (Mouse),524,,plasma membrane [GO:0005886],plasma membrane [GO:0005886]; protein phosphatase regulator activity [GO:0019888],protein phosphatase regulator activity [GO:0019888],GO:0005886; GO:0019888,"LIPID 520; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000256|PIRSR:PIRSR038159-50""; LIPID 521; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000256|PIRSR:PIRSR038159-50"""
Q8BR92,reviewed,PALM2_MOUSE,Paralemmin-2,Palm2,Mus musculus (Mouse),376,regulation of cell shape [GO:0008360],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; regulation of cell shape [GO:0008360],,GO:0005886; GO:0008360,"LIPID 370; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 372; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000255""; LIPID 373; /note=""S-farnesyl cysteine""; /evidence=""ECO:0000255"""
Q9CPS8,reviewed,SMAKA_MOUSE,Small membrane A-kinase anchor protein (Small membrane AKAP) (smAKAP),,Mus musculus (Mouse),106,,plasma membrane [GO:0005886],plasma membrane [GO:0005886]; protein kinase A regulatory subunit binding [GO:0034237],protein kinase A regulatory subunit binding [GO:0034237],GO:0005886; GO:0034237,"LIPID 2; /note=""N-myristoyl glycine""; /evidence=""ECO:0000255""; LIPID 3; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000250"""
Q9Z2M6,reviewed,UBL3_MOUSE,Ubiquitin-like protein 3 (Membrane-anchored ubiquitin-fold protein) (MUB) (MmMUB) (Protein HCG-1),Ubl3,Mus musculus (Mouse),117,,plasma membrane [GO:0005886],plasma membrane [GO:0005886],,GO:0005886,"LIPID 113; /note=""S-palmitoyl cysteine""; /evidence=""ECO:0000305|PubMed:16831869""; LIPID 114; /note=""S-geranylgeranyl cysteine""; /evidence=""ECO:0000305|PubMed:16831869"""